id	sid	tid	token	lemma	pos
ihlr-16572	1	1	follow	follow	VERB
ihlr-16572	1	2	-	-	PUNCT
ihlr-16572	1	3	on	on	ADP
ihlr-16572	1	4	biologics	biologic	NOUN
ihlr-16572	1	5	legislation	legislation	NOUN
ihlr-16572	1	6	:	:	PUNCT
ihlr-16572	1	7	striking	strike	VERB
ihlr-16572	1	8	a	a	DET
ihlr-16572	1	9	balance	balance	NOUN
ihlr-16572	1	10	between	between	ADP
ihlr-16572	1	11	innovation	innovation	NOUN
ihlr-16572	1	12	and	and	CCONJ
ihlr-16572	1	13	affordability	affordability	NOUN
ihlr-16572	1	14	brian	brian	PROPN
ihlr-16572	1	15	r	r	PROPN
ihlr-16572	1	16	bouggy	bouggy	PROPN
ihlr-16572	1	17	•	•	NUM
ihlr-16572	1	18	i.	i.	NOUN
ihlr-16572	1	19	introduction	introduction	NOUN
ihlr-16572	1	20	......	......	PUNCT
ihlr-16572	2	1	•	•	NUM
ihlr-16572	2	2	..............	..............	SYM
ihlr-16572	2	3	•	•	NUM
ihlr-16572	2	4	......	......	SYM
ihlr-16572	2	5	•	•	NUM
ihlr-16572	2	6	......	......	SYM
ihlr-16572	2	7	•	•	NUM
ihlr-16572	2	8	......	......	SYM
ihlr-16572	2	9	•	•	NOUN
ihlr-16572	2	10	..	..	PUNCT
ihlr-16572	2	11	•	•	NUM
ihlr-16572	2	12	...	...	SYM
ihlr-16572	2	13	•	•	NUM
ihlr-16572	2	14	.......	.......	SYM
ihlr-16572	2	15	•	•	NOUN
ihlr-16572	2	16	............	............	SYM
ihlr-16572	2	17	•.•	•.•	NOUN
ihlr-16572	2	18	...	...	PUNCT
ihlr-16572	2	19	•	•	NUM
ihlr-16572	2	20	..	..	PUNCT
ihlr-16572	2	21	368	368	NUM
ihlr-16572	2	22	ii	ii	NOUN
ihlr-16572	2	23	.	.	PUNCT
ihlr-16572	3	1	background	background	PROPN
ihlr-16572	3	2	..............	..............	PUNCT
ihlr-16572	4	1	•	•	X
ihlr-16572	4	2	......	......	SYM
ihlr-16572	4	3	•	•	NUM
ihlr-16572	4	4	....	....	SYM
ihlr-16572	4	5	•	•	NUM
ihlr-16572	4	6	..	..	PUNCT
ihlr-16572	4	7	•	•	NUM
ihlr-16572	4	8	......	......	SYM
ihlr-16572	4	9	•	•	NOUN
ihlr-16572	4	10	......	......	SYM
ihlr-16572	4	11	••	••	NOUN
ihlr-16572	4	12	...	...	PUNCT
ihlr-16572	4	13	•.•	•.•	NOUN
ihlr-16572	4	14	......	......	SYM
ihlr-16572	4	15	••	••	NOUN
ihlr-16572	4	16	..........	..........	SYM
ihlr-16572	4	17	•	•	NUM
ihlr-16572	4	18	..........	..........	SYM
ihlr-16572	4	19	372	372	NUM
ihlr-16572	4	20	a.	a.	NOUN
ihlr-16572	4	21	biologics	biologic	NOUN
ihlr-16572	4	22	..................................................................................	..................................................................................	PUNCT
ihlr-16572	5	1	372	372	NUM
ihlr-16572	5	2	b.	b.	PROPN
ihlr-16572	5	3	health	health	PROPN
ihlr-16572	5	4	care	care	NOUN
ihlr-16572	5	5	expenditures	expenditure	NOUN
ihlr-16572	5	6	associated	associate	VERB
ihlr-16572	5	7	with	with	ADP
ihlr-16572	5	8	biologics	biologic	NOUN
ihlr-16572	5	9	.............	.............	PUNCT
ihlr-16572	5	10	373	373	NUM
ihlr-16572	5	11	c.	c.	NOUN
ihlr-16572	5	12	competing	compete	VERB
ihlr-16572	5	13	views	view	NOUN
ihlr-16572	5	14	regarding	regard	VERB
ihlr-16572	5	15	follow	follow	NOUN
ihlr-16572	5	16	-	-	PUNCT
ihlr-16572	5	17	on	on	ADP
ihlr-16572	5	18	biologics	biologic	NOUN
ihlr-16572	5	19	.....................	.....................	PUNCT
ihlr-16572	5	20	374	374	NUM
ihlr-16572	5	21	d.	d.	NOUN
ihlr-16572	5	22	degrees	degree	NOUN
ihlr-16572	5	23	of	of	ADP
ihlr-16572	5	24	exclusivity	exclusivity	NOUN
ihlr-16572	5	25	granted	grant	VERB
ihlr-16572	5	26	to	to	ADP
ihlr-16572	5	27	innovators	innovator	NOUN
ihlr-16572	5	28	by	by	ADP
ihlr-16572	5	29	generic	generic	ADJ
ihlr-16572	5	30	legislation	legislation	NOUN
ihlr-16572	5	31	...............................................................................	...............................................................................	PUNCT
ihlr-16572	5	32	378	378	NUM
ihlr-16572	5	33	1	1	NUM
ihlr-16572	5	34	.	.	PUNCT
ihlr-16572	5	35	genera	genera	NOUN
ihlr-16572	5	36	/	/	SYM
ihlr-16572	5	37	agreement	agreement	NOUN
ihlr-16572	5	38	on	on	ADP
ihlr-16572	5	39	tariffs	tariff	NOUN
ihlr-16572	5	40	and	and	CCONJ
ihlr-16572	5	41	trade	trade	NOUN
ihlr-16572	5	42	(	(	PUNCT
ihlr-16572	5	43	ga1	ga1	NOUN
ihlr-16572	5	44	t	t	PROPN
ihlr-16572	5	45	)	)	PUNCT
ihlr-16572	5	46	............	............	PUNCT
ihlr-16572	6	1	380	380	NUM
ihlr-16572	6	2	2	2	NUM
ihlr-16572	6	3	.	.	PUNCT
ihlr-16572	7	1	the	the	DET
ihlr-16572	7	2	inhibitory	inhibitory	ADJ
ihlr-16572	7	3	effect	effect	NOUN
ihlr-16572	7	4	of	of	ADP
ihlr-16572	7	5	exclusivity	exclusivity	NOUN
ihlr-16572	7	6	provisions	provision	NOUN
ihlr-16572	7	7	on	on	ADP
ihlr-16572	7	8	innovation	innovation	NOUN
ihlr-16572	7	9	..........................................................................	..........................................................................	PUNCT
ihlr-16572	7	10	381	381	NUM
ihlr-16572	7	11	3	3	NUM
ihlr-16572	7	12	.	.	PUNCT
ihlr-16572	7	13	access	access	NOUN
ihlr-16572	7	14	distortion	distortion	NOUN
ihlr-16572	7	15	...............................................................	...............................................................	PUNCT
ihlr-16572	7	16	382	382	NUM
ihlr-16572	7	17	4	4	NUM
ihlr-16572	7	18	.	.	PUNCT
ihlr-16572	7	19	hatch	hatch	NOUN
ihlr-16572	7	20	-	-	PUNCT
ihlr-16572	7	21	waxman	waxman	PROPN
ihlr-16572	7	22	actvery	actvery	PROPN
ihlr-16572	7	23	limited	limited	PROPN
ihlr-16572	7	24	exclusivity	exclusivity	NOUN
ihlr-16572	7	25	...................	...................	PUNCT
ihlr-16572	7	26	383	383	NUM
ihlr-16572	7	27	a.	a.	NOUN
ihlr-16572	7	28	potential	potential	ADJ
ihlr-16572	7	29	savings	saving	NOUN
ihlr-16572	7	30	associated	associate	VERB
ihlr-16572	7	31	with	with	ADP
ihlr-16572	7	32	follow	follow	NOUN
ihlr-16572	7	33	-	-	PUNCT
ihlr-16572	7	34	on	on	ADP
ihlr-16572	7	35	biologics	biologic	NOUN
ihlr-16572	7	36	......................................................................	......................................................................	PUNCT
ihlr-16572	8	1	383	383	NUM
ihlr-16572	8	2	b	b	NOUN
ihlr-16572	8	3	hatch	hatch	NOUN
ihlr-16572	8	4	-	-	PUNCT
ihlr-16572	8	5	waxman	waxman	NOUN
ihlr-16572	8	6	's	's	PART
ihlr-16572	8	7	effect	effect	NOUN
ihlr-16572	8	8	on	on	ADP
ihlr-16572	8	9	follow	follow	VERB
ihlr-16572	8	10	-	-	PUNCT
ihlr-16572	8	11	on	on	ADP
ihlr-16572	8	12	biologics	biologic	NOUN
ihlr-16572	8	13	..........	..........	PUNCT
ihlr-16572	9	1	384	384	NUM
ihlr-16572	9	2	e.	e.	PROPN
ihlr-16572	9	3	proposed	propose	VERB
ihlr-16572	9	4	legislation	legislation	NOUN
ihlr-16572	9	5	...............................................................	...............................................................	PUNCT
ihlr-16572	9	6	385	385	NUM
ihlr-16572	9	7	f.	f.	PROPN
ihlr-16572	9	8	shorter	short	ADJ
ihlr-16572	9	9	exclusivity	exclusivity	NOUN
ihlr-16572	9	10	periods	period	NOUN
ihlr-16572	9	11	may	may	AUX
ihlr-16572	9	12	actually	actually	ADV
ihlr-16572	9	13	promote	promote	VERB
ihlr-16572	9	14	innovation	innovation	NOUN
ihlr-16572	9	15	.	.	PUNCT
ihlr-16572	10	1	...............................................................................	...............................................................................	PUNCT
ihlr-16572	11	1	387	387	NUM
ihlr-16572	11	2	1	1	NUM
ihlr-16572	11	3	.	.	PUNCT
ihlr-16572	12	1	the	the	DET
ihlr-16572	12	2	generic	generic	PROPN
ihlr-16572	12	3	pharmaceutical	pharmaceutical	PROPN
ihlr-16572	12	4	association	association	NOUN
ihlr-16572	12	5	's	's	PART
ihlr-16572	12	6	response	response	NOUN
ihlr-16572	12	7	to	to	ADP
ihlr-16572	12	8	the	the	DET
ihlr-16572	12	9	kotlikoff	kotlikoff	NOUN
ihlr-16572	12	10	study	study	NOUN
ihlr-16572	12	11	:	:	PUNCT
ihlr-16572	12	12	..................................................................	..................................................................	PUNCT
ihlr-16572	12	13	388	388	NUM
ihlr-16572	12	14	iii	iii	NOUN
ihlr-16572	12	15	.	.	PUNCT
ihlr-16572	13	1	analysis	analysis	NOUN
ihlr-16572	13	2	:	:	PUNCT
ihlr-16572	13	3	modified	modify	VERB
ihlr-16572	13	4	version	version	NOUN
ihlr-16572	13	5	of	of	ADP
ihlr-16572	13	6	hatch	hatch	NOUN
ihlr-16572	13	7	-	-	PUNCT
ihlr-16572	13	8	waxman	waxman	NOUN
ihlr-16572	13	9	applicable	applicable	ADJ
ihlr-16572	13	10	to	to	ADP
ihlr-16572	13	11	biologics	biologic	NOUN
ihlr-16572	13	12	.................................................................................	.................................................................................	PUNCT
ihlr-16572	13	13	390	390	NUM
ihlr-16572	13	14	a.	a.	NOUN
ihlr-16572	13	15	downfalls	downfall	NOUN
ihlr-16572	13	16	of	of	ADP
ihlr-16572	13	17	proposed	propose	VERB
ihlr-16572	13	18	biogenerics	biogeneric	NOUN
ihlr-16572	13	19	bills	bill	NOUN
ihlr-16572	13	20	..................................	..................................	PUNCT
ihlr-16572	13	21	390	390	NUM
ihlr-16572	13	22	1	1	NUM
ihlr-16572	13	23	.	.	PUNCT
ihlr-16572	13	24	cost	cost	NOUN
ihlr-16572	13	25	/	/	SYM
ihlr-16572	13	26	risk	risk	NOUN
ihlr-16572	13	27	justification	justification	NOUN
ihlr-16572	13	28	argument	argument	NOUN
ihlr-16572	13	29	........................................	........................................	PUNCT
ihlr-16572	13	30	391	391	NUM
ihlr-16572	13	31	b.	b.	NOUN
ihlr-16572	14	1	the	the	DET
ihlr-16572	14	2	hatch	hatch	PROPN
ihlr-16572	14	3	-	-	PUNCT
ihlr-16572	14	4	waxman	waxman	PROPN
ihlr-16572	14	5	act	act	NOUN
ihlr-16572	14	6	should	should	AUX
ihlr-16572	14	7	be	be	AUX
ihlr-16572	14	8	used	use	VERB
ihlr-16572	14	9	as	as	ADP
ihlr-16572	14	10	a	a	DET
ihlr-16572	14	11	template	template	NOUN
ihlr-16572	14	12	for	for	ADP
ihlr-16572	14	13	generic	generic	ADJ
ihlr-16572	14	14	biologics	biologic	NOUN
ihlr-16572	14	15	legislation	legislation	NOUN
ihlr-16572	14	16	..................................................	..................................................	PUNCT
ihlr-16572	15	1	391	391	NUM
ihlr-16572	15	2	c.	c.	PROPN
ihlr-16572	15	3	congress	congress	PROPN
ihlr-16572	15	4	should	should	AUX
ihlr-16572	15	5	assess	assess	VERB
ihlr-16572	15	6	the	the	DET
ihlr-16572	15	7	arguments	argument	NOUN
ihlr-16572	15	8	from	from	ADP
ihlr-16572	15	9	these	these	DET
ihlr-16572	15	10	two	two	NUM
ihlr-16572	15	11	inherently	inherently	ADV
ihlr-16572	15	12	biased	biased	ADJ
ihlr-16572	15	13	groups	group	NOUN
ihlr-16572	15	14	with	with	ADP
ihlr-16572	15	15	a	a	DET
ihlr-16572	15	16	focus	focus	NOUN
ihlr-16572	15	17	on	on	ADP
ihlr-16572	15	18	our	our	PRON
ihlr-16572	15	19	country	country	NOUN
ihlr-16572	15	20	's	's	PART
ihlr-16572	15	21	biotech	biotech	ADJ
ihlr-16572	15	22	consumers	consumer	NOUN
ihlr-16572	15	23	..................................................................	..................................................................	PUNCT
ihlr-16572	15	24	392	392	NUM
ihlr-16572	15	25	d.	d.	PROPN
ihlr-16572	15	26	biogeneric	biogeneric	PROPN
ihlr-16572	15	27	legislation	legislation	PROPN
ihlr-16572	15	28	as	as	ADP
ihlr-16572	15	29	a	a	DET
ihlr-16572	15	30	catalyst	catalyst	NOUN
ihlr-16572	15	31	for	for	ADP
ihlr-16572	15	32	innovation	innovation	NOUN
ihlr-16572	15	33	.	.	PUNCT
ihlr-16572	16	1	................	................	PUNCT
ihlr-16572	17	1	394	394	NUM
ihlr-16572	17	2	e.	e.	PROPN
ihlr-16572	17	3	economic	economic	ADJ
ihlr-16572	17	4	/	/	SYM
ihlr-16572	17	5	welfare	welfare	NOUN
ihlr-16572	17	6	implications	implication	NOUN
ihlr-16572	17	7	...............................................	...............................................	PUNCT
ihlr-16572	17	8	394	394	NUM
ihlr-16572	17	9	f.	f.	NOUN
ihlr-16572	17	10	exclusivity	exclusivity	NOUN
ihlr-16572	17	11	provisions	provision	NOUN
ihlr-16572	17	12	should	should	AUX
ihlr-16572	17	13	allow	allow	VERB
ihlr-16572	17	14	for	for	ADP
ihlr-16572	17	15	abbreviated	abbreviate	VERB
ihlr-16572	17	16	periods	period	NOUN
ihlr-16572	17	17	of	of	ADP
ihlr-16572	17	18	monopoly	monopoly	NOUN
ihlr-16572	17	19	protection	protection	NOUN
ihlr-16572	17	20	.	.	PUNCT
ihlr-16572	18	1	...............................................................	...............................................................	PUNCT
ihlr-16572	19	1	395	395	NUM
ihlr-16572	19	2	n.	n.	NOUN
ihlr-16572	19	3	conclusion	conclusion	NOUN
ihlr-16572	19	4	..................................................................................	..................................................................................	PUNCT
ihlr-16572	19	5	396	396	NUM
ihlr-16572	19	6	•	•	NUM
ihlr-16572	19	7	j.d	j.d	PROPN
ihlr-16572	19	8	.	.	PROPN
ihlr-16572	19	9	,	,	PUNCT
ihlr-16572	19	10	2010	2010	NUM
ihlr-16572	19	11	,	,	PUNCT
ihlr-16572	19	12	indiana	indiana	PROPN
ihlr-16572	19	13	university	university	PROPN
ihlr-16572	19	14	school	school	NOUN
ihlr-16572	19	15	of	of	ADP
ihlr-16572	19	16	lawindianapolis	lawindianapolis	PROPN
ihlr-16572	19	17	;	;	PUNCT
ihlr-16572	19	18	b.s	b.s	PROPN
ihlr-16572	19	19	.	.	PROPN
ihlr-16572	19	20	,	,	PUNCT
ihlr-16572	19	21	2007	2007	NUM
ihlr-16572	19	22	,	,	PUNCT
ihlr-16572	19	23	purdue	purdue	PROPN
ihlr-16572	19	24	university	university	NOUN
ihlr-16572	19	25	.	.	PUNCT
ihlr-16572	20	1	368	368	NUM
ihlr-16572	20	2	indiana	indiana	PROPN
ihlr-16572	20	3	health	health	PROPN
ihlr-16572	20	4	law	law	PROPN
ihlr-16572	20	5	review	review	NOUN
ihlr-16572	20	6	[	[	X
ihlr-16572	20	7	vol	vol	NOUN
ihlr-16572	20	8	.	.	PUNCT
ihlr-16572	21	1	7:367	7:367	NUM
ihlr-16572	21	2	i.	i.	NOUN
ihlr-16572	21	3	introduction	introduction	NOUN
ihlr-16572	21	4	recent	recent	ADJ
ihlr-16572	21	5	scientific	scientific	ADJ
ihlr-16572	21	6	advances	advance	NOUN
ihlr-16572	21	7	have	have	AUX
ihlr-16572	21	8	resulted	result	VERB
ihlr-16572	21	9	in	in	ADP
ihlr-16572	21	10	new	new	ADJ
ihlr-16572	21	11	drugs	drug	NOUN
ihlr-16572	21	12	and	and	CCONJ
ihlr-16572	21	13	biological	biological	ADJ
ihlr-16572	21	14	compounds	compound	NOUN
ihlr-16572	21	15	which	which	PRON
ihlr-16572	21	16	provide	provide	VERB
ihlr-16572	21	17	incredible	incredible	ADJ
ihlr-16572	21	18	life	life	NOUN
ihlr-16572	21	19	-	-	PUNCT
ihlr-16572	21	20	saving	save	VERB
ihlr-16572	21	21	potential	potential	NOUN
ihlr-16572	21	22	,	,	PUNCT
ihlr-16572	21	23	but	but	CCONJ
ihlr-16572	21	24	come	come	VERB
ihlr-16572	21	25	with	with	ADP
ihlr-16572	21	26	a	a	DET
ihlr-16572	21	27	high	high	ADJ
ihlr-16572	21	28	price	price	NOUN
ihlr-16572	21	29	tag	tag	NOUN
ihlr-16572	21	30	.	.	PUNCT
ihlr-16572	22	1	1	1	NUM
ihlr-16572	22	2	biologics	biologic	NOUN
ihlr-16572	22	3	,	,	PUNCT
ihlr-16572	22	4	such	such	ADJ
ihlr-16572	22	5	as	as	ADP
ihlr-16572	22	6	insulin	insulin	NOUN
ihlr-16572	22	7	and	and	CCONJ
ihlr-16572	22	8	various	various	ADJ
ihlr-16572	22	9	cancer	cancer	NOUN
ihlr-16572	22	10	drugs	drug	NOUN
ihlr-16572	22	11	,	,	PUNCT
ihlr-16572	22	12	pro­	pro­	NOUN
ihlr-16572	22	13	duced	duce	VERB
ihlr-16572	22	14	by	by	ADP
ihlr-16572	22	15	extracting	extract	VERB
ihlr-16572	22	16	cellular	cellular	ADJ
ihlr-16572	22	17	proteins	protein	NOUN
ihlr-16572	22	18	from	from	ADP
ihlr-16572	22	19	animals	animal	NOUN
ihlr-16572	22	20	,	,	PUNCT
ihlr-16572	22	21	are	be	AUX
ihlr-16572	22	22	changing	change	VERB
ihlr-16572	22	23	the	the	DET
ihlr-16572	22	24	land­	land­	ADJ
ihlr-16572	22	25	scape	scape	NOUN
ihlr-16572	22	26	of	of	ADP
ihlr-16572	22	27	modem	modem	ADJ
ihlr-16572	22	28	medicine	medicine	NOUN
ihlr-16572	22	29	.	.	PUNCT
ihlr-16572	23	1	there	there	PRON
ihlr-16572	23	2	exists	exist	VERB
ihlr-16572	23	3	remarkable	remarkable	ADJ
ihlr-16572	23	4	potential	potential	NOUN
ihlr-16572	23	5	for	for	ADP
ihlr-16572	23	6	the	the	DET
ihlr-16572	23	7	discovery	discovery	NOUN
ihlr-16572	23	8	of	of	ADP
ihlr-16572	23	9	new	new	ADJ
ihlr-16572	23	10	life	life	NOUN
ihlr-16572	23	11	-	-	PUNCT
ihlr-16572	23	12	saving	save	VERB
ihlr-16572	23	13	biologics	biologic	NOUN
ihlr-16572	23	14	,	,	PUNCT
ihlr-16572	23	15	but	but	CCONJ
ihlr-16572	23	16	the	the	DET
ihlr-16572	23	17	consumer	consumer	NOUN
ihlr-16572	23	18	too	too	ADV
ihlr-16572	23	19	often	often	ADV
ihlr-16572	23	20	bears	bear	VERB
ihlr-16572	23	21	the	the	DET
ihlr-16572	23	22	high	high	ADJ
ihlr-16572	23	23	cost	cost	NOUN
ihlr-16572	23	24	of	of	ADP
ihlr-16572	23	25	access	access	NOUN
ihlr-16572	23	26	to	to	ADP
ihlr-16572	23	27	these	these	DET
ihlr-16572	23	28	revolutionary	revolutionary	ADJ
ihlr-16572	23	29	treatments	treatment	NOUN
ihlr-16572	23	30	.	.	PUNCT
ihlr-16572	24	1	on	on	ADP
ihlr-16572	24	2	average	average	ADJ
ihlr-16572	24	3	,	,	PUNCT
ihlr-16572	24	4	biologics	biologic	NOUN
ihlr-16572	24	5	cost	cost	VERB
ihlr-16572	24	6	twenty	twenty	NUM
ihlr-16572	24	7	-	-	PUNCT
ihlr-16572	24	8	two	two	NUM
ihlr-16572	24	9	times	time	NOUN
ihlr-16572	24	10	more	more	ADJ
ihlr-16572	24	11	per	per	ADP
ihlr-16572	24	12	daily	daily	ADJ
ihlr-16572	24	13	dose	dose	NOUN
ihlr-16572	24	14	than	than	ADP
ihlr-16572	24	15	chemical	chemical	NOUN
ihlr-16572	24	16	medications	medication	NOUN
ihlr-16572	24	17	?	?	PUNCT
ihlr-16572	25	1	many	many	ADJ
ihlr-16572	25	2	biologic	biologic	ADJ
ihlr-16572	25	3	cancer	cancer	NOUN
ihlr-16572	25	4	treatments	treatment	NOUN
ihlr-16572	25	5	cost	cost	VERB
ihlr-16572	25	6	over	over	ADP
ihlr-16572	25	7	$	$	SYM
ihlr-16572	25	8	100,000	100,000	NUM
ihlr-16572	25	9	a	a	DET
ihlr-16572	25	10	year.3	year.3	NOUN
ihlr-16572	25	11	in	in	ADP
ihlr-16572	25	12	the	the	DET
ihlr-16572	25	13	united	united	PROPN
ihlr-16572	25	14	states	states	PROPN
ihlr-16572	25	15	,	,	PUNCT
ihlr-16572	25	16	spending	spend	VERB
ihlr-16572	25	17	on	on	ADP
ihlr-16572	25	18	biologics	biologic	NOUN
ihlr-16572	25	19	has	have	AUX
ihlr-16572	25	20	increased	increase	VERB
ihlr-16572	25	21	approximately	approximately	ADV
ihlr-16572	25	22	fifteen	fifteen	NUM
ihlr-16572	25	23	to	to	PART
ihlr-16572	25	24	twenty	twenty	NUM
ihlr-16572	25	25	percent	percent	NOUN
ihlr-16572	25	26	annually	annually	ADV
ihlr-16572	25	27	,	,	PUNCT
ihlr-16572	25	28	and	and	CCONJ
ihlr-16572	25	29	exceeded	exceed	VERB
ihlr-16572	25	30	$	$	SYM
ihlr-16572	25	31	40	40	NUM
ihlr-16572	25	32	billion	billion	NUM
ihlr-16572	25	33	in	in	ADP
ihlr-16572	25	34	2006.4	2006.4	NUM
ihlr-16572	25	35	this	this	DET
ihlr-16572	25	36	note	note	NOUN
ihlr-16572	25	37	will	will	AUX
ihlr-16572	25	38	de­	de­	AUX
ihlr-16572	25	39	scribe	scribe	VERB
ihlr-16572	25	40	the	the	DET
ihlr-16572	25	41	barriers	barrier	NOUN
ihlr-16572	25	42	generic	generic	ADJ
ihlr-16572	25	43	drug	drug	NOUN
ihlr-16572	25	44	makers	maker	NOUN
ihlr-16572	25	45	face	face	VERB
ihlr-16572	25	46	when	when	SCONJ
ihlr-16572	25	47	seeking	seek	VERB
ihlr-16572	25	48	approval	approval	NOUN
ihlr-16572	25	49	of	of	ADP
ihlr-16572	25	50	ge­	ge­	PROPN
ihlr-16572	25	51	neric	neric	ADJ
ihlr-16572	25	52	biologics	biologic	NOUN
ihlr-16572	25	53	.	.	PUNCT
ihlr-16572	26	1	it	it	PRON
ihlr-16572	26	2	will	will	AUX
ihlr-16572	26	3	then	then	ADV
ihlr-16572	26	4	assess	assess	VERB
ihlr-16572	26	5	the	the	DET
ihlr-16572	26	6	meritorious	meritorious	ADJ
ihlr-16572	26	7	arguments	argument	NOUN
ihlr-16572	26	8	of	of	ADP
ihlr-16572	26	9	each	each	DET
ihlr-16572	26	10	side	side	NOUN
ihlr-16572	26	11	of	of	ADP
ihlr-16572	26	12	this	this	DET
ihlr-16572	26	13	hotly	hotly	ADV
ihlr-16572	26	14	debated	debate	VERB
ihlr-16572	26	15	issue	issue	NOUN
ihlr-16572	26	16	.	.	PUNCT
ihlr-16572	27	1	finally	finally	ADV
ihlr-16572	27	2	,	,	PUNCT
ihlr-16572	27	3	this	this	DET
ihlr-16572	27	4	note	note	NOUN
ihlr-16572	27	5	will	will	AUX
ihlr-16572	27	6	describe	describe	VERB
ihlr-16572	27	7	how	how	SCONJ
ihlr-16572	27	8	a	a	DET
ihlr-16572	27	9	balance	balance	NOUN
ihlr-16572	27	10	should	should	AUX
ihlr-16572	27	11	be	be	AUX
ihlr-16572	27	12	struck	strike	VERB
ihlr-16572	27	13	by	by	ADP
ihlr-16572	27	14	lawmakers	lawmaker	NOUN
ihlr-16572	27	15	implementing	implement	VERB
ihlr-16572	27	16	new	new	ADJ
ihlr-16572	27	17	legislation	legislation	NOUN
ihlr-16572	27	18	to	to	PART
ihlr-16572	27	19	reduce	reduce	VERB
ihlr-16572	27	20	ris­	ris­	NOUN
ihlr-16572	27	21	ing	ing	ADJ
ihlr-16572	27	22	medical	medical	ADJ
ihlr-16572	27	23	costs	cost	NOUN
ihlr-16572	27	24	by	by	ADP
ihlr-16572	27	25	permitting	permit	VERB
ihlr-16572	27	26	the	the	DET
ihlr-16572	27	27	marketing	marketing	NOUN
ihlr-16572	27	28	of	of	ADP
ihlr-16572	27	29	generic	generic	ADJ
ihlr-16572	27	30	biologics	biologic	NOUN
ihlr-16572	27	31	,	,	PUNCT
ihlr-16572	27	32	while	while	SCONJ
ihlr-16572	27	33	maintaining	maintain	VERB
ihlr-16572	27	34	these	these	DET
ihlr-16572	27	35	drugs	drug	NOUN
ihlr-16572	27	36	'	'	PART
ihlr-16572	27	37	initial	initial	ADJ
ihlr-16572	27	38	profitability	profitability	NOUN
ihlr-16572	27	39	,	,	PUNCT
ihlr-16572	27	40	which	which	PRON
ihlr-16572	27	41	will	will	AUX
ihlr-16572	27	42	in	in	ADP
ihlr-16572	27	43	turn	turn	NOUN
ihlr-16572	27	44	continue	continue	VERB
ihlr-16572	27	45	to	to	PART
ihlr-16572	27	46	encourage	encourage	VERB
ihlr-16572	27	47	innovation	innovation	NOUN
ihlr-16572	27	48	.	.	PUNCT
ihlr-16572	28	1	biologics	biologic	NOUN
ihlr-16572	28	2	offer	offer	VERB
ihlr-16572	28	3	remarkable	remarkable	ADJ
ihlr-16572	28	4	hope	hope	NOUN
ihlr-16572	28	5	to	to	ADP
ihlr-16572	28	6	those	those	PRON
ihlr-16572	28	7	fortunate	fortunate	ADJ
ihlr-16572	28	8	enough	enough	ADV
ihlr-16572	28	9	to	to	PART
ihlr-16572	28	10	gain	gain	VERB
ihlr-16572	28	11	access	access	NOUN
ihlr-16572	28	12	to	to	ADP
ihlr-16572	28	13	them	they	PRON
ihlr-16572	28	14	.	.	PUNCT
ihlr-16572	29	1	currently	currently	ADV
ihlr-16572	29	2	,	,	PUNCT
ihlr-16572	29	3	compounds	compound	VERB
ihlr-16572	29	4	either	either	CCONJ
ihlr-16572	29	5	being	be	AUX
ihlr-16572	29	6	developed	develop	VERB
ihlr-16572	29	7	,	,	PUNCT
ihlr-16572	29	8	being	be	AUX
ihlr-16572	29	9	tested	test	VERB
ihlr-16572	29	10	or	or	CCONJ
ihlr-16572	29	11	on	on	ADP
ihlr-16572	29	12	the	the	DET
ihlr-16572	29	13	market	market	NOUN
ihlr-16572	29	14	fight	fight	VERB
ihlr-16572	29	15	an	an	DET
ihlr-16572	29	16	array	array	NOUN
ihlr-16572	29	17	of	of	ADP
ihlr-16572	29	18	conditions	condition	NOUN
ihlr-16572	29	19	including	include	VERB
ihlr-16572	29	20	arthritis	arthritis	NOUN
ihlr-16572	29	21	,	,	PUNCT
ihlr-16572	29	22	asthma	asthma	NOUN
ihlr-16572	29	23	,	,	PUNCT
ihlr-16572	29	24	alzheimer	alzheimer	PROPN
ihlr-16572	29	25	's	's	PART
ihlr-16572	29	26	disease	disease	NOUN
ihlr-16572	29	27	,	,	PUNCT
ihlr-16572	29	28	heart	heart	NOUN
ihlr-16572	29	29	disease	disease	NOUN
ihlr-16572	29	30	,	,	PUNCT
ihlr-16572	29	31	crohn	crohn	PROPN
ihlr-16572	29	32	's	's	PART
ihlr-16572	29	33	disease	disease	NOUN
ihlr-16572	29	34	,	,	PUNCT
ihlr-16572	29	35	various	various	ADJ
ihlr-16572	29	36	cancers	cancer	NOUN
ihlr-16572	29	37	,	,	PUNCT
ihlr-16572	29	38	pso­	pso­	NOUN
ihlr-16572	29	39	riasis	riasis	NOUN
ihlr-16572	29	40	,	,	PUNCT
ihlr-16572	29	41	multiple	multiple	ADJ
ihlr-16572	29	42	sclerosis	sclerosis	NOUN
ihlr-16572	29	43	,	,	PUNCT
ihlr-16572	29	44	lou	lou	PROPN
ihlr-16572	29	45	gehrig	gehrig	PROPN
ihlr-16572	29	46	's	's	PART
ihlr-16572	29	47	disease	disease	NOUN
ihlr-16572	29	48	,	,	PUNCT
ihlr-16572	29	49	and	and	CCONJ
ihlr-16572	29	50	aids	aid	NOUN
ihlr-16572	29	51	.	.	PUNCT
ihlr-16572	30	1	5	5	NUM
ihlr-16572	30	2	these	these	PRON
ihlr-16572	30	3	and	and	CCONJ
ihlr-16572	30	4	oth­	oth­	ADJ
ihlr-16572	30	5	er	er	INTJ
ihlr-16572	30	6	serious	serious	ADJ
ihlr-16572	30	7	conditions	condition	NOUN
ihlr-16572	30	8	treated	treat	VERB
ihlr-16572	30	9	by	by	ADP
ihlr-16572	30	10	biologics	biologic	NOUN
ihlr-16572	30	11	account	account	VERB
ihlr-16572	30	12	for	for	ADP
ihlr-16572	30	13	a	a	DET
ihlr-16572	30	14	substantial	substantial	ADJ
ihlr-16572	30	15	portion	portion	NOUN
ihlr-16572	30	16	of	of	ADP
ihlr-16572	30	17	our	our	PRON
ihlr-16572	30	18	nation	nation	NOUN
ihlr-16572	30	19	's	's	PART
ihlr-16572	30	20	health	health	NOUN
ihlr-16572	30	21	problems	problem	NOUN
ihlr-16572	30	22	,	,	PUNCT
ihlr-16572	30	23	and	and	CCONJ
ihlr-16572	30	24	a	a	DET
ihlr-16572	30	25	similarly	similarly	ADV
ihlr-16572	30	26	substantial	substantial	ADJ
ihlr-16572	30	27	portion	portion	NOUN
ihlr-16572	30	28	ofhealth	ofhealth	NOUN
ihlr-16572	30	29	care	care	NOUN
ihlr-16572	30	30	spending	spending	NOUN
ihlr-16572	30	31	.	.	PUNCT
ihlr-16572	31	1	itis	itis	NOUN
ihlr-16572	31	2	paramount	paramount	ADJ
ihlr-16572	31	3	that	that	SCONJ
ihlr-16572	31	4	congress	congress	PROPN
ihlr-16572	31	5	implement	implement	VERB
ihlr-16572	31	6	new	new	ADJ
ihlr-16572	31	7	legislation	legislation	NOUN
ihlr-16572	31	8	in	in	ADP
ihlr-16572	31	9	a	a	DET
ihlr-16572	31	10	manner	manner	NOUN
ihlr-16572	31	11	which	which	PRON
ihlr-16572	31	12	will	will	AUX
ihlr-16572	31	13	promote	promote	VERB
ihlr-16572	31	14	innovation	innovation	NOUN
ihlr-16572	31	15	in	in	ADP
ihlr-16572	31	16	this	this	DET
ihlr-16572	31	17	field	field	NOUN
ihlr-16572	31	18	and	and	CCONJ
ihlr-16572	31	19	maximize	maximize	VERB
ihlr-16572	31	20	the	the	DET
ihlr-16572	31	21	po­	po­	PROPN
ihlr-16572	31	22	tential	tential	ADJ
ihlr-16572	31	23	of	of	ADP
ihlr-16572	31	24	these	these	DET
ihlr-16572	31	25	discoveries	discovery	NOUN
ihlr-16572	31	26	,	,	PUNCT
ihlr-16572	31	27	while	while	SCONJ
ihlr-16572	31	28	simultaneously	simultaneously	ADV
ihlr-16572	31	29	making	make	VERB
ihlr-16572	31	30	biologics	biologic	NOUN
ihlr-16572	31	31	more	more	ADV
ihlr-16572	31	32	affordable	affordable	ADJ
ihlr-16572	31	33	to	to	ADP
ihlr-16572	31	34	the	the	DET
ihlr-16572	31	35	general	general	ADJ
ihlr-16572	31	36	public	public	NOUN
ihlr-16572	31	37	.	.	PUNCT
ihlr-16572	32	1	1	1	X
ihlr-16572	32	2	.	.	X
ihlr-16572	32	3	health	health	NOUN
ihlr-16572	32	4	premium	premium	NOUN
ihlr-16572	32	5	hikes	hike	NOUN
ihlr-16572	32	6	tied	tie	VERB
ihlr-16572	32	7	to	to	ADP
ihlr-16572	32	8	costly	costly	ADJ
ihlr-16572	32	9	specialty	specialty	NOUN
ihlr-16572	32	10	dnlgs	dnlgs	NOUN
ihlr-16572	32	11	,	,	PUNCT
ihlr-16572	32	12	ins	ins	PROPN
ihlr-16572	32	13	.	.	PUNCT
ihlr-16572	33	1	j.	j.	PROPN
ihlr-16572	33	2	,	,	PUNCT
ihlr-16572	33	3	dec	dec	PROPN
ihlr-16572	33	4	.	.	PROPN
ihlr-16572	33	5	6	6	NUM
ihlr-16572	33	6	,	,	PUNCT
ihlr-16572	33	7	2006	2006	NUM
ihlr-16572	33	8	,	,	PUNCT
ihlr-16572	33	9	http://www.insurancejoumal.com/news/east/2006112/06n4723.htm	http://www.insurancejoumal.com/news/east/2006112/06n4723.htm	X
ihlr-16572	33	10	(	(	PUNCT
ihlr-16572	33	11	last	last	ADJ
ihlr-16572	33	12	visited	visit	VERB
ihlr-16572	33	13	oct	oct	PROPN
ihlr-16572	33	14	.	.	PROPN
ihlr-16572	33	15	27	27	NUM
ihlr-16572	33	16	,	,	PUNCT
ihlr-16572	33	17	2009	2009	NUM
ihlr-16572	33	18	)	)	PUNCT
ihlr-16572	33	19	.	.	PUNCT
ihlr-16572	34	1	2	2	X
ihlr-16572	34	2	.	.	X
ihlr-16572	34	3	centers	center	NOUN
ihlr-16572	34	4	for	for	ADP
ihlr-16572	34	5	medicare	medicare	PROPN
ihlr-16572	34	6	and	and	CCONJ
ihlr-16572	34	7	medicaid	medicaid	PROPN
ihlr-16572	34	8	,	,	PUNCT
ihlr-16572	34	9	national	national	ADJ
ihlr-16572	34	10	health	health	NOUN
ihlr-16572	34	11	expenditures	expenditure	NOUN
ihlr-16572	34	12	by	by	ADP
ihlr-16572	34	13	type	type	NOUN
ihlr-16572	34	14	of	of	ADP
ihlr-16572	34	15	service	service	NOUN
ihlr-16572	34	16	and	and	CCONJ
ihlr-16572	34	17	source	source	NOUN
ihlr-16572	34	18	of	of	ADP
ihlr-16572	34	19	funds	fund	NOUN
ihlr-16572	34	20	(	(	PUNCT
ihlr-16572	34	21	2008	2008	NUM
ihlr-16572	34	22	)	)	PUNCT
ihlr-16572	34	23	,	,	PUNCT
ihlr-16572	34	24	http://www.cms.hhs.gov/nationalhealthexpenddata/	http://www.cms.hhs.gov/nationalhealthexpenddata/	NOUN
ihlr-16572	34	25	03	03	NUM
ihlr-16572	35	1	_	_	NOUN
ihlr-16572	35	2	nationalhealthaccountsprojected.asp	nationalhealthaccountsprojected.asp	X
ihlr-16572	35	3	qast	qast	PROPN
ihlr-16572	35	4	visited	visit	VERB
ihlr-16572	35	5	oct	oct	PROPN
ihlr-16572	35	6	.	.	PROPN
ihlr-16572	35	7	29	29	NUM
ihlr-16572	35	8	,	,	PUNCT
ihlr-16572	35	9	2009	2009	NUM
ihlr-16572	35	10	)	)	PUNCT
ihlr-16572	35	11	.	.	PUNCT
ihlr-16572	36	1	3	3	X
ihlr-16572	36	2	.	.	X
ihlr-16572	36	3	health	health	NOUN
ihlr-16572	36	4	premium	premium	NOUN
ihlr-16572	36	5	hikes	hike	NOUN
ihlr-16572	36	6	tied	tie	VERB
ihlr-16572	36	7	to	to	ADP
ihlr-16572	36	8	costly	costly	ADJ
ihlr-16572	36	9	specialty	specialty	NOUN
ihlr-16572	36	10	drugs	drug	NOUN
ihlr-16572	36	11	,	,	PUNCT
ihlr-16572	36	12	supra	supra	NOUN
ihlr-16572	36	13	note	note	NOUN
ihlr-16572	36	14	1	1	NUM
ihlr-16572	36	15	.	.	SYM
ihlr-16572	36	16	4	4	NUM
ihlr-16572	36	17	.	.	X
ihlr-16572	37	1	biologics	biologic	NOUN
ihlr-16572	37	2	price	price	NOUN
ihlr-16572	37	3	competition	competition	NOUN
ihlr-16572	37	4	and	and	CCONJ
ihlr-16572	37	5	innovation	innovation	NOUN
ihlr-16572	37	6	act	act	NOUN
ihlr-16572	37	7	of2007	of2007	PROPN
ihlr-16572	37	8	,	,	PUNCT
ihlr-16572	37	9	s.	s.	PROPN
ihlr-16572	37	10	1695	1695	NUM
ihlr-16572	37	11	,	,	PUNCT
ihlr-16572	37	12	(	(	PUNCT
ihlr-16572	37	13	as	as	SCONJ
ihlr-16572	37	14	reported	report	VERB
ihlr-16572	37	15	by	by	ADP
ihlr-16572	37	16	s.	s.	PROPN
ihlr-16572	37	17	comm	comm	PROPN
ihlr-16572	37	18	.	.	PUNCT
ihlr-16572	38	1	on	on	ADP
ihlr-16572	38	2	health	health	NOUN
ihlr-16572	38	3	,	,	PUNCT
ihlr-16572	38	4	education	education	NOUN
ihlr-16572	38	5	,	,	PUNCT
ihlr-16572	38	6	labor	labor	NOUN
ihlr-16572	38	7	and	and	CCONJ
ihlr-16572	38	8	pensions	pension	NOUN
ihlr-16572	38	9	,	,	PUNCT
ihlr-16572	38	10	jun	jun	PROPN
ihlr-16572	38	11	.	.	PROPN
ihlr-16572	38	12	27	27	NUM
ihlr-16572	38	13	,	,	PUNCT
ihlr-16572	38	14	2007	2007	NUM
ihlr-16572	38	15	)	)	PUNCT
ihlr-16572	38	16	(	(	PUNCT
ihlr-16572	38	17	recognizing	recognize	VERB
ihlr-16572	38	18	this	this	DET
ihlr-16572	38	19	ex­	ex­	NOUN
ihlr-16572	38	20	penditure	penditure	NOUN
ihlr-16572	38	21	is	be	AUX
ihlr-16572	38	22	being	be	AUX
ihlr-16572	38	23	made	make	VERB
ihlr-16572	38	24	primarily	primarily	ADV
ihlr-16572	38	25	via	via	ADP
ihlr-16572	38	26	third	third	ADJ
ihlr-16572	38	27	-	-	PUNCT
ihlr-16572	38	28	party	party	NOUN
ihlr-16572	38	29	insurers	insurer	NOUN
ihlr-16572	38	30	or	or	CCONJ
ihlr-16572	38	31	the	the	DET
ihlr-16572	38	32	government	government	NOUN
ihlr-16572	38	33	)	)	PUNCT
ihlr-16572	38	34	.	.	PUNCT
ihlr-16572	39	1	5	5	X
ihlr-16572	39	2	.	.	X
ihlr-16572	39	3	pharmaceullcal	pharmaceullcal	ADJ
ihlr-16572	39	4	research	research	NOUN
ihlr-16572	39	5	and	and	CCONJ
ihlr-16572	39	6	manufacturers	manufacturer	NOUN
ihlr-16572	39	7	of	of	ADP
ihlr-16572	39	8	america	america	PROPN
ihlr-16572	39	9	(	(	PUNCT
ihlr-16572	39	10	phrma	phrma	PROPN
ihlr-16572	39	11	)	)	PUNCT
ihlr-16572	39	12	,	,	PUNCT
ihlr-16572	39	13	2006	2006	NUM
ihlr-16572	39	14	report	report	NOUN
ihlr-16572	39	15	on	on	ADP
ihlr-16572	39	16	medicines	medicine	NOUN
ihlr-16572	39	17	in	in	ADP
ihlr-16572	39	18	development	development	NOUN
ihlr-16572	39	19	biotechnology	biotechnology	NOUN
ihlr-16572	39	20	:	:	PUNCT
ihlr-16572	39	21	418	418	NUM
ihlr-16572	39	22	biotechnology	biotechnology	NOUN
ihlr-16572	39	23	medicines	medicine	NOUN
ihlr-16572	39	24	in	in	ADP
ihlr-16572	39	25	testing	testing	NOUN
ihlr-16572	39	26	promise	promise	NOUN
ihlr-16572	39	27	to	to	PART
ihlr-16572	39	28	bolster	bolster	VERB
ihlr-16572	39	29	the	the	DET
ihlr-16572	39	30	arsenal	arsenal	NOUN
ihlr-16572	39	31	against	against	ADP
ihlr-16572	39	32	disease	disease	NOUN
ihlr-16572	39	33	1	1	NUM
ihlr-16572	39	34	(	(	PUNCT
ihlr-16572	39	35	2006	2006	NUM
ihlr-16572	39	36	)	)	PUNCT
ihlr-16572	39	37	,	,	PUNCT
ihlr-16572	39	38	available	available	ADJ
ihlr-16572	39	39	at	at	ADP
ihlr-16572	39	40	http://www.phrma.org/files/biotecho/o202006.pdt	http://www.phrma.org/files/biotecho/o202006.pdt	NUM
ihlr-16572	39	41	)	)	PUNCT
ihlr-16572	39	42	(	(	PUNCT
ihlr-16572	39	43	last	last	ADJ
ihlr-16572	39	44	visited	visit	VERB
ihlr-16572	39	45	feb.12	feb.12	NOUN
ihlr-16572	39	46	,	,	PUNCT
ihlr-16572	39	47	2009	2009	NUM
ihlr-16572	39	48	)	)	PUNCT
ihlr-16572	40	1	[	[	X
ihlr-16572	40	2	hereinafter	hereinafter	NOUN
ihlr-16572	40	3	"	"	PUNCT
ihlr-16572	40	4	phrma	phrma	NOUN
ihlr-16572	40	5	report'1	report'1	VERB
ihlr-16572	40	6	.	.	PROPN
ihlr-16572	40	7	2010	2010	NUM
ihlr-16572	40	8	]	]	PUNCT
ihlr-16572	40	9	follow	follow	VERB
ihlr-16572	40	10	-	-	PUNCT
ihlr-16572	40	11	on	on	ADP
ihlr-16572	40	12	biologics	biologic	NOUN
ihlr-16572	40	13	legislation	legislation	NOUN
ihlr-16572	40	14	369	369	NUM
ihlr-16572	40	15	until	until	SCONJ
ihlr-16572	40	16	the	the	DET
ihlr-16572	40	17	recent	recent	ADJ
ihlr-16572	40	18	passage	passage	NOUN
ihlr-16572	40	19	of	of	ADP
ihlr-16572	40	20	the	the	DET
ihlr-16572	40	21	patient	patient	NOUN
ihlr-16572	40	22	protection	protection	NOUN
ihlr-16572	40	23	and	and	CCONJ
ihlr-16572	40	24	affordable	affordable	ADJ
ihlr-16572	40	25	care	care	NOUN
ihlr-16572	40	26	act	act	NOUN
ihlr-16572	40	27	of	of	ADP
ihlr-16572	40	28	2009	2009	NUM
ihlr-16572	40	29	,	,	PUNCT
ihlr-16572	40	30	food	food	NOUN
ihlr-16572	40	31	and	and	CCONJ
ihlr-16572	40	32	drug	drug	PROPN
ihlr-16572	40	33	administration	administration	PROPN
ihlr-16572	40	34	(	(	PUNCT
ihlr-16572	40	35	fda	fda	PROPN
ihlr-16572	40	36	)	)	PUNCT
ihlr-16572	40	37	regulations	regulation	NOUN
ihlr-16572	40	38	precluded	preclude	VERB
ihlr-16572	40	39	the	the	DET
ihlr-16572	40	40	marketing	marketing	NOUN
ihlr-16572	40	41	of	of	ADP
ihlr-16572	40	42	generic	generic	ADJ
ihlr-16572	40	43	forms	form	NOUN
ihlr-16572	40	44	of	of	ADP
ihlr-16572	40	45	biologics	biologic	NOUN
ihlr-16572	40	46	,	,	PUNCT
ihlr-16572	40	47	often	often	ADV
ihlr-16572	40	48	referred	refer	VERB
ihlr-16572	40	49	to	to	ADP
ihlr-16572	40	50	interchangea­	interchangea­	NOUN
ihlr-16572	40	51	bly	bly	ADV
ihlr-16572	40	52	as	as	ADP
ihlr-16572	40	53	biogenerics	biogeneric	NOUN
ihlr-16572	40	54	,	,	PUNCT
ihlr-16572	40	55	biosimilars	biosimilar	NOUN
ihlr-16572	40	56	,	,	PUNCT
ihlr-16572	40	57	or	or	CCONJ
ihlr-16572	40	58	follow	follow	VERB
ihlr-16572	40	59	-	-	PUNCT
ihlr-16572	40	60	on	on	ADP
ihlr-16572	40	61	biologics	biologic	NOUN
ihlr-16572	40	62	.	.	PUNCT
ihlr-16572	41	1	6	6	NUM
ihlr-16572	41	2	the	the	DET
ihlr-16572	41	3	justification	justification	NOUN
ihlr-16572	41	4	for	for	ADP
ihlr-16572	41	5	more	more	ADV
ihlr-16572	41	6	stringent	stringent	ADJ
ihlr-16572	41	7	control	control	NOUN
ihlr-16572	41	8	of	of	ADP
ihlr-16572	41	9	biologics	biologic	NOUN
ihlr-16572	41	10	than	than	ADP
ihlr-16572	41	11	of	of	ADP
ihlr-16572	41	12	chemical	chemical	ADJ
ihlr-16572	41	13	drugs	drug	NOUN
ihlr-16572	41	14	lies	lie	VERB
ihlr-16572	41	15	in	in	ADP
ihlr-16572	41	16	the	the	DET
ihlr-16572	41	17	theory	theory	NOUN
ihlr-16572	41	18	that	that	SCONJ
ihlr-16572	41	19	the	the	DET
ihlr-16572	41	20	complexity	complexity	NOUN
ihlr-16572	41	21	of	of	ADP
ihlr-16572	41	22	biologics	biologic	NOUN
ihlr-16572	41	23	renders	render	VERB
ihlr-16572	41	24	them	they	PRON
ihlr-16572	41	25	less	less	ADV
ihlr-16572	41	26	amenable	amenable	ADJ
ihlr-16572	41	27	to	to	ADP
ihlr-16572	41	28	safe	safe	ADJ
ihlr-16572	41	29	and	and	CCONJ
ihlr-16572	41	30	effective	effective	ADJ
ihlr-16572	41	31	duplication	duplication	NOUN
ihlr-16572	41	32	by	by	ADP
ihlr-16572	41	33	generic	generic	ADJ
ihlr-16572	41	34	manufacturers	manufacturer	NOUN
ihlr-16572	41	35	.	.	PUNCT
ihlr-16572	42	1	7	7	NUM
ihlr-16572	42	2	as	as	SCONJ
ihlr-16572	42	3	the	the	DET
ihlr-16572	42	4	scientific	scientific	ADJ
ihlr-16572	42	5	community	community	NOUN
ihlr-16572	42	6	learns	learn	VERB
ihlr-16572	42	7	more	more	ADJ
ihlr-16572	42	8	about	about	ADP
ihlr-16572	42	9	biologics	biologic	NOUN
ihlr-16572	42	10	,	,	PUNCT
ihlr-16572	42	11	however	however	ADV
ihlr-16572	42	12	,	,	PUNCT
ihlr-16572	42	13	it	it	PRON
ihlr-16572	42	14	appears	appear	VERB
ihlr-16572	42	15	increasingly	increasingly	ADV
ihlr-16572	42	16	likely	likely	ADJ
ihlr-16572	42	17	that	that	SCONJ
ihlr-16572	42	18	many	many	ADJ
ihlr-16572	42	19	of	of	ADP
ihlr-16572	42	20	these	these	DET
ihlr-16572	42	21	drugs	drug	NOUN
ihlr-16572	42	22	can	can	AUX
ihlr-16572	42	23	be	be	AUX
ihlr-16572	42	24	safely	safely	ADV
ihlr-16572	42	25	and	and	CCONJ
ihlr-16572	42	26	effectively	effectively	ADV
ihlr-16572	42	27	duplicated	duplicate	VERB
ihlr-16572	42	28	.	.	PUNCT
ihlr-16572	43	1	at	at	ADP
ihlr-16572	43	2	a	a	DET
ihlr-16572	43	3	time	time	NOUN
ihlr-16572	43	4	when	when	SCONJ
ihlr-16572	43	5	medical	medical	ADJ
ihlr-16572	43	6	costs	cost	NOUN
ihlr-16572	43	7	are	be	AUX
ihlr-16572	43	8	increasing	increase	VERB
ihlr-16572	43	9	at	at	ADP
ihlr-16572	43	10	an	an	DET
ihlr-16572	43	11	alarming	alarming	ADJ
ihlr-16572	43	12	rate	rate	NOUN
ihlr-16572	43	13	,	,	PUNCT
ihlr-16572	43	14	con­	con­	PROPN
ihlr-16572	43	15	gress	gress	NOUN
ihlr-16572	43	16	must	must	AUX
ihlr-16572	43	17	consider	consider	VERB
ihlr-16572	43	18	all	all	DET
ihlr-16572	43	19	viable	viable	ADJ
ihlr-16572	43	20	options	option	NOUN
ihlr-16572	43	21	for	for	ADP
ihlr-16572	43	22	reducing	reduce	VERB
ihlr-16572	43	23	this	this	DET
ihlr-16572	43	24	inefficient	inefficient	ADJ
ihlr-16572	43	25	sector	sector	NOUN
ihlr-16572	43	26	of	of	ADP
ihlr-16572	43	27	our	our	PRON
ihlr-16572	43	28	economy	economy	NOUN
ihlr-16572	43	29	.	.	PUNCT
ihlr-16572	44	1	health	health	NOUN
ihlr-16572	44	2	care	care	NOUN
ihlr-16572	44	3	spending	spending	NOUN
ihlr-16572	44	4	in	in	ADP
ihlr-16572	44	5	the	the	DET
ihlr-16572	44	6	united	united	PROPN
ihlr-16572	44	7	states	states	PROPN
ihlr-16572	44	8	totaled	total	VERB
ihlr-16572	44	9	$	$	SYM
ihlr-16572	44	10	2.4	2.4	NUM
ihlr-16572	44	11	trillion	trillion	NUM
ihlr-16572	44	12	in	in	ADP
ihlr-16572	44	13	2008	2008	NUM
ihlr-16572	44	14	and	and	CCONJ
ihlr-16572	44	15	is	be	AUX
ihlr-16572	44	16	projected	project	VERB
ihlr-16572	44	17	to	to	PART
ihlr-16572	44	18	reach	reach	VERB
ihlr-16572	44	19	$	$	SYM
ihlr-16572	44	20	3.1	3.1	NUM
ihlr-16572	44	21	trillion	trillion	NUM
ihlr-16572	44	22	in	in	ADP
ihlr-16572	44	23	2012	2012	NUM
ihlr-16572	44	24	,	,	PUNCT
ihlr-16572	44	25	and	and	CCONJ
ihlr-16572	44	26	$	$	SYM
ihlr-16572	44	27	4.3	4.3	NUM
ihlr-16572	44	28	trillion	trillion	NUM
ihlr-16572	44	29	in	in	ADP
ihlr-16572	44	30	2017.8	2017.8	NUM
ihlr-16572	44	31	health	health	NOUN
ihlr-16572	44	32	care	care	NOUN
ihlr-16572	44	33	costs	cost	NOUN
ihlr-16572	44	34	accounted	account	VERB
ihlr-16572	44	35	for	for	ADP
ihlr-16572	44	36	approximately	approximately	ADV
ihlr-16572	44	37	seventeen	seventeen	NUM
ihlr-16572	44	38	percent	percent	NOUN
ihlr-16572	44	39	of	of	ADP
ihlr-16572	44	40	our	our	PRON
ihlr-16572	44	41	nation	nation	NOUN
ihlr-16572	44	42	's	's	PART
ihlr-16572	44	43	gross	gross	ADJ
ihlr-16572	44	44	domestic	domestic	ADJ
ihlr-16572	44	45	product	product	NOUN
ihlr-16572	44	46	(	(	PUNCT
ihlr-16572	44	47	gdp	gdp	NOUN
ihlr-16572	44	48	)	)	PUNCT
ihlr-16572	44	49	in	in	ADP
ihlr-16572	44	50	2008	2008	NUM
ihlr-16572	44	51	,	,	PUNCT
ihlr-16572	44	52	and	and	CCONJ
ihlr-16572	44	53	is	be	AUX
ihlr-16572	44	54	projected	project	VERB
ihlr-16572	44	55	to	to	PART
ihlr-16572	44	56	ac­	ac­	PART
ihlr-16572	44	57	count	count	VERB
ihlr-16572	44	58	for	for	ADP
ihlr-16572	44	59	almost	almost	ADV
ihlr-16572	44	60	twenty	twenty	NUM
ihlr-16572	44	61	percent	percent	NOUN
ihlr-16572	44	62	of	of	ADP
ihlr-16572	44	63	our	our	PRON
ihlr-16572	44	64	gop	gop	NOUN
ihlr-16572	44	65	in	in	ADP
ihlr-16572	44	66	2017.9	2017.9	NUM
ihlr-16572	44	67	prescription	prescription	NOUN
ihlr-16572	44	68	costs	cost	NOUN
ihlr-16572	44	69	,	,	PUNCT
ihlr-16572	44	70	particularly	particularly	ADV
ihlr-16572	44	71	for	for	ADP
ihlr-16572	44	72	extremely	extremely	ADV
ihlr-16572	44	73	expensive	expensive	ADJ
ihlr-16572	44	74	biologics	biologic	NOUN
ihlr-16572	44	75	,	,	PUNCT
ihlr-16572	44	76	are	be	AUX
ihlr-16572	44	77	a	a	DET
ihlr-16572	44	78	major	major	ADJ
ihlr-16572	44	79	cause	cause	NOUN
ihlr-16572	44	80	of	of	ADP
ihlr-16572	44	81	rising	rise	VERB
ihlr-16572	44	82	medical	medical	ADJ
ihlr-16572	44	83	expenditures.10	expenditures.10	NOUN
ihlr-16572	44	84	these	these	DET
ihlr-16572	44	85	expenses	expense	NOUN
ihlr-16572	44	86	have	have	VERB
ihlr-16572	44	87	a	a	DET
ihlr-16572	44	88	significant	significant	ADJ
ihlr-16572	44	89	financial	financial	ADJ
ihlr-16572	44	90	impact	impact	NOUN
ihlr-16572	44	91	on	on	ADP
ihlr-16572	44	92	individuals	individual	NOUN
ihlr-16572	44	93	,	,	PUNCT
ihlr-16572	44	94	employers	employer	NOUN
ihlr-16572	44	95	,	,	PUNCT
ihlr-16572	44	96	our	our	PRON
ihlr-16572	44	97	government	government	NOUN
ihlr-16572	44	98	,	,	PUNCT
ihlr-16572	44	99	and	and	CCONJ
ihlr-16572	44	100	the	the	DET
ihlr-16572	44	101	world	world	NOUN
ihlr-16572	44	102	at	at	ADP
ihlr-16572	44	103	large	large	ADJ
ihlr-16572	44	104	.	.	PUNCT
ihlr-16572	45	1	indi­	indi­	ADJ
ihlr-16572	45	2	viduals	vidual	NOUN
ihlr-16572	45	3	faced	face	VERB
ihlr-16572	45	4	with	with	ADP
ihlr-16572	45	5	the	the	DET
ihlr-16572	45	6	life	life	NOUN
ihlr-16572	45	7	-	-	PUNCT
ihlr-16572	45	8	threatening	threaten	VERB
ihlr-16572	45	9	specter	specter	NOUN
ihlr-16572	45	10	of	of	ADP
ihlr-16572	45	11	cancer	cancer	NOUN
ihlr-16572	45	12	may	may	AUX
ihlr-16572	45	13	be	be	AUX
ihlr-16572	45	14	forced	force	VERB
ihlr-16572	45	15	to	to	PART
ihlr-16572	45	16	deplete	deplete	VERB
ihlr-16572	45	17	their	their	PRON
ihlr-16572	45	18	finances	finance	NOUN
ihlr-16572	45	19	to	to	ADP
ihlr-16572	45	20	the	the	DET
ihlr-16572	45	21	point	point	NOUN
ihlr-16572	45	22	of	of	ADP
ihlr-16572	45	23	bankruptcy	bankruptcy	NOUN
ihlr-16572	45	24	in	in	ADP
ihlr-16572	45	25	order	order	NOUN
ihlr-16572	45	26	to	to	PART
ihlr-16572	45	27	receive	receive	VERB
ihlr-16572	45	28	the	the	DET
ihlr-16572	45	29	treatment	treatment	NOUN
ihlr-16572	45	30	recommended	recommend	VERB
ihlr-16572	45	31	by	by	ADP
ihlr-16572	45	32	their	their	PRON
ihlr-16572	45	33	oncologist.11	oncologist.11	PROPN
ihlr-16572	45	34	harvard	harvard	PROPN
ihlr-16572	45	35	university	university	NOUN
ihlr-16572	45	36	researchers	researcher	NOUN
ihlr-16572	45	37	recently	recently	ADV
ihlr-16572	45	38	published	publish	VERB
ihlr-16572	45	39	findings	finding	NOUN
ihlr-16572	45	40	which	which	PRON
ihlr-16572	45	41	suggest	suggest	VERB
ihlr-16572	45	42	the	the	DET
ihlr-16572	45	43	average	average	ADJ
ihlr-16572	45	44	out	out	ADP
ihlr-16572	45	45	-	-	PUNCT
ihlr-16572	45	46	of	of	ADP
ihlr-16572	45	47	-	-	PUNCT
ihlr-16572	45	48	pocket	pocket	NOUN
ihlr-16572	45	49	medical	medical	ADJ
ihlr-16572	45	50	debt	debt	NOUN
ihlr-16572	45	51	for	for	ADP
ihlr-16572	45	52	individuals	individual	NOUN
ihlr-16572	45	53	who	who	PRON
ihlr-16572	45	54	filed	file	VERB
ihlr-16572	45	55	for	for	ADP
ihlr-16572	45	56	bankruptcy	bankruptcy	NOUN
ihlr-16572	45	57	is	be	AUX
ihlr-16572	45	58	$	$	SYM
ihlr-16572	45	59	12,000.12	12,000.12	NUM
ihlr-16572	45	60	approximately	approximately	ADV
ihlr-16572	45	61	seventy	seventy	NUM
ihlr-16572	45	62	-	-	PUNCT
ihlr-16572	45	63	five	five	NUM
ihlr-16572	45	64	percent	percent	NOUN
ihlr-16572	45	65	of	of	ADP
ihlr-16572	45	66	those	those	DET
ihlr-16572	45	67	fil­	fil­	PROPN
ihlr-16572	45	68	ing	ing	NOUN
ihlr-16572	45	69	for	for	ADP
ihlr-16572	45	70	bankruptcy	bankruptcy	NOUN
ihlr-16572	45	71	in	in	ADP
ihlr-16572	45	72	the	the	DET
ihlr-16572	45	73	study	study	NOUN
ihlr-16572	45	74	had	have	VERB
ihlr-16572	45	75	health	health	NOUN
ihlr-16572	45	76	insurance	insurance	NOUN
ihlr-16572	45	77	,	,	PUNCT
ihlr-16572	45	78	and	and	CCONJ
ihlr-16572	45	79	fifty	fifty	NUM
ihlr-16572	45	80	percent	percent	NOUN
ihlr-16572	45	81	of	of	ADP
ihlr-16572	45	82	all	all	DET
ihlr-16572	45	83	bankruptcy	bankruptcy	NOUN
ihlr-16572	45	84	filings	filing	NOUN
ihlr-16572	45	85	were	be	AUX
ihlr-16572	45	86	caused	cause	VERB
ihlr-16572	45	87	,	,	PUNCT
ihlr-16572	45	88	at	at	ADP
ihlr-16572	45	89	least	least	ADJ
ihlr-16572	45	90	in	in	ADP
ihlr-16572	45	91	part	part	NOUN
ihlr-16572	45	92	,	,	PUNCT
ihlr-16572	45	93	by	by	ADP
ihlr-16572	45	94	medical	medical	ADJ
ihlr-16572	45	95	expenses.13	expenses.13	NOUN
ihlr-16572	45	96	the	the	DET
ihlr-16572	45	97	reality	reality	NOUN
ihlr-16572	45	98	of	of	ADP
ihlr-16572	45	99	this	this	DET
ihlr-16572	45	100	problem	problem	NOUN
ihlr-16572	45	101	is	be	AUX
ihlr-16572	45	102	put	put	VERB
ihlr-16572	45	103	into	into	ADP
ihlr-16572	45	104	sobering	sobering	ADJ
ihlr-16572	45	105	perspective	perspective	NOUN
ihlr-16572	45	106	by	by	ADP
ihlr-16572	45	107	the	the	DET
ihlr-16572	45	108	fact	fact	NOUN
ihlr-16572	45	109	that	that	SCONJ
ihlr-16572	45	110	every	every	DET
ihlr-16572	45	111	thirty	thirty	NUM
ihlr-16572	45	112	seconds	second	NOUN
ihlr-16572	45	113	in	in	ADP
ihlr-16572	45	114	the	the	DET
ihlr-16572	45	115	united	united	PROPN
ihlr-16572	45	116	states	states	PROPN
ihlr-16572	45	117	someone	someone	PRON
ihlr-16572	45	118	files	file	VERB
ihlr-16572	45	119	for	for	ADP
ihlr-16572	45	120	bankruptcy	bankruptcy	NOUN
ihlr-16572	45	121	in	in	ADP
ihlr-16572	45	122	the	the	DET
ihlr-16572	45	123	af6	af6	PROPN
ihlr-16572	45	124	.	.	PUNCT
ihlr-16572	46	1	see	see	VERB
ihlr-16572	46	2	federal	federal	ADJ
ihlr-16572	46	3	food	food	NOUN
ihlr-16572	46	4	.	.	PUNCT
ihlr-16572	47	1	drug	drug	NOUN
ihlr-16572	47	2	,	,	PUNCT
ihlr-16572	47	3	and	and	CCONJ
ihlr-16572	47	4	cosmetic	cosmetic	ADJ
ihlr-16572	47	5	act	act	NOUN
ihlr-16572	47	6	,	,	PUNCT
ihlr-16572	47	7	21	21	NUM
ihlr-16572	47	8	u.s.c	u.s.c	ADJ
ihlr-16572	47	9	.	.	PUNCT
ihlr-16572	48	1	§	§	PROPN
ihlr-16572	48	2	301	301	NUM
ihlr-16572	48	3	et	et	PROPN
ihlr-16572	48	4	seq	seq	PROPN
ihlr-16572	48	5	.	.	PUNCT
ihlr-16572	49	1	(	(	PUNCT
ihlr-16572	49	2	1938	1938	NUM
ihlr-16572	49	3	)	)	PUNCT
ihlr-16572	49	4	.	.	PUNCT
ihlr-16572	50	1	7	7	X
ihlr-16572	50	2	.	.	X
ihlr-16572	50	3	letter	letter	NOUN
ihlr-16572	50	4	from	from	ADP
ihlr-16572	50	5	john	john	PROPN
ihlr-16572	50	6	taylor	taylor	PROPN
ihlr-16572	50	7	,	,	PUNCT
ihlr-16572	50	8	executive	executive	ADJ
ihlr-16572	50	9	vice	vice	NOUN
ihlr-16572	50	10	president	president	NOUN
ihlr-16572	50	11	,	,	PUNCT
ihlr-16572	50	12	health	health	NOUN
ihlr-16572	50	13	,	,	PUNCT
ihlr-16572	50	14	biotechnology	biotechnology	NOUN
ihlr-16572	50	15	indus­	indus­	PROPN
ihlr-16572	50	16	try	try	VERB
ihlr-16572	50	17	organization	organization	NOUN
ihlr-16572	50	18	,	,	PUNCT
ihlr-16572	50	19	to	to	ADP
ihlr-16572	50	20	secretary	secretary	NOUN
ihlr-16572	50	21	,	,	PUNCT
ihlr-16572	50	22	federal	federal	ADJ
ihlr-16572	50	23	trade	trade	PROPN
ihlr-16572	50	24	commission	commission	PROPN
ihlr-16572	50	25	(	(	PUNCT
ihlr-16572	50	26	dec	dec	PROPN
ihlr-16572	50	27	.	.	PROPN
ihlr-16572	50	28	22	22	NUM
ihlr-16572	50	29	,	,	PUNCT
ihlr-16572	50	30	2008	2008	NUM
ihlr-16572	50	31	)	)	PUNCT
ihlr-16572	50	32	available	available	ADJ
ihlr-16572	50	33	at	at	ADP
ihlr-16572	50	34	http://www.ftc.gov/os/commentslhealthcarecompissues/537778-00042.pdf	http://www.ftc.gov/os/commentslhealthcarecompissues/537778-00042.pdf	PROPN
ihlr-16572	50	35	(	(	PUNCT
ihlr-16572	50	36	last	last	ADV
ihlr-16572	50	37	visited	visit	VERB
ihlr-16572	50	38	mar	mar	PROPN
ihlr-16572	50	39	.	.	PROPN
ihlr-16572	50	40	6	6	NUM
ihlr-16572	50	41	,	,	PUNCT
ihlr-16572	50	42	2010	2010	NUM
ihlr-16572	50	43	)	)	PUNCT
ihlr-16572	51	1	[	[	X
ihlr-16572	51	2	hereinafter	hereinafter	NOUN
ihlr-16572	51	3	"	"	PUNCT
ihlr-16572	51	4	letter	letter	NOUN
ihlr-16572	51	5	from	from	ADP
ihlr-16572	51	6	john	john	PROPN
ihlr-16572	51	7	taylor	taylor	PROPN
ihlr-16572	51	8	"	"	PUNCT
ihlr-16572	51	9	)	)	PUNCT
ihlr-16572	51	10	.	.	PUNCT
ihlr-16572	52	1	8	8	X
ihlr-16572	52	2	.	.	X
ihlr-16572	52	3	sean	sean	PROPN
ihlr-16572	52	4	keehan	keehan	PROPN
ihlr-16572	52	5	,	,	PUNCT
ihlr-16572	52	6	et	et	PROPN
ihlr-16572	52	7	al	al	PROPN
ihlr-16572	52	8	.	.	PROPN
ihlr-16572	52	9	,	,	PUNCT
ihlr-16572	52	10	health	health	NOUN
ihlr-16572	52	11	spending	spending	NOUN
ihlr-16572	52	12	projection	projection	NOUN
ihlr-16572	52	13	through	through	ADP
ihlr-16572	52	14	2017	2017	NUM
ihlr-16572	52	15	:	:	PUNCT
ihlr-16572	52	16	the	the	DET
ihlr-16572	52	17	baby	baby	NOUN
ihlr-16572	52	18	boom	boom	NOUN
ihlr-16572	52	19	generation	generation	NOUN
ihlr-16572	52	20	is	be	AUX
ihlr-16572	52	21	coming	come	VERB
ihlr-16572	52	22	to	to	ADP
ihlr-16572	52	23	medicare	medicare	PROPN
ihlr-16572	52	24	,	,	PUNCT
ihlr-16572	52	25	2	2	NUM
ihlr-16572	52	26	healm	healm	NOUN
ihlr-16572	52	27	affairs	affair	NOUN
ihlr-16572	52	28	w145,w145	w145,w145	PROPN
ihlr-16572	52	29	(	(	PUNCT
ihlr-16572	52	30	2008	2008	NUM
ihlr-16572	52	31	)	)	PUNCT
ihlr-16572	52	32	,	,	PUNCT
ihlr-16572	52	33	http://content	http://content	PROPN
ihlr-16572	52	34	healthaffairs.org/cgilcontentlabstract/27/2/w145	healthaffairs.org/cgilcontentlabstract/27/2/w145	PROPN
ihlr-16572	52	35	(	(	PUNCT
ihlr-16572	52	36	last	last	ADV
ihlr-16572	52	37	visited	visit	VERB
ihlr-16572	52	38	mar	mar	PROPN
ihlr-16572	52	39	.	.	PROPN
ihlr-16572	52	40	15	15	NUM
ihlr-16572	52	41	,	,	PUNCT
ihlr-16572	52	42	2010	2010	NUM
ihlr-16572	52	43	)	)	PUNCT
ihlr-16572	52	44	.	.	PUNCT
ihlr-16572	53	1	9	9	X
ihlr-16572	53	2	.	.	X
ihlr-16572	53	3	/d	/d	PUNCT
ihlr-16572	53	4	.	.	PUNCT
ihlr-16572	53	5	10	10	NUM
ihlr-16572	53	6	.	.	PUNCT
ihlr-16572	53	7	wendy	wendy	PROPN
ihlr-16572	53	8	h.	h.	PROPN
ihlr-16572	53	9	schacht	schacht	PROPN
ihlr-16572	53	10	&	&	CCONJ
ihlr-16572	53	11	john	john	PROPN
ihlr-16572	53	12	r.	r.	PROPN
ihlr-16572	53	13	thomas	thomas	PROPN
ihlr-16572	53	14	,	,	PUNCT
ihlr-16572	53	15	follow	follow	VERB
ihlr-16572	53	16	-	-	PUNCT
ihlr-16572	53	17	on	on	ADP
ihlr-16572	53	18	biologics	biologic	NOUN
ihlr-16572	53	19	:	:	PUNCT
ihlr-16572	53	20	intellectual	intellectual	ADJ
ihlr-16572	53	21	property	property	NOUN
ihlr-16572	53	22	and	and	CCONJ
ihlr-16572	53	23	innovation	innovation	NOUN
ihlr-16572	53	24	issues	issue	NOUN
ihlr-16572	53	25	,	,	PUNCT
ihlr-16572	53	26	congressional	congressional	ADJ
ihlr-16572	53	27	research	research	NOUN
ihlr-16572	53	28	service	service	NOUN
ihlr-16572	53	29	(	(	PUNCT
ihlr-16572	53	30	aug	aug	PROPN
ihlr-16572	53	31	.	.	PROPN
ihlr-16572	53	32	3	3	NUM
ihlr-16572	53	33	,	,	PUNCT
ihlr-16572	53	34	2009	2009	NUM
ihlr-16572	53	35	)	)	PUNCT
ihlr-16572	53	36	,	,	PUNCT
ihlr-16572	53	37	available	available	ADJ
ihlr-16572	53	38	at	at	ADP
ihlr-16572	53	39	http://www.assets.opencrs.com/rpts/rl33901_20090803.pdf(last	http://www.assets.opencrs.com/rpts/rl33901_20090803.pdf(last	ADV
ihlr-16572	53	40	visited	visit	VERB
ihlr-16572	53	41	mar	mar	PROPN
ihlr-16572	53	42	.	.	PROPN
ihlr-16572	53	43	6	6	NUM
ihlr-16572	53	44	,	,	PUNCT
ihlr-16572	53	45	2010	2010	NUM
ihlr-16572	53	46	)	)	PUNCT
ihlr-16572	53	47	.	.	PUNCT
ihlr-16572	54	1	11	11	NUM
ihlr-16572	54	2	.	.	PUNCT
ihlr-16572	55	1	david	david	PROPN
ihlr-16572	55	2	u.	u.	PROPN
ihlr-16572	55	3	himmelstein	himmelstein	PROPN
ihlr-16572	55	4	,	,	PUNCT
ihlr-16572	55	5	et	et	PROPN
ihlr-16572	55	6	al	al	PROPN
ihlr-16572	55	7	.	.	PROPN
ihlr-16572	55	8	,	,	PUNCT
ihlr-16572	55	9	market	market	NOUN
ihlr-16572	55	10	watch	watch	NOUN
ihlr-16572	55	11	:	:	PUNCT
ihlr-16572	55	12	illness	illness	NOUN
ihlr-16572	55	13	and	and	CCONJ
ihlr-16572	55	14	injury	injury	NOUN
ihlr-16572	55	15	as	as	ADP
ihlr-16572	55	16	contributors	contributor	NOUN
ihlr-16572	55	17	to	to	ADP
ihlr-16572	55	18	bankruptcy	bankruptcy	NOUN
ihlr-16572	55	19	,	,	PUNCT
ihlr-16572	55	20	health	health	NOUN
ihlr-16572	55	21	affairs	affair	NOUN
ihlr-16572	55	22	,	,	PUNCT
ihlr-16572	55	23	feb	feb	PROPN
ihlr-16572	55	24	.	.	PROPN
ihlr-16572	55	25	2	2	NUM
ihlr-16572	55	26	,	,	PUNCT
ihlr-16572	55	27	2005	2005	NUM
ihlr-16572	55	28	,	,	PUNCT
ihlr-16572	55	29	at	at	ADP
ihlr-16572	55	30	w5	w5	PROPN
ihlr-16572	55	31	-	-	PUNCT
ihlr-16572	55	32	63,w5	63,w5	PROPN
ihlr-16572	55	33	-	-	NUM
ihlr-16572	55	34	64	64	NUM
ihlr-16572	55	35	,	,	PUNCT
ihlr-16572	55	36	http://content.healthaffairs	http://content.healthaffair	NOUN
ihlr-16572	55	37	.	.	PUNCT
ihlr-16572	56	1	org!cgilcontentlfull!hlthaff.w5.63	org!cgilcontentlfull!hlthaff.w5.63	PROPN
ihlr-16572	56	2	/	/	SYM
ihlr-16572	56	3	dc1	dc1	PROPN
ihlr-16572	56	4	(	(	PUNCT
ihlr-16572	56	5	last	last	ADV
ihlr-16572	56	6	visited	visit	VERB
ihlr-16572	56	7	mar	mar	PROPN
ihlr-16572	56	8	.	.	PROPN
ihlr-16572	56	9	1	1	NUM
ihlr-16572	56	10	,	,	PUNCT
ihlr-16572	56	11	2010	2010	NUM
ihlr-16572	56	12	)	)	PUNCT
ihlr-16572	56	13	.	.	PUNCT
ihlr-16572	57	1	12	12	NUM
ihlr-16572	57	2	.	.	PUNCT
ihlr-16572	57	3	!	!	PUNCT
ihlr-16572	58	1	d.	d.	PROPN
ihlr-16572	58	2	at	at	ADP
ihlr-16572	58	3	w5	w5	PROPN
ihlr-16572	58	4	-	-	PUNCT
ihlr-16572	58	5	63	63	NUM
ihlr-16572	58	6	.	.	PUNCT
ihlr-16572	59	1	13	13	NUM
ihlr-16572	59	2	.	.	X
ihlr-16572	59	3	ld	ld	PROPN
ihlr-16572	59	4	370	370	NUM
ihlr-16572	59	5	indiana	indiana	PROPN
ihlr-16572	59	6	health	health	PROPN
ihlr-16572	59	7	law	law	PROPN
ihlr-16572	59	8	review	review	NOUN
ihlr-16572	60	1	[	[	X
ihlr-16572	60	2	vol	vol	NOUN
ihlr-16572	60	3	.	.	PUNCT
ihlr-16572	61	1	7:367	7:367	NUM
ihlr-16572	61	2	termath	termath	NOUN
ihlr-16572	61	3	of	of	ADP
ihlr-16572	61	4	a	a	DET
ihlr-16572	61	5	serious	serious	ADJ
ihlr-16572	61	6	health	health	NOUN
ihlr-16572	61	7	problem.14	problem.14	PROPN
ihlr-16572	61	8	therefore	therefore	ADV
ihlr-16572	61	9	,	,	PUNCT
ihlr-16572	61	10	establishing	establish	VERB
ihlr-16572	61	11	a	a	DET
ihlr-16572	61	12	regulatory	regulatory	ADJ
ihlr-16572	61	13	pathway	pathway	NOUN
ihlr-16572	61	14	for	for	ADP
ihlr-16572	61	15	generic	generic	ADJ
ihlr-16572	61	16	biologics	biologic	NOUN
ihlr-16572	61	17	would	would	AUX
ihlr-16572	61	18	help	help	VERB
ihlr-16572	61	19	provide	provide	VERB
ihlr-16572	61	20	both	both	CCONJ
ihlr-16572	61	21	economic	economic	ADJ
ihlr-16572	61	22	and	and	CCONJ
ihlr-16572	61	23	phys­	phys­	NOUN
ihlr-16572	61	24	ical	ical	ADJ
ihlr-16572	61	25	relief	relief	NOUN
ihlr-16572	61	26	to	to	ADP
ihlr-16572	61	27	those	those	PRON
ihlr-16572	61	28	faced	face	VERB
ihlr-16572	61	29	with	with	ADP
ihlr-16572	61	30	catastrophic	catastrophic	ADJ
ihlr-16572	61	31	illness	illness	NOUN
ihlr-16572	61	32	.	.	PUNCT
ihlr-16572	62	1	the	the	DET
ihlr-16572	62	2	more	more	ADJ
ihlr-16572	62	3	than	than	ADP
ihlr-16572	62	4	47	47	NUM
ihlr-16572	62	5	million	million	NUM
ihlr-16572	62	6	americans	americans	PROPN
ihlr-16572	62	7	without	without	ADP
ihlr-16572	62	8	health	health	NOUN
ihlr-16572	62	9	insurance	insurance	NOUN
ihlr-16572	62	10	are	be	AUX
ihlr-16572	62	11	un­	un­	PUNCT
ihlr-16572	62	12	likely	likely	ADJ
ihlr-16572	62	13	to	to	PART
ihlr-16572	62	14	have	have	VERB
ihlr-16572	62	15	access	access	NOUN
ihlr-16572	62	16	to	to	ADP
ihlr-16572	62	17	these	these	DET
ihlr-16572	62	18	drugs	drug	NOUN
ihlr-16572	62	19	at	at	ADV
ihlr-16572	62	20	all	all	ADV
ihlr-16572	62	21	.	.	PUNCT
ihlr-16572	63	1	15	15	NUM
ihlr-16572	63	2	additionalll	additionalll	NOUN
ihlr-16572	63	3	,	,	PUNCT
ihlr-16572	63	4	those	those	PRON
ihlr-16572	63	5	with	with	ADP
ihlr-16572	63	6	health	health	NOUN
ihlr-16572	63	7	insurance	insurance	NOUN
ihlr-16572	63	8	may	may	AUX
ihlr-16572	63	9	not	not	PART
ihlr-16572	63	10	be	be	AUX
ihlr-16572	63	11	covered	cover	VERB
ihlr-16572	63	12	for	for	ADP
ihlr-16572	63	13	life	life	NOUN
ihlr-16572	63	14	-	-	PUNCT
ihlr-16572	63	15	saving	save	VERB
ihlr-16572	63	16	biologics.1	biologics.1	NOUN
ihlr-16572	63	17	in	in	ADP
ihlr-16572	63	18	response	response	NOUN
ihlr-16572	63	19	to	to	ADP
ihlr-16572	63	20	the	the	DET
ihlr-16572	63	21	increase	increase	NOUN
ihlr-16572	63	22	in	in	ADP
ihlr-16572	63	23	expensive	expensive	ADJ
ihlr-16572	63	24	specialty	specialty	NOUN
ihlr-16572	63	25	drugs	drug	NOUN
ihlr-16572	63	26	,	,	PUNCT
ihlr-16572	63	27	many	many	ADJ
ihlr-16572	63	28	insurers	insurer	NOUN
ihlr-16572	63	29	are	be	AUX
ihlr-16572	63	30	restructuring	restructure	VERB
ihlr-16572	63	31	the	the	DET
ihlr-16572	63	32	system	system	NOUN
ihlr-16572	63	33	they	they	PRON
ihlr-16572	63	34	use	use	VERB
ihlr-16572	63	35	to	to	PART
ihlr-16572	63	36	determine	determine	VERB
ihlr-16572	63	37	which	which	DET
ihlr-16572	63	38	drugs	drug	NOUN
ihlr-16572	63	39	they	they	PRON
ihlr-16572	63	40	will	will	AUX
ihlr-16572	63	41	pay	pay	VERB
ihlr-16572	63	42	for	for	ADP
ihlr-16572	63	43	,	,	PUNCT
ihlr-16572	63	44	and	and	CCONJ
ihlr-16572	63	45	how	how	SCONJ
ihlr-16572	63	46	much	much	ADV
ihlr-16572	63	47	the	the	DET
ihlr-16572	63	48	patient	patient	NOUN
ihlr-16572	63	49	is	be	AUX
ihlr-16572	63	50	required	require	VERB
ihlr-16572	63	51	to	to	PART
ihlr-16572	63	52	pay	pay	VERB
ihlr-16572	63	53	.	.	PUNCT
ihlr-16572	64	1	until	until	ADP
ihlr-16572	64	2	recently	recently	ADV
ihlr-16572	64	3	,	,	PUNCT
ihlr-16572	64	4	insurance	insurance	NOUN
ihlr-16572	64	5	companies	company	NOUN
ihlr-16572	64	6	classi­	classi­	PROPN
ihlr-16572	64	7	fied	fie	VERB
ihlr-16572	64	8	drugs	drug	NOUN
ihlr-16572	64	9	in	in	ADP
ihlr-16572	64	10	three	three	NUM
ihlr-16572	64	11	tiers	tier	NOUN
ihlr-16572	64	12	based	base	VERB
ihlr-16572	64	13	on	on	ADP
ihlr-16572	64	14	cost	cost	NOUN
ihlr-16572	64	15	and	and	CCONJ
ihlr-16572	64	16	whether	whether	SCONJ
ihlr-16572	64	17	less	less	ADV
ihlr-16572	64	18	expensive	expensive	ADJ
ihlr-16572	64	19	alterna­	alterna­	NOUN
ihlr-16572	64	20	tives	tive	VERB
ihlr-16572	64	21	exist.17	exist.17	NOUN
ihlr-16572	64	22	under	under	ADP
ihlr-16572	64	23	this	this	DET
ihlr-16572	64	24	tiered	tiere	VERB
ihlr-16572	64	25	copayment	copayment	NOUN
ihlr-16572	64	26	structure	structure	NOUN
ihlr-16572	64	27	,	,	PUNCT
ihlr-16572	64	28	patients	patient	NOUN
ihlr-16572	64	29	would	would	AUX
ihlr-16572	64	30	pay	pay	VERB
ihlr-16572	64	31	a	a	DET
ihlr-16572	64	32	fixed	fix	VERB
ihlr-16572	64	33	amount	amount	NOUN
ihlr-16572	64	34	,	,	PUNCT
ihlr-16572	64	35	"	"	PUNCT
ihlr-16572	64	36	$	$	SYM
ihlr-16572	64	37	5	5	NUM
ihlr-16572	64	38	to	to	PART
ihlr-16572	64	39	$	$	SYM
ihlr-16572	64	40	10	10	NUM
ihlr-16572	64	41	per	per	ADP
ihlr-16572	64	42	month	month	NOUN
ihlr-16572	64	43	for	for	ADP
ihlr-16572	64	44	a	a	DET
ihlr-16572	64	45	generic	generic	ADJ
ihlr-16572	64	46	medication	medication	NOUN
ihlr-16572	64	47	(	(	PUNCT
ihlr-16572	64	48	tier	tier	NOUN
ihlr-16572	64	49	1	1	NUM
ihlr-16572	64	50	)	)	PUNCT
ihlr-16572	64	51	,	,	PUNCT
ihlr-16572	64	52	$	$	SYM
ihlr-16572	64	53	20	20	NUM
ihlr-16572	64	54	to	to	PART
ihlr-16572	64	55	$	$	SYM
ihlr-16572	64	56	30	30	NUM
ihlr-16572	64	57	for	for	ADP
ihlr-16572	64	58	a	a	DET
ihlr-16572	64	59	moderately	moderately	ADV
ihlr-16572	64	60	priced	price	VERB
ihlr-16572	64	61	brand	brand	NOUN
ihlr-16572	64	62	-	-	PUNCT
ihlr-16572	64	63	name	name	NOUN
ihlr-16572	64	64	drug	drug	NOUN
ihlr-16572	64	65	(	(	PUNCT
ihlr-16572	64	66	tier	tier	NOUN
ihlr-16572	64	67	2	2	NUM
ihlr-16572	64	68	)	)	PUNCT
ihlr-16572	64	69	,	,	PUNCT
ihlr-16572	64	70	and	and	CCONJ
ihlr-16572	64	71	$	$	SYM
ihlr-16572	64	72	50	50	NUM
ihlr-16572	64	73	for	for	ADP
ihlr-16572	64	74	a	a	DET
ihlr-16572	64	75	high­	high­	NOUN
ihlr-16572	64	76	priced	price	VERB
ihlr-16572	64	77	brand	brand	NOUN
ihlr-16572	64	78	-	-	PUNCT
ihlr-16572	64	79	name	name	NOUN
ihlr-16572	64	80	drug	drug	NOUN
ihlr-16572	64	81	(	(	PUNCT
ihlr-16572	64	82	tier	tier	NOUN
ihlr-16572	64	83	3)."18	3)."18	NUM
ihlr-16572	64	84	in	in	ADP
ihlr-16572	64	85	response	response	NOUN
ihlr-16572	64	86	to	to	ADP
ihlr-16572	64	87	the	the	DET
ihlr-16572	64	88	rising	rise	VERB
ihlr-16572	64	89	number	number	NOUN
ihlr-16572	64	90	of	of	ADP
ihlr-16572	64	91	high	high	ADV
ihlr-16572	64	92	-	-	PUNCT
ihlr-16572	64	93	priced	price	VERB
ihlr-16572	64	94	medications	medication	NOUN
ihlr-16572	64	95	,	,	PUNCT
ihlr-16572	64	96	many	many	ADJ
ihlr-16572	64	97	insurers	insurer	NOUN
ihlr-16572	64	98	have	have	AUX
ihlr-16572	64	99	now	now	ADV
ihlr-16572	64	100	implemented	implement	VERB
ihlr-16572	64	101	a	a	DET
ihlr-16572	64	102	fourth	fourth	ADJ
ihlr-16572	64	103	tier	tier	NOUN
ihlr-16572	64	104	,	,	PUNCT
ihlr-16572	64	105	under	under	ADP
ihlr-16572	64	106	which	which	PRON
ihlr-16572	64	107	patients	patient	NOUN
ihlr-16572	64	108	must	must	AUX
ihlr-16572	64	109	pay	pay	VERB
ihlr-16572	64	110	a	a	DET
ihlr-16572	64	111	fixed	fix	VERB
ihlr-16572	64	112	percentage	percentage	NOUN
ihlr-16572	64	113	(	(	PUNCT
ihlr-16572	64	114	often	often	ADV
ihlr-16572	64	115	20	20	NUM
ihlr-16572	64	116	to	to	PART
ihlr-16572	64	117	33	33	NUM
ihlr-16572	64	118	%	%	NOUN
ihlr-16572	64	119	)	)	PUNCT
ihlr-16572	64	120	for	for	ADP
ihlr-16572	64	121	all	all	DET
ihlr-16572	64	122	fourth	fourth	ADJ
ihlr-16572	64	123	tier	tier	NOUN
ihlr-16572	64	124	drugs	drug	NOUN
ihlr-16572	64	125	.	.	PUNCT
ihlr-16572	65	1	19	19	NUM
ihlr-16572	65	2	with	with	ADP
ihlr-16572	65	3	many	many	ADJ
ihlr-16572	65	4	biologic	biologic	NOUN
ihlr-16572	65	5	treatments	treatment	NOUN
ihlr-16572	65	6	costing	cost	VERB
ihlr-16572	65	7	well	well	ADV
ihlr-16572	65	8	over	over	ADP
ihlr-16572	65	9	$	$	SYM
ihlr-16572	65	10	100,000	100,000	NUM
ihlr-16572	65	11	annually	annually	ADV
ihlr-16572	65	12	,	,	PUNCT
ihlr-16572	65	13	access	access	NOUN
ihlr-16572	65	14	to	to	ADP
ihlr-16572	65	15	these	these	DET
ihlr-16572	65	16	drugs	drug	NOUN
ihlr-16572	65	17	is	be	AUX
ihlr-16572	65	18	often	often	ADV
ihlr-16572	65	19	impractical	impractical	ADJ
ihlr-16572	65	20	for	for	ADP
ihlr-16572	65	21	even	even	ADV
ihlr-16572	65	22	in­	in­	NOUN
ihlr-16572	65	23	sured	sure	VERB
ihlr-16572	65	24	middle	middle	ADJ
ihlr-16572	65	25	-	-	PUNCT
ihlr-16572	65	26	upper	upper	ADJ
ihlr-16572	65	27	class	class	NOUN
ihlr-16572	65	28	families.20	families.20	NOUN
ihlr-16572	65	29	unfortunately	unfortunately	ADV
ihlr-16572	65	30	,	,	PUNCT
ihlr-16572	65	31	many	many	ADJ
ihlr-16572	65	32	are	be	AUX
ihlr-16572	65	33	faced	face	VERB
ihlr-16572	65	34	with	with	ADP
ihlr-16572	65	35	the	the	DET
ihlr-16572	65	36	tragic	tragic	ADJ
ihlr-16572	65	37	choice	choice	NOUN
ihlr-16572	65	38	between	between	ADP
ihlr-16572	65	39	pursuing	pursue	VERB
ihlr-16572	65	40	effective	effective	ADJ
ihlr-16572	65	41	cancer	cancer	NOUN
ihlr-16572	65	42	treatment	treatment	NOUN
ihlr-16572	65	43	or	or	CCONJ
ihlr-16572	65	44	providing	provide	VERB
ihlr-16572	65	45	for	for	ADP
ihlr-16572	65	46	family	family	NOUN
ihlr-16572	65	47	expenses	expense	NOUN
ihlr-16572	65	48	.	.	PUNCT
ihlr-16572	66	1	employers	employer	NOUN
ihlr-16572	66	2	providing	provide	VERB
ihlr-16572	66	3	health	health	NOUN
ihlr-16572	66	4	benefits	benefit	NOUN
ihlr-16572	66	5	feel	feel	VERB
ihlr-16572	66	6	the	the	DET
ihlr-16572	66	7	economic	economic	ADJ
ihlr-16572	66	8	impact	impact	NOUN
ihlr-16572	66	9	of	of	ADP
ihlr-16572	66	10	high­	high­	NOUN
ihlr-16572	66	11	priced	price	VERB
ihlr-16572	66	12	biologics	biologic	NOUN
ihlr-16572	66	13	in	in	ADP
ihlr-16572	66	14	the	the	DET
ihlr-16572	66	15	form	form	NOUN
ihlr-16572	66	16	of	of	ADP
ihlr-16572	66	17	rapidly	rapidly	ADV
ihlr-16572	66	18	rising	rise	VERB
ihlr-16572	66	19	insurance	insurance	NOUN
ihlr-16572	66	20	premiums	premium	NOUN
ihlr-16572	66	21	.	.	PUNCT
ihlr-16572	67	1	united	united	PROPN
ihlr-16572	67	2	states	states	PROPN
ihlr-16572	67	3	employers	employer	NOUN
ihlr-16572	67	4	saw	see	VERB
ihlr-16572	67	5	their	their	PRON
ihlr-16572	67	6	health	health	NOUN
ihlr-16572	67	7	insurance	insurance	NOUN
ihlr-16572	67	8	premiums	premium	NOUN
ihlr-16572	67	9	rise	rise	VERB
ihlr-16572	67	10	by	by	ADP
ihlr-16572	67	11	an	an	DET
ihlr-16572	67	12	alarming	alarming	ADJ
ihlr-16572	67	13	five	five	NUM
ihlr-16572	67	14	percent	percent	NOUN
ihlr-16572	67	15	in	in	ADP
ihlr-16572	67	16	2008	2008	NUM
ihlr-16572	67	17	two	two	NUM
ihlr-16572	67	18	times	time	NOUN
ihlr-16572	67	19	the	the	DET
ihlr-16572	67	20	rate	rate	NOUN
ihlr-16572	67	21	of	of	ADP
ihlr-16572	67	22	inflation	inflation	NOUN
ihlr-16572	67	23	.	.	PUNCT
ihlr-16572	68	1	21	21	NUM
ihlr-16572	68	2	as	as	ADP
ihlr-16572	68	3	biologics	biologic	NOUN
ihlr-16572	68	4	be­	be­	VERB
ihlr-16572	68	5	come	come	VERB
ihlr-16572	68	6	more	more	ADV
ihlr-16572	68	7	prevalent	prevalent	ADJ
ihlr-16572	68	8	,	,	PUNCT
ihlr-16572	68	9	it	it	PRON
ihlr-16572	68	10	is	be	AUX
ihlr-16572	68	11	becoming	become	VERB
ihlr-16572	68	12	increasingly	increasingly	ADV
ihlr-16572	68	13	expensive	expensive	ADJ
ihlr-16572	68	14	for	for	SCONJ
ihlr-16572	68	15	employers	employer	NOUN
ihlr-16572	68	16	to	to	PART
ihlr-16572	68	17	insure	insure	VERB
ihlr-16572	68	18	a	a	DET
ihlr-16572	68	19	large	large	ADJ
ihlr-16572	68	20	workforce	workforce	NOUN
ihlr-16572	68	21	.	.	PUNCT
ihlr-16572	69	1	to	to	PART
ihlr-16572	69	2	maintain	maintain	VERB
ihlr-16572	69	3	the	the	DET
ihlr-16572	69	4	viability	viability	NOUN
ihlr-16572	69	5	of	of	ADP
ihlr-16572	69	6	the	the	DET
ihlr-16572	69	7	employment­	employment­	NOUN
ihlr-16572	69	8	based	base	VERB
ihlr-16572	69	9	insurance	insurance	NOUN
ihlr-16572	69	10	scheme	scheme	NOUN
ihlr-16572	69	11	,	,	PUNCT
ihlr-16572	69	12	it	it	PRON
ihlr-16572	69	13	is	be	AUX
ihlr-16572	69	14	necessary	necessary	ADJ
ihlr-16572	69	15	to	to	PART
ihlr-16572	69	16	cut	cut	VERB
ihlr-16572	69	17	medical	medical	ADJ
ihlr-16572	69	18	costs	cost	NOUN
ihlr-16572	69	19	.	.	PUNCT
ihlr-16572	70	1	failing	fail	VERB
ihlr-16572	70	2	to	to	PART
ihlr-16572	70	3	do	do	VERB
ihlr-16572	70	4	so	so	ADV
ihlr-16572	70	5	,	,	PUNCT
ihlr-16572	70	6	when	when	SCONJ
ihlr-16572	70	7	many	many	ADJ
ihlr-16572	70	8	employers	employer	NOUN
ihlr-16572	70	9	are	be	AUX
ihlr-16572	70	10	already	already	ADV
ihlr-16572	70	11	cutting	cut	VERB
ihlr-16572	70	12	medical	medical	ADJ
ihlr-16572	70	13	benefits	benefit	NOUN
ihlr-16572	70	14	due	due	ADP
ihlr-16572	70	15	to	to	ADP
ihlr-16572	70	16	the	the	DET
ihlr-16572	70	17	prohibitive	prohibitive	ADJ
ihlr-16572	70	18	cost	cost	NOUN
ihlr-16572	70	19	of	of	ADP
ihlr-16572	70	20	health	health	NOUN
ihlr-16572	70	21	care	care	NOUN
ihlr-16572	70	22	,	,	PUNCT
ihlr-16572	70	23	could	could	AUX
ihlr-16572	70	24	have	have	VERB
ihlr-16572	70	25	catastrophic	catastrophic	ADJ
ihlr-16572	70	26	effects	effect	NOUN
ihlr-16572	70	27	on	on	ADP
ihlr-16572	70	28	our	our	PRON
ihlr-16572	70	29	health	health	NOUN
ihlr-16572	70	30	14	14	NUM
ihlr-16572	70	31	.	.	PUNCT
ihlr-16572	71	1	elizabeth	elizabeth	PROPN
ihlr-16572	71	2	warren	warren	PROPN
ihlr-16572	71	3	,	,	PUNCT
ihlr-16572	71	4	sick	sick	ADJ
ihlr-16572	71	5	&	&	CCONJ
ihlr-16572	71	6	broke	break	VERB
ihlr-16572	71	7	,	,	PUNCT
ihlr-16572	71	8	wash	wash	NOUN
ihlr-16572	71	9	.	.	PUNCT
ihlr-16572	72	1	post	post	PROPN
ihlr-16572	72	2	,	,	PUNCT
ihlr-16572	72	3	feb	feb	PROPN
ihlr-16572	72	4	.	.	PROPN
ihlr-16572	72	5	9	9	NUM
ihlr-16572	72	6	,	,	PUNCT
ihlr-16572	72	7	2005	2005	NUM
ihlr-16572	72	8	,	,	PUNCT
ihlr-16572	72	9	at	at	ADP
ihlr-16572	72	10	a23	a23	PROPN
ihlr-16572	72	11	,	,	PUNCT
ihlr-16572	72	12	available	available	ADJ
ihlr-16572	72	13	at	at	ADP
ihlr-16572	72	14	http://www.washingtonpost.com/wp-dyn/articles/a9447-2005feb8.html	http://www.washingtonpost.com/wp-dyn/articles/a9447-2005feb8.html	PROPN
ihlr-16572	72	15	(	(	PUNCT
ihlr-16572	72	16	last	last	ADV
ihlr-16572	72	17	visited	visit	VERB
ihlr-16572	72	18	mar	mar	PROPN
ihlr-16572	72	19	.	.	PUNCT
ihlr-16572	73	1	i	i	PRON
ihlr-16572	73	2	,	,	PUNCT
ihlr-16572	73	3	2010	2010	NUM
ihlr-16572	73	4	)	)	PUNCT
ihlr-16572	73	5	.	.	PUNCT
ihlr-16572	74	1	i5	i5	ADJ
ihlr-16572	74	2	.	.	PUNCT
ihlr-16572	75	1	u.s	u.s	PROPN
ihlr-16572	75	2	.	.	PROPN
ihlr-16572	75	3	dept	dept	PROPN
ihlr-16572	75	4	.	.	PROPN
ihlr-16572	75	5	of	of	ADP
ihlr-16572	75	6	commerce	commerce	PROPN
ihlr-16572	75	7	,	,	PUNCT
ihlr-16572	75	8	economics	economic	NOUN
ihlr-16572	75	9	and	and	CCONJ
ihlr-16572	75	10	statistics	statistics	PROPN
ihlr-16572	75	11	administration	administration	PROPN
ihlr-16572	75	12	,	,	PUNCT
ihlr-16572	75	13	u.s	u.s	PROPN
ihlr-16572	75	14	.	.	PROPN
ihlr-16572	75	15	census	census	PROPN
ihlr-16572	75	16	bureau	bureau	PROPN
ihlr-16572	75	17	report	report	NOUN
ihlr-16572	75	18	:	:	PUNCT
ihlr-16572	75	19	income	income	NOUN
ihlr-16572	75	20	,	,	PUNCT
ihlr-16572	75	21	poverty	poverty	NOUN
ihlr-16572	75	22	,	,	PUNCT
ihlr-16572	75	23	and	and	CCONJ
ihlr-16572	75	24	health	health	NOUN
ihlr-16572	75	25	insurance	insurance	NOUN
ihlr-16572	75	26	coverage	coverage	NOUN
ihlr-16572	75	27	ln	ln	ADP
ihlr-16572	75	28	the	the	DET
ihlr-16572	75	29	united	united	PROPN
ihlr-16572	75	30	stales	stales	PROPN
ihlr-16572	75	31	:	:	PUNCT
ihlr-16572	75	32	2005	2005	NUM
ihlr-16572	75	33	20	20	NUM
ihlr-16572	75	34	(	(	PUNCT
ihlr-16572	75	35	2006	2006	NUM
ihlr-16572	75	36	)	)	PUNCT
ihlr-16572	75	37	,	,	PUNCT
ihlr-16572	75	38	available	available	ADJ
ihlr-16572	75	39	at	at	ADP
ihlr-16572	75	40	http://www.census.gov/prod/2006pubs/p60231.pdf	http://www.census.gov/prod/2006pubs/p60231.pdf	NOUN
ihlr-16572	75	41	(	(	PUNCT
ihlr-16572	75	42	last	last	ADJ
ihlr-16572	75	43	visited	visit	VERB
ihlr-16572	75	44	mar	mar	PROPN
ihlr-16572	75	45	.	.	PROPN
ihlr-16572	75	46	1	1	NUM
ihlr-16572	75	47	,	,	PUNCT
ihlr-16572	75	48	201	201	NUM
ihlr-16572	75	49	0	0	NUM
ihlr-16572	75	50	)	)	PUNCT
ihlr-16572	76	1	[	[	X
ihlr-16572	76	2	hereinafter	hereinafter	NOUN
ihlr-16572	76	3	"	"	PUNCT
ihlr-16572	76	4	census	census	NOUN
ihlr-16572	76	5	report	report	NOUN
ihlr-16572	76	6	"	"	PUNCT
ihlr-16572	76	7	]	]	PUNCT
ihlr-16572	76	8	.	.	PUNCT
ihlr-16572	77	1	16	16	NUM
ihlr-16572	77	2	.	.	PUNCT
ihlr-16572	78	1	/d	/d	INTJ
ihlr-16572	78	2	.	.	PUNCT
ihlr-16572	79	1	i7	i7	NOUN
ihlr-16572	79	2	.	.	PUNCT
ihlr-16572	80	1	thomas	thomas	PROPN
ihlr-16572	80	2	h.	h.	PROPN
ihlr-16572	80	3	lee	lee	PROPN
ihlr-16572	80	4	,	,	PUNCT
ihlr-16572	80	5	m.d	m.d	PROPN
ihlr-16572	80	6	.	.	PROPN
ihlr-16572	80	7	,	,	PUNCT
ihlr-16572	80	8	and	and	CCONJ
ihlr-16572	80	9	ezekiel	ezekiel	PROPN
ihlr-16572	80	10	j.	j.	PROPN
ihlr-16572	80	11	emanuel	emanuel	PROPN
ihlr-16572	80	12	,	,	PUNCT
ihlr-16572	80	13	m.d	m.d	PROPN
ihlr-16572	80	14	.	.	PROPN
ihlr-16572	80	15	,	,	PUNCT
ihlr-16572	80	16	ph.d	ph.d	PROPN
ihlr-16572	80	17	.	.	PROPN
ihlr-16572	80	18	,	,	PUNCT
ihlr-16572	80	19	tier	tier	NOUN
ihlr-16572	80	20	4	4	NUM
ihlr-16572	80	21	drugs	drug	NOUN
ihlr-16572	80	22	and	and	CCONJ
ihlr-16572	80	23	the	the	DET
ihlr-16572	80	24	fraying	fraying	NOUN
ihlr-16572	80	25	of	of	ADP
ihlr-16572	80	26	the	the	DET
ihlr-16572	80	27	social	social	ADJ
ihlr-16572	80	28	compact	compact	ADJ
ihlr-16572	80	29	,	,	PUNCT
ihlr-16572	80	30	359	359	NUM
ihlr-16572	80	31	n.	n.	PROPN
ihlr-16572	80	32	engl	engl	PROPN
ihlr-16572	80	33	.	.	PUNCT
ihlr-16572	81	1	j.	j.	PROPN
ihlr-16572	81	2	med	med	PROPN
ihlr-16572	81	3	.	.	PROPN
ihlr-16572	82	1	333	333	NUM
ihlr-16572	82	2	,	,	PUNCT
ihlr-16572	82	3	333	333	NUM
ihlr-16572	82	4	(	(	PUNCT
ihlr-16572	82	5	2008	2008	NUM
ihlr-16572	82	6	)	)	PUNCT
ihlr-16572	82	7	.	.	PUNCT
ihlr-16572	83	1	18	18	NUM
ihlr-16572	83	2	.	.	PUNCT
ihlr-16572	84	1	/d	/d	INTJ
ihlr-16572	84	2	.	.	PROPN
ihlr-16572	85	1	19	19	NUM
ihlr-16572	85	2	.	.	PUNCT
ihlr-16572	86	1	/d	/d	INTJ
ihlr-16572	86	2	.	.	PUNCT
ihlr-16572	87	1	20	20	NUM
ihlr-16572	87	2	.	.	PUNCT
ihlr-16572	88	1	health	health	NOUN
ihlr-16572	88	2	premium	premium	NOUN
ihlr-16572	88	3	hikes	hike	NOUN
ihlr-16572	88	4	tied	tie	VERB
ihlr-16572	88	5	to	to	ADP
ihlr-16572	88	6	costly	costly	ADJ
ihlr-16572	88	7	specialty	specialty	NOUN
ihlr-16572	88	8	drugs	drug	NOUN
ihlr-16572	88	9	,	,	PUNCT
ihlr-16572	88	10	supra	supra	PROPN
ihlr-16572	88	11	note	note	NOUN
ihlr-16572	88	12	1	1	NUM
ihlr-16572	88	13	.	.	NUM
ihlr-16572	88	14	21	21	NUM
ihlr-16572	88	15	.	.	PUNCT
ihlr-16572	89	1	the	the	DET
ihlr-16572	89	2	kaiser	kaiser	PROPN
ihlr-16572	89	3	family	family	PROPN
ihlr-16572	89	4	foundation	foundation	PROPN
ihlr-16572	89	5	&	&	CCONJ
ihlr-16572	89	6	health	health	PROPN
ihlr-16572	89	7	research	research	PROPN
ihlr-16572	89	8	&	&	CCONJ
ihlr-16572	89	9	education	education	PROPN
ihlr-16572	89	10	trust	trust	PROPN
ihlr-16572	89	11	,	,	PUNCT
ihlr-16572	89	12	employer	employer	NOUN
ihlr-16572	89	13	health	health	NOUN
ihlr-16572	89	14	benefits	benefit	NOUN
ihlr-16572	89	15	:	:	PUNCT
ihlr-16572	89	16	2008	2008	NUM
ihlr-16572	89	17	annual	annual	ADJ
ihlr-16572	89	18	survey	survey	NOUN
ihlr-16572	89	19	i	i	PRON
ihlr-16572	89	20	{	{	PUNCT
ihlr-16572	89	21	2008	2008	NUM
ihlr-16572	89	22	)	)	PUNCT
ihlr-16572	89	23	,	,	PUNCT
ihlr-16572	89	24	available	available	ADJ
ihlr-16572	89	25	at	at	ADP
ihlr-16572	89	26	http://ehbs.kff	http://ehbs.kff	PROPN
ihlr-16572	89	27	.	.	PUNCT
ihlr-16572	90	1	orglped/7790.pdf(last	orglped/7790.pdf(last	PROPN
ihlr-16572	90	2	visited	visit	VERB
ihlr-16572	90	3	mar	mar	PROPN
ihlr-16572	90	4	.	.	PUNCT
ihlr-16572	91	1	i	i	PRON
ihlr-16572	91	2	,	,	PUNCT
ihlr-16572	91	3	2010	2010	NUM
ihlr-16572	91	4	)	)	PUNCT
ihlr-16572	91	5	.	.	PUNCT
ihlr-16572	92	1	2010	2010	NUM
ihlr-16572	92	2	)	)	PUNCT
ihlr-16572	92	3	follow	follow	NOUN
ihlr-16572	92	4	-	-	PUNCT
ihlr-16572	92	5	on	on	ADP
ihlr-16572	92	6	biologics	biologic	NOUN
ihlr-16572	92	7	legislation	legislation	NOUN
ihlr-16572	92	8	371	371	NUM
ihlr-16572	92	9	care	care	NOUN
ihlr-16572	92	10	system.22	system.22	NOUN
ihlr-16572	92	11	allowing	allow	VERB
ihlr-16572	92	12	follow	follow	VERB
ihlr-16572	92	13	-	-	PUNCT
ihlr-16572	92	14	on	on	ADP
ihlr-16572	92	15	biologics	biologic	NOUN
ihlr-16572	92	16	would	would	AUX
ihlr-16572	92	17	be	be	AUX
ihlr-16572	92	18	an	an	DET
ihlr-16572	92	19	effective	effective	ADJ
ihlr-16572	92	20	method	method	NOUN
ihlr-16572	92	21	to	to	PART
ihlr-16572	92	22	provide	provide	VERB
ihlr-16572	92	23	relief	relief	NOUN
ihlr-16572	92	24	to	to	ADP
ihlr-16572	92	25	employers	employer	NOUN
ihlr-16572	92	26	,	,	PUNCT
ihlr-16572	92	27	and	and	CCONJ
ihlr-16572	92	28	would	would	AUX
ihlr-16572	92	29	reduce	reduce	VERB
ihlr-16572	92	30	the	the	DET
ihlr-16572	92	31	likelihood	likelihood	NOUN
ihlr-16572	92	32	ofemploy­	ofemploy­	PROPN
ihlr-16572	92	33	ers	er	VERB
ihlr-16572	92	34	discontinuing	discontinue	VERB
ihlr-16572	92	35	health	health	NOUN
ihlr-16572	92	36	benefits	benefit	NOUN
ihlr-16572	92	37	.	.	PUNCT
ihlr-16572	93	1	the	the	DET
ihlr-16572	93	2	country	country	NOUN
ihlr-16572	93	3	's	's	PART
ihlr-16572	93	4	biggest	big	ADJ
ihlr-16572	93	5	insurer	insurer	NOUN
ihlr-16572	93	6	,	,	PUNCT
ihlr-16572	93	7	the	the	DET
ihlr-16572	93	8	united	united	PROPN
ihlr-16572	93	9	states	states	PROPN
ihlr-16572	93	10	government	government	NOUN
ihlr-16572	93	11	,	,	PUNCT
ihlr-16572	93	12	could	could	AUX
ihlr-16572	93	13	al­	al­	VERB
ihlr-16572	93	14	so	so	ADV
ihlr-16572	93	15	benefit	benefit	VERB
ihlr-16572	93	16	from	from	ADP
ihlr-16572	93	17	follow	follow	NOUN
ihlr-16572	93	18	-	-	PUNCT
ihlr-16572	93	19	on	on	ADP
ihlr-16572	93	20	biologics.z3	biologics.z3	PROPN
ihlr-16572	93	21	a	a	DET
ihlr-16572	93	22	congressional	congressional	ADJ
ihlr-16572	93	23	budget	budget	NOUN
ihlr-16572	93	24	office	office	NOUN
ihlr-16572	93	25	re­	re­	PROPN
ihlr-16572	93	26	port	port	NOUN
ihlr-16572	93	27	released	release	VERB
ihlr-16572	93	28	in	in	ADP
ihlr-16572	93	29	december	december	PROPN
ihlr-16572	93	30	2008	2008	NUM
ihlr-16572	93	31	analyzes	analyze	VERB
ihlr-16572	93	32	an	an	DET
ihlr-16572	93	33	abbreviated	abbreviate	VERB
ihlr-16572	93	34	regulatory	regulatory	ADJ
ihlr-16572	93	35	pathway	pathway	NOUN
ihlr-16572	93	36	for	for	ADP
ihlr-16572	93	37	follow	follow	VERB
ihlr-16572	93	38	-	-	PUNCT
ihlr-16572	93	39	on	on	ADP
ihlr-16572	93	40	biologics	biologic	NOUN
ihlr-16572	93	41	as	as	ADP
ihlr-16572	93	42	a	a	DET
ihlr-16572	93	43	potential	potential	ADJ
ihlr-16572	93	44	measure	measure	NOUN
ihlr-16572	93	45	to	to	PART
ihlr-16572	93	46	decrease	decrease	VERB
ihlr-16572	93	47	federal	federal	ADJ
ihlr-16572	93	48	health	health	NOUN
ihlr-16572	93	49	care	care	NOUN
ihlr-16572	93	50	expenditures.z4	expenditures.z4	VERB
ihlr-16572	93	51	the	the	DET
ihlr-16572	93	52	report	report	NOUN
ihlr-16572	93	53	estimates	estimate	VERB
ihlr-16572	93	54	such	such	DET
ihlr-16572	93	55	a	a	DET
ihlr-16572	93	56	plan	plan	NOUN
ihlr-16572	93	57	would	would	AUX
ihlr-16572	93	58	save	save	VERB
ihlr-16572	93	59	the	the	DET
ihlr-16572	93	60	medicare	medicare	PROPN
ihlr-16572	93	61	and	and	CCONJ
ihlr-16572	93	62	medicaid	medicaid	PROPN
ihlr-16572	93	63	programs	program	NOUN
ihlr-16572	93	64	$	$	SYM
ihlr-16572	93	65	10.6	10.6	NUM
ihlr-16572	93	66	billion	billion	NUM
ihlr-16572	93	67	between	between	ADP
ihlr-16572	93	68	2010	2010	NUM
ihlr-16572	93	69	and	and	CCONJ
ihlr-16572	93	70	2019.25	2019.25	NUM
ihlr-16572	93	71	the	the	DET
ihlr-16572	93	72	benefits	benefit	NOUN
ihlr-16572	93	73	of	of	ADP
ihlr-16572	93	74	a	a	DET
ihlr-16572	93	75	regulatory	regulatory	ADJ
ihlr-16572	93	76	pathway	pathway	NOUN
ihlr-16572	93	77	for	for	ADP
ihlr-16572	93	78	follow	follow	VERB
ihlr-16572	93	79	-	-	PUNCT
ihlr-16572	93	80	on	on	ADP
ihlr-16572	93	81	biologics	biologic	NOUN
ihlr-16572	93	82	in	in	ADP
ihlr-16572	93	83	the	the	DET
ihlr-16572	93	84	united	united	PROPN
ihlr-16572	93	85	states	states	PROPN
ihlr-16572	93	86	would	would	AUX
ihlr-16572	93	87	be	be	AUX
ihlr-16572	93	88	realized	realize	VERB
ihlr-16572	93	89	worldwide	worldwide	ADV
ihlr-16572	93	90	.	.	PUNCT
ihlr-16572	94	1	biogeneric	biogeneric	ADJ
ihlr-16572	94	2	legislation	legislation	NOUN
ihlr-16572	94	3	in	in	ADP
ihlr-16572	94	4	the	the	DET
ihlr-16572	94	5	united	united	PROPN
ihlr-16572	94	6	states	states	PROPN
ihlr-16572	94	7	could	could	AUX
ihlr-16572	94	8	also	also	ADV
ihlr-16572	94	9	aid	aid	VERB
ihlr-16572	94	10	our	our	PRON
ihlr-16572	94	11	country	country	NOUN
ihlr-16572	94	12	's	's	PART
ihlr-16572	94	13	use	use	NOUN
ihlr-16572	94	14	of	of	ADP
ihlr-16572	94	15	life	life	NOUN
ihlr-16572	94	16	-	-	PUNCT
ihlr-16572	94	17	saving	save	VERB
ihlr-16572	94	18	drugs	drug	NOUN
ihlr-16572	94	19	to	to	ADP
ihlr-16572	94	20	com­	com­	NOUN
ihlr-16572	94	21	bat	bat	VERB
ihlr-16572	94	22	serious	serious	ADJ
ihlr-16572	94	23	illness	illness	NOUN
ihlr-16572	94	24	in	in	ADP
ihlr-16572	94	25	third	third	ADJ
ihlr-16572	94	26	world	world	NOUN
ihlr-16572	94	27	countries	country	NOUN
ihlr-16572	94	28	,	,	PUNCT
ihlr-16572	94	29	such	such	ADJ
ihlr-16572	94	30	as	as	ADP
ihlr-16572	94	31	human	human	ADJ
ihlr-16572	94	32	immunodeficien­	immunodeficien­	PROPN
ihlr-16572	94	33	cy	cy	PROPN
ihlr-16572	94	34	virus	virus	NOUN
ihlr-16572	94	35	(	(	PUNCT
ihlr-16572	94	36	"	"	PUNCT
ihlr-16572	94	37	hn	hn	PROPN
ihlr-16572	94	38	''	''	PUNCT
ihlr-16572	94	39	)	)	PUNCT
ihlr-16572	94	40	in	in	ADP
ihlr-16572	94	41	many	many	ADJ
ihlr-16572	94	42	african	african	ADJ
ihlr-16572	94	43	nations.z6	nations.z6	PROPN
ihlr-16572	94	44	a	a	DET
ihlr-16572	94	45	majority	majority	NOUN
ihlr-16572	94	46	of	of	ADP
ihlr-16572	94	47	the	the	DET
ihlr-16572	94	48	antiretroviral	antiretroviral	ADJ
ihlr-16572	94	49	drugs	drug	NOUN
ihlr-16572	94	50	which	which	PRON
ihlr-16572	94	51	have	have	AUX
ihlr-16572	94	52	proven	prove	VERB
ihlr-16572	94	53	successful	successful	ADJ
ihlr-16572	94	54	in	in	ADP
ihlr-16572	94	55	treating	treat	VERB
ihlr-16572	94	56	hn	hn	PROPN
ihlr-16572	94	57	are	be	AUX
ihlr-16572	94	58	bi­	bi­	ADP
ihlr-16572	94	59	ologics.27	ologics.27	PROPN
ihlr-16572	94	60	the	the	DET
ihlr-16572	94	61	availability	availability	NOUN
ihlr-16572	94	62	of	of	ADP
ihlr-16572	94	63	follow	follow	NOUN
ihlr-16572	94	64	-	-	PUNCT
ihlr-16572	94	65	on	on	ADP
ihlr-16572	94	66	biologics	biologic	NOUN
ihlr-16572	94	67	would	would	AUX
ihlr-16572	94	68	be	be	AUX
ihlr-16572	94	69	invaluable	invaluable	ADJ
ihlr-16572	94	70	to	to	ADP
ihlr-16572	94	71	african	african	ADJ
ihlr-16572	94	72	nations	nation	NOUN
ihlr-16572	94	73	in	in	ADP
ihlr-16572	94	74	their	their	PRON
ihlr-16572	94	75	fight	fight	NOUN
ihlr-16572	94	76	against	against	ADP
ihlr-16572	94	77	the	the	DET
ihlr-16572	94	78	aids	aids	PROPN
ihlr-16572	94	79	epidemic	epidemic	NOUN
ihlr-16572	94	80	.	.	PUNCT
ihlr-16572	95	1	a	a	DET
ihlr-16572	95	2	well	well	ADV
ihlr-16572	95	3	-	-	PUNCT
ihlr-16572	95	4	crafted	craft	VERB
ihlr-16572	95	5	abbreviated	abbreviate	VERB
ihlr-16572	95	6	regulatory	regulatory	ADJ
ihlr-16572	95	7	pathway	pathway	NOUN
ihlr-16572	95	8	for	for	ADP
ihlr-16572	95	9	follow	follow	VERB
ihlr-16572	95	10	-	-	PUNCT
ihlr-16572	95	11	on	on	ADP
ihlr-16572	95	12	biologics	biologic	NOUN
ihlr-16572	95	13	would	would	AUX
ihlr-16572	95	14	help	help	VERB
ihlr-16572	95	15	alleviate	alleviate	VERB
ihlr-16572	95	16	the	the	DET
ihlr-16572	95	17	economic	economic	ADJ
ihlr-16572	95	18	strain	strain	NOUN
ihlr-16572	95	19	high	high	ADV
ihlr-16572	95	20	-	-	PUNCT
ihlr-16572	95	21	priced	price	VERB
ihlr-16572	95	22	drugs	drug	NOUN
ihlr-16572	95	23	place	place	NOUN
ihlr-16572	95	24	on	on	ADP
ihlr-16572	95	25	domes­	domes­	NOUN
ihlr-16572	95	26	tic	tic	ADJ
ihlr-16572	95	27	and	and	CCONJ
ihlr-16572	95	28	international	international	ADJ
ihlr-16572	95	29	health	health	NOUN
ihlr-16572	95	30	care	care	NOUN
ihlr-16572	95	31	systems	system	NOUN
ihlr-16572	95	32	,	,	PUNCT
ihlr-16572	95	33	while	while	SCONJ
ihlr-16572	95	34	encouraging	encourage	VERB
ihlr-16572	95	35	the	the	DET
ihlr-16572	95	36	discovery	discovery	NOUN
ihlr-16572	95	37	of	of	ADP
ihlr-16572	95	38	new	new	ADJ
ihlr-16572	95	39	biologics	biologic	NOUN
ihlr-16572	95	40	through	through	ADP
ihlr-16572	95	41	increased	increase	VERB
ihlr-16572	95	42	competition.28	competition.28	NOUN
ihlr-16572	95	43	the	the	DET
ihlr-16572	95	44	need	need	NOUN
ihlr-16572	95	45	for	for	ADP
ihlr-16572	95	46	generic	generic	ADJ
ihlr-16572	95	47	biologics	biologic	NOUN
ihlr-16572	95	48	has	have	AUX
ihlr-16572	95	49	become	become	VERB
ihlr-16572	95	50	so	so	ADV
ihlr-16572	95	51	great	great	ADJ
ihlr-16572	95	52	that	that	SCONJ
ihlr-16572	95	53	even	even	ADV
ihlr-16572	95	54	brand	brand	NOUN
ihlr-16572	95	55	name	name	PROPN
ihlr-16572	95	56	biotech	biotech	ADJ
ihlr-16572	95	57	lobbyists	lobbyist	NOUN
ihlr-16572	95	58	are	be	AUX
ihlr-16572	95	59	beginning	begin	VERB
ihlr-16572	95	60	to	to	PART
ihlr-16572	95	61	acknowledge	acknowledge	VERB
ihlr-16572	95	62	the	the	DET
ihlr-16572	95	63	need	need	NOUN
ihlr-16572	95	64	for	for	ADP
ihlr-16572	95	65	a	a	DET
ihlr-16572	95	66	practical	practical	ADJ
ihlr-16572	95	67	regulatory	regulatory	ADJ
ihlr-16572	95	68	pathway	pathway	NOUN
ihlr-16572	95	69	for	for	ADP
ihlr-16572	95	70	generic	generic	ADJ
ihlr-16572	95	71	forms	form	NOUN
ihlr-16572	95	72	of	of	ADP
ihlr-16572	95	73	their	their	PRON
ihlr-16572	95	74	drugs	drug	NOUN
ihlr-16572	95	75	.	.	PUNCT
ihlr-16572	96	1	the	the	DET
ihlr-16572	96	2	biotechnology	biotechnology	NOUN
ihlr-16572	96	3	industry	industry	NOUN
ihlr-16572	96	4	organization	organization	NOUN
ihlr-16572	96	5	(	(	PUNCT
ihlr-16572	96	6	"	"	PUNCT
ihlr-16572	96	7	bio	bio	NOUN
ihlr-16572	96	8	"	"	PUNCT
ihlr-16572	96	9	)	)	PUNCT
ihlr-16572	96	10	,	,	PUNCT
ihlr-16572	96	11	a	a	DET
ihlr-16572	96	12	lobbying	lobbying	NOUN
ihlr-16572	96	13	group	group	NOUN
ihlr-16572	96	14	which	which	PRON
ihlr-16572	96	15	represents	represent	VERB
ihlr-16572	96	16	the	the	DET
ihlr-16572	96	17	interests	interest	NOUN
ihlr-16572	96	18	of	of	ADP
ihlr-16572	96	19	name	name	NOUN
ihlr-16572	96	20	-	-	PUNCT
ihlr-16572	96	21	brand	brand	NOUN
ihlr-16572	96	22	biologics	biologic	NOUN
ihlr-16572	96	23	manufacturers	manufacturer	NOUN
ihlr-16572	96	24	,	,	PUNCT
ihlr-16572	96	25	recently	recently	ADV
ihlr-16572	96	26	conceded	concede	VERB
ihlr-16572	96	27	the	the	DET
ihlr-16572	96	28	necessity	necessity	NOUN
ihlr-16572	96	29	of	of	ADP
ihlr-16572	96	30	follow	follow	NOUN
ihlr-16572	96	31	-	-	PUNCT
ihlr-16572	96	32	on	on	ADP
ihlr-16572	96	33	bi­	bi­	PROPN
ihlr-16572	96	34	ologics	ologic	NOUN
ihlr-16572	96	35	legislation	legislation	NOUN
ihlr-16572	96	36	:	:	PUNCT
ihlr-16572	97	1	22	22	NUM
ihlr-16572	97	2	.	.	PUNCT
ihlr-16572	98	1	bruce	bruce	PROPN
ihlr-16572	98	2	japsen	japsen	PROPN
ihlr-16572	98	3	,	,	PUNCT
ihlr-16572	98	4	employers	employer	NOUN
ihlr-16572	98	5	to	to	PART
ihlr-16572	98	6	shrink	shrink	VERB
ihlr-16572	98	7	insurance	insurance	NOUN
ihlr-16572	98	8	benefits	benefit	NOUN
ihlr-16572	98	9	,	,	PUNCT
ihlr-16572	98	10	chi	chi	PROPN
ihlr-16572	98	11	.	.	PUNCT
ihlr-16572	99	1	tr.m	tr.m	PROPN
ihlr-16572	99	2	.	.	PROPN
ihlr-16572	99	3	,	,	PUNCT
ihlr-16572	99	4	mar	mar	PROPN
ihlr-16572	99	5	.	.	PROPN
ihlr-16572	99	6	5	5	NUM
ihlr-16572	99	7	,	,	PUNCT
ihlr-16572	99	8	2009	2009	NUM
ihlr-16572	99	9	,	,	PUNCT
ihlr-16572	99	10	at	at	ADP
ihlr-16572	99	11	20	20	NUM
ihlr-16572	99	12	.	.	PUNCT
ihlr-16572	99	13	23	23	NUM
ihlr-16572	99	14	.	.	PUNCT
ihlr-16572	99	15	census	census	NOUN
ihlr-16572	99	16	report	report	NOUN
ihlr-16572	99	17	,	,	PUNCT
ihlr-16572	99	18	supra	supra	PROPN
ihlr-16572	99	19	note	note	PROPN
ihlr-16572	99	20	15	15	NUM
ihlr-16572	99	21	;	;	PUNCT
ihlr-16572	99	22	letter	letter	NOUN
ihlr-16572	99	23	from	from	ADP
ihlr-16572	99	24	john	john	PROPN
ihlr-16572	99	25	taylor	taylor	PROPN
ihlr-16572	99	26	,	,	PUNCT
ihlr-16572	99	27	supra	supra	PROPN
ihlr-16572	99	28	note	note	NOUN
ihlr-16572	99	29	7	7	NUM
ihlr-16572	99	30	.	.	SYM
ihlr-16572	99	31	24	24	NUM
ihlr-16572	99	32	.	.	PUNCT
ihlr-16572	100	1	congressional	congressional	ADJ
ihlr-16572	100	2	budget	budget	NOUN
ihlr-16572	100	3	office	office	NOUN
ihlr-16572	100	4	,	,	PUNCT
ihlr-16572	100	5	budget	budget	NOUN
ihlr-16572	100	6	options	option	NOUN
ihlr-16572	100	7	volume	volume	NOUN
ihlr-16572	100	8	1	1	NUM
ihlr-16572	100	9	:	:	PUNCT
ihlr-16572	100	10	health	health	NOUN
ihlr-16572	100	11	care	care	NOUN
ihlr-16572	100	12	126	126	NUM
ihlr-16572	100	13	(	(	PUNCT
ihlr-16572	100	14	2008	2008	NUM
ihlr-16572	100	15	)	)	PUNCT
ihlr-16572	100	16	,	,	PUNCT
ihlr-16572	100	17	available	available	ADJ
ihlr-16572	100	18	at	at	ADP
ihlr-16572	100	19	http://www.cbo.gov/ftpdocs/99xx/doc9925/12-18-health0ptions.pdf	http://www.cbo.gov/ftpdocs/99xx/doc9925/12-18-health0ptions.pdf	PROPN
ihlr-16572	100	20	(	(	PUNCT
ihlr-16572	100	21	last	last	ADJ
ihlr-16572	100	22	vi­	vi­	NOUN
ihlr-16572	100	23	sited	site	VERB
ihlr-16572	100	24	mar	mar	PROPN
ihlr-16572	100	25	.	.	PROPN
ihlr-16572	100	26	3	3	NUM
ihlr-16572	100	27	,	,	PUNCT
ihlr-16572	100	28	2010	2010	NUM
ihlr-16572	100	29	)	)	PUNCT
ihlr-16572	100	30	.	.	PUNCT
ihlr-16572	101	1	25	25	NUM
ihlr-16572	101	2	.	.	X
ihlr-16572	102	1	jd	jd	PROPN
ihlr-16572	102	2	.	.	PUNCT
ihlr-16572	103	1	at	at	ADP
ihlr-16572	103	2	127	127	NUM
ihlr-16572	103	3	.	.	PUNCT
ihlr-16572	104	1	26	26	NUM
ihlr-16572	104	2	.	.	PUNCT
ihlr-16572	104	3	arachu	arachu	PROPN
ihlr-16572	104	4	castro	castro	PROPN
ihlr-16572	104	5	&	&	CCONJ
ihlr-16572	104	6	michael	michael	PROPN
ihlr-16572	104	7	westerhaus	westerhaus	PROPN
ihlr-16572	104	8	,	,	PUNCT
ihlr-16572	104	9	how	how	SCONJ
ihlr-16572	104	10	do	do	AUX
ihlr-16572	104	11	intellectual	intellectual	ADJ
ihlr-16572	104	12	property	property	NOUN
ihlr-16572	104	13	law	law	NOUN
ihlr-16572	104	14	and	and	CCONJ
ihlr-16572	104	15	international	international	ADJ
ihlr-16572	104	16	trade	trade	NOUN
ihlr-16572	104	17	agreements	agreement	NOUN
ihlr-16572	104	18	affect	affect	VERB
ihlr-16572	104	19	access	access	NOUN
ihlr-16572	104	20	to	to	ADP
ihlr-16572	104	21	antiretroviral	antiretroviral	ADJ
ihlr-16572	104	22	therapy	therapy	NOUN
ihlr-16572	104	23	?	?	PUNCT
ihlr-16572	105	1	,	,	PUNCT
ihlr-16572	105	2	3	3	NUM
ihlr-16572	105	3	plos	plo	NOUN
ihlr-16572	105	4	med	med	PROPN
ihlr-16572	105	5	.	.	PUNCT
ihlr-16572	105	6	1230	1230	NUM
ihlr-16572	105	7	,	,	PUNCT
ihlr-16572	105	8	1233	1233	NUM
ihlr-16572	105	9	-	-	SYM
ihlr-16572	105	10	34	34	NUM
ihlr-16572	105	11	(	(	PUNCT
ihlr-16572	105	12	2006	2006	NUM
ihlr-16572	105	13	)	)	PUNCT
ihlr-16572	105	14	,	,	PUNCT
ihlr-16572	105	15	available	available	ADJ
ihlr-16572	105	16	at	at	ADP
ihlr-16572	105	17	http://www.plosmedicine.org/article/info%3adoi%2f10	http://www.plosmedicine.org/article/info%3adoi%2f10	NUM
ihlr-16572	105	18	.	.	PUNCT
ihlr-16572	106	1	1371	1371	NUM
ihlr-16572	106	2	%	%	NOUN
ihlr-16572	106	3	2fjournal.pmed.0030332	2fjournal.pmed.0030332	NOUN
ihlr-16572	106	4	(	(	PUNCT
ihlr-16572	106	5	last	last	ADV
ihlr-16572	106	6	visited	visit	VERB
ihlr-16572	106	7	mar	mar	PROPN
ihlr-16572	106	8	.	.	PROPN
ihlr-16572	106	9	3	3	NUM
ihlr-16572	106	10	,	,	PUNCT
ihlr-16572	106	11	2010	2010	NUM
ihlr-16572	106	12	)	)	PUNCT
ihlr-16572	106	13	(	(	PUNCT
ihlr-16572	106	14	discussing	discuss	VERB
ihlr-16572	106	15	united	united	PROPN
ihlr-16572	106	16	states	states	PROPN
ihlr-16572	106	17	policies	policy	NOUN
ihlr-16572	106	18	addressing	address	VERB
ihlr-16572	106	19	the	the	DET
ihlr-16572	106	20	need	need	NOUN
ihlr-16572	106	21	to	to	PART
ihlr-16572	106	22	increase	increase	VERB
ihlr-16572	106	23	treatment	treatment	NOUN
ihlr-16572	106	24	for	for	ADP
ihlr-16572	106	25	mv	mv	PROPN
ihlr-16572	106	26	in	in	ADP
ihlr-16572	106	27	the	the	DET
ihlr-16572	106	28	u.s	u.s	PROPN
ihlr-16572	106	29	.	.	PROPN
ihlr-16572	106	30	and	and	CCONJ
ihlr-16572	106	31	in	in	ADP
ihlr-16572	106	32	foreign	foreign	ADJ
ihlr-16572	106	33	countries	country	NOUN
ihlr-16572	106	34	)	)	PUNCT
ihlr-16572	106	35	.	.	PUNCT
ihlr-16572	107	1	27	27	NUM
ihlr-16572	107	2	.	.	X
ihlr-16572	107	3	castro	castro	PROPN
ihlr-16572	107	4	&	&	CCONJ
ihlr-16572	107	5	westerhaus	westerhaus	PROPN
ihlr-16572	107	6	,	,	PUNCT
ihlr-16572	107	7	supra	supra	PROPN
ihlr-16572	107	8	note	note	PROPN
ihlr-16572	107	9	26	26	NUM
ihlr-16572	107	10	,	,	PUNCT
ihlr-16572	107	11	at	at	ADP
ihlr-16572	107	12	1232	1232	NUM
ihlr-16572	107	13	.	.	PUNCT
ihlr-16572	108	1	28	28	NUM
ihlr-16572	108	2	.	.	PUNCT
ihlr-16572	109	1	see	see	VERB
ihlr-16572	109	2	laurence	laurence	PROPN
ihlr-16572	109	3	j.	j.	PROPN
ihlr-16572	109	4	kotlikoft	kotlikoft	PROPN
ihlr-16572	109	5	stimulating	stimulate	VERB
ihlr-16572	109	6	innovation	innovation	NOUN
ihlr-16572	109	7	in	in	ADP
ihlr-16572	109	8	1he	1he	ADJ
ihlr-16572	109	9	biologics	biologic	NOUN
ihlr-16572	109	10	industry	industry	NOUN
ihlr-16572	109	11	:	:	PUNCT
ihlr-16572	109	12	a	a	DET
ihlr-16572	109	13	balanced	balanced	ADJ
ihlr-16572	109	14	approach	approach	NOUN
ihlr-16572	109	15	to	to	ADP
ihlr-16572	109	16	1\tf.arketing	1\tf.arketing	NOUN
ihlr-16572	109	17	exclusivoy	exclusivoy	NOUN
ihlr-16572	109	18	1	1	NUM
ihlr-16572	109	19	(	(	PUNCT
ihlr-16572	109	20	teva	teva	PROPN
ihlr-16572	109	21	usa	usa	PROPN
ihlr-16572	109	22	government	government	PROPN
ihlr-16572	109	23	affilirs	affilir	NOUN
ihlr-16572	109	24	)	)	PUNCT
ihlr-16572	109	25	(	(	PUNCT
ihlr-16572	109	26	2008	2008	NUM
ihlr-16572	109	27	)	)	PUNCT
ihlr-16572	109	28	available	available	ADJ
ihlr-16572	109	29	at	at	ADP
ihlr-16572	109	30	http:/lwww.kotlikoft	http:/lwww.kotlikoft	ADV
ihlr-16572	109	31	:	:	PUNCT
ihlr-16572	109	32	netlsitesldefuult	netlsitesldefuult	ADJ
ihlr-16572	109	33	/	/	SYM
ihlr-16572	109	34	files	file	NOUN
ihlr-16572	109	35	/	/	SYM
ihlr-16572	109	36	kotlikoff	kotlikoff	NOUN
ihlr-16572	109	37	_	_	NOUN
ihlr-16572	109	38	innovation	innovation	NOUN
ihlr-16572	109	39	_	_	PUNCT
ihlr-16572	110	1	in	in	ADP
ihlr-16572	110	2	_	_	PUNCT
ihlr-16572	110	3	biologics21.pdf	biologics21.pdf	NOUN
ihlr-16572	110	4	(	(	PUNCT
ihlr-16572	110	5	last	last	ADJ
ihlr-16572	110	6	visited	visit	VERB
ihlr-16572	110	7	mar	mar	PROPN
ihlr-16572	110	8	.	.	PROPN
ihlr-16572	110	9	6	6	NUM
ihlr-16572	110	10	,	,	PUNCT
ihlr-16572	110	11	2010	2010	NUM
ihlr-16572	110	12	)	)	PUNCT
ihlr-16572	110	13	(	(	PUNCT
ihlr-16572	110	14	asserting	assert	VERB
ihlr-16572	110	15	that	that	SCONJ
ihlr-16572	110	16	"	"	PUNCT
ihlr-16572	110	17	competition	competition	NOUN
ihlr-16572	110	18	,	,	PUNCT
ihlr-16572	110	19	not	not	PART
ihlr-16572	110	20	protection	protection	NOUN
ihlr-16572	110	21	,	,	PUNCT
ihlr-16572	110	22	is	be	AUX
ihlr-16572	110	23	the	the	DET
ihlr-16572	110	24	1rue	1rue	ADJ
ihlr-16572	110	25	source	source	NOUN
ihlr-16572	110	26	of	of	ADP
ihlr-16572	110	27	innova­	innova­	NOUN
ihlr-16572	110	28	tion	tion	NOUN
ihlr-16572	110	29	and	and	CCONJ
ihlr-16572	110	30	.	.	PUNCT
ihlr-16572	110	31	.	.	PUNCT
ihlr-16572	110	32	.	.	PUNCT
ihlr-16572	111	1	overextending	overextend	VERB
ihlr-16572	111	2	monopoly	monopoly	NOUN
ihlr-16572	111	3	protection	protection	NOUN
ihlr-16572	111	4	can	can	AUX
ihlr-16572	111	5	be	be	AUX
ihlr-16572	111	6	couiltel	couiltel	NOUN
ihlr-16572	111	7	:	:	PUNCT
ihlr-16572	111	8	producve	producve	NOUN
ihlr-16572	111	9	"	"	PUNCT
ihlr-16572	111	10	i	i	PROPN
ihlr-16572	111	11	d	d	PROPN
ihlr-16572	111	12	)	)	PUNCT
ihlr-16572	111	13	.	.	PUNCT
ihlr-16572	112	1	372	372	NUM
ihlr-16572	112	2	indiana	indiana	PROPN
ihlr-16572	112	3	health	health	PROPN
ihlr-16572	112	4	law	law	PROPN
ihlr-16572	112	5	review	review	NOUN
ihlr-16572	112	6	bio	bio	NOUN
ihlr-16572	112	7	strongly	strongly	ADV
ihlr-16572	112	8	supports	support	VERB
ihlr-16572	112	9	bipartisan	bipartisan	ADJ
ihlr-16572	112	10	efforts	effort	NOUN
ihlr-16572	112	11	to	to	PART
ihlr-16572	112	12	pass	pass	VERB
ihlr-16572	112	13	legis­	legis­	ADJ
ihlr-16572	112	14	lation	lation	NOUN
ihlr-16572	112	15	to	to	PART
ihlr-16572	112	16	create	create	VERB
ihlr-16572	112	17	a	a	DET
ihlr-16572	112	18	pathway	pathway	NOUN
ihlr-16572	112	19	for	for	ADP
ihlr-16572	112	20	approval	approval	NOUN
ihlr-16572	112	21	of	of	ADP
ihlr-16572	112	22	follow	follow	VERB
ihlr-16572	112	23	-	-	PUNCT
ihlr-16572	112	24	on	on	ADP
ihlr-16572	112	25	biologics	biologic	NOUN
ihlr-16572	112	26	this	this	DET
ihlr-16572	112	27	year	year	NOUN
ihlr-16572	112	28	.	.	PUNCT
ihlr-16572	113	1	this	this	DET
ihlr-16572	113	2	issue	issue	NOUN
ihlr-16572	113	3	is	be	AUX
ihlr-16572	113	4	too	too	ADV
ihlr-16572	113	5	important	important	ADJ
ihlr-16572	113	6	to	to	PART
ihlr-16572	113	7	sub­	sub­	VERB
ihlr-16572	113	8	ject	ject	PROPN
ihlr-16572	113	9	to	to	ADP
ihlr-16572	113	10	special	special	ADJ
ihlr-16572	113	11	-	-	PUNCT
ihlr-16572	113	12	interest	interest	NOUN
ihlr-16572	113	13	politics	politic	NOUN
ihlr-16572	113	14	and	and	CCONJ
ihlr-16572	113	15	misinformation	misinformation	NOUN
ihlr-16572	113	16	campaigns	campaign	NOUN
ihlr-16572	113	17	.	.	PUNCT
ihlr-16572	114	1	patients	patient	NOUN
ihlr-16572	114	2	,	,	PUNCT
ihlr-16572	114	3	employers	employer	NOUN
ihlr-16572	114	4	,	,	PUNCT
ihlr-16572	114	5	and	and	CCONJ
ihlr-16572	114	6	public	public	ADJ
ihlr-16572	114	7	programs	program	NOUN
ihlr-16572	114	8	such	such	ADJ
ihlr-16572	114	9	as	as	ADP
ihlr-16572	114	10	medicare	medicare	PROPN
ihlr-16572	114	11	have	have	AUX
ihlr-16572	114	12	waited	wait	VERB
ihlr-16572	114	13	long	long	ADV
ihlr-16572	114	14	enough	enough	ADV
ihlr-16572	114	15	.	.	PUNCT
ihlr-16572	115	1	the	the	DET
ihlr-16572	115	2	time	time	NOUN
ihlr-16572	115	3	for	for	ADP
ihlr-16572	115	4	responsible	responsible	ADJ
ihlr-16572	115	5	follow	follow	NOUN
ihlr-16572	115	6	-	-	PUNCT
ihlr-16572	115	7	on	on	ADP
ihlr-16572	115	8	biologics	biologic	NOUN
ihlr-16572	115	9	legislation	legislation	NOUN
ihlr-16572	115	10	is	be	AUX
ihlr-16572	115	11	29	29	NUM
ihlr-16572	115	12	now	now	ADV
ihlr-16572	115	13	.	.	PUNCT
ihlr-16572	116	1	[	[	X
ihlr-16572	116	2	vol	vol	NOUN
ihlr-16572	116	3	.	.	PUNCT
ihlr-16572	117	1	7:367	7:367	NUM
ihlr-16572	117	2	this	this	DET
ihlr-16572	117	3	note	note	NOUN
ihlr-16572	117	4	will	will	AUX
ihlr-16572	117	5	provide	provide	VERB
ihlr-16572	117	6	background	background	NOUN
ihlr-16572	117	7	information	information	NOUN
ihlr-16572	117	8	regarding	regard	VERB
ihlr-16572	117	9	biologics	biologic	NOUN
ihlr-16572	117	10	and	and	CCONJ
ihlr-16572	117	11	their	their	PRON
ihlr-16572	117	12	importance	importance	NOUN
ihlr-16572	117	13	in	in	ADP
ihlr-16572	117	14	our	our	PRON
ihlr-16572	117	15	health	health	NOUN
ihlr-16572	117	16	care	care	NOUN
ihlr-16572	117	17	system	system	NOUN
ihlr-16572	117	18	.	.	PUNCT
ihlr-16572	118	1	this	this	DET
ihlr-16572	118	2	note	note	NOUN
ihlr-16572	118	3	will	will	AUX
ihlr-16572	118	4	then	then	ADV
ihlr-16572	118	5	assess	assess	VERB
ihlr-16572	118	6	the	the	DET
ihlr-16572	118	7	position	position	NOUN
ihlr-16572	118	8	of	of	ADP
ihlr-16572	118	9	those	those	DET
ihlr-16572	118	10	groups	group	NOUN
ihlr-16572	118	11	with	with	ADP
ihlr-16572	118	12	the	the	DET
ihlr-16572	118	13	greatest	great	ADJ
ihlr-16572	118	14	interest	interest	NOUN
ihlr-16572	118	15	in	in	ADP
ihlr-16572	118	16	follow	follow	NOUN
ihlr-16572	118	17	-	-	PUNCT
ihlr-16572	118	18	on	on	ADP
ihlr-16572	118	19	biologics	biologic	NOUN
ihlr-16572	118	20	legislation	legislation	NOUN
ihlr-16572	118	21	.	.	PUNCT
ihlr-16572	119	1	finally	finally	ADV
ihlr-16572	119	2	,	,	PUNCT
ihlr-16572	119	3	this	this	DET
ihlr-16572	119	4	note	note	NOUN
ihlr-16572	119	5	will	will	AUX
ihlr-16572	119	6	analyze	analyze	VERB
ihlr-16572	119	7	how	how	SCONJ
ihlr-16572	119	8	congress	congress	PROPN
ihlr-16572	119	9	should	should	AUX
ihlr-16572	119	10	seek	seek	VERB
ihlr-16572	119	11	to	to	PART
ihlr-16572	119	12	strike	strike	VERB
ihlr-16572	119	13	a	a	DET
ihlr-16572	119	14	balance	balance	NOUN
ihlr-16572	119	15	between	between	ADP
ihlr-16572	119	16	innovation	innovation	NOUN
ihlr-16572	119	17	and	and	CCONJ
ihlr-16572	119	18	competition	competition	NOUN
ihlr-16572	119	19	in	in	ADP
ihlr-16572	119	20	order	order	NOUN
ihlr-16572	119	21	to	to	PART
ihlr-16572	119	22	make	make	VERB
ihlr-16572	119	23	af­	af­	ADJ
ihlr-16572	119	24	fordable	fordable	ADJ
ihlr-16572	119	25	biologics	biologic	NOUN
ihlr-16572	119	26	a	a	DET
ihlr-16572	119	27	reality	reality	NOUN
ihlr-16572	119	28	.	.	PUNCT
ihlr-16572	120	1	the	the	DET
ihlr-16572	120	2	benefits	benefit	NOUN
ihlr-16572	120	3	to	to	PART
ihlr-16572	120	4	be	be	AUX
ihlr-16572	120	5	gained	gain	VERB
ihlr-16572	120	6	are	be	AUX
ihlr-16572	120	7	too	too	ADV
ihlr-16572	120	8	great	great	ADJ
ihlr-16572	120	9	,	,	PUNCT
ihlr-16572	120	10	and	and	CCONJ
ihlr-16572	120	11	the	the	DET
ihlr-16572	120	12	consequences	consequence	NOUN
ihlr-16572	120	13	of	of	ADP
ihlr-16572	120	14	inaction	inaction	NOUN
ihlr-16572	120	15	are	be	AUX
ihlr-16572	120	16	too	too	ADV
ihlr-16572	120	17	dire	dire	ADJ
ihlr-16572	120	18	,	,	PUNCT
ihlr-16572	120	19	for	for	ADP
ihlr-16572	120	20	further	further	ADJ
ihlr-16572	120	21	delay	delay	NOUN
ihlr-16572	120	22	in	in	ADP
ihlr-16572	120	23	the	the	DET
ihlr-16572	120	24	passage	passage	NOUN
ihlr-16572	120	25	of	of	ADP
ihlr-16572	120	26	effective	effective	ADJ
ihlr-16572	120	27	follow	follow	NOUN
ihlr-16572	120	28	-	-	PUNCT
ihlr-16572	120	29	on	on	ADP
ihlr-16572	120	30	biologics	biologic	NOUN
ihlr-16572	120	31	legislation	legislation	NOUN
ihlr-16572	120	32	.	.	PUNCT
ihlr-16572	121	1	ii	ii	PROPN
ihlr-16572	121	2	.	.	PUNCT
ihlr-16572	121	3	background	background	PROPN
ihlr-16572	121	4	a.	a.	NOUN
ihlr-16572	121	5	biologics	biologic	NOUN
ihlr-16572	121	6	the	the	DET
ihlr-16572	121	7	term	term	NOUN
ihlr-16572	121	8	"	"	PUNCT
ihlr-16572	121	9	biologics	biologic	NOUN
ihlr-16572	121	10	"	"	PUNCT
ihlr-16572	121	11	generally	generally	ADV
ihlr-16572	121	12	refers	refer	VERB
ihlr-16572	121	13	to	to	ADP
ihlr-16572	121	14	a	a	DET
ihlr-16572	121	15	class	class	NOUN
ihlr-16572	121	16	of	of	ADP
ihlr-16572	121	17	medications	medication	NOUN
ihlr-16572	121	18	which	which	PRON
ihlr-16572	121	19	are	be	AUX
ihlr-16572	121	20	derived	derive	VERB
ihlr-16572	121	21	from	from	ADP
ihlr-16572	121	22	living	live	VERB
ihlr-16572	121	23	organisms	organism	NOUN
ihlr-16572	121	24	using	use	VERB
ihlr-16572	121	25	recombinant	recombinant	ADJ
ihlr-16572	121	26	dna	dna	NOUN
ihlr-16572	121	27	technology?0	technology?0	PROPN
ihlr-16572	121	28	although	although	SCONJ
ihlr-16572	121	29	biologics	biologic	NOUN
ihlr-16572	121	30	are	be	AUX
ihlr-16572	121	31	used	use	VERB
ihlr-16572	121	32	to	to	PART
ihlr-16572	121	33	treat	treat	VERB
ihlr-16572	121	34	a	a	DET
ihlr-16572	121	35	wide	wide	ADJ
ihlr-16572	121	36	range	range	NOUN
ihlr-16572	121	37	of	of	ADP
ihlr-16572	121	38	medical	medical	ADJ
ihlr-16572	121	39	conditions	condition	NOUN
ihlr-16572	121	40	,	,	PUNCT
ihlr-16572	121	41	they	they	PRON
ihlr-16572	121	42	are	be	AUX
ihlr-16572	121	43	most	most	ADV
ihlr-16572	121	44	prevalent	prevalent	ADJ
ihlr-16572	121	45	in	in	ADP
ihlr-16572	121	46	the	the	DET
ihlr-16572	121	47	areas	area	NOUN
ihlr-16572	121	48	of	of	ADP
ihlr-16572	121	49	immunological	immunological	ADJ
ihlr-16572	121	50	disease	disease	NOUN
ihlr-16572	121	51	,	,	PUNCT
ihlr-16572	121	52	cancer	cancer	NOUN
ihlr-16572	121	53	,	,	PUNCT
ihlr-16572	121	54	car­	car­	NOUN
ihlr-16572	121	55	diology	diology	NOUN
ihlr-16572	121	56	,	,	PUNCT
ihlr-16572	121	57	gastroenterology	gastroenterology	NOUN
ihlr-16572	121	58	,	,	PUNCT
ihlr-16572	121	59	neurology	neurology	NOUN
ihlr-16572	121	60	,	,	PUNCT
ihlr-16572	121	61	and	and	CCONJ
ihlr-16572	121	62	others.31	others.31	VERB
ihlr-16572	121	63	the	the	DET
ihlr-16572	121	64	high	high	ADJ
ihlr-16572	121	65	price	price	NOUN
ihlr-16572	121	66	tag	tag	NOUN
ihlr-16572	121	67	these	these	DET
ihlr-16572	121	68	drugs	drug	NOUN
ihlr-16572	121	69	carry	carry	VERB
ihlr-16572	121	70	with	with	ADP
ihlr-16572	121	71	them	they	PRON
ihlr-16572	121	72	,	,	PUNCT
ihlr-16572	121	73	however	however	ADV
ihlr-16572	121	74	,	,	PUNCT
ihlr-16572	121	75	present	present	ADJ
ihlr-16572	121	76	serious	serious	ADJ
ihlr-16572	121	77	budgetary	budgetary	ADJ
ihlr-16572	121	78	and	and	CCONJ
ihlr-16572	121	79	regula­	regula­	PROPN
ihlr-16572	121	80	tory	tory	NOUN
ihlr-16572	121	81	concerns	concern	NOUN
ihlr-16572	121	82	,	,	PUNCT
ihlr-16572	121	83	particularlt	particularlt	NOUN
ihlr-16572	121	84	because	because	SCONJ
ihlr-16572	121	85	they	they	PRON
ihlr-16572	121	86	are	be	AUX
ihlr-16572	121	87	often	often	ADV
ihlr-16572	121	88	used	use	VERB
ihlr-16572	121	89	for	for	ADP
ihlr-16572	121	90	long	long	ADJ
ihlr-16572	121	91	-	-	PUNCT
ihlr-16572	121	92	term	term	NOUN
ihlr-16572	121	93	treat­	treat­	DET
ihlr-16572	121	94	ment	ment	NOUN
ihlr-16572	121	95	of	of	ADP
ihlr-16572	121	96	chronic	chronic	ADJ
ihlr-16572	121	97	diseases	disease	NOUN
ihlr-16572	121	98	.	.	PUNCT
ihlr-16572	122	1	2	2	NUM
ihlr-16572	122	2	for	for	ADP
ihlr-16572	122	3	example	example	NOUN
ihlr-16572	122	4	,	,	PUNCT
ihlr-16572	122	5	cerezyme	cerezyme	NOUN
ihlr-16572	122	6	,	,	PUNCT
ihlr-16572	122	7	a	a	DET
ihlr-16572	122	8	biologic	biologic	NOUN
ihlr-16572	122	9	used	use	VERB
ihlr-16572	122	10	to	to	PART
ihlr-16572	122	11	treat	treat	VERB
ihlr-16572	122	12	gaucher	gaucher	PROPN
ihlr-16572	122	13	's	's	PART
ihlr-16572	122	14	disease	disease	NOUN
ihlr-16572	122	15	,	,	PUNCT
ihlr-16572	122	16	costs	cost	VERB
ihlr-16572	122	17	approximately	approximately	ADV
ihlr-16572	122	18	$	$	SYM
ihlr-16572	122	19	200,000	200,000	NUM
ihlr-16572	122	20	per	per	ADP
ihlr-16572	122	21	patient	patient	ADJ
ihlr-16572	122	22	annually?3	annually?3	NOUN
ihlr-16572	122	23	some	some	PRON
ihlr-16572	122	24	of	of	ADP
ihlr-16572	122	25	the	the	DET
ihlr-16572	122	26	most	most	ADV
ihlr-16572	122	27	widely	widely	ADV
ihlr-16572	122	28	prescribed	prescribe	VERB
ihlr-16572	122	29	biologics	biologic	NOUN
ihlr-16572	122	30	(	(	PUNCT
ihlr-16572	122	31	and	and	CCONJ
ihlr-16572	122	32	their	their	PRON
ihlr-16572	122	33	main	main	ADJ
ihlr-16572	122	34	use	use	NOUN
ihlr-16572	122	35	)	)	PUNCT
ihlr-16572	122	36	in­	in­	NOUN
ihlr-16572	122	37	clude	clude	NOUN
ihlr-16572	122	38	bristol	bristol	NOUN
ihlr-16572	122	39	-	-	PUNCT
ihlr-16572	122	40	myers	myers	PROPN
ihlr-16572	122	41	squibb	squibb	PROPN
ihlr-16572	122	42	's	's	PART
ihlr-16572	122	43	orencia	orencia	NOUN
ihlr-16572	122	44	(	(	PUNCT
ihlr-16572	122	45	rheumatoid	rheumatoid	VERB
ihlr-16572	122	46	arthritis	arthritis	NOUN
ihlr-16572	122	47	treatment	treatment	NOUN
ihlr-16572	122	48	)	)	PUNCT
ihlr-16572	122	49	,	,	PUNCT
ihlr-16572	122	50	29	29	NUM
ihlr-16572	122	51	.	.	PUNCT
ihlr-16572	123	1	press	press	NOUN
ihlr-16572	123	2	release	release	NOUN
ihlr-16572	123	3	,	,	PUNCT
ihlr-16572	123	4	biotechnology	biotechnology	NOUN
ihlr-16572	123	5	industry	industry	NOUN
ihlr-16572	123	6	organization	organization	NOUN
ihlr-16572	123	7	,	,	PUNCT
ihlr-16572	123	8	setting	set	VERB
ihlr-16572	123	9	the	the	DET
ihlr-16572	123	10	record	record	NOUN
ihlr-16572	123	11	straight	straight	ADV
ihlr-16572	123	12	:	:	PUNCT
ihlr-16572	123	13	ge­	ge­	PROPN
ihlr-16572	123	14	neric	neric	ADJ
ihlr-16572	123	15	drug	drug	NOUN
ihlr-16572	123	16	industry	industry	NOUN
ihlr-16572	123	17	lobby	lobby	NOUN
ihlr-16572	123	18	'	'	PUNCT
ihlr-16572	123	19	flat	flat	ADJ
ihlr-16572	123	20	out	out	ADV
ihlr-16572	123	21	wrong	wrong	ADJ
ihlr-16572	123	22	'	'	PUNCT
ihlr-16572	123	23	about	about	ADP
ihlr-16572	123	24	bio	bio	PROPN
ihlr-16572	123	25	position	position	NOUN
ihlr-16572	123	26	on	on	ADP
ihlr-16572	123	27	follow	follow	NOUN
ihlr-16572	123	28	-	-	PUNCT
ihlr-16572	123	29	on	on	ADP
ihlr-16572	123	30	biologics	biologic	NOUN
ihlr-16572	123	31	(	(	PUNCT
ihlr-16572	123	32	april	april	PROPN
ihlr-16572	123	33	i	i	PRON
ihlr-16572	123	34	,	,	PUNCT
ihlr-16572	123	35	2008	2008	NUM
ihlr-16572	123	36	)	)	PUNCT
ihlr-16572	123	37	.	.	PUNCT
ihlr-16572	124	1	available	available	ADJ
ihlr-16572	124	2	at	at	ADP
ihlr-16572	124	3	ht1p://bio.orglnews/pressreleaseslnewsitem.asp?id=2008	ht1p://bio.orglnews/pressreleaseslnewsitem.asp?id=2008	NOUN
ihlr-16572	124	4	_	_	NOUN
ihlr-16572	124	5	0401	0401	NUM
ihlr-16572	125	1	_	_	PUNCT
ihlr-16572	125	2	02&p	02&p	NOUN
ihlr-16572	125	3	--	--	PUNCT
ihlr-16572	125	4	yes	yes	INTJ
ihlr-16572	125	5	(	(	PUNCT
ihlr-16572	125	6	last	last	ADJ
ihlr-16572	125	7	visited	visit	VERB
ihlr-16572	125	8	oct	oct	PROPN
ihlr-16572	125	9	.	.	PROPN
ihlr-16572	125	10	28	28	NUM
ihlr-16572	125	11	,	,	PUNCT
ihlr-16572	125	12	2009	2009	NUM
ihlr-16572	125	13	)	)	PUNCT
ihlr-16572	126	1	[	[	X
ihlr-16572	126	2	hereinafter	hereinafter	NOUN
ihlr-16572	126	3	"	"	PUNCT
ihlr-16572	126	4	bio	bio	NOUN
ihlr-16572	126	5	press	press	NOUN
ihlr-16572	126	6	release	release	NOUN
ihlr-16572	126	7	i'1	i'1	NOUN
ihlr-16572	126	8	.	.	PUNCT
ihlr-16572	127	1	30	30	NUM
ihlr-16572	127	2	.	.	PUNCT
ihlr-16572	128	1	see	see	VERB
ihlr-16572	128	2	press	press	NOUN
ihlr-16572	128	3	release	release	NOUN
ihlr-16572	128	4	,	,	PUNCT
ihlr-16572	128	5	generic	generic	ADJ
ihlr-16572	128	6	pharmaceutical	pharmaceutical	PROPN
ihlr-16572	128	7	association	association	NOUN
ihlr-16572	128	8	,	,	PUNCT
ihlr-16572	128	9	gpha	gpha	ADJ
ihlr-16572	128	10	statement	statement	NOUN
ihlr-16572	128	11	on	on	ADP
ihlr-16572	128	12	bio	bio	PROPN
ihlr-16572	128	13	's	's	PART
ihlr-16572	128	14	flawed	flawed	ADJ
ihlr-16572	128	15	data	datum	NOUN
ihlr-16572	128	16	exclusivity	exclusivity	NOUN
ihlr-16572	128	17	white	white	PROPN
ihlr-16572	128	18	paper	paper	NOUN
ihlr-16572	128	19	(	(	PUNCT
ihlr-16572	128	20	january	january	PROPN
ihlr-16572	128	21	30	30	NUM
ihlr-16572	128	22	,	,	PUNCT
ihlr-16572	128	23	2009	2009	NUM
ihlr-16572	128	24	)	)	PUNCT
ihlr-16572	128	25	,	,	PUNCT
ihlr-16572	128	26	available	available	ADJ
ihlr-16572	128	27	at	at	ADP
ihlr-16572	128	28	http://	http://	PROPN
ihlr-16572	128	29	www.gphaonline.org/print/media/press-releases/2009/gpha-statement-bios-flawed-data­	www.gphaonline.org/print/media/press-releases/2009/gpha-statement-bios-flawed-data­	PUNCT
ihlr-16572	128	30	exclusivity	exclusivity	NOUN
ihlr-16572	128	31	-	-	PUNCT
ihlr-16572	128	32	white	white	ADJ
ihlr-16572	128	33	-	-	PUNCT
ihlr-16572	128	34	paper	paper	NOUN
ihlr-16572	128	35	(	(	PUNCT
ihlr-16572	128	36	last	last	ADV
ihlr-16572	128	37	visited	visit	VERB
ihlr-16572	128	38	oct	oct	PROPN
ihlr-16572	128	39	.	.	PROPN
ihlr-16572	128	40	28	28	NUM
ihlr-16572	128	41	,	,	PUNCT
ihlr-16572	128	42	2009	2009	NUM
ihlr-16572	128	43	)	)	PUNCT
ihlr-16572	129	1	[	[	X
ihlr-16572	129	2	hereinafter	hereinafter	NOUN
ihlr-16572	129	3	"	"	PUNCT
ihlr-16572	129	4	gpha	gpha	ADJ
ihlr-16572	129	5	press	press	NOUN
ihlr-16572	129	6	release	release	NOUN
ihlr-16572	129	7	i	i	PRON
ihlr-16572	129	8	"	"	PUNCT
ihlr-16572	129	9	]	]	X
ihlr-16572	129	10	;	;	PUNCT
ihlr-16572	129	11	bio	bio	PROPN
ihlr-16572	129	12	press	press	PROPN
ihlr-16572	129	13	release	release	NOUN
ihlr-16572	129	14	i	i	PROPN
ihlr-16572	129	15	,	,	PUNCT
ihlr-16572	129	16	supra	supra	PROPN
ihlr-16572	129	17	note	note	NOUN
ihlr-16572	129	18	29	29	NUM
ihlr-16572	129	19	.	.	PUNCT
ihlr-16572	129	20	31	31	NUM
ihlr-16572	129	21	.	.	PUNCT
ihlr-16572	130	1	phrma	phrma	PROPN
ihlr-16572	130	2	report	report	NOUN
ihlr-16572	130	3	,	,	PUNCT
ihlr-16572	130	4	supra	supra	PROPN
ihlr-16572	130	5	note	note	NOUN
ihlr-16572	130	6	5	5	NUM
ihlr-16572	130	7	,	,	PUNCT
ihlr-16572	130	8	at	at	ADP
ihlr-16572	130	9	i.	i.	PROPN
ihlr-16572	130	10	32	32	NUM
ihlr-16572	130	11	.	.	PUNCT
ihlr-16572	131	1	thomas	thomas	PROPN
ihlr-16572	131	2	morrow	morrow	PROPN
ihlr-16572	131	3	,	,	PUNCT
ihlr-16572	131	4	m.d	m.d	PROPN
ihlr-16572	131	5	.	.	PROPN
ihlr-16572	131	6	,	,	PUNCT
ihlr-16572	131	7	five	five	NUM
ihlr-16572	131	8	steps	step	NOUN
ihlr-16572	131	9	to	to	ADP
ihlr-16572	131	10	managing	manage	VERB
ihlr-16572	131	11	biologics	biologic	NOUN
ihlr-16572	131	12	,	,	PUNCT
ihlr-16572	131	13	2004	2004	NUM
ihlr-16572	131	14	biotechnology	biotechnology	NOUN
ihlr-16572	131	15	healthcare	healthcare	PROPN
ihlr-16572	131	16	20	20	NUM
ihlr-16572	131	17	,	,	PUNCT
ihlr-16572	131	18	20	20	NUM
ihlr-16572	131	19	-	-	SYM
ihlr-16572	131	20	26	26	NUM
ihlr-16572	131	21	.	.	PUNCT
ihlr-16572	132	1	33	33	NUM
ihlr-16572	132	2	.	.	PUNCT
ihlr-16572	133	1	health	health	NOUN
ihlr-16572	133	2	premium	premium	NOUN
ihlr-16572	133	3	hikes	hike	NOUN
ihlr-16572	133	4	tied	tie	VERB
ihlr-16572	133	5	to	to	ADP
ihlr-16572	133	6	costly	costly	ADJ
ihlr-16572	133	7	specialty	specialty	NOUN
ihlr-16572	133	8	drugs	drug	NOUN
ihlr-16572	133	9	,	,	PUNCT
ihlr-16572	133	10	supra	supra	NOUN
ihlr-16572	133	11	note	note	NOUN
ihlr-16572	133	12	1	1	NUM
ihlr-16572	133	13	.	.	X
ihlr-16572	133	14	2010	2010	NUM
ihlr-16572	133	15	]	]	PUNCT
ihlr-16572	133	16	follow	follow	VERB
ihlr-16572	133	17	-	-	PUNCT
ihlr-16572	133	18	on	on	ADP
ihlr-16572	133	19	biologics	biologic	NOUN
ihlr-16572	133	20	legislation	legislation	NOUN
ihlr-16572	133	21	373	373	NUM
ihlr-16572	133	22	amgen	amgen	PROPN
ihlr-16572	133	23	's	's	PART
ihlr-16572	133	24	epogen	epogen	NOUN
ihlr-16572	133	25	(	(	PUNCT
ihlr-16572	133	26	treatment	treatment	NOUN
ihlr-16572	133	27	of	of	ADP
ihlr-16572	133	28	anemia	anemia	NOUN
ihlr-16572	133	29	arising	arise	VERB
ihlr-16572	133	30	from	from	ADP
ihlr-16572	133	31	cancer	cancer	NOUN
ihlr-16572	133	32	chemotherapy	chemotherapy	NOUN
ihlr-16572	133	33	)	)	PUNCT
ihlr-16572	133	34	,	,	PUNCT
ihlr-16572	133	35	genentech	genentech	NOUN
ihlr-16572	133	36	's	's	PART
ihlr-16572	133	37	herceptin	herceptin	PROPN
ihlr-16572	133	38	(	(	PUNCT
ihlr-16572	133	39	breast	breast	NOUN
ihlr-16572	133	40	cancer	cancer	NOUN
ihlr-16572	133	41	treatment	treatment	NOUN
ihlr-16572	133	42	)	)	PUNCT
ihlr-16572	133	43	,	,	PUNCT
ihlr-16572	133	44	human	human	ADJ
ihlr-16572	133	45	insulin	insulin	NOUN
ihlr-16572	133	46	(	(	PUNCT
ihlr-16572	133	47	diabetes	diabetes	NOUN
ihlr-16572	133	48	management	management	NOUN
ihlr-16572	133	49	)	)	PUNCT
ihlr-16572	133	50	,	,	PUNCT
ihlr-16572	133	51	and	and	CCONJ
ihlr-16572	133	52	human	human	ADJ
ihlr-16572	133	53	growth	growth	NOUN
ihlr-16572	133	54	hormone	hormone	NOUN
ihlr-16572	133	55	(	(	PUNCT
ihlr-16572	133	56	various	various	ADJ
ihlr-16572	133	57	uses).34	uses).34	NOUN
ihlr-16572	133	58	the	the	DET
ihlr-16572	133	59	preva­	preva­	NOUN
ihlr-16572	133	60	lence	lence	NOUN
ihlr-16572	133	61	of	of	ADP
ihlr-16572	133	62	these	these	DET
ihlr-16572	133	63	drugs	drug	NOUN
ihlr-16572	133	64	,	,	PUNCT
ihlr-16572	133	65	and	and	CCONJ
ihlr-16572	133	66	the	the	DET
ihlr-16572	133	67	great	great	ADJ
ihlr-16572	133	68	potential	potential	NOUN
ihlr-16572	133	69	associated	associate	VERB
ihlr-16572	133	70	with	with	ADP
ihlr-16572	133	71	them	they	PRON
ihlr-16572	133	72	,	,	PUNCT
ihlr-16572	133	73	illustrates	illustrate	VERB
ihlr-16572	133	74	the	the	DET
ihlr-16572	133	75	urgency	urgency	NOUN
ihlr-16572	133	76	for	for	ADP
ihlr-16572	133	77	comprehensive	comprehensive	ADJ
ihlr-16572	133	78	legislation	legislation	NOUN
ihlr-16572	133	79	to	to	PART
ihlr-16572	133	80	ensure	ensure	VERB
ihlr-16572	133	81	affordability	affordability	NOUN
ihlr-16572	133	82	and	and	CCONJ
ihlr-16572	133	83	en­	en­	NOUN
ihlr-16572	133	84	courage	courage	NOUN
ihlr-16572	133	85	innovation	innovation	NOUN
ihlr-16572	133	86	.	.	PUNCT
ihlr-16572	134	1	b.	b.	PROPN
ihlr-16572	134	2	health	health	PROPN
ihlr-16572	134	3	care	care	NOUN
ihlr-16572	134	4	expenditures	expenditure	NOUN
ihlr-16572	134	5	associated	associate	VERB
ihlr-16572	134	6	with	with	ADP
ihlr-16572	134	7	biologics	biologic	NOUN
ihlr-16572	134	8	increasing	increase	VERB
ihlr-16572	134	9	in	in	ADP
ihlr-16572	134	10	both	both	PRON
ihlr-16572	134	11	number	number	NOUN
ihlr-16572	134	12	and	and	CCONJ
ihlr-16572	134	13	effectiveness	effectiveness	NOUN
ihlr-16572	134	14	,	,	PUNCT
ihlr-16572	134	15	prescription	prescription	NOUN
ihlr-16572	134	16	drugs	drug	NOUN
ihlr-16572	134	17	play	play	VERB
ihlr-16572	134	18	a	a	DET
ihlr-16572	134	19	significant	significant	ADJ
ihlr-16572	134	20	role	role	NOUN
ihlr-16572	134	21	in	in	ADP
ihlr-16572	134	22	our	our	PRON
ihlr-16572	134	23	nation	nation	NOUN
ihlr-16572	134	24	's	's	PART
ihlr-16572	134	25	$	$	SYM
ihlr-16572	134	26	2	2	NUM
ihlr-16572	134	27	trillion	trillion	NUM
ihlr-16572	134	28	health	health	NOUN
ihlr-16572	134	29	care	care	NOUN
ihlr-16572	134	30	system.35	system.35	NOUN
ihlr-16572	134	31	currently	currently	ADV
ihlr-16572	134	32	,	,	PUNCT
ihlr-16572	134	33	prescription	prescription	NOUN
ihlr-16572	134	34	drug	drug	NOUN
ihlr-16572	134	35	expenditures	expenditure	NOUN
ihlr-16572	134	36	comprise	comprise	VERB
ihlr-16572	134	37	one	one	NUM
ihlr-16572	134	38	-	-	PUNCT
ihlr-16572	134	39	tenth	tenth	NOUN
ihlr-16572	134	40	of	of	ADP
ihlr-16572	134	41	total	total	ADJ
ihlr-16572	134	42	healthcare	healthcare	PROPN
ihlr-16572	134	43	ex­	ex­	PROPN
ihlr-16572	134	44	penditures	penditure	VERB
ihlr-16572	134	45	nationwide	nationwide	ADV
ihlr-16572	134	46	,	,	PUNCT
ihlr-16572	134	47	compared	compare	VERB
ihlr-16572	134	48	with	with	ADP
ihlr-16572	134	49	one	one	NUM
ihlr-16572	134	50	-	-	PUNCT
ihlr-16572	134	51	twentieth	twentieth	NOUN
ihlr-16572	134	52	of	of	ADP
ihlr-16572	134	53	health	health	NOUN
ihlr-16572	134	54	care	care	PROPN
ihlr-16572	134	55	expendi­	expendi­	PROPN
ihlr-16572	134	56	tures	ture	NOUN
ihlr-16572	134	57	in	in	ADP
ihlr-16572	134	58	1980?6	1980?6	NUM
ihlr-16572	134	59	biologics	biologic	NOUN
ihlr-16572	134	60	are	be	AUX
ihlr-16572	134	61	being	be	AUX
ihlr-16572	134	62	used	use	VERB
ihlr-16572	134	63	to	to	PART
ihlr-16572	134	64	treat	treat	VERB
ihlr-16572	134	65	more	more	ADJ
ihlr-16572	134	66	than	than	ADP
ihlr-16572	134	67	800	800	NUM
ihlr-16572	134	68	million	million	NUM
ihlr-16572	134	69	patients	patient	NOUN
ihlr-16572	134	70	worldwide?7	worldwide?7	VERB
ihlr-16572	134	71	according	accord	VERB
ihlr-16572	134	72	to	to	ADP
ihlr-16572	134	73	a	a	DET
ihlr-16572	134	74	recent	recent	ADJ
ihlr-16572	134	75	study	study	NOUN
ihlr-16572	134	76	,	,	PUNCT
ihlr-16572	134	77	biologic	biologic	ADJ
ihlr-16572	134	78	sales	sale	NOUN
ihlr-16572	134	79	world­	world­	NOUN
ihlr-16572	134	80	wide	wide	ADV
ihlr-16572	134	81	increased	increase	VERB
ihlr-16572	134	82	twelve	twelve	NUM
ihlr-16572	134	83	and	and	CCONJ
ihlr-16572	134	84	one	one	NUM
ihlr-16572	134	85	-	-	PUNCT
ihlr-16572	134	86	half	half	NOUN
ihlr-16572	134	87	percent	percent	NOUN
ihlr-16572	134	88	in	in	ADP
ihlr-16572	134	89	2007	2007	NUM
ihlr-16572	134	90	,	,	PUNCT
ihlr-16572	134	91	amounting	amount	VERB
ihlr-16572	134	92	to	to	ADP
ihlr-16572	134	93	more	more	ADJ
ihlr-16572	134	94	than	than	ADP
ihlr-16572	134	95	$	$	SYM
ihlr-16572	134	96	75	75	NUM
ihlr-16572	134	97	billion	billion	NUM
ihlr-16572	134	98	,	,	PUNCT
ihlr-16572	134	99	which	which	PRON
ihlr-16572	134	100	is	be	AUX
ihlr-16572	134	101	an	an	DET
ihlr-16572	134	102	increase	increase	NOUN
ihlr-16572	134	103	twice	twice	ADV
ihlr-16572	134	104	as	as	ADV
ihlr-16572	134	105	much	much	ADJ
ihlr-16572	134	106	as	as	ADP
ihlr-16572	134	107	in	in	ADP
ihlr-16572	134	108	chemical	chemical	ADJ
ihlr-16572	134	109	dru~	dru~	ADJ
ihlr-16572	134	110	sales.38	sales.38	NOUN
ihlr-16572	134	111	spending	spend	VERB
ihlr-16572	134	112	on	on	ADP
ihlr-16572	134	113	biologics	biologic	NOUN
ihlr-16572	134	114	is	be	AUX
ihlr-16572	134	115	expected	expect	VERB
ihlr-16572	134	116	to	to	PART
ihlr-16572	134	117	reach	reach	VERB
ihlr-16572	134	118	$	$	SYM
ihlr-16572	134	119	90	90	NUM
ihlr-16572	134	120	billion	billion	NUM
ihlr-16572	134	121	by	by	ADP
ihlr-16572	134	122	2009.3	2009.3	NUM
ihlr-16572	134	123	the	the	DET
ihlr-16572	134	124	centers	center	NOUN
ihlr-16572	134	125	for	for	ADP
ihlr-16572	134	126	medicare	medicare	PROPN
ihlr-16572	134	127	and	and	CCONJ
ihlr-16572	134	128	medicaid	medicaid	PROPN
ihlr-16572	134	129	services	service	NOUN
ihlr-16572	134	130	(	(	PUNCT
ihlr-16572	134	131	"	"	PUNCT
ihlr-16572	134	132	cms	cms	NOUN
ihlr-16572	134	133	"	"	PUNCT
ihlr-16572	134	134	)	)	PUNCT
ihlr-16572	134	135	,	,	PUNCT
ihlr-16572	134	136	states	state	VERB
ihlr-16572	134	137	that	that	SCONJ
ihlr-16572	134	138	the	the	DET
ihlr-16572	134	139	top	top	ADJ
ihlr-16572	134	140	two	two	NUM
ihlr-16572	134	141	anemia	anemia	NOUN
ihlr-16572	134	142	drugs	drug	NOUN
ihlr-16572	134	143	,	,	PUNCT
ihlr-16572	134	144	both	both	DET
ihlr-16572	134	145	biologics	biologic	NOUN
ihlr-16572	134	146	,	,	PUNCT
ihlr-16572	134	147	accounted	account	VERB
ihlr-16572	134	148	for	for	ADP
ihlr-16572	134	149	17	17	NUM
ihlr-16572	134	150	percent	percent	NOUN
ihlr-16572	134	151	of	of	ADP
ihlr-16572	134	152	all	all	DET
ihlr-16572	134	153	medi­	medi­	PROPN
ihlr-16572	134	154	care	care	NOUN
ihlr-16572	134	155	part	part	PROPN
ihlr-16572	134	156	b	b	PROPN
ihlr-16572	134	157	carrier	carrier	NOUN
ihlr-16572	134	158	drug	drug	NOUN
ihlr-16572	134	159	spending	spending	NOUN
ihlr-16572	134	160	in	in	ADP
ihlr-16572	134	161	fiscal	fiscal	ADJ
ihlr-16572	134	162	year	year	NOUN
ihlr-16572	134	163	2005	2005	NUM
ihlr-16572	134	164	,	,	PUNCT
ihlr-16572	134	165	and	and	CCONJ
ihlr-16572	134	166	two	two	NUM
ihlr-16572	134	167	other	other	ADJ
ihlr-16572	134	168	biolog­	biolog­	PROPN
ihlr-16572	134	169	ics	ics	NOUN
ihlr-16572	134	170	for	for	ADP
ihlr-16572	134	171	rheumatoid	rheumatoid	NOUN
ihlr-16572	134	172	arthritis	arthritis	NOUN
ihlr-16572	134	173	and	and	CCONJ
ihlr-16572	134	174	cancer	cancer	NOUN
ihlr-16572	134	175	accounted	account	VERB
ihlr-16572	134	176	for	for	ADP
ihlr-16572	134	177	an	an	DET
ihlr-16572	134	178	additional	additional	ADJ
ihlr-16572	134	179	13	13	NUM
ihlr-16572	134	180	percent	percent	NOUN
ihlr-16572	134	181	of	of	ADP
ihlr-16572	134	182	all	all	DET
ihlr-16572	134	183	carrier	carrier	NOUN
ihlr-16572	134	184	spending.40	spending.40	PROPN
ihlr-16572	134	185	due	due	ADP
ihlr-16572	134	186	to	to	ADP
ihlr-16572	134	187	tremendous	tremendous	ADJ
ihlr-16572	134	188	advances	advance	NOUN
ihlr-16572	134	189	in	in	ADP
ihlr-16572	134	190	medicine	medicine	NOUN
ihlr-16572	134	191	,	,	PUNCT
ihlr-16572	134	192	life	life	NOUN
ihlr-16572	134	193	expectancy	expectancy	NOUN
ihlr-16572	134	194	in	in	ADP
ihlr-16572	134	195	america	america	PROPN
ihlr-16572	134	196	has	have	AUX
ihlr-16572	134	197	increased	increase	VERB
ihlr-16572	134	198	greatly	greatly	ADV
ihlr-16572	134	199	,	,	PUNCT
ihlr-16572	134	200	resulting	result	VERB
ihlr-16572	134	201	in	in	ADP
ihlr-16572	134	202	a	a	DET
ihlr-16572	134	203	life	life	NOUN
ihlr-16572	134	204	expectancy	expectancy	NOUN
ihlr-16572	134	205	in	in	ADP
ihlr-16572	134	206	the	the	DET
ihlr-16572	134	207	upper	upper	ADJ
ihlr-16572	134	208	70	70	NUM
ihlr-16572	134	209	's	's	PART
ihlr-16572	134	210	for	for	ADP
ihlr-16572	134	211	34	34	NUM
ihlr-16572	134	212	.	.	PUNCT
ihlr-16572	135	1	phrma	phrma	PROPN
ihlr-16572	135	2	report	report	NOUN
ihlr-16572	135	3	,	,	PUNCT
ihlr-16572	135	4	supra	supra	PROPN
ihlr-16572	135	5	note	note	NOUN
ihlr-16572	135	6	5	5	NUM
ihlr-16572	135	7	,	,	PUNCT
ihlr-16572	135	8	at	at	ADP
ihlr-16572	135	9	5	5	NUM
ihlr-16572	135	10	,	,	PUNCT
ihlr-16572	135	11	6	6	NUM
ihlr-16572	135	12	,	,	PUNCT
ihlr-16572	135	13	12	12	NUM
ihlr-16572	135	14	,	,	PUNCT
ihlr-16572	135	15	23	23	NUM
ihlr-16572	135	16	,	,	PUNCT
ihlr-16572	135	17	and	and	CCONJ
ihlr-16572	136	1	26	26	NUM
ihlr-16572	136	2	.	.	NOUN
ihlr-16572	136	3	35	35	NUM
ihlr-16572	136	4	.	.	PUNCT
ihlr-16572	136	5	centers	center	NOUN
ihlr-16572	136	6	for	for	ADP
ihlr-16572	136	7	medicare	medicare	PROPN
ihlr-16572	136	8	and	and	CCONJ
ihlr-16572	136	9	medicaid	medicaid	PROPN
ihlr-16572	136	10	services	services	PROPN
ihlr-16572	136	11	,	,	PUNCT
ihlr-16572	136	12	national	national	ADJ
ihlr-16572	136	13	health	health	NOUN
ihlr-16572	136	14	expenditures	expenditure	NOUN
ihlr-16572	136	15	ac­	ac­	PUNCT
ihlr-16572	136	16	counts	count	NOUN
ihlr-16572	136	17	:	:	PUNCT
ihlr-16572	137	1	definitions	definition	NOUN
ihlr-16572	137	2	,	,	PUNCT
ihlr-16572	137	3	sources	source	NOUN
ihlr-16572	137	4	and	and	CCONJ
ihlr-16572	137	5	methods	method	NOUN
ihlr-16572	137	6	23	23	NUM
ihlr-16572	137	7	(	(	PUNCT
ihlr-16572	137	8	2008	2008	NUM
ihlr-16572	137	9	)	)	PUNCT
ihlr-16572	137	10	,	,	PUNCT
ihlr-16572	137	11	available	available	ADJ
ihlr-16572	137	12	at	at	ADP
ihlr-16572	137	13	http://www	http://www	PROPN
ihlr-16572	137	14	.	.	PUNCT
ihlr-16572	138	1	cms.hhs.gov/nationa1healthexpenddata/downloadsldsm-08.pdf	cms.hhs.gov/nationa1healthexpenddata/downloadsldsm-08.pdf	NOUN
ihlr-16572	138	2	(	(	PUNCT
ihlr-16572	138	3	last	last	ADV
ihlr-16572	138	4	visited	visit	VERB
ihlr-16572	138	5	mar	mar	PROPN
ihlr-16572	138	6	.	.	PROPN
ihlr-16572	138	7	4	4	NUM
ihlr-16572	138	8	,	,	PUNCT
ihlr-16572	138	9	201	201	NUM
ihlr-16572	138	10	0	0	NUM
ihlr-16572	138	11	)	)	PUNCT
ihlr-16572	138	12	.	.	PUNCT
ihlr-16572	139	1	36	36	NUM
ihlr-16572	139	2	.	.	X
ihlr-16572	139	3	ld	ld	PROPN
ihlr-16572	139	4	.	.	PUNCT
ihlr-16572	140	1	37	37	NUM
ihlr-16572	140	2	.	.	PUNCT
ihlr-16572	140	3	biotechnology	biotechnology	NOUN
ihlr-16572	140	4	industry	industry	NOUN
ihlr-16572	140	5	organization	organization	NOUN
ihlr-16572	140	6	,	,	PUNCT
ihlr-16572	140	7	milestones	milestone	NOUN
ihlr-16572	140	8	2006	2006	NUM
ihlr-16572	140	9	:	:	PUNCT
ihlr-16572	141	1	health	health	NOUN
ihlr-16572	141	2	,	,	PUNCT
ihlr-16572	141	3	http://www.bio	http://www.bio	NOUN
ihlr-16572	141	4	.	.	PUNCT
ihlr-16572	141	5	orglspeeches	orglspeeche	NOUN
ihlr-16572	141	6	/	/	SYM
ihlr-16572	141	7	pubs	pub	NOUN
ihlr-16572	141	8	/	/	SYM
ihlr-16572	141	9	milestone06	milestone06	NOUN
ihlr-16572	141	10	/	/	SYM
ihlr-16572	141	11	health.asp	health.asp	X
ihlr-16572	141	12	(	(	PUNCT
ihlr-16572	141	13	last	last	ADV
ihlr-16572	141	14	visited	visit	VERB
ihlr-16572	141	15	jan	jan	PROPN
ihlr-16572	141	16	.	.	PROPN
ihlr-16572	141	17	5	5	NUM
ihlr-16572	141	18	,	,	PUNCT
ihlr-16572	141	19	2009	2009	NUM
ihlr-16572	141	20	)	)	PUNCT
ihlr-16572	141	21	.	.	PUNCT
ihlr-16572	142	1	38	38	NUM
ihlr-16572	142	2	.	.	PUNCT
ihlr-16572	143	1	press	press	NOUN
ihlr-16572	143	2	release	release	NOUN
ihlr-16572	143	3	,	,	PUNCT
ihlr-16572	143	4	ims	ims	PROPN
ihlr-16572	143	5	health	health	NOUN
ihlr-16572	143	6	,	,	PUNCT
ihlr-16572	143	7	ims	ims	PROPN
ihlr-16572	143	8	health	health	NOUN
ihlr-16572	143	9	reports	report	NOUN
ihlr-16572	143	10	global	global	ADJ
ihlr-16572	143	11	biotech	biotech	ADJ
ihlr-16572	143	12	sales	sale	NOUN
ihlr-16572	143	13	grew	grow	VERB
ihlr-16572	143	14	12.5	12.5	NUM
ihlr-16572	143	15	percent	percent	NOUN
ihlr-16572	143	16	in	in	ADP
ihlr-16572	143	17	2007	2007	NUM
ihlr-16572	143	18	,	,	PUNCT
ihlr-16572	143	19	exceeding	exceed	VERB
ihlr-16572	143	20	$	$	SYM
ihlr-16572	143	21	75	75	NUM
ihlr-16572	143	22	billion	billion	NUM
ihlr-16572	143	23	(	(	PUNCT
ihlr-16572	143	24	june	june	PROPN
ihlr-16572	143	25	17	17	NUM
ihlr-16572	143	26	,	,	PUNCT
ihlr-16572	143	27	2008	2008	NUM
ihlr-16572	143	28	)	)	PUNCT
ihlr-16572	143	29	,	,	PUNCT
ihlr-16572	143	30	available	available	ADJ
ihlr-16572	143	31	at	at	ADP
ihlr-16572	143	32	http://www.imshealth	http://www.imshealth	PROPN
ihlr-16572	144	1	.	.	PUNCT
ihlr-16572	144	2	com	com	PROPN
ihlr-16572	144	3	(	(	PUNCT
ihlr-16572	144	4	select	select	ADJ
ihlr-16572	144	5	"	"	PUNCT
ihlr-16572	144	6	press	press	NOUN
ihlr-16572	144	7	room	room	NOUN
ihlr-16572	144	8	"	"	PUNCT
ihlr-16572	144	9	in	in	ADP
ihlr-16572	144	10	top	top	ADJ
ihlr-16572	144	11	right	right	ADJ
ihlr-16572	144	12	comer	comer	NOUN
ihlr-16572	144	13	,	,	PUNCT
ihlr-16572	144	14	then	then	ADV
ihlr-16572	144	15	select	select	VERB
ihlr-16572	144	16	''	''	PUNCT
ihlr-16572	144	17	press	press	NOUN
ihlr-16572	144	18	releases	release	NOUN
ihlr-16572	144	19	"	"	PUNCT
ihlr-16572	144	20	in	in	ADP
ihlr-16572	144	21	column	column	NOUN
ihlr-16572	144	22	to	to	PART
ihlr-16572	144	23	left	left	VERB
ihlr-16572	144	24	,	,	PUNCT
ihlr-16572	144	25	then	then	ADV
ihlr-16572	144	26	select	select	VERB
ihlr-16572	144	27	"	"	PUNCT
ihlr-16572	144	28	2008	2008	NUM
ihlr-16572	144	29	"	"	PUNCT
ihlr-16572	144	30	from	from	ADP
ihlr-16572	144	31	drop	drop	NOUN
ihlr-16572	144	32	-	-	PUNCT
ihlr-16572	144	33	down	down	ADP
ihlr-16572	144	34	menu	menu	NOUN
ihlr-16572	144	35	for	for	ADP
ihlr-16572	144	36	year	year	NOUN
ihlr-16572	144	37	,	,	PUNCT
ihlr-16572	144	38	then	then	ADV
ihlr-16572	144	39	scroll	scroll	VERB
ihlr-16572	144	40	down	down	ADP
ihlr-16572	144	41	and	and	CCONJ
ihlr-16572	144	42	select	select	VERB
ihlr-16572	144	43	"	"	PUNCT
ihlr-16572	144	44	ims	im	NOUN
ihlr-16572	144	45	health	health	NOUN
ihlr-16572	144	46	reports	report	NOUN
ihlr-16572	144	47	global	global	ADJ
ihlr-16572	144	48	biotech	biotech	ADJ
ihlr-16572	144	49	sales	sale	NOUN
ihlr-16572	144	50	grew	grow	VERB
ihlr-16572	144	51	12.5	12.5	NUM
ihlr-16572	144	52	percent	percent	NOUN
ihlr-16572	144	53	in	in	ADP
ihlr-16572	144	54	2007	2007	NUM
ihlr-16572	144	55	,	,	PUNCT
ihlr-16572	144	56	exceeding	exceed	VERB
ihlr-16572	144	57	$	$	SYM
ihlr-16572	144	58	75	75	NUM
ihlr-16572	144	59	billion	billion	NUM
ihlr-16572	144	60	"	"	PUNCT
ihlr-16572	144	61	hyperlink	hyperlink	NOUN
ihlr-16572	144	62	)	)	PUNCT
ihlr-16572	144	63	(	(	PUNCT
ihlr-16572	144	64	last	last	ADV
ihlr-16572	144	65	visited	visit	VERB
ihlr-16572	144	66	mar	mar	PROPN
ihlr-16572	144	67	.	.	PROPN
ihlr-16572	144	68	4	4	NUM
ihlr-16572	144	69	,	,	PUNCT
ihlr-16572	144	70	2010	2010	NUM
ihlr-16572	144	71	)	)	PUNCT
ihlr-16572	144	72	.	.	PUNCT
ihlr-16572	145	1	39	39	NUM
ihlr-16572	145	2	.	.	PUNCT
ihlr-16572	146	1	the	the	DET
ihlr-16572	146	2	generic	generic	ADJ
ihlr-16572	146	3	drng	drng	NOUN
ihlr-16572	146	4	maze	maze	NOUN
ihlr-16572	146	5	:	:	PUNCT
ihlr-16572	146	6	speeding	speed	VERB
ihlr-16572	146	7	access	access	NOUN
ihlr-16572	146	8	to	to	ADP
ihlr-16572	146	9	affordable	affordable	ADJ
ihlr-16572	146	10	,	,	PUNCT
ihlr-16572	146	11	life	life	NOUN
ihlr-16572	146	12	saving	save	VERB
ihlr-16572	146	13	drngs	drng	NOUN
ihlr-16572	146	14	:	:	PUNCT
ihlr-16572	146	15	hearing	hear	VERB
ihlr-16572	146	16	on	on	ADP
ihlr-16572	146	17	8.2300	8.2300	NUM
ihlr-16572	146	18	before	before	ADP
ihlr-16572	146	19	the	the	DET
ihlr-16572	146	20	s.	s.	PROPN
ihlr-16572	146	21	special	special	PROPN
ihlr-16572	146	22	comm	comm	NOUN
ihlr-16572	146	23	.	.	PUNCT
ihlr-16572	147	1	on	on	ADP
ihlr-16572	147	2	aging	age	VERB
ihlr-16572	147	3	,	,	PUNCT
ihlr-16572	147	4	109th	109th	ADJ
ihlr-16572	147	5	cong	cong	NOUN
ihlr-16572	147	6	.	.	PUNCT
ihlr-16572	148	1	11	11	NUM
ihlr-16572	148	2	(	(	PUNCT
ihlr-16572	148	3	2006)(statement	2006)(statement	NUM
ihlr-16572	148	4	of	of	ADP
ihlr-16572	148	5	mark	mark	PROPN
ihlr-16572	148	6	merritt	merritt	PROPN
ihlr-16572	148	7	.	.	PUNCT
ihlr-16572	149	1	president	president	PROPN
ihlr-16572	149	2	and	and	CCONJ
ihlr-16572	149	3	chief	chief	ADJ
ihlr-16572	149	4	executive	executive	ADJ
ihlr-16572	149	5	officer	officer	NOUN
ihlr-16572	149	6	,	,	PUNCT
ihlr-16572	149	7	phannaceutical	phannaceutical	ADJ
ihlr-16572	149	8	care	care	NOUN
ihlr-16572	149	9	management	management	PROPN
ihlr-16572	149	10	association	association	PROPN
ihlr-16572	149	11	)	)	PUNCT
ihlr-16572	149	12	,	,	PUNCT
ihlr-16572	149	13	available	available	ADJ
ihlr-16572	149	14	at	at	ADP
ihlr-16572	149	15	http://www.pcmanetorglnewsroom/ju1y%20200617-20-2002/pcmao/o20finalo/o20senate"/o	http://www.pcmanetorglnewsroom/ju1y%20200617-20-2002/pcmao/o20finalo/o20senate"/o	PROPN
ihlr-16572	149	16	20aging0	20aging0	NUM
ihlr-16572	149	17	/	/	SYM
ihlr-16572	149	18	o207%20200	o207%20200	PROPN
ihlr-16572	149	19	/	/	SYM
ihlr-16572	149	20	o2006.pdf(last	o2006.pdf(last	NOUN
ihlr-16572	149	21	visited	visit	VERB
ihlr-16572	149	22	jan	jan	PROPN
ihlr-16572	149	23	.	.	PROPN
ihlr-16572	149	24	15	15	NUM
ihlr-16572	149	25	,	,	PUNCT
ihlr-16572	149	26	2009	2009	NUM
ihlr-16572	149	27	)	)	PUNCT
ihlr-16572	149	28	.	.	PUNCT
ihlr-16572	150	1	40	40	NUM
ihlr-16572	150	2	.	.	PUNCT
ihlr-16572	150	3	payment	payment	NOUN
ihlr-16572	150	4	for	for	ADP
ihlr-16572	150	5	medicare	medicare	PROPN
ihlr-16572	150	6	part	part	PROPN
ihlr-16572	150	7	b	b	NOUN
ihlr-16572	150	8	:	:	PUNCT
ihlr-16572	150	9	hearing	hearing	NOUN
ihlr-16572	150	10	before	before	ADP
ihlr-16572	150	11	h.	h.	PROPN
ihlr-16572	150	12	subcomm	subcomm	PROPN
ihlr-16572	150	13	.	.	PUNCT
ihlr-16572	151	1	on	on	ADP
ihlr-16572	151	2	health	health	NOUN
ihlr-16572	151	3	of	of	ADP
ihlr-16572	151	4	the	the	DET
ihlr-16572	151	5	h.	h.	PROPN
ihlr-16572	151	6	comm	comm	NOUN
ihlr-16572	151	7	.	.	PUNCT
ihlr-16572	152	1	on	on	ADP
ihlr-16572	152	2	ways	way	NOUN
ihlr-16572	152	3	and	and	CCONJ
ihlr-16572	152	4	means	mean	NOUN
ihlr-16572	152	5	,	,	PUNCT
ihlr-16572	152	6	l09th	l09th	PROPN
ihlr-16572	152	7	cong	cong	NOUN
ihlr-16572	152	8	.	.	PUNCT
ihlr-16572	153	1	(	(	PUNCT
ihlr-16572	153	2	2006	2006	NUM
ihlr-16572	153	3	)	)	PUNCT
ihlr-16572	153	4	(	(	PUNCT
ihlr-16572	153	5	statement	statement	NOUN
ihlr-16572	153	6	of	of	ADP
ihlr-16572	153	7	herb	herb	PROPN
ihlr-16572	153	8	kuhn	kuhn	PROPN
ihlr-16572	153	9	,	,	PUNCT
ihlr-16572	153	10	director	director	NOUN
ihlr-16572	153	11	,	,	PUNCT
ihlr-16572	153	12	cmm	cmm	NOUN
ihlr-16572	153	13	)	)	PUNCT
ihlr-16572	153	14	,	,	PUNCT
ihlr-16572	153	15	available	available	ADJ
ihlr-16572	153	16	at	at	ADP
ihlr-16572	153	17	http://www.cn1s.hhs.gov/appslmedialpresslrelease.asp?counter=l904	http://www.cn1s.hhs.gov/appslmedialpresslrelease.asp?counter=l904	PROPN
ihlr-16572	153	18	(	(	PUNCT
ihlr-16572	153	19	last	last	ADJ
ihlr-16572	153	20	vi­	vi­	NOUN
ihlr-16572	153	21	sited	site	VERB
ihlr-16572	153	22	mar	mar	PROPN
ihlr-16572	153	23	.	.	PROPN
ihlr-16572	153	24	4	4	NUM
ihlr-16572	153	25	,	,	PUNCT
ihlr-16572	153	26	2010	2010	NUM
ihlr-16572	153	27	)	)	PUNCT
ihlr-16572	153	28	.	.	PUNCT
ihlr-16572	154	1	374	374	NUM
ihlr-16572	154	2	indiana	indiana	PROPN
ihlr-16572	154	3	health	health	PROPN
ihlr-16572	154	4	law	law	PROPN
ihlr-16572	154	5	review	review	NOUN
ihlr-16572	154	6	[	[	X
ihlr-16572	154	7	vol	vol	NOUN
ihlr-16572	154	8	.	.	PUNCT
ihlr-16572	155	1	7:367	7:367	NUM
ihlr-16572	155	2	americans.41	americans.41	NOUN
ihlr-16572	155	3	because	because	SCONJ
ihlr-16572	155	4	this	this	DET
ihlr-16572	155	5	increase	increase	NOUN
ihlr-16572	155	6	in	in	ADP
ihlr-16572	155	7	life	life	NOUN
ihlr-16572	155	8	expectancy	expectancy	NOUN
ihlr-16572	155	9	is	be	AUX
ihlr-16572	155	10	often	often	ADV
ihlr-16572	155	11	made	make	VERB
ihlr-16572	155	12	possi­	possi­	PROPN
ihlr-16572	155	13	ble·through	ble·through	NOUN
ihlr-16572	155	14	the	the	DET
ihlr-16572	155	15	administration	administration	NOUN
ihlr-16572	155	16	of	of	ADP
ihlr-16572	155	17	biologic	biologic	ADJ
ihlr-16572	155	18	drugs	drug	NOUN
ihlr-16572	155	19	over	over	ADP
ihlr-16572	155	20	an	an	DET
ihlr-16572	155	21	extended	extended	ADJ
ihlr-16572	155	22	period	period	NOUN
ihlr-16572	155	23	of	of	ADP
ihlr-16572	155	24	time	time	NOUN
ihlr-16572	155	25	;	;	PUNCT
ihlr-16572	155	26	the	the	DET
ihlr-16572	155	27	elderly	elderly	ADJ
ihlr-16572	155	28	population	population	NOUN
ihlr-16572	155	29	faces	face	VERB
ihlr-16572	155	30	skyrocketing	skyrocket	VERB
ihlr-16572	155	31	increases	increase	NOUN
ihlr-16572	155	32	in	in	ADP
ihlr-16572	155	33	health	health	NOUN
ihlr-16572	155	34	expendi­	expendi­	PROPN
ihlr-16572	155	35	tures	ture	NOUN
ihlr-16572	155	36	.	.	PUNCT
ihlr-16572	156	1	legislation	legislation	NOUN
ihlr-16572	156	2	allowing	allow	VERB
ihlr-16572	156	3	for	for	ADP
ihlr-16572	156	4	an	an	DET
ihlr-16572	156	5	abbreviated	abbreviate	VERB
ihlr-16572	156	6	regulatory	regulatory	ADJ
ihlr-16572	156	7	pathway	pathway	NOUN
ihlr-16572	156	8	for	for	ADP
ihlr-16572	156	9	fol­	fol­	NOUN
ihlr-16572	156	10	low	low	ADJ
ihlr-16572	156	11	-	-	PUNCT
ihlr-16572	156	12	on	on	ADP
ihlr-16572	156	13	biologics	biologic	NOUN
ihlr-16572	156	14	should	should	AUX
ihlr-16572	156	15	be	be	AUX
ihlr-16572	156	16	a	a	DET
ihlr-16572	156	17	priority	priority	NOUN
ihlr-16572	156	18	for	for	ADP
ihlr-16572	156	19	the	the	DET
ihlr-16572	156	20	new	new	ADJ
ihlr-16572	156	21	administration	administration	NOUN
ihlr-16572	156	22	in	in	ADP
ihlr-16572	156	23	order	order	NOUN
ihlr-16572	156	24	to	to	PART
ihlr-16572	156	25	alleviate	alleviate	VERB
ihlr-16572	156	26	the	the	DET
ihlr-16572	156	27	burdens	burden	NOUN
ihlr-16572	156	28	created	create	VERB
ihlr-16572	156	29	by	by	ADP
ihlr-16572	156	30	the	the	DET
ihlr-16572	156	31	prohibitive	prohibitive	ADJ
ihlr-16572	156	32	costs	cost	NOUN
ihlr-16572	156	33	of	of	ADP
ihlr-16572	156	34	these	these	DET
ihlr-16572	156	35	drugs	drug	NOUN
ihlr-16572	156	36	.	.	PUNCT
ihlr-16572	157	1	experts	expert	NOUN
ihlr-16572	157	2	predict	predict	VERB
ihlr-16572	157	3	that	that	SCONJ
ihlr-16572	157	4	in	in	ADP
ihlr-16572	157	5	coming	come	VERB
ihlr-16572	157	6	years	year	NOUN
ihlr-16572	157	7	half	half	NOUN
ihlr-16572	157	8	of	of	ADP
ihlr-16572	157	9	all	all	DET
ihlr-16572	157	10	newly	newly	ADV
ihlr-16572	157	11	approved	approve	VERB
ihlr-16572	157	12	drugs	drug	NOUN
ihlr-16572	157	13	will	will	AUX
ihlr-16572	157	14	be	be	AUX
ihlr-16572	157	15	.	.	PUNCT
ihlr-16572	158	1	biologics	biologic	NOUN
ihlr-16572	158	2	.	.	PUNCT
ihlr-16572	159	1	42	42	NUM
ihlr-16572	159	2	this	this	DET
ihlr-16572	159	3	increase	increase	NOUN
ihlr-16572	159	4	in	in	ADP
ihlr-16572	159	5	market	market	NOUN
ihlr-16572	159	6	share	share	NOUN
ihlr-16572	159	7	will	will	AUX
ihlr-16572	159	8	serve	serve	VERB
ihlr-16572	159	9	to	to	PART
ihlr-16572	159	10	exacerbate	exacerbate	VERB
ihlr-16572	159	11	the	the	DET
ihlr-16572	159	12	existing	exist	VERB
ihlr-16572	159	13	financial	financial	ADJ
ihlr-16572	159	14	problems	problem	NOUN
ihlr-16572	159	15	stemming	stem	VERB
ihlr-16572	159	16	from	from	ADP
ihlr-16572	159	17	these	these	DET
ihlr-16572	159	18	costly	costly	ADJ
ihlr-16572	159	19	drugs	drug	NOUN
ihlr-16572	159	20	.	.	PUNCT
ihlr-16572	160	1	each	each	DET
ihlr-16572	160	2	new	new	ADJ
ihlr-16572	160	3	safe	safe	ADJ
ihlr-16572	160	4	and	and	CCONJ
ihlr-16572	160	5	effective	effective	ADJ
ihlr-16572	160	6	biologic	biologic	NOUN
ihlr-16572	160	7	is	be	AUX
ihlr-16572	160	8	a	a	DET
ihlr-16572	160	9	victory	victory	NOUN
ihlr-16572	160	10	for	for	ADP
ihlr-16572	160	11	modem	modem	NOUN
ihlr-16572	160	12	medicine	medicine	NOUN
ihlr-16572	160	13	,	,	PUNCT
ihlr-16572	160	14	but	but	CCONJ
ihlr-16572	160	15	the	the	DET
ihlr-16572	160	16	potential	potential	NOUN
ihlr-16572	160	17	of	of	ADP
ihlr-16572	160	18	these	these	DET
ihlr-16572	160	19	drugs	drug	NOUN
ihlr-16572	160	20	will	will	AUX
ihlr-16572	160	21	never	never	ADV
ihlr-16572	160	22	be	be	AUX
ihlr-16572	160	23	realized	realize	VERB
ihlr-16572	160	24	unless	unless	SCONJ
ihlr-16572	160	25	they	they	PRON
ihlr-16572	160	26	are	be	AUX
ihlr-16572	160	27	made	make	VERB
ihlr-16572	160	28	relative­	relative­	PRON
ihlr-16572	160	29	ly	ly	ADP
ihlr-16572	160	30	affordable.43	affordable.43	PROPN
ihlr-16572	160	31	absent	absent	ADJ
ihlr-16572	160	32	calculated	calculate	VERB
ihlr-16572	160	33	measures	measure	NOUN
ihlr-16572	160	34	by	by	ADP
ihlr-16572	160	35	congress	congress	PROPN
ihlr-16572	160	36	to	to	PART
ihlr-16572	160	37	decrease	decrease	VERB
ihlr-16572	160	38	the	the	DET
ihlr-16572	160	39	cost	cost	NOUN
ihlr-16572	160	40	of	of	ADP
ihlr-16572	160	41	biologics	biologic	NOUN
ihlr-16572	160	42	,	,	PUNCT
ihlr-16572	160	43	their	their	PRON
ihlr-16572	160	44	life	life	NOUN
ihlr-16572	160	45	-	-	PUNCT
ihlr-16572	160	46	saving	save	VERB
ihlr-16572	160	47	capabilities	capability	NOUN
ihlr-16572	160	48	will	will	AUX
ihlr-16572	160	49	be	be	AUX
ihlr-16572	160	50	available	available	ADJ
ihlr-16572	160	51	only	only	ADV
ihlr-16572	160	52	to	to	ADP
ihlr-16572	160	53	those	those	PRON
ihlr-16572	160	54	fortunate	fortunate	ADJ
ihlr-16572	160	55	enough	enough	ADV
ihlr-16572	160	56	to	to	PART
ihlr-16572	160	57	afford	afford	VERB
ihlr-16572	160	58	the	the	DET
ihlr-16572	160	59	high	high	ADJ
ihlr-16572	160	60	cost	cost	NOUN
ihlr-16572	160	61	,	,	PUNCT
ihlr-16572	160	62	or	or	CCONJ
ihlr-16572	160	63	those	those	PRON
ihlr-16572	160	64	with	with	ADP
ihlr-16572	160	65	exceptional	exceptional	ADJ
ihlr-16572	160	66	health	health	NOUN
ihlr-16572	160	67	benefits	benefit	NOUN
ihlr-16572	160	68	.	.	PUNCT
ihlr-16572	161	1	c.	c.	NOUN
ihlr-16572	161	2	competing	compete	VERB
ihlr-16572	161	3	views	view	NOUN
ihlr-16572	161	4	regardingfollow	regardingfollow	NOUN
ihlr-16572	161	5	-	-	PUNCT
ihlr-16572	161	6	on	on	ADP
ihlr-16572	161	7	biologics	biologic	NOUN
ihlr-16572	161	8	the	the	DET
ihlr-16572	161	9	debate	debate	NOUN
ihlr-16572	161	10	regarding	regard	VERB
ihlr-16572	161	11	whether	whether	SCONJ
ihlr-16572	161	12	generic	generic	ADJ
ihlr-16572	161	13	biologics	biologic	NOUN
ihlr-16572	161	14	should	should	AUX
ihlr-16572	161	15	be	be	AUX
ihlr-16572	161	16	approved	approve	VERB
ihlr-16572	161	17	by	by	ADP
ihlr-16572	161	18	fda	fda	PROPN
ihlr-16572	161	19	centers	center	NOUN
ihlr-16572	161	20	around	around	ADP
ihlr-16572	161	21	two	two	NUM
ihlr-16572	161	22	main	main	ADJ
ihlr-16572	161	23	areas	area	NOUN
ihlr-16572	161	24	of	of	ADP
ihlr-16572	161	25	contention	contention	NOUN
ihlr-16572	161	26	:	:	PUNCT
ihlr-16572	161	27	1	1	X
ihlr-16572	161	28	)	)	PUNCT
ihlr-16572	161	29	whether	whether	SCONJ
ihlr-16572	161	30	it	it	PRON
ihlr-16572	161	31	is	be	AUX
ihlr-16572	161	32	feasi­	feasi­	NOUN
ihlr-16572	161	33	ble	ble	ADJ
ihlr-16572	161	34	for	for	ADP
ihlr-16572	161	35	generic	generic	ADJ
ihlr-16572	161	36	drug	drug	NOUN
ihlr-16572	161	37	companies	company	NOUN
ihlr-16572	161	38	to	to	PART
ihlr-16572	161	39	replicate	replicate	VERB
ihlr-16572	161	40	name	name	NOUN
ihlr-16572	161	41	brand	brand	NOUN
ihlr-16572	161	42	biologics	biologic	NOUN
ihlr-16572	161	43	safely	safely	ADV
ihlr-16572	161	44	and	and	CCONJ
ihlr-16572	161	45	effectively	effectively	ADV
ihlr-16572	161	46	;	;	PUNCT
ihlr-16572	161	47	and	and	CCONJ
ihlr-16572	161	48	2	2	X
ihlr-16572	161	49	)	)	PUNCT
ihlr-16572	161	50	whether	whether	SCONJ
ihlr-16572	161	51	the	the	DET
ihlr-16572	161	52	introduction	introduction	NOUN
ihlr-16572	161	53	of	of	ADP
ihlr-16572	161	54	generic	generic	ADJ
ihlr-16572	161	55	biologics	biologic	NOUN
ihlr-16572	161	56	into	into	ADP
ihlr-16572	161	57	the	the	DET
ihlr-16572	161	58	marketplace	marketplace	NOUN
ihlr-16572	161	59	will	will	AUX
ihlr-16572	161	60	destroy	destroy	VERB
ihlr-16572	161	61	name	name	NOUN
ihlr-16572	161	62	brand	brand	NOUN
ihlr-16572	161	63	drug	drug	NOUN
ihlr-16572	161	64	companies	company	NOUN
ihlr-16572	161	65	'	'	PART
ihlr-16572	161	66	incentive	incentive	NOUN
ihlr-16572	161	67	to	to	PART
ihlr-16572	161	68	innovate	innovate	VERB
ihlr-16572	161	69	by	by	ADP
ihlr-16572	161	70	rendering	render	VERB
ihlr-16572	161	71	the	the	DET
ihlr-16572	161	72	drugs	drug	NOUN
ihlr-16572	161	73	unprofitable.44	unprofitable.44	NOUN
ihlr-16572	161	74	·	·	PUNCT
ihlr-16572	161	75	not	not	PART
ihlr-16572	161	76	surprisingly	surprisingly	ADV
ihlr-16572	161	77	,	,	PUNCT
ihlr-16572	161	78	viewpoints	viewpoint	NOUN
ihlr-16572	161	79	of	of	ADP
ihlr-16572	161	80	in­	in­	ADJ
ihlr-16572	161	81	terested	tereste	VERB
ihlr-16572	161	82	parties	party	NOUN
ihlr-16572	161	83	on	on	ADP
ihlr-16572	161	84	the	the	DET
ihlr-16572	161	85	viability	viability	NOUN
ihlr-16572	161	86	of	of	ADP
ihlr-16572	161	87	follow	follow	VERB
ihlr-16572	161	88	-	-	PUNCT
ihlr-16572	161	89	on	on	ADP
ihlr-16572	161	90	biologics	biologic	NOUN
ihlr-16572	161	91	,	,	PUNCT
ihlr-16572	161	92	and	and	CCONJ
ihlr-16572	161	93	the	the	DET
ihlr-16572	161	94	effect	effect	NOUN
ihlr-16572	161	95	they	they	PRON
ihlr-16572	161	96	would	would	AUX
ihlr-16572	161	97	have	have	VERB
ihlr-16572	161	98	on	on	ADP
ihlr-16572	161	99	our	our	PRON
ihlr-16572	161	100	nation	nation	NOUN
ihlr-16572	161	101	's	's	PART
ihlr-16572	161	102	health	health	NOUN
ihlr-16572	161	103	care	care	NOUN
ihlr-16572	161	104	system	system	NOUN
ihlr-16572	161	105	,	,	PUNCT
ihlr-16572	161	106	vary	vary	VERB
ihlr-16572	161	107	greatly.45	greatly.45	VERB
ihlr-16572	161	108	generic	generic	ADJ
ihlr-16572	161	109	versions	version	NOUN
ihlr-16572	161	110	of	of	ADP
ihlr-16572	161	111	chemical	chemical	ADJ
ihlr-16572	161	112	drugs	drug	NOUN
ihlr-16572	161	113	,	,	PUNCT
ihlr-16572	161	114	manufactured	manufacture	VERB
ihlr-16572	161	115	using	use	VERB
ihlr-16572	161	116	precise	precise	ADJ
ihlr-16572	161	117	chemical	chemical	NOUN
ihlr-16572	161	118	formulas	formula	NOUN
ihlr-16572	161	119	,	,	PUNCT
ihlr-16572	161	120	reach	reach	VERB
ihlr-16572	161	121	market	market	NOUN
ihlr-16572	161	122	through	through	ADP
ihlr-16572	161	123	the	the	DET
ihlr-16572	161	124	abbreviated	abbreviate	VERB
ihlr-16572	161	125	regulatory	regulatory	ADJ
ihlr-16572	161	126	path­	path­	NUM
ihlr-16572	161	127	way	way	NOUN
ihlr-16572	161	128	provided	provide	VERB
ihlr-16572	161	129	by	by	ADP
ihlr-16572	161	130	the	the	DET
ihlr-16572	161	131	drug	drug	NOUN
ihlr-16572	161	132	price	price	NOUN
ihlr-16572	161	133	competition	competition	NOUN
ihlr-16572	161	134	and	and	CCONJ
ihlr-16572	161	135	patent	patent	NOUN
ihlr-16572	161	136	term	term	NOUN
ihlr-16572	161	137	restoration	restoration	NOUN
ihlr-16572	161	138	act	act	NOUN
ihlr-16572	161	139	,	,	PUNCT
ihlr-16572	161	140	more	more	ADV
ihlr-16572	161	141	commonly	commonly	ADV
ihlr-16572	161	142	referred	refer	VERB
ihlr-16572	161	143	to	to	ADP
ihlr-16572	161	144	as	as	ADP
ihlr-16572	161	145	the	the	DET
ihlr-16572	161	146	hatch	hatch	NOUN
ihlr-16572	161	147	-	-	PUNCT
ihlr-16572	161	148	waxman	waxman	NOUN
ihlr-16572	161	149	act.46	act.46	NOUN
ihlr-16572	161	150	the	the	DET
ihlr-16572	161	151	generic	generic	ADJ
ihlr-16572	161	152	41	41	NUM
ihlr-16572	161	153	.	.	PUNCT
ihlr-16572	162	1	arialdi	arialdi	PROPN
ihlr-16572	162	2	m.	m.	PROPN
ihlr-16572	162	3	miniflo	miniflo	PROPN
ihlr-16572	162	4	,	,	PUNCT
ihlr-16572	162	5	melonie	melonie	PROPN
ihlr-16572	162	6	p.	p.	PROPN
ihlr-16572	162	7	heron	heron	PROPN
ihlr-16572	162	8	&	&	CCONJ
ihlr-16572	162	9	betty	betty	PROPN
ihlr-16572	162	10	l.	l.	PROPN
ihlr-16572	162	11	smith	smith	PROPN
ihlr-16572	162	12	.	.	PUNCT
ihlr-16572	163	1	deaths	death	NOUN
ihlr-16572	163	2	:	:	PUNCT
ihlr-16572	163	3	preliminary	preliminary	ADJ
ihlr-16572	163	4	data	datum	NOUN
ihlr-16572	163	5	for	for	ADP
ihlr-16572	163	6	2004	2004	NUM
ihlr-16572	163	7	,	,	PUNCT
ihlr-16572	163	8	nat'l	nat'l	NOUN
ihlr-16572	163	9	vital	vital	ADJ
ihlr-16572	163	10	stat	stat	NOUN
ihlr-16572	163	11	.	.	PUNCT
ihlr-16572	164	1	rep	rep	PROPN
ihlr-16572	164	2	.	.	PROPN
ihlr-16572	164	3	,	,	PUNCT
ihlr-16572	164	4	june	june	PROPN
ihlr-16572	164	5	28	28	NUM
ihlr-16572	164	6	,	,	PUNCT
ihlr-16572	164	7	2006	2006	NUM
ihlr-16572	164	8	,	,	PUNCT
ihlr-16572	164	9	at	at	ADP
ihlr-16572	164	10	3	3	NUM
ihlr-16572	164	11	,	,	PUNCT
ihlr-16572	164	12	available	available	ADJ
ihlr-16572	164	13	aj	aj	PROPN
ihlr-16572	164	14	http://www.cdc.gov/	http://www.cdc.gov/	PROPN
ihlr-16572	164	15	nchs	nch	NOUN
ihlr-16572	164	16	/	/	SYM
ihlr-16572	164	17	data	data	PROPN
ihlr-16572	164	18	/	/	SYM
ihlr-16572	164	19	nvsr	nvsr	NOUN
ihlr-16572	164	20	/	/	SYM
ihlr-16572	164	21	nvsr54	nvsr54	NOUN
ihlr-16572	164	22	/	/	SYM
ihlr-16572	164	23	nvsr54	nvsr54	PROPN
ihlr-16572	164	24	_	_	PROPN
ihlr-16572	164	25	19	19	NUM
ihlr-16572	164	26	.pdf	.pdf	PUNCT
ihlr-16572	165	1	(	(	PUNCT
ihlr-16572	165	2	last	last	ADJ
ihlr-16572	165	3	visited	visit	VERB
ihlr-16572	165	4	mar	mar	PROPN
ihlr-16572	165	5	.	.	PROPN
ihlr-16572	165	6	6	6	NUM
ihlr-16572	165	7	,	,	PUNCT
ihlr-16572	165	8	201	201	NUM
ihlr-16572	165	9	0	0	NUM
ihlr-16572	165	10	)	)	PUNCT
ihlr-16572	165	11	.	.	PUNCT
ihlr-16572	166	1	42	42	NUM
ihlr-16572	166	2	.	.	PUNCT
ihlr-16572	167	1	schacht	schacht	PROPN
ihlr-16572	167	2	,	,	PUNCT
ihlr-16572	167	3	supra	supra	PROPN
ihlr-16572	167	4	note	note	NOUN
ihlr-16572	167	5	10	10	NUM
ihlr-16572	167	6	,	,	PUNCT
ihlr-16572	167	7	at	at	ADP
ihlr-16572	167	8	6	6	NUM
ihlr-16572	167	9	-	-	SYM
ihlr-16572	167	10	8	8	NUM
ihlr-16572	167	11	(	(	PUNCT
ihlr-16572	167	12	highlighting	highlight	VERB
ihlr-16572	167	13	the	the	DET
ihlr-16572	167	14	efficient	efficient	ADJ
ihlr-16572	167	15	production	production	NOUN
ihlr-16572	167	16	of	of	ADP
ihlr-16572	167	17	and	and	CCONJ
ihlr-16572	167	18	grow­	grow­	NOUN
ihlr-16572	167	19	ing	ing	ADJ
ihlr-16572	167	20	need	need	NOUN
ihlr-16572	167	21	for	for	ADP
ihlr-16572	167	22	biologics	biologic	NOUN
ihlr-16572	167	23	)	)	PUNCT
ihlr-16572	167	24	;	;	PUNCT
ihlr-16572	167	25	gina	gina	PROPN
ihlr-16572	167	26	kolata	kolata	PROPN
ihlr-16572	167	27	,	,	PUNCT
ihlr-16572	167	28	co	co	NOUN
ihlr-16572	167	29	-	-	NOUN
ihlr-16572	167	30	payments	payment	NOUN
ihlr-16572	167	31	go	go	VERB
ihlr-16572	167	32	way	way	ADV
ihlr-16572	167	33	up	up	ADV
ihlr-16572	167	34	for	for	ADP
ihlr-16572	167	35	drugs	drug	NOUN
ihlr-16572	167	36	with	with	ADP
ihlr-16572	167	37	high	high	ADJ
ihlr-16572	167	38	prices	price	NOUN
ihlr-16572	167	39	,	,	PUNCT
ihlr-16572	167	40	n.y	n.y	PROPN
ihlr-16572	167	41	.	.	PROPN
ihlr-16572	167	42	times	times	PROPN
ihlr-16572	167	43	,	,	PUNCT
ihlr-16572	167	44	aprill4	aprill4	PROPN
ihlr-16572	167	45	,	,	PUNCT
ihlr-16572	167	46	2008	2008	NUM
ihlr-16572	167	47	(	(	PUNCT
ihlr-16572	167	48	discussing	discuss	VERB
ihlr-16572	167	49	the	the	DET
ihlr-16572	167	50	fact	fact	NOUN
ihlr-16572	167	51	that	that	SCONJ
ihlr-16572	167	52	both	both	PRON
ihlr-16572	167	53	medicare	medicare	PROPN
ihlr-16572	167	54	and	and	CCONJ
ihlr-16572	167	55	private	private	ADJ
ihlr-16572	167	56	insurers	insurer	NOUN
ihlr-16572	167	57	now	now	ADV
ihlr-16572	167	58	offer	offer	VERB
ihlr-16572	167	59	tier	tier	NOUN
ihlr-16572	167	60	4	4	NUM
ihlr-16572	167	61	plans	plan	NOUN
ihlr-16572	167	62	)	)	PUNCT
ihlr-16572	167	63	.	.	PUNCT
ihlr-16572	168	1	43	43	NUM
ihlr-16572	168	2	.	.	PUNCT
ihlr-16572	169	1	see	see	VERB
ihlr-16572	169	2	e.g.	e.g.	ADV
ihlr-16572	169	3	,	,	PUNCT
ihlr-16572	169	4	kolata	kolata	ADJ
ihlr-16572	169	5	,	,	PUNCT
ihlr-16572	169	6	supra	supra	PROPN
ihlr-16572	169	7	note	note	NOUN
ihlr-16572	169	8	42	42	NUM
ihlr-16572	169	9	.	.	PUNCT
ihlr-16572	170	1	44	44	NUM
ihlr-16572	170	2	.	.	PUNCT
ihlr-16572	171	1	see	see	VERB
ihlr-16572	171	2	kotlikoff	kotlikoff	NOUN
ihlr-16572	171	3	,	,	PUNCT
ihlr-16572	171	4	supra	supra	PROPN
ihlr-16572	171	5	note	note	PROPN
ihlr-16572	171	6	28	28	NUM
ihlr-16572	171	7	,	,	PUNCT
ihlr-16572	171	8	at	at	ADP
ihlr-16572	171	9	4	4	NUM
ihlr-16572	171	10	;	;	PUNCT
ihlr-16572	171	11	see	see	VERB
ihlr-16572	171	12	also	also	ADV
ihlr-16572	171	13	e.g.	e.g.	ADV
ihlr-16572	171	14	,	,	PUNCT
ihlr-16572	171	15	gpha	gpha	ADJ
ihlr-16572	171	16	press	press	NOUN
ihlr-16572	171	17	release	release	NOUN
ihlr-16572	171	18	i	i	PRON
ihlr-16572	171	19	,	,	PUNCT
ihlr-16572	171	20	supra	supra	PROPN
ihlr-16572	171	21	note	note	PROPN
ihlr-16572	171	22	30	30	NUM
ihlr-16572	171	23	;	;	PUNCT
ihlr-16572	171	24	bio	bio	PROPN
ihlr-16572	171	25	press	press	PROPN
ihlr-16572	171	26	release	release	NOUN
ihlr-16572	171	27	i	i	PROPN
ihlr-16572	171	28	,	,	PUNCT
ihlr-16572	171	29	supra	supra	PROPN
ihlr-16572	171	30	note	note	NOUN
ihlr-16572	171	31	29	29	NUM
ihlr-16572	171	32	.	.	X
ihlr-16572	172	1	45	45	NUM
ihlr-16572	172	2	.	.	X
ihlr-16572	172	3	compare	compare	PROPN
ihlr-16572	172	4	bio	bio	PROPN
ihlr-16572	172	5	press	press	PROPN
ihlr-16572	172	6	release	release	NOUN
ihlr-16572	173	1	i	i	PROPN
ihlr-16572	173	2	,	,	PUNCT
ihlr-16572	173	3	supra	supra	PROPN
ihlr-16572	173	4	note	note	PROPN
ihlr-16572	173	5	29	29	NUM
ihlr-16572	173	6	(	(	PUNCT
ihlr-16572	173	7	supporting	support	VERB
ihlr-16572	173	8	the	the	DET
ihlr-16572	173	9	idea	idea	NOUN
ihlr-16572	173	10	that	that	SCONJ
ihlr-16572	173	11	legislation	legislation	NOUN
ihlr-16572	173	12	creating	create	VERB
ihlr-16572	173	13	a	a	DET
ihlr-16572	173	14	regulatory	regulatory	ADJ
ihlr-16572	173	15	pathway	pathway	NOUN
ihlr-16572	173	16	for	for	ADP
ihlr-16572	173	17	follow	follow	VERB
ihlr-16572	173	18	-	-	PUNCT
ihlr-16572	173	19	on	on	ADP
ihlr-16572	173	20	biologics	biologic	NOUN
ihlr-16572	173	21	should	should	AUX
ihlr-16572	173	22	require	require	VERB
ihlr-16572	173	23	fourteen	fourteen	NUM
ihlr-16572	173	24	years	year	NOUN
ihlr-16572	173	25	of	of	ADP
ihlr-16572	173	26	data	datum	NOUN
ihlr-16572	173	27	exclusivity	exclusivity	NOUN
ihlr-16572	173	28	)	)	PUNCT
ihlr-16572	173	29	,	,	PUNCT
ihlr-16572	173	30	with	with	ADP
ihlr-16572	173	31	gpha	gpha	ADJ
ihlr-16572	173	32	press	press	NOUN
ihlr-16572	173	33	release	release	NOUN
ihlr-16572	173	34	i	i	PRON
ihlr-16572	173	35	,	,	PUNCT
ihlr-16572	173	36	supra	supra	PROPN
ihlr-16572	173	37	note	note	NOUN
ihlr-16572	173	38	30	30	NUM
ihlr-16572	173	39	(	(	PUNCT
ihlr-16572	173	40	contending	contend	VERB
ihlr-16572	173	41	that	that	SCONJ
ihlr-16572	173	42	exclusivity	exclusivity	NOUN
ihlr-16572	173	43	does	do	AUX
ihlr-16572	173	44	not	not	PART
ihlr-16572	173	45	promote	promote	VERB
ihlr-16572	173	46	a	a	DET
ihlr-16572	173	47	balance	balance	NOUN
ihlr-16572	173	48	between	between	ADP
ihlr-16572	173	49	competition	competition	NOUN
ihlr-16572	173	50	and	and	CCONJ
ihlr-16572	173	51	innovation	innovation	NOUN
ihlr-16572	173	52	)	)	PUNCT
ihlr-16572	173	53	.	.	PUNCT
ihlr-16572	174	1	46	46	NUM
ihlr-16572	174	2	.	.	PUNCT
ihlr-16572	174	3	drug	drug	NOUN
ihlr-16572	174	4	price	price	NOUN
ihlr-16572	174	5	competition	competition	NOUN
ihlr-16572	174	6	and	and	CCONJ
ihlr-16572	174	7	patent	patent	NOUN
ihlr-16572	174	8	term	term	NOUN
ihlr-16572	174	9	restoration	restoration	NOUN
ihlr-16572	174	10	act	act	NOUN
ihlr-16572	174	11	,	,	PUNCT
ihlr-16572	174	12	pub	pub	NOUN
ihlr-16572	174	13	.	.	PUNCT
ihlr-16572	175	1	l.	l.	PROPN
ihlr-16572	175	2	no	no	INTJ
ihlr-16572	175	3	.	.	PROPN
ihlr-16572	176	1	98	98	NUM
ihlr-16572	176	2	-	-	SYM
ihlr-16572	176	3	417	417	NUM
ihlr-16572	176	4	,	,	PUNCT
ihlr-16572	176	5	98	98	NUM
ihlr-16572	176	6	stat	stat	NOUN
ihlr-16572	176	7	.	.	PUNCT
ihlr-16572	177	1	1585	1585	NUM
ihlr-16572	177	2	(	(	PUNCT
ihlr-16572	177	3	1984	1984	NUM
ihlr-16572	177	4	)	)	PUNCT
ihlr-16572	177	5	.	.	PUNCT
ihlr-16572	178	1	2010	2010	NUM
ihlr-16572	178	2	]	]	PUNCT
ihlr-16572	178	3	follow	follow	VERB
ihlr-16572	178	4	-	-	PUNCT
ihlr-16572	178	5	on	on	ADP
ihlr-16572	178	6	biologics	biologic	NOUN
ihlr-16572	178	7	legislation	legislation	NOUN
ihlr-16572	178	8	375	375	NUM
ihlr-16572	178	9	legislation	legislation	NOUN
ihlr-16572	178	10	's	's	PART
ihlr-16572	178	11	congressional	congressional	ADJ
ihlr-16572	178	12	sponsors	sponsor	NOUN
ihlr-16572	178	13	,	,	PUNCT
ihlr-16572	178	14	senator	senator	PROPN
ihlr-16572	178	15	orrin	orrin	PROPN
ihlr-16572	178	16	hatch	hatch	PROPN
ihlr-16572	178	17	and	and	CCONJ
ihlr-16572	178	18	representa­	representa­	PROPN
ihlr-16572	178	19	tive	tive	PROPN
ihlr-16572	178	20	henry	henry	PROPN
ihlr-16572	178	21	waxman	waxman	PROPN
ihlr-16572	178	22	,	,	PUNCT
ihlr-16572	178	23	remain	remain	VERB
ihlr-16572	178	24	strong	strong	ADJ
ihlr-16572	178	25	advocates	advocate	NOUN
ihlr-16572	178	26	of	of	ADP
ihlr-16572	178	27	generic	generic	ADJ
ihlr-16572	178	28	drugs.47	drugs.47	NOUN
ihlr-16572	178	29	under	under	ADP
ihlr-16572	178	30	the	the	DET
ihlr-16572	178	31	~atch	~atch	ADJ
ihlr-16572	178	32	-	-	ADJ
ihlr-16572	178	33	waxman	waxman	ADJ
ihlr-16572	178	34	regulatory	regulatory	ADJ
ihlr-16572	178	35	structure	structure	NOUN
ihlr-16572	178	36	,	,	PUNCT
ihlr-16572	178	37	generic	generic	ADJ
ihlr-16572	178	38	drug	drug	NOUN
ihlr-16572	178	39	companies	company	NOUN
ihlr-16572	178	40	are	be	AUX
ihlr-16572	178	41	able	able	ADJ
ihlr-16572	178	42	to	to	PART
ihlr-16572	178	43	forgo	forgo	VERB
ihlr-16572	178	44	the	the	DET
ihlr-16572	178	45	extensive	extensive	ADJ
ihlr-16572	178	46	human	human	ADJ
ihlr-16572	178	47	clinical	clinical	ADJ
ihlr-16572	178	48	trials	trial	NOUN
ihlr-16572	178	49	brand	brand	NOUN
ihlr-16572	178	50	-	-	PUNCT
ihlr-16572	178	51	name	name	NOUN
ihlr-16572	178	52	druf	druf	NOUN
ihlr-16572	178	53	companies	company	NOUN
ihlr-16572	178	54	must	must	AUX
ihlr-16572	178	55	undertake	undertake	VERB
ihlr-16572	178	56	to	to	PART
ihlr-16572	178	57	show	show	VERB
ihlr-16572	178	58	that	that	SCONJ
ihlr-16572	178	59	their	their	PRON
ihlr-16572	178	60	drug	drug	NOUN
ihlr-16572	178	61	is	be	AUX
ihlr-16572	178	62	safe	safe	ADJ
ihlr-16572	178	63	and	and	CCONJ
ihlr-16572	178	64	effective.4	effective.4	DET
ihlr-16572	178	65	a	a	DET
ihlr-16572	178	66	generic	generic	ADJ
ihlr-16572	178	67	drug	drug	NOUN
ihlr-16572	178	68	company	company	NOUN
ihlr-16572	178	69	must	must	AUX
ihlr-16572	178	70	establish	establish	VERB
ihlr-16572	178	71	that	that	SCONJ
ihlr-16572	178	72	its	its	PRON
ihlr-16572	178	73	drug	drug	NOUN
ihlr-16572	178	74	it	it	PRON
ihlr-16572	178	75	is	be	AUX
ihlr-16572	178	76	"	"	PUNCT
ihlr-16572	178	77	pharmaceutically	pharmaceutically	ADV
ihlr-16572	178	78	equivalent	equivalent	ADJ
ihlr-16572	178	79	"	"	PUNCT
ihlr-16572	178	80	that	that	PRON
ihlr-16572	178	81	is	be	AUX
ihlr-16572	178	82	it	it	PRON
ihlr-16572	178	83	contains	contain	VERB
ihlr-16572	178	84	the	the	DET
ihlr-16572	178	85	same	same	ADJ
ihlr-16572	178	86	active	active	ADJ
ihlr-16572	178	87	ingredient	ingredient	NOUN
ihlr-16572	178	88	,	,	PUNCT
ihlr-16572	178	89	in	in	ADP
ihlr-16572	178	90	the	the	DET
ihlr-16572	178	91	same	same	ADJ
ihlr-16572	178	92	amount	amount	NOUN
ihlr-16572	178	93	and	and	CCONJ
ihlr-16572	178	94	do­	do­	NOUN
ihlr-16572	178	95	sage.49	sage.49	NOUN
ihlr-16572	178	96	as	as	ADP
ihlr-16572	178	97	part	part	NOUN
ihlr-16572	178	98	of	of	ADP
ihlr-16572	178	99	the	the	DET
ihlr-16572	178	100	approval	approval	NOUN
ihlr-16572	178	101	process	process	NOUN
ihlr-16572	178	102	,	,	PUNCT
ihlr-16572	178	103	a	a	DET
ihlr-16572	178	104	generic	generic	ADJ
ihlr-16572	178	105	drug	drug	NOUN
ihlr-16572	178	106	company	company	NOUN
ihlr-16572	178	107	must	must	AUX
ihlr-16572	178	108	also	also	ADV
ihlr-16572	178	109	establish	establish	VERB
ihlr-16572	178	110	its	its	PRON
ihlr-16572	178	111	drugs	drug	NOUN
ihlr-16572	178	112	'	'	PART
ihlr-16572	178	113	"	"	PUNCT
ihlr-16572	178	114	bioequivalence	bioequivalence	NOUN
ihlr-16572	178	115	"	"	PUNCT
ihlr-16572	178	116	by	by	ADP
ihlr-16572	178	117	showing	show	VERB
ihlr-16572	178	118	that	that	SCONJ
ihlr-16572	178	119	it	it	PRON
ihlr-16572	178	120	absorbs	absorb	VERB
ihlr-16572	178	121	into	into	ADP
ihlr-16572	178	122	a	a	DET
ihlr-16572	178	123	pa­	pa­	ADJ
ihlr-16572	178	124	tient	tient	NOUN
ihlr-16572	178	125	's	's	PART
ihlr-16572	178	126	bloodstream	bloodstream	NOUN
ihlr-16572	178	127	at	at	ADP
ihlr-16572	178	128	a	a	DET
ihlr-16572	178	129	similar	similar	ADJ
ihlr-16572	178	130	rate	rate	NOUN
ihlr-16572	178	131	as	as	ADP
ihlr-16572	178	132	the	the	DET
ihlr-16572	178	133	brand	brand	NOUN
ihlr-16572	178	134	name	name	NOUN
ihlr-16572	178	135	drug	drug	NOUN
ihlr-16572	178	136	.	.	PUNCT
ihlr-16572	179	1	50	50	NUM
ihlr-16572	179	2	provided	provide	VERB
ihlr-16572	179	3	the	the	DET
ihlr-16572	179	4	generic	generic	ADJ
ihlr-16572	179	5	company	company	NOUN
ihlr-16572	179	6	satisfies	satisfy	VERB
ihlr-16572	179	7	these	these	PRON
ihlr-16572	179	8	,	,	PUNCT
ihlr-16572	179	9	and	and	CCONJ
ihlr-16572	179	10	other	other	ADJ
ihlr-16572	179	11	minor	minor	ADJ
ihlr-16572	179	12	requirements	requirement	NOUN
ihlr-16572	179	13	,	,	PUNCT
ihlr-16572	179	14	it	it	PRON
ihlr-16572	179	15	is	be	AUX
ihlr-16572	179	16	not	not	PART
ihlr-16572	179	17	re­	re­	AUX
ihlr-16572	179	18	quired	quire	VERB
ihlr-16572	179	19	to	to	PART
ihlr-16572	179	20	undertake	undertake	VERB
ihlr-16572	179	21	clinical	clinical	ADJ
ihlr-16572	179	22	studies	study	NOUN
ihlr-16572	179	23	in	in	ADP
ihlr-16572	179	24	order	order	NOUN
ihlr-16572	179	25	to	to	PART
ihlr-16572	179	26	gain	gain	VERB
ihlr-16572	179	27	fda	fda	PROPN
ihlr-16572	179	28	approval	approval	NOUN
ihlr-16572	179	29	for	for	ADP
ihlr-16572	179	30	their	their	PRON
ihlr-16572	179	31	dru	dru	NOUN
ihlr-16572	179	32	51	51	NUM
ihlr-16572	179	33	g.	g.	NOUN
ihlr-16572	179	34	the	the	DET
ihlr-16572	179	35	savings	saving	NOUN
ihlr-16572	179	36	a	a	DET
ihlr-16572	179	37	generic	generic	ADJ
ihlr-16572	179	38	drug	drug	NOUN
ihlr-16572	179	39	company	company	NOUN
ihlr-16572	179	40	enjoys	enjoy	VERB
ihlr-16572	179	41	under	under	ADP
ihlr-16572	179	42	the	the	DET
ihlr-16572	179	43	hatch	hatch	NOUN
ihlr-16572	179	44	-	-	PUNCT
ihlr-16572	179	45	waxman	waxman	NOUN
ihlr-16572	179	46	abbreviated	abbreviate	VERB
ihlr-16572	179	47	approval	approval	NOUN
ihlr-16572	179	48	process	process	NOUN
ihlr-16572	179	49	account	account	VERB
ihlr-16572	179	50	for	for	SCONJ
ihlr-16572	179	51	the	the	DET
ihlr-16572	179	52	savings	saving	NOUN
ihlr-16572	179	53	consumers	consumer	NOUN
ihlr-16572	179	54	enjoy	enjoy	VERB
ihlr-16572	179	55	when	when	SCONJ
ihlr-16572	179	56	purchasing	purchase	VERB
ihlr-16572	179	57	generic	generic	ADJ
ihlr-16572	179	58	drugs	drug	NOUN
ihlr-16572	179	59	.	.	PUNCT
ihlr-16572	180	1	there	there	PRON
ihlr-16572	180	2	is	be	VERB
ihlr-16572	180	3	currently	currently	ADV
ihlr-16572	180	4	no	no	PRON
ihlr-16572	180	5	abbreviated	abbreviate	VERB
ihlr-16572	180	6	regulato­	regulato­	NOUN
ihlr-16572	180	7	ry	ry	NOUN
ihlr-16572	180	8	pathway	pathway	NOUN
ihlr-16572	180	9	for	for	ADP
ihlr-16572	180	10	follow	follow	NOUN
ihlr-16572	180	11	-	-	PUNCT
ihlr-16572	180	12	on	on	ADP
ihlr-16572	180	13	biologics.52	biologics.52	ADJ
ihlr-16572	180	14	consumers	consumer	NOUN
ihlr-16572	180	15	are	be	AUX
ihlr-16572	180	16	still	still	ADV
ihlr-16572	180	17	waiting	wait	VERB
ihlr-16572	180	18	for	for	ADP
ihlr-16572	180	19	af­	af­	ADJ
ihlr-16572	180	20	fordable	fordable	ADJ
ihlr-16572	180	21	versions	version	NOUN
ihlr-16572	180	22	of	of	ADP
ihlr-16572	180	23	these	these	DET
ihlr-16572	180	24	drugs	drug	NOUN
ihlr-16572	180	25	.	.	PUNCT
ihlr-16572	181	1	the	the	DET
ihlr-16572	181	2	biotechnology	biotechnology	NOUN
ihlr-16572	181	3	industry	industry	NOUN
ihlr-16572	181	4	organization	organization	NOUN
ihlr-16572	181	5	(	(	PUNCT
ihlr-16572	181	6	bio	bio	NOUN
ihlr-16572	181	7	)	)	PUNCT
ihlr-16572	181	8	,	,	PUNCT
ihlr-16572	181	9	which	which	PRON
ihlr-16572	181	10	represents	represent	VERB
ihlr-16572	181	11	the	the	DET
ihlr-16572	181	12	interests	interest	NOUN
ihlr-16572	181	13	of	of	ADP
ihlr-16572	181	14	leading	lead	VERB
ihlr-16572	181	15	biotechnology	biotechnology	NOUN
ihlr-16572	181	16	companies	company	NOUN
ihlr-16572	181	17	such	such	ADJ
ihlr-16572	181	18	as	as	ADP
ihlr-16572	181	19	amgen	amgen	PROPN
ihlr-16572	181	20	and	and	CCONJ
ihlr-16572	181	21	genen­	genen­	PROPN
ihlr-16572	181	22	tech	tech	NOUN
ihlr-16572	181	23	,	,	PUNCT
ihlr-16572	181	24	contends	contend	VERB
ihlr-16572	181	25	that	that	SCONJ
ihlr-16572	181	26	the	the	DET
ihlr-16572	181	27	complexity	complexity	NOUN
ihlr-16572	181	28	of	of	ADP
ihlr-16572	181	29	biologics	biologic	NOUN
ihlr-16572	181	30	may	may	AUX
ihlr-16572	181	31	preclude	preclude	VERB
ihlr-16572	181	32	their	their	PRON
ihlr-16572	181	33	safe	safe	ADJ
ihlr-16572	181	34	dup-­	dup-­	NOUN
ihlr-16572	181	35	lication	lication	NOUN
ihlr-16572	181	36	by	by	ADP
ihlr-16572	181	37	generic	generic	ADJ
ihlr-16572	181	38	drug	drug	NOUN
ihlr-16572	181	39	companies.53	companies.53	NOUN
ihlr-16572	181	40	it	it	PRON
ihlr-16572	181	41	is	be	AUX
ihlr-16572	181	42	the	the	DET
ihlr-16572	181	43	general	general	ADJ
ihlr-16572	181	44	consensus	consensus	NOUN
ihlr-16572	181	45	among	among	ADP
ihlr-16572	181	46	researchers	researcher	NOUN
ihlr-16572	181	47	that	that	SCONJ
ihlr-16572	181	48	"	"	PUNCT
ihlr-16572	181	49	[	[	X
ihlr-16572	181	50	b]iologics	b]iologic	NOUN
ihlr-16572	181	51	differ	differ	VERB
ihlr-16572	181	52	significantly	significantly	ADV
ihlr-16572	181	53	from	from	ADP
ihlr-16572	181	54	traditional	traditional	ADJ
ihlr-16572	181	55	small­	small­	PUNCT
ihlr-16572	181	56	molecule	molecule	NOUN
ihlr-16572	181	57	pharmaceuticals	pharmaceutical	NOUN
ihlr-16572	181	58	in	in	ADP
ihlr-16572	181	59	their	their	PRON
ihlr-16572	181	60	size	size	NOUN
ihlr-16572	181	61	,	,	PUNCT
ihlr-16572	181	62	structural	structural	ADJ
ihlr-16572	181	63	complexity	complexity	NOUN
ihlr-16572	181	64	,	,	PUNCT
ihlr-16572	181	65	and	and	CCONJ
ihlr-16572	181	66	method	method	NOUN
ihlr-16572	181	67	of	of	ADP
ihlr-16572	181	68	manufacture	manufacture	NOUN
ihlr-16572	181	69	.	.	PUNCT
ihlr-16572	182	1	"54	"54	PROPN
ihlr-16572	182	2	further	far	ADV
ihlr-16572	182	3	,	,	PUNCT
ihlr-16572	182	4	bio	bio	PROPN
ihlr-16572	182	5	argues	argue	VERB
ihlr-16572	182	6	that	that	SCONJ
ihlr-16572	182	7	approval	approval	NOUN
ihlr-16572	182	8	of	of	ADP
ihlr-16572	182	9	follow	follow	VERB
ihlr-16572	182	10	-	-	PUNCT
ihlr-16572	182	11	on	on	ADP
ihlr-16572	182	12	biolog­	biolog­	NOUN
ihlr-16572	182	13	ics	ics	NOUN
ihlr-16572	182	14	would	would	AUX
ihlr-16572	182	15	destroy	destroy	VERB
ihlr-16572	182	16	the	the	DET
ihlr-16572	182	17	incentive	incentive	NOUN
ihlr-16572	182	18	to	to	PART
ihlr-16572	182	19	develop	develop	VERB
ihlr-16572	182	20	lifesaving	lifesaving	NOUN
ihlr-16572	182	21	drugs	drug	NOUN
ihlr-16572	182	22	,	,	PUNCT
ihlr-16572	182	23	as	as	SCONJ
ihlr-16572	182	24	the	the	DET
ihlr-16572	182	25	loss	loss	NOUN
ihlr-16572	182	26	in	in	ADP
ihlr-16572	182	27	profits	profit	NOUN
ihlr-16572	182	28	to	to	ADP
ihlr-16572	182	29	generic	generic	ADJ
ihlr-16572	182	30	manufacturers	manufacturer	NOUN
ihlr-16572	182	31	would	would	AUX
ihlr-16572	182	32	render	render	VERB
ihlr-16572	182	33	it	it	PRON
ihlr-16572	182	34	impractical	impractical	ADJ
ihlr-16572	182	35	to	to	AUX
ihlr-16572	182	36	fund	fund	VERB
ihlr-16572	182	37	neces­	neces­	PROPN
ihlr-16572	182	38	sary	sary	PROPN
ihlr-16572	182	39	research	research	NOUN
ihlr-16572	182	40	.	.	PUNCT
ihlr-16572	183	1	55	55	NUM
ihlr-16572	183	2	conversely	conversely	ADV
ihlr-16572	183	3	,	,	PUNCT
ihlr-16572	183	4	the	the	DET
ihlr-16572	183	5	generic	generic	ADJ
ihlr-16572	183	6	pharmaceutical	pharmaceutical	NOUN
ihlr-16572	183	7	association	association	NOUN
ihlr-16572	183	8	asserts	assert	VERB
ihlr-16572	183	9	that	that	SCONJ
ihlr-16572	183	10	they	they	PRON
ihlr-16572	183	11	are	be	AUX
ihlr-16572	183	12	capable	capable	ADJ
ihlr-16572	183	13	of	of	ADP
ihlr-16572	183	14	safely	safely	ADV
ihlr-16572	183	15	duplicating	duplicate	VERB
ihlr-16572	183	16	biologics	biologic	NOUN
ihlr-16572	183	17	,	,	PUNCT
ihlr-16572	183	18	and	and	CCONJ
ihlr-16572	183	19	that	that	SCONJ
ihlr-16572	183	20	the	the	DET
ihlr-16572	183	21	resultant	resultant	NOUN
ihlr-16572	183	22	savings	saving	NOUN
ihlr-16572	183	23	are	be	AUX
ihlr-16572	183	24	47	47	NUM
ihlr-16572	183	25	.	.	PUNCT
ihlr-16572	184	1	i	i	PRON
ihlr-16572	184	2	d.	d.	PROPN
ihlr-16572	184	3	48	48	NUM
ihlr-16572	184	4	.	.	PUNCT
ihlr-16572	185	1	jd	jd	PROPN
ihlr-16572	185	2	.	.	PROPN
ihlr-16572	185	3	49	49	NUM
ihlr-16572	185	4	.	.	PUNCT
ihlr-16572	186	1	i	i	PRON
ihlr-16572	186	2	d.	d.	PROPN
ihlr-16572	186	3	50	50	NUM
ihlr-16572	186	4	.	.	PUNCT
ihlr-16572	187	1	i	i	PRON
ihlr-16572	187	2	d.	d.	PROPN
ihlr-16572	187	3	51	51	NUM
ihlr-16572	187	4	.	.	PUNCT
ihlr-16572	188	1	jd	jd	PROPN
ihlr-16572	188	2	52	52	NUM
ihlr-16572	188	3	.	.	PUNCT
ihlr-16572	189	1	see	see	VERB
ihlr-16572	189	2	u.s	u.s	PROPN
ihlr-16572	189	3	.	.	PROPN
ihlr-16572	189	4	food	food	PROPN
ihlr-16572	189	5	&	&	CCONJ
ihlr-16572	189	6	drug	drug	PROPN
ihlr-16572	189	7	admin	admin	PROPN
ihlr-16572	189	8	,	,	PUNCT
ihlr-16572	189	9	center	center	NOUN
ihlr-16572	189	10	for	for	ADP
ihlr-16572	189	11	drug	drug	NOUN
ihlr-16572	189	12	evaluation	evaluation	NOUN
ihlr-16572	189	13	&	&	CCONJ
ihlr-16572	189	14	research	research	NOUN
ihlr-16572	189	15	,	,	PUNCT
ihlr-16572	189	16	frequently	frequently	ADV
ihlr-16572	189	17	asked	ask	VERB
ihlr-16572	189	18	questions	question	NOUN
ihlr-16572	189	19	about	about	ADP
ihlr-16572	189	20	therapeutic	therapeutic	ADJ
ihlr-16572	189	21	biological	biological	ADJ
ihlr-16572	189	22	products	product	NOUN
ihlr-16572	189	23	,	,	PUNCT
ihlr-16572	189	24	available	available	ADJ
ihlr-16572	189	25	at	at	ADP
ihlr-16572	189	26	http://www	http://www	PROPN
ihlr-16572	189	27	/	/	SYM
ihlr-16572	189	28	fda	fda	PROPN
ihlr-16572	189	29	/	/	SYM
ihlr-16572	189	30	gov/	gov/	PROPN
ihlr-16572	189	31	cder	cder	NOUN
ihlr-16572	189	32	/	/	SYM
ihlr-16572	189	33	biologics	biologic	NOUN
ihlr-16572	189	34	/	/	SYM
ihlr-16572	189	35	qa.htm	qa.htm	PROPN
ihlr-16572	189	36	(	(	PUNCT
ihlr-16572	189	37	last	last	ADV
ihlr-16572	189	38	visited	visit	VERB
ihlr-16572	189	39	mar	mar	PROPN
ihlr-16572	189	40	.	.	PROPN
ihlr-16572	189	41	6	6	NUM
ihlr-16572	189	42	,	,	PUNCT
ihlr-16572	189	43	2010	2010	NUM
ihlr-16572	189	44	)	)	PUNCT
ihlr-16572	189	45	.	.	PUNCT
ihlr-16572	190	1	53	53	NUM
ihlr-16572	190	2	.	.	PUNCT
ihlr-16572	190	3	press	press	NOUN
ihlr-16572	190	4	release	release	NOUN
ihlr-16572	190	5	,	,	PUNCT
ihlr-16572	190	6	biotechnology	biotechnology	NOUN
ihlr-16572	190	7	industry	industry	NOUN
ihlr-16572	190	8	organization	organization	NOUN
ihlr-16572	190	9	,	,	PUNCT
ihlr-16572	190	10	congress	congress	PROPN
ihlr-16572	190	11	must	must	AUX
ihlr-16572	190	12	protect	protect	VERB
ihlr-16572	190	13	pa­	pa­	ADJ
ihlr-16572	190	14	tient	tient	NOUN
ihlr-16572	190	15	safety	safety	NOUN
ihlr-16572	190	16	and	and	CCONJ
ihlr-16572	190	17	promote	promote	VERB
ihlr-16572	190	18	innovation	innovation	NOUN
ihlr-16572	190	19	in	in	ADP
ihlr-16572	190	20	considering	consider	VERB
ihlr-16572	190	21	follow	follow	VERB
ihlr-16572	190	22	-	-	PUNCT
ihlr-16572	190	23	on	on	ADP
ihlr-16572	190	24	biologics	biologic	NOUN
ihlr-16572	190	25	pathway	pathway	NOUN
ihlr-16572	190	26	(	(	PUNCT
ihlr-16572	190	27	mar	mar	PROPN
ihlr-16572	190	28	.	.	PROPN
ihlr-16572	190	29	8	8	NUM
ihlr-16572	190	30	,	,	PUNCT
ihlr-16572	190	31	2007	2007	NUM
ihlr-16572	190	32	)	)	PUNCT
ihlr-16572	190	33	,	,	PUNCT
ihlr-16572	190	34	available	available	ADJ
ihlr-16572	190	35	at	at	ADP
ihlr-16572	190	36	http://bio.org/newslpressreleases/newsitem.asp?id=2007	http://bio.org/newslpressreleases/newsitem.asp?id=2007	PROPN
ihlr-16572	190	37	_	_	PRON
ihlr-16572	190	38	0308	0308	NUM
ihlr-16572	191	1	_	_	PUNCT
ihlr-16572	191	2	01	01	PUNCT
ihlr-16572	192	1	(	(	PUNCT
ihlr-16572	192	2	last	last	ADV
ihlr-16572	192	3	visited	visit	VERB
ihlr-16572	192	4	mar	mar	PROPN
ihlr-16572	192	5	.	.	PROPN
ihlr-16572	192	6	6	6	NUM
ihlr-16572	192	7	,	,	PUNCT
ihlr-16572	192	8	2010	2010	NUM
ihlr-16572	192	9	)	)	PUNCT
ihlr-16572	193	1	[	[	X
ihlr-16572	193	2	hereinafter	hereinafter	NOUN
ihlr-16572	193	3	"	"	PUNCT
ihlr-16572	193	4	bio	bio	PROPN
ihlr-16572	193	5	press	press	NOUN
ihlr-16572	193	6	release	release	PROPN
ihlr-16572	193	7	if1	if1	NOUN
ihlr-16572	193	8	.	.	PUNCT
ihlr-16572	194	1	54	54	NUM
ihlr-16572	194	2	.	.	PUNCT
ihlr-16572	195	1	schacht	schacht	PROPN
ihlr-16572	195	2	,	,	PUNCT
ihlr-16572	195	3	supra	supra	PROPN
ihlr-16572	195	4	note	note	NOUN
ihlr-16572	195	5	i	i	PRON
ihlr-16572	195	6	0	0	NUM
ihlr-16572	195	7	,	,	PUNCT
ihlr-16572	195	8	at	at	ADP
ihlr-16572	195	9	summary	summary	NOUN
ihlr-16572	195	10	.	.	PUNCT
ihlr-16572	196	1	55	55	NUM
ihlr-16572	196	2	.	.	PUNCT
ihlr-16572	196	3	press	press	NOUN
ihlr-16572	196	4	release	release	NOUN
ihlr-16572	196	5	,	,	PUNCT
ihlr-16572	196	6	biotechnology	biotechnology	NOUN
ihlr-16572	196	7	industry	industry	NOUN
ihlr-16572	196	8	organization	organization	NOUN
ihlr-16572	196	9	,	,	PUNCT
ihlr-16572	196	10	bio	bio	NOUN
ihlr-16572	196	11	calls	call	VERB
ihlr-16572	196	12	for	for	ADP
ihlr-16572	196	13	14	14	NUM
ihlr-16572	196	14	years	year	NOUN
ihlr-16572	196	15	of	of	ADP
ihlr-16572	196	16	data	datum	NOUN
ihlr-16572	196	17	exclusivity	exclusivity	NOUN
ihlr-16572	196	18	in	in	ADP
ihlr-16572	196	19	any	any	DET
ihlr-16572	196	20	follow	follow	NOUN
ihlr-16572	196	21	-	-	PUNCT
ihlr-16572	196	22	on	on	ADP
ihlr-16572	196	23	biologics	biologic	NOUN
ihlr-16572	196	24	legislation	legislation	NOUN
ihlr-16572	196	25	(	(	PUNCT
ihlr-16572	196	26	may	may	PROPN
ihlr-16572	196	27	3	3	NUM
ihlr-16572	196	28	,	,	PUNCT
ihlr-16572	196	29	2007	2007	NUM
ihlr-16572	196	30	)	)	PUNCT
ihlr-16572	196	31	,	,	PUNCT
ihlr-16572	196	32	available	available	ADJ
ihlr-16572	196	33	at	at	ADP
ihlr-16572	196	34	http://bio.org/newslpressreleaseslnewsitem.asp?id=2007	http://bio.org/newslpressreleaseslnewsitem.asp?id=2007	NOUN
ihlr-16572	196	35	_	_	NOUN
ihlr-16572	196	36	0503	0503	NUM
ihlr-16572	197	1	_	_	PUNCT
ihlr-16572	197	2	01	01	PUNCT
ihlr-16572	198	1	(	(	PUNCT
ihlr-16572	198	2	last	last	ADV
ihlr-16572	198	3	visited	visit	VERB
ihlr-16572	198	4	mar	mar	PROPN
ihlr-16572	198	5	.	.	PROPN
ihlr-16572	198	6	6	6	NUM
ihlr-16572	198	7	,	,	PUNCT
ihlr-16572	198	8	201	201	NUM
ihlr-16572	198	9	0	0	NUM
ihlr-16572	198	10	)	)	PUNCT
ihlr-16572	199	1	[	[	X
ihlr-16572	199	2	hereinafter	hereinafter	NOUN
ihlr-16572	199	3	"	"	PUNCT
ihlr-16572	199	4	bio	bio	NOUN
ihlr-16572	199	5	press	press	NOUN
ihlr-16572	199	6	release	release	NOUN
ihlr-16572	199	7	llf1	llf1	PROPN
ihlr-16572	199	8	.	.	PUNCT
ihlr-16572	200	1	376	376	NUM
ihlr-16572	200	2	lndianahealtii	lndianahealtii	PROPN
ihlr-16572	200	3	law	law	NOUN
ihlr-16572	200	4	review	review	NOUN
ihlr-16572	200	5	[	[	X
ihlr-16572	200	6	vol	vol	NOUN
ihlr-16572	200	7	.	.	PUNCT
ihlr-16572	201	1	7:367	7:367	NUM
ihlr-16572	201	2	so	so	ADV
ihlr-16572	201	3	significant	significant	ADJ
ihlr-16572	201	4	that	that	SCONJ
ihlr-16572	201	5	they	they	PRON
ihlr-16572	201	6	should	should	AUX
ihlr-16572	201	7	compel	compel	VERB
ihlr-16572	201	8	the	the	DET
ihlr-16572	201	9	enactment	enactment	NOUN
ihlr-16572	201	10	of	of	ADP
ihlr-16572	201	11	legislation	legislation	NOUN
ihlr-16572	201	12	approv­	approv­	PRON
ihlr-16572	201	13	ing	ing	ADJ
ihlr-16572	201	14	follow	follow	VERB
ihlr-16572	201	15	-	-	PUNCT
ihlr-16572	201	16	on	on	ADP
ihlr-16572	201	17	biologics	biologic	NOUN
ihlr-16572	201	18	.	.	PUNCT
ihlr-16572	202	1	56	56	NUM
ihlr-16572	202	2	some	some	DET
ihlr-16572	202	3	experts	expert	NOUN
ihlr-16572	202	4	in	in	ADP
ihlr-16572	202	5	this	this	DET
ihlr-16572	202	6	field	field	NOUN
ihlr-16572	202	7	contend	contend	VERB
ihlr-16572	202	8	that	that	SCONJ
ihlr-16572	202	9	"	"	PUNCT
ihlr-16572	202	10	different	different	ADJ
ihlr-16572	202	11	kinds	kind	NOUN
ihlr-16572	202	12	of	of	ADP
ihlr-16572	202	13	biologics	biologic	NOUN
ihlr-16572	202	14	vary	vary	VERB
ihlr-16572	202	15	considerably	considerably	ADV
ihlr-16572	202	16	in	in	ADP
ihlr-16572	202	17	their	their	PRON
ihlr-16572	202	18	size	size	NOUN
ihlr-16572	202	19	and	and	CCONJ
ihlr-16572	202	20	structure	structure	NOUN
ihlr-16572	202	21	,	,	PUNCT
ihlr-16572	202	22	and	and	CCONJ
ihlr-16572	202	23	...	...	PUNCT
ihlr-16572	202	24	existing	exist	VERB
ihlr-16572	202	25	hatch	hatch	NOUN
ihlr-16572	202	26	-	-	PUNCT
ihlr-16572	202	27	waxman	waxman	NOUN
ihlr-16572	202	28	mechanisms	mechanism	NOUN
ihlr-16572	202	29	are	be	AUX
ihlr-16572	202	30	appropriately	appropriately	ADV
ihlr-16572	202	31	applied	apply	VERB
ihlr-16572	202	32	to	to	ADP
ihlr-16572	202	33	many	many	ADJ
ihlr-16572	202	34	biologics	biologic	NOUN
ihlr-16572	202	35	.	.	PUNCT
ihlr-16572	203	1	"57	"57	PUNCT
ihlr-16572	204	1	the	the	DET
ihlr-16572	204	2	debate	debate	NOUN
ihlr-16572	204	3	between	between	ADP
ihlr-16572	204	4	these	these	DET
ihlr-16572	204	5	two	two	NUM
ihlr-16572	204	6	powerful	powerful	ADJ
ihlr-16572	204	7	lobbying	lobbying	NOUN
ihlr-16572	204	8	groups	group	NOUN
ihlr-16572	204	9	has	have	AUX
ihlr-16572	204	10	grown	grow	VERB
ihlr-16572	204	11	more	more	ADV
ihlr-16572	204	12	contentious	contentious	ADJ
ihlr-16572	204	13	over	over	ADP
ihlr-16572	204	14	the	the	DET
ihlr-16572	204	15	past	past	ADJ
ihlr-16572	204	16	year	year	NOUN
ihlr-16572	204	17	,	,	PUNCT
ihlr-16572	204	18	with	with	ADP
ihlr-16572	204	19	accusations	accusation	NOUN
ihlr-16572	204	20	of	of	ADP
ihlr-16572	204	21	misleading	mislead	VERB
ihlr-16572	204	22	tac­	tac­	NOUN
ihlr-16572	204	23	tics	tic	NOUN
ihlr-16572	204	24	.	.	PUNCT
ihlr-16572	205	1	58	58	NUM
ihlr-16572	205	2	in	in	ADP
ihlr-16572	205	3	an	an	DET
ihlr-16572	205	4	april	april	PROPN
ihlr-16572	205	5	i	i	PRON
ihlr-16572	205	6	,	,	PUNCT
ihlr-16572	205	7	2008	2008	NUM
ihlr-16572	205	8	press	press	NOUN
ihlr-16572	205	9	release	release	NOUN
ihlr-16572	205	10	,	,	PUNCT
ihlr-16572	205	11	bio	bio	PROPN
ihlr-16572	205	12	condemned	condemn	VERB
ihlr-16572	205	13	the	the	DET
ihlr-16572	205	14	generic	generic	ADJ
ihlr-16572	205	15	drug	drug	NOUN
ihlr-16572	205	16	industry	industry	NOUN
ihlr-16572	205	17	's	's	PART
ihlr-16572	205	18	lobbying	lobbying	NOUN
ihlr-16572	205	19	groups	group	NOUN
ihlr-16572	205	20	for	for	ADP
ihlr-16572	205	21	engaging	engage	VERB
ihlr-16572	205	22	in	in	ADP
ihlr-16572	205	23	what	what	PRON
ihlr-16572	205	24	it	it	PRON
ihlr-16572	205	25	considered	consider	VERB
ihlr-16572	205	26	a	a	DET
ihlr-16572	205	27	gross	gross	ADJ
ihlr-16572	205	28	mi­	mi­	VERB
ihlr-16572	205	29	scharacterization	scharacterization	NOUN
ihlr-16572	205	30	of	of	ADP
ihlr-16572	205	31	bio	bio	PROPN
ihlr-16572	205	32	's	's	PART
ihlr-16572	205	33	position	position	NOUN
ihlr-16572	205	34	on	on	ADP
ihlr-16572	205	35	follow	follow	NOUN
ihlr-16572	205	36	-	-	PUNCT
ihlr-16572	205	37	on	on	ADP
ihlr-16572	205	38	biologics	biologic	NOUN
ihlr-16572	205	39	.	.	PUNCT
ihlr-16572	206	1	bio	bio	PROPN
ihlr-16572	206	2	expressed	express	VERB
ihlr-16572	206	3	its	its	PRON
ihlr-16572	206	4	disappointment	disappointment	NOUN
ihlr-16572	206	5	that	that	SCONJ
ihlr-16572	206	6	,	,	PUNCT
ihlr-16572	206	7	instead	instead	ADV
ihlr-16572	206	8	of	of	ADP
ihlr-16572	206	9	engaging	engage	VERB
ihlr-16572	206	10	in	in	ADP
ihlr-16572	206	11	a	a	DET
ihlr-16572	206	12	healthy	healthy	ADJ
ihlr-16572	206	13	discussion	discussion	NOUN
ihlr-16572	206	14	"	"	PUNCT
ihlr-16572	206	15	based	base	VERB
ihlr-16572	206	16	on	on	ADP
ihlr-16572	206	17	facts	fact	NOUN
ihlr-16572	206	18	and	and	CCONJ
ihlr-16572	206	19	credible	credible	ADJ
ihlr-16572	206	20	data	datum	NOUN
ihlr-16572	206	21	,	,	PUNCT
ihlr-16572	206	22	the	the	DET
ihlr-16572	206	23	generic	generic	ADJ
ihlr-16572	206	24	drug	drug	NOUN
ihlr-16572	206	25	industry	industry	NOUN
ihlr-16572	206	26	's	's	PART
ihlr-16572	206	27	lobby	lobby	NOUN
ihlr-16572	206	28	keeps	keep	VERB
ihlr-16572	206	29	pushing	push	VERB
ihlr-16572	206	30	misinformation	misinformation	NOUN
ihlr-16572	206	31	to	to	ADP
ihlr-16572	206	32	the	the	DET
ihlr-16572	206	33	news	news	NOUN
ihlr-16572	206	34	media	medium	NOUN
ihlr-16572	206	35	,	,	PUNCT
ihlr-16572	206	36	policymakers	policymaker	NOUN
ihlr-16572	206	37	,	,	PUNCT
ihlr-16572	206	38	and	and	CCONJ
ihlr-16572	206	39	others	other	NOUN
ihlr-16572	206	40	that	that	PRON
ihlr-16572	206	41	is	be	AUX
ihlr-16572	206	42	flat	flat	ADJ
ihlr-16572	206	43	out	out	ADV
ihlr-16572	206	44	wrong	wrong	ADJ
ihlr-16572	206	45	.	.	PUNCT
ihlr-16572	207	1	',s9	',s9	NOUN
ihlr-16572	207	2	bio	bio	NOUN
ihlr-16572	207	3	recently	recently	ADV
ihlr-16572	207	4	expressed	express	VERB
ihlr-16572	207	5	their	their	PRON
ihlr-16572	207	6	concerns	concern	NOUN
ihlr-16572	207	7	regarding	regard	VERB
ihlr-16572	207	8	follow	follow	NOUN
ihlr-16572	207	9	-	-	PUNCT
ihlr-16572	207	10	on	on	ADP
ihlr-16572	207	11	biologics	biologic	NOUN
ihlr-16572	207	12	through	through	ADP
ihlr-16572	207	13	comments	comment	NOUN
ihlr-16572	207	14	submitted	submit	VERB
ihlr-16572	207	15	to	to	ADP
ihlr-16572	207	16	the	the	DET
ihlr-16572	207	17	federal	federal	ADJ
ihlr-16572	207	18	trade	trade	NOUN
ihlr-16572	207	19	commission.60	commission.60	PROPN
ihlr-16572	207	20	in	in	ADP
ihlr-16572	207	21	their	their	PRON
ihlr-16572	207	22	comments	comment	NOUN
ihlr-16572	207	23	,	,	PUNCT
ihlr-16572	207	24	bio	bio	PROPN
ihlr-16572	207	25	ftrst	ftrst	PROPN
ihlr-16572	207	26	expresses	express	VERB
ihlr-16572	207	27	skepticism	skepticism	NOUN
ihlr-16572	207	28	regarding	regard	VERB
ihlr-16572	207	29	the	the	DET
ihlr-16572	207	30	extent	extent	NOUN
ihlr-16572	207	31	to	to	PART
ihlr-16572	207	32	which	which	PRON
ihlr-16572	207	33	follow	follow	VERB
ihlr-16572	207	34	-	-	PUNCT
ihlr-16572	207	35	on	on	ADP
ihlr-16572	207	36	biologics	biologic	NOUN
ihlr-16572	207	37	are	be	AUX
ihlr-16572	207	38	interchangeable	interchangeable	ADJ
ihlr-16572	207	39	with	with	ADP
ihlr-16572	207	40	their	their	PRON
ihlr-16572	207	41	brand	brand	NOUN
ihlr-16572	207	42	-	-	PUNCT
ihlr-16572	207	43	name	name	NOUN
ihlr-16572	207	44	predeces­	predeces­	NOUN
ihlr-16572	207	45	sors.61	sors.61	NOUN
ihlr-16572	207	46	it	it	PRON
ihlr-16572	207	47	contends	contend	VERB
ihlr-16572	207	48	that	that	SCONJ
ihlr-16572	207	49	"	"	PUNCT
ihlr-16572	207	50	assumptions	assumption	NOUN
ihlr-16572	207	51	regarding	regard	VERB
ihlr-16572	207	52	...	...	PUNCT
ihlr-16572	207	53	interchangeability	interchangeability	NOUN
ihlr-16572	207	54	of	of	ADP
ihlr-16572	207	55	[	[	X
ihlr-16572	207	56	fol­	fol­	NOUN
ihlr-16572	207	57	low	low	ADJ
ihlr-16572	207	58	-	-	PUNCT
ihlr-16572	207	59	on	on	ADP
ihlr-16572	207	60	biologics	biologic	NOUN
ihlr-16572	207	61	]	]	PUNCT
ihlr-16572	207	62	in	in	ADP
ihlr-16572	207	63	the	the	DET
ihlr-16572	207	64	foreseeable	foreseeable	ADJ
ihlr-16572	207	65	future	future	NOUN
ihlr-16572	207	66	are	be	AUX
ihlr-16572	207	67	not	not	PART
ihlr-16572	207	68	science	science	NOUN
ihlr-16572	207	69	-	-	PUNCT
ihlr-16572	207	70	based	base	VERB
ihlr-16572	207	71	.	.	PUNCT
ihlr-16572	207	72	',62	',62	PROPN
ihlr-16572	207	73	further	far	ADV
ihlr-16572	207	74	,	,	PUNCT
ihlr-16572	207	75	bio	bio	PROPN
ihlr-16572	207	76	argues	argue	VERB
ihlr-16572	207	77	that	that	SCONJ
ihlr-16572	207	78	allowing	allow	VERB
ihlr-16572	207	79	for	for	ADP
ihlr-16572	207	80	"	"	PUNCT
ihlr-16572	207	81	[	[	PUNCT
ihlr-16572	207	82	i]nterchangeability	i]nterchangeability	PROPN
ihlr-16572	207	83	will	will	AUX
ihlr-16572	207	84	not	not	PART
ihlr-16572	207	85	neces­	neces­	AUX
ihlr-16572	207	86	sarily	sarily	ADV
ihlr-16572	207	87	provide	provide	VERB
ihlr-16572	207	88	greater	great	ADJ
ihlr-16572	207	89	economic	economic	ADJ
ihlr-16572	207	90	benefit	benefit	NOUN
ihlr-16572	207	91	.	.	PUNCT
ihlr-16572	208	1	';63	';63	PROPN
ihlr-16572	208	2	the	the	DET
ihlr-16572	208	3	lobbying	lobbying	NOUN
ihlr-16572	208	4	group	group	NOUN
ihlr-16572	208	5	's	's	PART
ihlr-16572	208	6	stance	stance	NOUN
ihlr-16572	208	7	regarding	regard	VERB
ihlr-16572	208	8	data	datum	NOUN
ihlr-16572	208	9	exclusivity	exclusivity	NOUN
ihlr-16572	208	10	remains	remain	VERB
ihlr-16572	208	11	that	that	SCONJ
ihlr-16572	208	12	a	a	DET
ihlr-16572	208	13	''	''	PUNCT
ihlr-16572	208	14	period	period	NOUN
ihlr-16572	208	15	of	of	ADP
ihlr-16572	208	16	14	14	NUM
ihlr-16572	208	17	years	year	NOUN
ihlr-16572	208	18	is	be	AUX
ihlr-16572	208	19	necessary	necessary	ADJ
ihlr-16572	208	20	to	to	PART
ihlr-16572	208	21	maintain	maintain	VERB
ihlr-16572	208	22	effective	effective	ADJ
ihlr-16572	208	23	market	market	NOUN
ihlr-16572	208	24	protection	protection	NOUN
ihlr-16572	208	25	for	for	ADP
ihlr-16572	208	26	innovator	innovator	NOUN
ihlr-16572	208	27	biologics	biologic	NOUN
ihlr-16572	208	28	,	,	PUNCT
ihlr-16572	208	29	and	and	CCONJ
ihlr-16572	208	30	thus	thus	ADV
ihlr-16572	208	31	suffi­	suffi­	PROPN
ihlr-16572	208	32	cient	cient	NOUN
ihlr-16572	208	33	incentives	incentive	NOUN
ihlr-16572	208	34	for	for	ADP
ihlr-16572	208	35	innovation	innovation	NOUN
ihlr-16572	208	36	.	.	PUNCT
ihlr-16572	208	37	',64	',64	PUNCT
ihlr-16572	209	1	notwithstanding	notwithstanding	ADP
ihlr-16572	209	2	these	these	DET
ihlr-16572	209	3	serious	serious	PROPN
ihlr-16572	209	4	reserva­	reserva­	PROPN
ihlr-16572	209	5	tions	tion	NOUN
ihlr-16572	209	6	regarding	regard	VERB
ihlr-16572	209	7	follow	follow	NOUN
ihlr-16572	209	8	-	-	PUNCT
ihlr-16572	209	9	on	on	ADP
ihlr-16572	209	10	biologics	biologic	NOUN
ihlr-16572	209	11	,	,	PUNCT
ihlr-16572	209	12	bio	bio	PROPN
ihlr-16572	209	13	contends	contend	VERB
ihlr-16572	209	14	that	that	SCONJ
ihlr-16572	209	15	legislation	legislation	NOUN
ihlr-16572	209	16	addressing	address	VERB
ihlr-16572	209	17	follow	follow	NOUN
ihlr-16572	209	18	-	-	PUNCT
ihlr-16572	209	19	on	on	ADP
ihlr-16572	209	20	biologics	biologic	NOUN
ihlr-16572	209	21	would	would	AUX
ihlr-16572	209	22	be	be	AUX
ihlr-16572	209	23	appropriate	appropriate	ADJ
ihlr-16572	209	24	if	if	SCONJ
ihlr-16572	209	25	it	it	PRON
ihlr-16572	209	26	allows	allow	VERB
ihlr-16572	209	27	for	for	ADP
ihlr-16572	209	28	jroper	jroper	ADJ
ihlr-16572	209	29	"	"	PUNCT
ihlr-16572	209	30	incentives	incentive	NOUN
ihlr-16572	209	31	for	for	ADP
ihlr-16572	209	32	continued	continue	VERB
ihlr-16572	209	33	development	development	NOUN
ihlr-16572	209	34	of	of	ADP
ihlr-16572	209	35	next	next	ADJ
ihlr-16572	209	36	-	-	PUNCT
ihlr-16572	209	37	generation	generation	NOUN
ihlr-16572	209	38	products	product	NOUN
ihlr-16572	209	39	.	.	PUNCT
ihlr-16572	209	40	'	'	PUNCT
ihlr-16572	210	1	the	the	DET
ihlr-16572	210	2	primary	primary	ADJ
ihlr-16572	210	3	incentive	incentive	NOUN
ihlr-16572	210	4	for	for	ADP
ihlr-16572	210	5	innovation	innovation	NOUN
ihlr-16572	210	6	that	that	PRON
ihlr-16572	210	7	bio	bio	NOUN
ihlr-16572	210	8	seeks	seek	VERB
ihlr-16572	210	9	is	be	AUX
ihlr-16572	210	10	assurance	assurance	NOUN
ihlr-16572	210	11	that	that	PRON
ihlr-16572	210	12	itwill	itwill	NOUN
ihlr-16572	210	13	be	be	AUX
ihlr-16572	210	14	provided	provide	VERB
ihlr-16572	210	15	what	what	PRON
ihlr-16572	210	16	it	it	PRON
ihlr-16572	210	17	deems	deem	VERB
ihlr-16572	210	18	as	as	ADP
ihlr-16572	210	19	sufficiently	sufficiently	ADV
ihlr-16572	210	20	lengthy	lengthy	ADJ
ihlr-16572	210	21	data	datum	NOUN
ihlr-16572	210	22	exclusivity	exclusivity	NOUN
ihlr-16572	210	23	protection	protection	NOUN
ihlr-16572	210	24	fourteen	fourteen	NUM
ihlr-16572	210	25	years.66	years.66	NOUN
ihlr-16572	210	26	this	this	DET
ihlr-16572	210	27	protection	protection	NOUN
ihlr-16572	210	28	,	,	PUNCT
ihlr-16572	210	29	the	the	DET
ihlr-16572	210	30	organization	organization	NOUN
ihlr-16572	210	31	argues	argue	VERB
ihlr-16572	210	32	,	,	PUNCT
ihlr-16572	210	33	is	be	AUX
ihlr-16572	210	34	"	"	PUNCT
ihlr-16572	210	35	important	important	ADJ
ihlr-16572	210	36	for	for	ADP
ihlr-16572	210	37	advancement	advancement	NOUN
ihlr-16572	210	38	of	of	ADP
ihlr-16572	210	39	medical	medical	ADJ
ihlr-16572	210	40	treatment	treatment	NOUN
ihlr-16572	210	41	and	and	CCONJ
ihlr-16572	210	42	would	would	AUX
ihlr-16572	210	43	not	not	PART
ihlr-16572	210	44	prevent	prevent	VERB
ihlr-16572	210	45	fob	fob	NOUN
ihlr-16572	210	46	market	market	NOUN
ihlr-16572	210	47	en­	en­	X
ihlr-16572	210	48	try	try	VERB
ihlr-16572	210	49	.	.	PUNCT
ihlr-16572	210	50	',67	',67	PART
ihlr-16572	210	51	56	56	NUM
ihlr-16572	210	52	.	.	PUNCT
ihlr-16572	210	53	gpha	gpha	PROPN
ihlr-16572	210	54	press	press	NOUN
ihlr-16572	210	55	release	release	NOUN
ihlr-16572	211	1	i	i	PRON
ihlr-16572	211	2	,	,	PUNCT
ihlr-16572	211	3	supra	supra	PROPN
ihlr-16572	211	4	note	note	NOUN
ihlr-16572	211	5	30	30	NUM
ihlr-16572	211	6	.	.	PUNCT
ihlr-16572	212	1	57	57	NUM
ihlr-16572	212	2	.	.	PUNCT
ihlr-16572	213	1	schacht	schacht	PROPN
ihlr-16572	213	2	,	,	PUNCT
ihlr-16572	213	3	supra	supra	PROPN
ihlr-16572	213	4	note	note	NOUN
ihlr-16572	213	5	10	10	NUM
ihlr-16572	213	6	,	,	PUNCT
ihlr-16572	213	7	at	at	ADP
ihlr-16572	213	8	summary	summary	NOUN
ihlr-16572	213	9	.	.	PUNCT
ihlr-16572	214	1	58	58	NUM
ihlr-16572	214	2	.	.	PUNCT
ihlr-16572	215	1	see	see	VERB
ihlr-16572	215	2	e.g.	e.g.	ADV
ihlr-16572	215	3	,	,	PUNCT
ihlr-16572	215	4	bio	bio	PROPN
ihlr-16572	215	5	press	press	PROPN
ihlr-16572	215	6	release	release	NOUN
ihlr-16572	215	7	i	i	PROPN
ihlr-16572	215	8	,	,	PUNCT
ihlr-16572	215	9	supra	supra	PROPN
ihlr-16572	215	10	note	note	PROPN
ihlr-16572	215	11	29	29	NUM
ihlr-16572	215	12	.	.	PUNCT
ihlr-16572	215	13	59	59	NUM
ihlr-16572	215	14	.	.	PUNCT
ihlr-16572	216	1	/d	/d	INTJ
ihlr-16572	216	2	.	.	PUNCT
ihlr-16572	217	1	60	60	NUM
ihlr-16572	217	2	.	.	PUNCT
ihlr-16572	217	3	letter	letter	NOUN
ihlr-16572	217	4	from	from	ADP
ihlr-16572	217	5	john	john	PROPN
ihlr-16572	217	6	taylor	taylor	PROPN
ihlr-16572	217	7	,	,	PUNCT
ihlr-16572	217	8	supra	supra	PROPN
ihlr-16572	217	9	note	note	NOUN
ihlr-16572	217	10	7	7	NUM
ihlr-16572	217	11	.	.	NOUN
ihlr-16572	217	12	61	61	NUM
ihlr-16572	217	13	.	.	PUNCT
ihlr-16572	218	1	i	i	PRON
ihlr-16572	218	2	d	d	PROPN
ihlr-16572	218	3	62	62	NUM
ihlr-16572	218	4	.	.	PUNCT
ihlr-16572	219	1	i	i	PRON
ihlr-16572	219	2	d	d	PROPN
ihlr-16572	219	3	63	63	NUM
ihlr-16572	219	4	.	.	PUNCT
ihlr-16572	220	1	·	·	PUNCT
ihlr-16572	220	2	jd	jd	PROPN
ihlr-16572	220	3	64	64	NUM
ihlr-16572	220	4	.	.	PUNCT
ihlr-16572	221	1	i	i	PRON
ihlr-16572	221	2	d	d	PROPN
ihlr-16572	221	3	65	65	NUM
ihlr-16572	221	4	.	.	PUNCT
ihlr-16572	221	5	letter	letter	NOUN
ihlr-16572	221	6	from	from	ADP
ihlr-16572	221	7	john	john	PROPN
ihlr-16572	221	8	taylor	taylor	PROPN
ihlr-16572	221	9	,	,	PUNCT
ihlr-16572	221	10	supra	supra	PROPN
ihlr-16572	221	11	note	note	NOUN
ihlr-16572	221	12	7	7	NUM
ihlr-16572	221	13	.	.	NUM
ihlr-16572	221	14	66	66	NUM
ihlr-16572	221	15	.	.	PUNCT
ihlr-16572	222	1	i	i	PRON
ihlr-16572	222	2	d	d	PROPN
ihlr-16572	222	3	67	67	NUM
ihlr-16572	222	4	.	.	PUNCT
ihlr-16572	223	1	i	i	PRON
ihlr-16572	223	2	d.	d.	PROPN
ihlr-16572	223	3	2010	2010	NUM
ihlr-16572	223	4	]	]	PUNCT
ihlr-16572	223	5	follow	follow	VERB
ihlr-16572	223	6	-	-	PUNCT
ihlr-16572	223	7	on	on	ADP
ihlr-16572	223	8	biologics	biologic	NOUN
ihlr-16572	223	9	legislation	legislation	NOUN
ihlr-16572	223	10	377	377	NUM
ihlr-16572	223	11	it	it	PRON
ihlr-16572	223	12	would	would	AUX
ihlr-16572	223	13	be	be	AUX
ihlr-16572	223	14	a	a	DET
ihlr-16572	223	15	significant	significant	ADJ
ihlr-16572	223	16	victory	victory	NOUN
ihlr-16572	223	17	for	for	ADP
ihlr-16572	223	18	brand	brand	NOUN
ihlr-16572	223	19	name	name	NOUN
ihlr-16572	223	20	drug	drug	NOUN
ihlr-16572	223	21	manufacturers	manufacturer	NOUN
ihlr-16572	223	22	if	if	SCONJ
ihlr-16572	223	23	follow	follow	VERB
ihlr-16572	223	24	-	-	PUNCT
ihlr-16572	223	25	on	on	ADP
ihlr-16572	223	26	·	·	PUNCT
ihlr-16572	223	27	biologics	biologic	NOUN
ihlr-16572	223	28	legislation	legislation	NOUN
ihlr-16572	223	29	were	be	AUX
ihlr-16572	223	30	to	to	PART
ihlr-16572	223	31	include	include	VERB
ihlr-16572	223	32	provisions	provision	NOUN
ihlr-16572	223	33	precluding	preclude	VERB
ihlr-16572	223	34	bi­	bi­	ADP
ihlr-16572	223	35	ologics	ologic	NOUN
ihlr-16572	223	36	from	from	ADP
ihlr-16572	223	37	the	the	DET
ihlr-16572	223	38	presumed	presume	VERB
ihlr-16572	223	39	substitutability	substitutability	NOUN
ihlr-16572	223	40	and	and	CCONJ
ihlr-16572	223	41	interchangeability	interchangeability	NOUN
ihlr-16572	223	42	chemical	chemical	NOUN
ihlr-16572	223	43	generic	generic	ADJ
ihlr-16572	223	44	drugs	drug	NOUN
ihlr-16572	223	45	enjoy	enjoy	VERB
ihlr-16572	223	46	under	under	ADP
ihlr-16572	223	47	the	the	DET
ihlr-16572	223	48	hatch	hatch	NOUN
ihlr-16572	223	49	-	-	PUNCT
ihlr-16572	223	50	waxman	waxman	NOUN
ihlr-16572	223	51	act.68	act.68	PROPN
ihlr-16572	223	52	bio	bio	PROPN
ihlr-16572	223	53	argues	argue	VERB
ihlr-16572	223	54	that	that	SCONJ
ihlr-16572	223	55	rec­	rec­	ADJ
ihlr-16572	223	56	ognition	ognition	NOUN
ihlr-16572	223	57	of	of	ADP
ihlr-16572	223	58	substitutability	substitutability	NOUN
ihlr-16572	223	59	and	and	CCONJ
ihlr-16572	223	60	interchangeability	interchangeability	NOUN
ihlr-16572	223	61	for	for	ADP
ihlr-16572	223	62	biologics	biologic	NOUN
ihlr-16572	223	63	would	would	AUX
ihlr-16572	223	64	un­	un­	AUX
ihlr-16572	223	65	dermine	dermine	VERB
ihlr-16572	223	66	the	the	DET
ihlr-16572	223	67	physician	physician	NOUN
ihlr-16572	223	68	's	's	PART
ihlr-16572	223	69	discretion	discretion	NOUN
ihlr-16572	223	70	in	in	ADP
ihlr-16572	223	71	prescribing	prescribing	NOUN
ihlr-16572	223	72	which	which	DET
ihlr-16572	223	73	biologic	biologic	NOUN
ihlr-16572	223	74	to	to	PART
ihlr-16572	223	75	take	take	VERB
ihlr-16572	223	76	,	,	PUNCT
ihlr-16572	223	77	because	because	SCONJ
ihlr-16572	223	78	"	"	PUNCT
ihlr-16572	223	79	[	[	PUNCT
ihlr-16572	223	80	n]o	n]o	NOUN
ihlr-16572	223	81	two	two	NUM
ihlr-16572	223	82	biologics	biologic	NOUN
ihlr-16572	223	83	are	be	AUX
ihlr-16572	223	84	identical	identical	ADJ
ihlr-16572	223	85	and	and	CCONJ
ihlr-16572	223	86	some	some	DET
ihlr-16572	223	87	differences	difference	NOUN
ihlr-16572	223	88	could	could	AUX
ihlr-16572	223	89	have	have	VERB
ihlr-16572	223	90	clinical	clinical	ADJ
ihlr-16572	223	91	implications	implication	NOUN
ihlr-16572	223	92	that	that	PRON
ihlr-16572	223	93	are	be	AUX
ihlr-16572	223	94	not	not	PART
ihlr-16572	223	95	known	know	VERB
ihlr-16572	223	96	at	at	ADP
ihlr-16572	223	97	the	the	DET
ihlr-16572	223	98	time	time	NOUN
ihlr-16572	223	99	of	of	ADP
ihlr-16572	223	100	approva1.',69	approva1.',69	VERB
ihlr-16572	223	101	concur­	concur­	ADJ
ihlr-16572	223	102	ring	ring	NOUN
ihlr-16572	223	103	with	with	ADP
ihlr-16572	223	104	bio	bio	NOUN
ihlr-16572	223	105	on	on	ADP
ihlr-16572	223	106	this	this	DET
ihlr-16572	223	107	issue	issue	NOUN
ihlr-16572	223	108	,	,	PUNCT
ihlr-16572	223	109	the	the	DET
ihlr-16572	223	110	american	american	PROPN
ihlr-16572	223	111	medical	medical	PROPN
ihlr-16572	223	112	association	association	PROPN
ihlr-16572	223	113	passed	pass	VERB
ihlr-16572	223	114	a	a	DET
ihlr-16572	223	115	resolution	resolution	NOUN
ihlr-16572	223	116	committing	commit	VERB
ihlr-16572	223	117	to	to	PART
ihlr-16572	223	118	''	''	PUNCT
ihlr-16572	223	119	work	work	VERB
ihlr-16572	223	120	with	with	ADP
ihlr-16572	223	121	the	the	DET
ihlr-16572	223	122	u.s	u.s	PROPN
ihlr-16572	223	123	.	.	PROPN
ihlr-16572	223	124	food	food	PROPN
ihlr-16572	223	125	and	and	CCONJ
ihlr-16572	223	126	drug	drug	NOUN
ihlr-16572	224	1	administra­	administra­	ADJ
ihlr-16572	224	2	tion	tion	NOUN
ihlr-16572	224	3	and	and	CCONJ
ihlr-16572	224	4	other	other	ADJ
ihlr-16572	224	5	scientific	scientific	ADJ
ihlr-16572	224	6	and	and	CCONJ
ihlr-16572	224	7	clinical	clinical	ADJ
ihlr-16572	224	8	organizations	organization	NOUN
ihlr-16572	224	9	to	to	PART
ihlr-16572	224	10	ensure	ensure	VERB
ihlr-16572	224	11	that	that	SCONJ
ihlr-16572	224	12	any	any	DET
ihlr-16572	224	13	legisla­	legisla­	ADJ
ihlr-16572	224	14	tion	tion	NOUN
ihlr-16572	224	15	that	that	PRON
ihlr-16572	224	16	establishes	establish	VERB
ihlr-16572	224	17	an	an	DET
ihlr-16572	224	18	approval	approval	NOUN
ihlr-16572	224	19	pathway	pathway	NOUN
ihlr-16572	224	20	for	for	ADP
ihlr-16572	224	21	follow	follow	VERB
ihlr-16572	224	22	-	-	PUNCT
ihlr-16572	224	23	on	on	ADP
ihlr-16572	224	24	biological	biological	ADJ
ihlr-16572	224	25	products	product	NOUN
ihlr-16572	224	26	prohibits	prohibit	VERB
ihlr-16572	224	27	the	the	DET
ihlr-16572	224	28	automatic	automatic	ADJ
ihlr-16572	224	29	substitution	substitution	NOUN
ihlr-16572	224	30	of	of	ADP
ihlr-16572	224	31	biosimilar	biosimilar	ADJ
ihlr-16572	224	32	medicines	medicine	NOUN
ihlr-16572	224	33	without	without	ADP
ihlr-16572	224	34	the	the	DET
ihlr-16572	224	35	consent	consent	NOUN
ihlr-16572	224	36	of	of	ADP
ihlr-16572	224	37	the	the	DET
ihlr-16572	224	38	patient	patient	NOUN
ihlr-16572	224	39	's	's	PART
ihlr-16572	224	40	treating	treat	VERB
ihlr-16572	224	41	physician	physician	NOUN
ihlr-16572	224	42	.	.	PUNCT
ihlr-16572	225	1	''70	''70	PROPN
ihlr-16572	225	2	bio	bio	PROPN
ihlr-16572	225	3	highlights	highlight	VERB
ihlr-16572	225	4	other	other	ADJ
ihlr-16572	225	5	countries	country	NOUN
ihlr-16572	225	6	'	'	PART
ihlr-16572	225	7	approach	approach	NOUN
ihlr-16572	225	8	to	to	ADP
ihlr-16572	225	9	substitutability	substitutability	NOUN
ihlr-16572	225	10	and	and	CCONJ
ihlr-16572	225	11	inter­	inter­	NUM
ihlr-16572	225	12	changeability	changeability	NOUN
ihlr-16572	225	13	in	in	ADP
ihlr-16572	225	14	their	their	PRON
ihlr-16572	225	15	treatment	treatment	NOUN
ihlr-16572	225	16	of	of	ADP
ihlr-16572	225	17	follow	follow	NOUN
ihlr-16572	225	18	-	-	PUNCT
ihlr-16572	225	19	on	on	ADP
ihlr-16572	225	20	biologics.71	biologics.71	NOUN
ihlr-16572	225	21	for	for	ADP
ihlr-16572	225	22	example	example	NOUN
ihlr-16572	225	23	,	,	PUNCT
ihlr-16572	225	24	united	united	ADJ
ihlr-16572	225	25	kingdom	kingdom	PROPN
ihlr-16572	225	26	government	government	NOUN
ihlr-16572	225	27	officials	official	NOUN
ihlr-16572	225	28	have	have	AUX
ihlr-16572	225	29	stated	state	VERB
ihlr-16572	225	30	,	,	PUNCT
ihlr-16572	225	31	"	"	PUNCT
ihlr-16572	225	32	when	when	SCONJ
ihlr-16572	225	33	prescribing	prescribe	VERB
ihlr-16572	225	34	bio­	bio­	NOUN
ihlr-16572	225	35	logical	logical	ADJ
ihlr-16572	225	36	products	product	NOUN
ihlr-16572	225	37	,	,	PUNCT
ihlr-16572	225	38	it	it	PRON
ihlr-16572	225	39	is	be	AUX
ihlr-16572	225	40	good	good	ADJ
ihlr-16572	225	41	practice	practice	NOUN
ihlr-16572	225	42	to	to	PART
ihlr-16572	225	43	use	use	VERB
ihlr-16572	225	44	the	the	DET
ihlr-16572	225	45	brand	brand	NOUN
ihlr-16572	225	46	name	name	NOUN
ihlr-16572	225	47	.	.	PUNCT
ihlr-16572	226	1	this	this	PRON
ihlr-16572	226	2	will	will	AUX
ihlr-16572	226	3	ensure	ensure	VERB
ihlr-16572	226	4	that	that	SCONJ
ihlr-16572	226	5	automatic	automatic	ADJ
ihlr-16572	226	6	substitution	substitution	NOUN
ihlr-16572	226	7	of	of	ADP
ihlr-16572	226	8	a	a	DET
ihlr-16572	226	9	biosimilar	biosimilar	NOUN
ihlr-16572	226	10	~uct	~uct	NOUN
ihlr-16572	226	11	does	do	AUX
ihlr-16572	226	12	not	not	PART
ihlr-16572	226	13	occur	occur	VERB
ihlr-16572	226	14	when	when	SCONJ
ihlr-16572	226	15	the	the	DET
ihlr-16572	226	16	medicine	medicine	NOUN
ihlr-16572	226	17	is	be	AUX
ihlr-16572	226	18	dispensed	dispense	VERB
ihlr-16572	226	19	by	by	ADP
ihlr-16572	226	20	the	the	DET
ihlr-16572	226	21	pharmacist	pharmacist	NOUN
ihlr-16572	226	22	.	.	PUNCT
ihlr-16572	226	23	''	''	PUNCT
ihlr-16572	227	1	2	2	NUM
ihlr-16572	227	2	french	french	ADJ
ihlr-16572	227	3	authorities	authority	NOUN
ihlr-16572	227	4	have	have	AUX
ihlr-16572	227	5	also	also	ADV
ihlr-16572	227	6	noted	note	VERB
ihlr-16572	227	7	,	,	PUNCT
ihlr-16572	227	8	"	"	PUNCT
ihlr-16572	227	9	a	a	DET
ihlr-16572	227	10	systematic	systematic	ADJ
ihlr-16572	227	11	and	and	CCONJ
ihlr-16572	227	12	uncontrolled	uncontrolled	ADJ
ihlr-16572	227	13	substitution	substitution	NOUN
ihlr-16572	227	14	,	,	PUNCT
ihlr-16572	227	15	based	base	VERB
ihlr-16572	227	16	on	on	ADP
ihlr-16572	227	17	the	the	DET
ihlr-16572	227	18	prescription	prescription	NOUN
ihlr-16572	227	19	of	of	ADP
ihlr-16572	227	20	the	the	DET
ihlr-16572	227	21	international	international	ADJ
ihlr-16572	227	22	common	common	ADJ
ihlr-16572	227	23	denomination	denomination	NOUN
ihlr-16572	227	24	of	of	ADP
ihlr-16572	227	25	the	the	DET
ihlr-16572	227	26	active	active	ADJ
ihlr-16572	227	27	substance	substance	NOUN
ihlr-16572	227	28	,	,	PUNCT
ihlr-16572	227	29	does	do	AUX
ihlr-16572	227	30	not	not	PART
ihlr-16572	227	31	appear	appear	VERB
ihlr-16572	227	32	reasonable	reasonable	ADJ
ihlr-16572	227	33	at	at	ADP
ihlr-16572	227	34	this	this	DET
ihlr-16572	227	35	time	time	NOUN
ihlr-16572	227	36	...	...	PUNCT
ihlr-16572	228	1	physicians	physician	NOUN
ihlr-16572	228	2	should	should	AUX
ihlr-16572	228	3	be	be	AUX
ihlr-16572	228	4	involved	involve	VERB
ihlr-16572	228	5	in	in	ADP
ihlr-16572	228	6	deci­	deci­	ADJ
ihlr-16572	228	7	sions	sion	NOUN
ihlr-16572	228	8	to	to	PART
ihlr-16572	228	9	substitute	substitute	VERB
ihlr-16572	228	10	any	any	DET
ihlr-16572	228	11	bmp	bmp	NOUN
ihlr-16572	229	1	[	[	X
ihlr-16572	229	2	biological	biological	ADJ
ihlr-16572	229	3	medicinal	medicinal	ADJ
ihlr-16572	229	4	product].'.73	product].'.73	PROPN
ihlr-16572	229	5	bio	bio	NOUN
ihlr-16572	229	6	further	far	ADV
ihlr-16572	229	7	asserts	assert	VERB
ihlr-16572	229	8	that	that	SCONJ
ihlr-16572	229	9	a	a	DET
ihlr-16572	229	10	finding	finding	NOUN
ihlr-16572	229	11	of	of	ADP
ihlr-16572	229	12	interchangeability	interchangeability	NOUN
ihlr-16572	229	13	will	will	AUX
ihlr-16572	229	14	not	not	PART
ihlr-16572	229	15	neces­	neces­	AUX
ihlr-16572	229	16	sarily	sarily	ADV
ihlr-16572	229	17	result	result	VERB
ihlr-16572	229	18	in	in	ADP
ihlr-16572	229	19	greater	great	ADJ
ihlr-16572	229	20	savings	saving	NOUN
ihlr-16572	229	21	to	to	ADP
ihlr-16572	229	22	consumers	consumer	NOUN
ihlr-16572	229	23	.	.	PUNCT
ihlr-16572	230	1	74	74	NUM
ihlr-16572	230	2	other	other	ADJ
ihlr-16572	230	3	factors	factor	NOUN
ihlr-16572	230	4	,	,	PUNCT
ihlr-16572	230	5	they	they	PRON
ihlr-16572	230	6	argue	argue	VERB
ihlr-16572	230	7	,	,	PUNCT
ihlr-16572	230	8	may	may	AUX
ihlr-16572	230	9	have	have	VERB
ihlr-16572	230	10	a	a	DET
ihlr-16572	230	11	greater	great	ADJ
ihlr-16572	230	12	effect	effect	NOUN
ihlr-16572	230	13	on	on	ADP
ihlr-16572	230	14	the	the	DET
ihlr-16572	230	15	extent	extent	NOUN
ihlr-16572	230	16	to	to	PART
ihlr-16572	230	17	which	which	PRON
ihlr-16572	230	18	consmners	consmner	NOUN
ihlr-16572	230	19	actually	actually	ADV
ihlr-16572	230	20	save	save	VERB
ihlr-16572	230	21	:	:	PUNCT
ihlr-16572	230	22	the	the	DET
ihlr-16572	230	23	degree	degree	NOUN
ihlr-16572	230	24	of	of	ADP
ihlr-16572	230	25	competition	competition	NOUN
ihlr-16572	230	26	and	and	CCONJ
ihlr-16572	230	27	potential	potential	ADJ
ihlr-16572	230	28	cost	cost	NOUN
ihlr-16572	230	29	savings	saving	NOUN
ihlr-16572	230	30	arising	arise	VERB
ihlr-16572	230	31	from	from	ADP
ihlr-16572	230	32	a	a	DET
ihlr-16572	230	33	follow	follow	VERB
ihlr-16572	230	34	-	-	PUNCT
ihlr-16572	230	35	on	on	ADP
ihlr-16572	230	36	biologics	biologic	NOUN
ihlr-16572	230	37	approval	approval	NOUN
ihlr-16572	230	38	pathway	pathway	NOUN
ihlr-16572	230	39	is	be	AUX
ihlr-16572	230	40	likely	likely	ADJ
ihlr-16572	230	41	to	to	PART
ihlr-16572	230	42	be	be	AUX
ihlr-16572	230	43	heavily	heavily	ADV
ihlr-16572	230	44	dependent	dependent	ADJ
ihlr-16572	230	45	on	on	ADP
ihlr-16572	230	46	numerous	numerous	ADJ
ihlr-16572	230	47	factors	factor	NOUN
ihlr-16572	230	48	beyond	beyond	ADP
ihlr-16572	230	49	the	the	DET
ihlr-16572	230	50	question	question	NOUN
ihlr-16572	230	51	of	of	ADP
ihlr-16572	230	52	interchangeability	interchangeability	NOUN
ihlr-16572	230	53	,	,	PUNCT
ihlr-16572	230	54	including	include	VERB
ihlr-16572	230	55	number	number	NOUN
ihlr-16572	230	56	·	·	PUNCT
ihlr-16572	230	57	of	of	ADP
ihlr-16572	230	58	market	market	NOUN
ihlr-16572	230	59	entrants	entrant	NOUN
ihlr-16572	230	60	,	,	PUNCT
ihlr-16572	230	61	product	product	NOUN
ihlr-16572	230	62	quality	quality	NOUN
ihlr-16572	230	63	,	,	PUNCT
ihlr-16572	230	64	cost	cost	NOUN
ihlr-16572	230	65	of	of	ADP
ihlr-16572	230	66	production	production	NOUN
ihlr-16572	230	67	,	,	PUNCT
ihlr-16572	230	68	price	price	NOUN
ihlr-16572	230	69	discounting	discounting	NOUN
ihlr-16572	230	70	,	,	PUNCT
ihlr-16572	230	71	market	market	NOUN
ihlr-16572	230	72	penetration	penetration	NOUN
ihlr-16572	230	73	,	,	PUNCT
ihlr-16572	230	74	po68	po68	PROPN
ihlr-16572	230	75	.	.	PUNCT
ihlr-16572	230	76	drug	drug	NOUN
ihlr-16572	230	77	price	price	NOUN
ihlr-16572	230	78	competition	competition	NOUN
ihlr-16572	230	79	and	and	CCONJ
ihlr-16572	230	80	patent	patent	NOUN
ihlr-16572	230	81	term	term	NOUN
ihlr-16572	230	82	restoration	restoration	NOUN
ihlr-16572	230	83	act	act	NOUN
ihlr-16572	230	84	,	,	PUNCT
ihlr-16572	230	85	pub	pub	NOUN
ihlr-16572	230	86	.	.	PUNCT
ihlr-16572	231	1	l.	l.	PROPN
ihlr-16572	231	2	no	no	INTJ
ihlr-16572	231	3	.	.	PROPN
ihlr-16572	232	1	98	98	NUM
ihlr-16572	232	2	-	-	SYM
ihlr-16572	232	3	417	417	NUM
ihlr-16572	232	4	,	,	PUNCT
ihlr-16572	232	5	98	98	NUM
ihlr-16572	232	6	stat	stat	NOUN
ihlr-16572	232	7	.	.	PUNCT
ihlr-16572	233	1	1585	1585	NUM
ihlr-16572	233	2	(	(	PUNCT
ihlr-16572	233	3	1984	1984	NUM
ihlr-16572	233	4	)	)	PUNCT
ihlr-16572	233	5	;	;	PUNCT
ihlr-16572	233	6	letter	letter	NOUN
ihlr-16572	233	7	from	from	ADP
ihlr-16572	233	8	john	john	PROPN
ihlr-16572	233	9	taylor	taylor	PROPN
ihlr-16572	233	10	,	,	PUNCT
ihlr-16572	233	11	supra	supra	PROPN
ihlr-16572	233	12	note	note	PROPN
ihlr-16572	233	13	7	7	NUM
ihlr-16572	233	14	..	..	SYM
ihlr-16572	233	15	69	69	NUM
ihlr-16572	233	16	.	.	PUNCT
ihlr-16572	234	1	letter	letter	NOUN
ihlr-16572	234	2	from	from	ADP
ihlr-16572	234	3	john	john	PROPN
ihlr-16572	234	4	taylor	taylor	PROPN
ihlr-16572	234	5	,	,	PUNCT
ihlr-16572	234	6	supra	supra	PROPN
ihlr-16572	234	7	note	note	NOUN
ihlr-16572	234	8	7	7	NUM
ihlr-16572	234	9	.	.	NOUN
ihlr-16572	234	10	70	70	NUM
ihlr-16572	234	11	.	.	PUNCT
ihlr-16572	235	1	i	i	PRON
ihlr-16572	235	2	d.	d.	PROPN
ihlr-16572	235	3	71	71	NUM
ihlr-16572	235	4	.	.	PUNCT
ihlr-16572	236	1	/d	/d	INTJ
ihlr-16572	236	2	.	.	PUNCT
ihlr-16572	237	1	72	72	NUM
ihlr-16572	237	2	.	.	PUNCT
ihlr-16572	238	1	jd	jd	PROPN
ihlr-16572	238	2	.	.	PUNCT
ihlr-16572	239	1	(	(	PUNCT
ihlr-16572	239	2	citing	cite	VERB
ihlr-16572	239	3	mhra	mhra	ADJ
ihlr-16572	239	4	drug	drug	NOUN
ihlr-16572	239	5	safety	safety	NOUN
ihlr-16572	239	6	update	update	NOUN
ihlr-16572	239	7	:	:	PUNCT
ihlr-16572	239	8	vol	vol	NOUN
ihlr-16572	239	9	.	.	NOUN
ihlr-16572	239	10	1	1	NUM
ihlr-16572	239	11	,	,	PUNCT
ihlr-16572	239	12	issue	issue	VERB
ihlr-16572	239	13	7	7	NUM
ihlr-16572	239	14	(	(	PUNCT
ihlr-16572	239	15	feb	feb	PROPN
ihlr-16572	239	16	.	.	PROPN
ihlr-16572	239	17	2008	2008	NUM
ihlr-16572	239	18	)	)	PUNCT
ihlr-16572	239	19	,	,	PUNCT
ihlr-16572	239	20	available	available	ADJ
ihlr-16572	239	21	at	at	ADP
ihlr-16572	239	22	http://www.mhra.gov.uk/publications/safetyguidance/drug	http://www.mhra.gov.uk/publications/safetyguidance/drug	ADJ
ihlr-16572	239	23	safetyupdate	safetyupdate	NOUN
ihlr-16572	239	24	/	/	SYM
ihlr-16572	239	25	con2033917	con2033917	NOUN
ihlr-16572	239	26	)	)	PUNCT
ihlr-16572	239	27	.	.	PUNCT
ihlr-16572	240	1	73	73	NUM
ihlr-16572	240	2	.	.	PUNCT
ihlr-16572	241	1	i	i	PRON
ihlr-16572	241	2	d.	d.	PROPN
ihlr-16572	241	3	(	(	PUNCT
ihlr-16572	241	4	citing	cite	VERB
ihlr-16572	241	5	pavlovic	pavlovic	ADV
ihlr-16572	241	6	et	et	PROPN
ihlr-16572	241	7	al	al	PROPN
ihlr-16572	241	8	;	;	PUNCT
ihlr-16572	241	9	similar	similar	ADJ
ihlr-16572	241	10	biological	biological	ADJ
ihlr-16572	241	11	medicinal	medicinal	ADJ
ihlr-16572	241	12	products	product	NOUN
ihlr-16572	241	13	containing	contain	VERB
ihlr-16572	241	14	re­	re­	PROPN
ihlr-16572	241	15	combinant	combinant	PROPN
ihlr-16572	241	16	human	human	ADJ
ihlr-16572	241	17	growth	growth	NOUN
ihlr-16572	241	18	hormone	hormone	NOUN
ihlr-16572	241	19	:	:	PUNCT
ihlr-16572	241	20	european	european	ADJ
ihlr-16572	241	21	regulation	regulation	NOUN
ihlr-16572	241	22	;	;	PUNCT
ihlr-16572	241	23	hormone	hormone	NOUN
ihlr-16572	241	24	research	research	NOUN
ihlr-16572	241	25	;	;	PUNCT
ihlr-16572	241	26	2008	2008	NUM
ihlr-16572	241	27	;	;	PUNCT
ihlr-16572	241	28	69	69	NUM
ihlr-16572	241	29	;	;	PUNCT
ihlr-16572	241	30	14	14	NUM
ihlr-16572	241	31	-	-	SYM
ihlr-16572	241	32	21	21	NUM
ihlr-16572	241	33	)	)	PUNCT
ihlr-16572	241	34	.	.	PUNCT
ihlr-16572	242	1	74	74	NUM
ihlr-16572	242	2	.	.	PUNCT
ihlr-16572	242	3	biotechnology	biotechnology	NOUN
ihlr-16572	242	4	industry	industry	NOUN
ihlr-16572	242	5	organization	organization	NOUN
ihlr-16572	242	6	,	,	PUNCT
ihlr-16572	242	7	supra	supra	PROPN
ihlr-16572	242	8	note	note	NOUN
ihlr-16572	242	9	8	8	NUM
ihlr-16572	242	10	.	.	X
ihlr-16572	242	11	378	378	NUM
ihlr-16572	242	12	indiana	indiana	PROPN
ihlr-16572	242	13	healrn	healrn	PROPN
ihlr-16572	242	14	law	law	PROPN
ihlr-16572	242	15	review	review	NOUN
ihlr-16572	242	16	.	.	PUNCT
ihlr-16572	243	1	[	[	X
ihlr-16572	243	2	vol	vol	NOUN
ihlr-16572	243	3	.	.	PUNCT
ihlr-16572	244	1	7:367	7:367	NUM
ihlr-16572	244	2	tential	tential	ADJ
ihlr-16572	244	3	market	market	NOUN
ihlr-16572	244	4	size	size	NOUN
ihlr-16572	244	5	for	for	ADP
ihlr-16572	244	6	any	any	DET
ihlr-16572	244	7	given	give	VERB
ihlr-16572	244	8	product	product	NOUN
ihlr-16572	244	9	,	,	PUNCT
ihlr-16572	244	10	etc	etc	X
ihlr-16572	244	11	.	.	X
ihlr-16572	244	12	indeed	indeed	ADV
ihlr-16572	244	13	,	,	PUNCT
ihlr-16572	244	14	a	a	DET
ihlr-16572	244	15	finding	finding	NOUN
ihlr-16572	244	16	of	of	ADP
ihlr-16572	244	17	interchangeability	interchangeability	NOUN
ihlr-16572	244	18	may	may	AUX
ihlr-16572	244	19	in	in	ADP
ihlr-16572	244	20	fact	fact	NOUN
ihlr-16572	244	21	lead	lead	VERB
ihlr-16572	244	22	to	to	ADP
ihlr-16572	244	23	.	.	PUNCT
ihlr-16572	245	1	lower	low	ADJ
ihlr-16572	245	2	savings	saving	NOUN
ihlr-16572	245	3	to	to	ADP
ihlr-16572	245	4	consumers	consumer	NOUN
ihlr-16572	245	5	,	,	PUNCT
ihlr-16572	245	6	depending	depend	VERB
ihlr-16572	245	7	on	on	ADP
ihlr-16572	245	8	its	its	PRON
ihlr-16572	245	9	impact	impact	NOUN
ihlr-16572	245	10	on	on	ADP
ihlr-16572	245	11	these	these	DET
ihlr-16572	245	12	other	other	ADJ
ihlr-16572	245	13	critical	critical	ADJ
ihlr-16572	245	14	factors	factor	NOUN
ihlr-16572	245	15	.	.	PUNCT
ihlr-16572	246	1	bio	bio	PROPN
ihlr-16572	246	2	therefore	therefore	ADV
ihlr-16572	246	3	believes	believe	VERB
ihlr-16572	246	4	it	it	PRON
ihlr-16572	246	5	would	would	AUX
ihlr-16572	246	6	[	[	X
ihlr-16572	246	7	be	be	AUX
ihlr-16572	246	8	]	]	PUNCT
ihlr-16572	246	9	imprudent	imprudent	ADJ
ihlr-16572	246	10	for	for	SCONJ
ihlr-16572	246	11	the	the	DET
ihlr-16572	246	12	ftc	ftc	PROPN
ihlr-16572	246	13	to	to	PART
ihlr-16572	246	14	rely	rely	VERB
ihlr-16572	246	15	on	on	ADP
ihlr-16572	246	16	erro­	erro­	NOUN
ihlr-16572	246	17	neous	neous	ADJ
ihlr-16572	246	18	scientific	scientific	ADJ
ihlr-16572	246	19	and	and	CCONJ
ihlr-16572	246	20	economic	economic	ADJ
ihlr-16572	246	21	assumptions	assumption	NOUN
ihlr-16572	246	22	i.e.	i.e.	ADV
ihlr-16572	246	23	,	,	PUNCT
ihlr-16572	246	24	that	that	SCONJ
ihlr-16572	246	25	interchangeability	interchangeability	NOUN
ihlr-16572	246	26	is·likely	is·likely	ADV
ihlr-16572	246	27	and	and	CCONJ
ihlr-16572	246	28	would	would	AUX
ihlr-16572	246	29	necessarily	necessarily	ADV
ihlr-16572	246	30	-lead	-lead	VERB
ihlr-16572	246	31	·	·	PUNCT
ihlr-16572	246	32	to	to	ADP
ihlr-16572	246	33	greater	great	ADJ
ihlr-16572	246	34	cost	cost	NOUN
ihlr-16572	246	35	savings	saving	NOUN
ihlr-16572	246	36	in	in	ADP
ihlr-16572	246	37	crafting	craft	VERB
ihlr-16572	246	38	any	any	DET
ihlr-16572	246	39	public	public	ADJ
ihlr-16572	246	40	policy	policy	NOUN
ihlr-16572	246	41	recommendations	recommendation	NOUN
ihlr-16572	246	42	relating	relate	VERB
ihlr-16572	246	43	to	to	ADP
ihlr-16572	246	44	a	a	DET
ihlr-16572	246	45	fobs	fobs	PROPN
ihlr-16572	246	46	regime	regime	NOUN
ihlr-16572	246	47	.	.	PUNCT
ihlr-16572	247	1	75	75	NUM
ihlr-16572	247	2	d.	d.	NOUN
ihlr-16572	247	3	degrees	degree	NOUN
ihlr-16572	247	4	of	of	ADP
ihlr-16572	247	5	exclusivity	exclusivity	NOUN
ihlr-16572	247	6	granted	grant	VERB
ihlr-16572	247	7	to	to	ADP
ihlr-16572	247	8	innovators	innovator	NOUN
ihlr-16572	247	9	by	by	ADP
ihlr-16572	247	10	generic	generic	ADJ
ihlr-16572	247	11	legislation	legislation	NOUN
ihlr-16572	247	12	,	,	PUNCT
ihlr-16572	247	13	laws	law	NOUN
ihlr-16572	247	14	granting	grant	VERB
ihlr-16572	247	15	generic	generic	ADJ
ihlr-16572	247	16	manufacturers	manufacturer	NOUN
ihlr-16572	247	17	the	the	DET
ihlr-16572	247	18	right	right	NOUN
ihlr-16572	247	19	to	to	PART
ihlr-16572	247	20	duplicate	duplicate	VERB
ihlr-16572	247	21	brand	brand	NOUN
ihlr-16572	247	22	name	name	NOUN
ihlr-16572	247	23	drugs	drug	NOUN
ihlr-16572	247	24	typically	typically	ADV
ihlr-16572	247	25	allow	allow	VERB
ihlr-16572	247	26	the	the	DET
ihlr-16572	247	27	original	original	ADJ
ihlr-16572	247	28	manufacturer	manufacturer	NOUN
ihlr-16572	247	29	a	a	DET
ihlr-16572	247	30	term	term	NOUN
ihlr-16572	247	31	of	of	ADP
ihlr-16572	247	32	exclusivity	exclusivity	NOUN
ihlr-16572	247	33	,	,	PUNCT
ihlr-16572	247	34	during	during	ADP
ihlr-16572	247	35	which	which	PRON
ihlr-16572	247	36	the	the	DET
ihlr-16572	247	37	original	original	ADJ
ihlr-16572	247	38	manufacturer	manufacturer	NOUN
ihlr-16572	247	39	is	be	AUX
ihlr-16572	247	40	able	able	ADJ
ihlr-16572	247	41	to	to	PART
ihlr-16572	247	42	profit	profit	VERB
ihlr-16572	247	43	from	from	ADP
ihlr-16572	247	44	its	its	PRON
ihlr-16572	247	45	innovation	innovation	NOUN
ihlr-16572	247	46	without	without	ADP
ihlr-16572	247	47	having	have	VERB
ihlr-16572	247	48	to	to	PART
ihlr-16572	247	49	compete	compete	VERB
ihlr-16572	247	50	with	with	ADP
ihlr-16572	247	51	less	less	ADV
ihlr-16572	247	52	expensive	expensive	ADJ
ihlr-16572	247	53	generics.76	generics.76	PROPN
ihlr-16572	247	54	exclusivity	exclusivity	NOUN
ihlr-16572	247	55	is	be	AUX
ihlr-16572	247	56	granted	grant	VERB
ihlr-16572	247	57	in	in	ADP
ihlr-16572	247	58	two	two	NUM
ihlr-16572	247	59	forms	form	NOUN
ihlr-16572	247	60	data	datum	NOUN
ihlr-16572	247	61	exclusivity	exclusivity	NOUN
ihlr-16572	247	62	and	and	CCONJ
ihlr-16572	247	63	approval	approval	NOUN
ihlr-16572	247	64	exclusivity	exclusivity	NOUN
ihlr-16572	247	65	(	(	PUNCT
ihlr-16572	247	66	market	market	NOUN
ihlr-16572	247	67	exclusivity).17	exclusivity).17	PROPN
ihlr-16572	247	68	data	data	NOUN
ihlr-16572	247	69	exclusivity	exclusivity	NOUN
ihlr-16572	247	70	in	in	ADP
ihlr-16572	247	71	this	this	DET
ihlr-16572	247	72	context	context	NOUN
ihlr-16572	247	73	typically	typically	ADV
ihlr-16572	247	74	refers	refer	VERB
ihlr-16572	247	75	to	to	ADP
ihlr-16572	247	76	statutory	statutory	ADJ
ihlr-16572	247	77	prohibition	prohibition	NOUN
ihlr-16572	247	78	.	.	PUNCT
ihlr-16572	248	1	of	of	ADP
ihlr-16572	248	2	the	the	DET
ihlr-16572	248	3	approval	approval	NOUN
ihlr-16572	248	4	for	for	ADP
ihlr-16572	248	5	a	a	DET
ihlr-16572	248	6	generic	generic	ADJ
ihlr-16572	248	7	product	product	NOUN
ihlr-16572	248	8	which	which	PRON
ihlr-16572	248	9	uses	use	VERB
ihlr-16572	248	10	an	an	DET
ihlr-16572	248	11	innovator	innovator	NOUN
ihlr-16572	248	12	product	product	NOUN
ihlr-16572	248	13	as	as	ADP
ihlr-16572	248	14	its	its	PRON
ihlr-16572	248	15	reference	reference	NOUN
ihlr-16572	248	16	product	product	NOUN
ihlr-16572	248	17	.	.	PUNCT
ihlr-16572	249	1	78	78	NUM
ihlr-16572	249	2	.	.	PUNCT
ihlr-16572	250	1	a	a	DET
ihlr-16572	250	2	data	data	NOUN
ihlr-16572	250	3	exclusivity	exclusivity	NOUN
ihlr-16572	250	4	period	period	NOUN
ihlr-16572	250	5	is	be	AUX
ihlr-16572	250	6	the	the	DET
ihlr-16572	250	7	time	time	NOUN
ihlr-16572	250	8	during	during	ADP
ihlr-16572	250	9	which	which	PRON
ihlr-16572	250	10	a	a	DET
ihlr-16572	250	11	potential	potential	ADJ
ihlr-16572	250	12	generic	generic	ADJ
ihlr-16572	250	13	supplier	supplier	NOUN
ihlr-16572	250	14	of	of	ADP
ihlr-16572	250	15	a	a	DET
ihlr-16572	250	16	given	give	VERB
ihlr-16572	250	17	drug	drug	NOUN
ihlr-16572	250	18	is	be	AUX
ihlr-16572	250	19	barred	bar	VERB
ihlr-16572	250	20	from	from	ADP
ihlr-16572	250	21	submitting	submit	VERB
ihlr-16572	250	22	an	an	DET
ihlr-16572	250	23	abbreviated	abbreviate	VERB
ihlr-16572	250	24	new	new	ADJ
ihlr-16572	250	25	drug	drug	NOUN
ihlr-16572	250	26	application	application	NOUN
ihlr-16572	250	27	(	(	PUNCT
ihlr-16572	250	28	"	"	PUNCT
ihlr-16572	250	29	anda").79	anda").79	VERB
ihlr-16572	250	30	an	an	DET
ihlr-16572	250	31	anda	anda	PROPN
ihlr-16572	250	32	allows	allow	VERB
ihlr-16572	250	33	generic	generic	ADJ
ihlr-16572	250	34	companies	company	NOUN
ihlr-16572	250	35	to	to	PART
ihlr-16572	250	36	save	save	VERB
ihlr-16572	250	37	the	the	DET
ihlr-16572	250	38	time	time	NOUN
ihlr-16572	250	39	and	and	CCONJ
ihlr-16572	250	40	expense	expense	NOUN
ihlr-16572	250	41	of	of	ADP
ihlr-16572	250	42	the	the	DET
ihlr-16572	250	43	extensive	extensive	ADJ
ihlr-16572	250	44	clinical	clinical	ADJ
ihlr-16572	250	45	trials	trial	NOUN
ihlr-16572	250	46	required	require	VERB
ihlr-16572	250	47	for	for	ADP
ihlr-16572	250	48	the	the	DET
ihlr-16572	250	49	approval	approval	NOUN
ihlr-16572	250	50	of	of	ADP
ihlr-16572	250	51	an	an	DET
ihlr-16572	250	52	entirely	entirely	ADV
ihlr-16572	250	53	new	new	ADJ
ihlr-16572	250	54	drug	drug	NOUN
ihlr-16572	250	55	.	.	PUNCT
ihlr-16572	251	1	80	80	NUM
ihlr-16572	251	2	·	·	PUNCT
ihlr-16572	251	3	during	during	ADP
ihlr-16572	251	4	a	a	DET
ihlr-16572	251	5	data	data	NOUN
ihlr-16572	251	6	exclusivity	exclusivity	NOUN
ihlr-16572	251	7	period	period	NOUN
ihlr-16572	251	8	,	,	PUNCT
ihlr-16572	251	9	the	the	DET
ihlr-16572	251	10	fda	fda	PROPN
ihlr-16572	251	11	may	may	AUX
ihlr-16572	251	12	not	not	PART
ihlr-16572	251	13	use	use	VERB
ihlr-16572	251	14	the	the	DET
ihlr-16572	251	15	innovator	innovator	NOUN
ihlr-16572	251	16	's	's	PART
ihlr-16572	251	17	safety	safety	NOUN
ihlr-16572	251	18	and	and	CCONJ
ihlr-16572	251	19	effectiveness	effectiveness	NOUN
ihlr-16572	251	20	data	datum	NOUN
ihlr-16572	251	21	as	as	ADP
ihlr-16572	251	22	a	a	DET
ihlr-16572	251	23	basis	basis	NOUN
ihlr-16572	251	24	for	for	ADP
ihlr-16572	251	25	approving	approve	VERB
ihlr-16572	251	26	a	a	DET
ihlr-16572	251	27	generic	generic	ADJ
ihlr-16572	251	28	alternative.81	alternative.81	PROPN
ihlr-16572	251	29	approval	approval	NOUN
ihlr-16572	251	30	exclusivity	exclusivity	NOUN
ihlr-16572	251	31	,	,	PUNCT
ihlr-16572	251	32	often	often	ADV
ihlr-16572	251	33	termed	term	VERB
ihlr-16572	251	34	market	market	NOUN
ihlr-16572	251	35	exclusivity	exclusivity	NOUN
ihlr-16572	251	36	,	,	PUNCT
ihlr-16572	251	37	refers	refer	VERB
ihlr-16572	251	38	to	to	ADP
ihlr-16572	251	39	the	the	DET
ihlr-16572	251	40	pe­	pe­	NOUN
ihlr-16572	251	41	riod	riod	NOUN
ihlr-16572	251	42	during	during	ADP
ihlr-16572	251	43	which	which	PRON
ihlr-16572	251	44	a	a	DET
ihlr-16572	251	45	drug	drug	NOUN
ihlr-16572	251	46	supplier	supplier	NOUN
ihlr-16572	251	47	is	be	AUX
ihlr-16572	251	48	free	free	ADJ
ihlr-16572	251	49	to	to	PART
ihlr-16572	251	50	file	file	VERB
ihlr-16572	251	51	their	their	PRON
ihlr-16572	251	52	anda	anda	NOUN
ihlr-16572	251	53	using	use	VERB
ihlr-16572	251	54	the	the	DET
ihlr-16572	251	55	brand	brand	NOUN
ihlr-16572	251	56	company	company	NOUN
ihlr-16572	251	57	's	's	PART
ihlr-16572	251	58	safety	safety	NOUN
ihlr-16572	251	59	and	and	CCONJ
ihlr-16572	251	60	effectiveness	effectiveness	NOUN
ihlr-16572	251	61	data	datum	NOUN
ihlr-16572	251	62	,	,	PUNCT
ihlr-16572	251	63	but	but	CCONJ
ihlr-16572	251	64	can	can	AUX
ihlr-16572	251	65	not	not	PART
ihlr-16572	251	66	receive	receive	VERB
ihlr-16572	251	67	approval.82	approval.82	NOUN
ihlr-16572	251	68	initially	initially	ADV
ihlr-16572	251	69	,	,	PUNCT
ihlr-16572	251	70	the	the	DET
ihlr-16572	251	71	distinction	distinction	NOUN
ihlr-16572	251	72	between	between	ADP
ihlr-16572	251	73	these	these	DET
ihlr-16572	251	74	two	two	NUM
ihlr-16572	251	75	types	type	NOUN
ihlr-16572	251	76	of	of	ADP
ihlr-16572	251	77	approval	approval	NOUN
ihlr-16572	251	78	seems	seem	VERB
ihlr-16572	251	79	trivial­	trivial­	PRON
ihlr-16572	251	80	being	be	AUX
ihlr-16572	251	81	barred	bar	VERB
ihlr-16572	251	82	from	from	ADP
ihlr-16572	251	83	filing	file	VERB
ihlr-16572	251	84	for	for	ADP
ihlr-16572	251	85	approval	approval	NOUN
ihlr-16572	251	86	under	under	ADP
ihlr-16572	251	87	data	datum	NOUN
ihlr-16572	251	88	exclusivity	exclusivity	NOUN
ihlr-16572	251	89	,	,	PUNCT
ihlr-16572	251	90	and	and	CCONJ
ihlr-16572	251	91	being	be	AUX
ihlr-16572	251	92	per75	per75	VERB
ihlr-16572	251	93	.	.	PUNCT
ihlr-16572	252	1	i	i	PRON
ihlr-16572	252	2	d.	d.	PROPN
ihlr-16572	252	3	76	76	NUM
ihlr-16572	252	4	.	.	PUNCT
ihlr-16572	253	1	drug	drug	NOUN
ihlr-16572	253	2	price	price	NOUN
ihlr-16572	253	3	competition	competition	NOUN
ihlr-16572	253	4	and	and	CCONJ
ihlr-16572	253	5	patent	patent	NOUN
ihlr-16572	253	6	term	term	NOUN
ihlr-16572	253	7	restoration	restoration	NOUN
ihlr-16572	253	8	act	act	NOUN
ihlr-16572	253	9	.	.	PUNCT
ihlr-16572	254	1	pub	pub	NOUN
ihlr-16572	254	2	.	.	PUNCT
ihlr-16572	255	1	l.	l.	PROPN
ihlr-16572	255	2	no	no	INTJ
ihlr-16572	255	3	.	.	PROPN
ihlr-16572	256	1	98	98	NUM
ihlr-16572	256	2	-	-	SYM
ihlr-16572	256	3	417	417	NUM
ihlr-16572	256	4	(	(	PUNCT
ihlr-16572	256	5	1984	1984	NUM
ihlr-16572	256	6	)	)	PUNCT
ihlr-16572	256	7	,	,	PUNCT
ihlr-16572	256	8	98	98	NUM
ihlr-16572	256	9	stat	stat	NOUN
ihlr-16572	256	10	.	.	PUNCT
ihlr-16572	257	1	1585	1585	NUM
ihlr-16572	257	2	(	(	PUNCT
ihlr-16572	257	3	1984	1984	NUM
ihlr-16572	257	4	)	)	PUNCT
ihlr-16572	257	5	.	.	PUNCT
ihlr-16572	258	1	77	77	NUM
ihlr-16572	258	2	.	.	PUNCT
ihlr-16572	259	1	schacht	schacht	PROPN
ihlr-16572	259	2	,	,	PUNCT
ihlr-16572	259	3	supra	supra	PROPN
ihlr-16572	259	4	note	note	NOUN
ihlr-16572	259	5	10	10	NUM
ihlr-16572	259	6	,	,	PUNCT
ihlr-16572	259	7	at	at	ADP
ihlr-16572	259	8	12	12	NUM
ihlr-16572	259	9	-	-	SYM
ihlr-16572	259	10	13	13	NUM
ihlr-16572	259	11	;	;	PUNCT
ihlr-16572	259	12	drug	drug	NOUN
ihlr-16572	259	13	price	price	NOUN
ihlr-16572	259	14	competition	competition	NOUN
ihlr-16572	259	15	and	and	CCONJ
ihlr-16572	259	16	patent	patent	NOUN
ihlr-16572	259	17	term	term	NOUN
ihlr-16572	259	18	resto­	resto­	PRON
ihlr-16572	259	19	ration	ration	NOUN
ihlr-16572	259	20	act	act	NOUN
ihlr-16572	259	21	.	.	PUNCT
ihlr-16572	260	1	pub	pub	NOUN
ihlr-16572	260	2	.	.	PUNCT
ihlr-16572	261	1	l.	l.	PROPN
ihlr-16572	261	2	no	no	INTJ
ihlr-16572	261	3	.	.	PROPN
ihlr-16572	262	1	98	98	NUM
ihlr-16572	262	2	-	-	SYM
ihlr-16572	262	3	417	417	NUM
ihlr-16572	262	4	(	(	PUNCT
ihlr-16572	262	5	1984	1984	NUM
ihlr-16572	262	6	)	)	PUNCT
ihlr-16572	262	7	,	,	PUNCT
ihlr-16572	262	8	98	98	NUM
ihlr-16572	262	9	stat	stat	NOUN
ihlr-16572	262	10	.	.	PUNCT
ihlr-16572	263	1	1585	1585	NUM
ihlr-16572	263	2	(	(	PUNCT
ihlr-16572	263	3	1984	1984	NUM
ihlr-16572	263	4	)	)	PUNCT
ihlr-16572	263	5	.	.	PUNCT
ihlr-16572	263	6	.	.	PUNCT
ihlr-16572	264	1	78	78	NUM
ihlr-16572	264	2	.	.	PUNCT
ihlr-16572	265	1	schacht	schacht	PROPN
ihlr-16572	265	2	,	,	PUNCT
ihlr-16572	265	3	supra	supra	PROPN
ihlr-16572	265	4	note	note	NOUN
ihlr-16572	265	5	10	10	NUM
ihlr-16572	265	6	,	,	PUNCT
ihlr-16572	265	7	at	at	ADP
ihlr-16572	265	8	13	13	NUM
ihlr-16572	265	9	;	;	PUNCT
ihlr-16572	265	10	drug	drug	NOUN
ihlr-16572	265	11	price	price	NOUN
ihlr-16572	265	12	competition	competition	NOUN
ihlr-16572	265	13	and	and	CCONJ
ihlr-16572	265	14	patent	patent	NOUN
ihlr-16572	265	15	term	term	NOUN
ihlr-16572	265	16	restora­	restora­	PROPN
ihlr-16572	265	17	tion	tion	NOUN
ihlr-16572	265	18	act	act	PROPN
ihlr-16572	265	19	.	.	PUNCT
ihlr-16572	266	1	pub	pub	NOUN
ihlr-16572	266	2	.	.	PUNCT
ihlr-16572	267	1	l.	l.	PROPN
ihlr-16572	267	2	no	no	INTJ
ihlr-16572	267	3	.	.	PROPN
ihlr-16572	268	1	98	98	NUM
ihlr-16572	268	2	-	-	SYM
ihlr-16572	268	3	417	417	NUM
ihlr-16572	268	4	(	(	PUNCT
ihlr-16572	268	5	1984	1984	NUM
ihlr-16572	268	6	)	)	PUNCT
ihlr-16572	268	7	,	,	PUNCT
ihlr-16572	268	8	98	98	NUM
ihlr-16572	268	9	stat.l585	stat.l585	NOUN
ihlr-16572	268	10	(	(	PUNCT
ihlr-16572	268	11	1984	1984	NUM
ihlr-16572	268	12	)	)	PUNCT
ihlr-16572	268	13	.	.	PUNCT
ihlr-16572	269	1	79	79	NUM
ihlr-16572	269	2	.	.	PUNCT
ihlr-16572	270	1	u.s	u.s	PROPN
ihlr-16572	270	2	.	.	PROPN
ihlr-16572	270	3	food	food	PROPN
ihlr-16572	270	4	and	and	CCONJ
ihlr-16572	270	5	drug	drug	NOUN
ihlr-16572	270	6	admin	admin	PROPN
ihlr-16572	270	7	.	.	PROPN
ihlr-16572	270	8	,	,	PUNCT
ihlr-16572	270	9	abbreviated	abbreviate	VERB
ihlr-16572	270	10	drug	drug	NOUN
ihlr-16572	270	11	application	application	NOUN
ihlr-16572	270	12	(	(	PUNCT
ihlr-16572	270	13	anda	anda	PROPN
ihlr-16572	270	14	):	):	PUNCT
ihlr-16572	270	15	generics	generic	NOUN
ihlr-16572	270	16	,	,	PUNCT
ihlr-16572	270	17	http://www.fda.gov/drugs/deve1opmentapprova1process/howdrugsaredevelopedandappro	http://www.fda.gov/drugs/deve1opmentapprova1process/howdrugsaredevelopedandappro	NOUN
ihlr-16572	270	18	ved	ve	VERB
ihlr-16572	270	19	/	/	SYM
ihlr-16572	270	20	approvalapplications	approvalapplication	NOUN
ihlr-16572	270	21	/	/	SYM
ihlr-16572	270	22	abbreviatednewdrugapplicationandagenerics	abbreviatednewdrugapplicationandageneric	NOUN
ihlr-16572	270	23	/	/	SYM
ihlr-16572	270	24	default.htm	default.htm	X
ihlr-16572	270	25	(	(	PUNCT
ihlr-16572	270	26	last	last	ADV
ihlr-16572	270	27	visited	visit	VERB
ihlr-16572	270	28	jan	jan	PROPN
ihlr-16572	270	29	.	.	PROPN
ihlr-16572	270	30	13	13	NUM
ihlr-16572	270	31	,	,	PUNCT
ihlr-16572	270	32	2009	2009	NUM
ihlr-16572	270	33	)	)	PUNCT
ihlr-16572	270	34	.	.	PUNCT
ihlr-16572	271	1	80	80	NUM
ihlr-16572	271	2	.	.	PUNCT
ihlr-16572	272	1	i	i	PRON
ihlr-16572	272	2	d.	d.	PROPN
ihlr-16572	272	3	81	81	NUM
ihlr-16572	272	4	.	.	PUNCT
ihlr-16572	273	1	i	i	PRON
ihlr-16572	273	2	d.	d.	PROPN
ihlr-16572	273	3	82	82	NUM
ihlr-16572	273	4	.	.	PUNCT
ihlr-16572	274	1	kotlikoff	kotlikoff	PROPN
ihlr-16572	274	2	,	,	PUNCT
ihlr-16572	274	3	supra	supra	PROPN
ihlr-16572	274	4	note	note	PROPN
ihlr-16572	274	5	28	28	NUM
ihlr-16572	274	6	,	,	PUNCT
ihlr-16572	274	7	at	at	ADP
ihlr-16572	274	8	6	6	NUM
ihlr-16572	274	9	.	.	PUNCT
ihlr-16572	274	10	2010	2010	NUM
ihlr-16572	274	11	]	]	PUNCT
ihlr-16572	274	12	follow	follow	VERB
ihlr-16572	274	13	-	-	PUNCT
ihlr-16572	274	14	on	on	ADP
ihlr-16572	274	15	biologics	biologic	NOUN
ihlr-16572	274	16	legislation	legislation	NOUN
ihlr-16572	274	17	379	379	NUM
ihlr-16572	274	18	mitted	mitte	VERB
ihlr-16572	274	19	to	to	PART
ihlr-16572	274	20	file	file	VERB
ihlr-16572	274	21	but	but	CCONJ
ihlr-16572	274	22	precluded	preclude	VERB
ihlr-16572	274	23	from	from	ADP
ihlr-16572	274	24	approval	approval	NOUN
ihlr-16572	274	25	under	under	ADP
ihlr-16572	274	26	approval	approval	NOUN
ihlr-16572	274	27	exclusivity	exclusivity	NOUN
ihlr-16572	274	28	.	.	PUNCT
ihlr-16572	275	1	however	however	ADV
ihlr-16572	275	2	,	,	PUNCT
ihlr-16572	275	3	the	the	DET
ihlr-16572	275	4	two	two	NUM
ihlr-16572	275	5	types	type	NOUN
ihlr-16572	275	6	of	of	ADP
ihlr-16572	275	7	exclusivity	exclusivity	NOUN
ihlr-16572	275	8	have	have	VERB
ihlr-16572	275	9	a	a	DET
ihlr-16572	275	10	very	very	ADV
ihlr-16572	275	11	practical	practical	ADJ
ihlr-16572	275	12	effect	effect	NOUN
ihlr-16572	275	13	on	on	ADP
ihlr-16572	275	14	the	the	DET
ihlr-16572	275	15	degree	degree	NOUN
ihlr-16572	275	16	of	of	ADP
ihlr-16572	275	17	monopoly	monopoly	NOUN
ihlr-16572	275	18	they	they	PRON
ihlr-16572	275	19	grant.83	grant.83	VERB
ihlr-16572	275	20	generic	generic	ADJ
ihlr-16572	275	21	drug	drug	NOUN
ihlr-16572	275	22	suppliers	supplier	NOUN
ihlr-16572	275	23	are	be	AUX
ihlr-16572	275	24	only	only	ADV
ihlr-16572	275	25	able	able	ADJ
ihlr-16572	275	26	to	to	PART
ihlr-16572	275	27	challenge	challenge	VERB
ihlr-16572	275	28	the	the	DET
ihlr-16572	275	29	patents	patent	NOUN
ihlr-16572	275	30	of	of	ADP
ihlr-16572	275	31	brand	brand	NOUN
ihlr-16572	275	32	name	name	NOUN
ihlr-16572	275	33	counterparts	counterpart	NOUN
ihlr-16572	275	34	if	if	SCONJ
ihlr-16572	275	35	they	they	PRON
ihlr-16572	275	36	have	have	AUX
ihlr-16572	275	37	filed	file	VERB
ihlr-16572	275	38	for	for	ADP
ihlr-16572	275	39	fda	fda	PROPN
ihlr-16572	275	40	approva1.84	approva1.84	PROPN
ihlr-16572	275	41	under	under	ADP
ihlr-16572	275	42	·	·	PUNCT
ihlr-16572	275	43	data	datum	NOUN
ihlr-16572	275	44	exclusivity	exclusivity	NOUN
ihlr-16572	275	45	,	,	PUNCT
ihlr-16572	275	46	even	even	ADV
ihlr-16572	275	47	patents	patent	NOUN
ihlr-16572	275	48	which	which	PRON
ihlr-16572	275	49	would	would	AUX
ihlr-16572	275	50	be	be	AUX
ihlr-16572	275	51	found	find	VERB
ihlr-16572	275	52	invalid	invalid	ADJ
ihlr-16572	275	53	underjudicial	underjudicial	ADJ
ihlr-16572	275	54	review	review	NOUN
ihlr-16572	275	55	are	be	AUX
ihlr-16572	275	56	immune	immune	ADJ
ihlr-16572	275	57	to	to	ADP
ihlr-16572	275	58	competitors	competitor	NOUN
ihlr-16572	275	59	'	'	PART
ihlr-16572	275	60	challenges.85	challenges.85	ADJ
ihlr-16572	275	61	bio	bio	NOUN
ihlr-16572	275	62	consistently	consistently	ADV
ihlr-16572	275	63	contends	contend	VERB
ihlr-16572	275	64	that	that	SCONJ
ihlr-16572	275	65	fourteen	fourteen	NUM
ihlr-16572	275	66	years	year	NOUN
ihlr-16572	275	67	of	of	ADP
ihlr-16572	275	68	data	datum	NOUN
ihlr-16572	275	69	exclusivity	exclusivity	NOUN
ihlr-16572	275	70	,	,	PUNCT
ihlr-16572	275	71	es­	es­	PROPN
ihlr-16572	275	72	sentially	sentially	ADV
ihlr-16572	275	73	comflete	comflete	ADJ
ihlr-16572	275	74	monopoly	monopoly	NOUN
ihlr-16572	275	75	,	,	PUNCT
ihlr-16572	275	76	is	be	AUX
ihlr-16572	275	77	necessary	necessary	ADJ
ihlr-16572	275	78	in	in	ADP
ihlr-16572	275	79	order	order	NOUN
ihlr-16572	275	80	to	to	PART
ihlr-16572	275	81	maintain	maintain	VERB
ihlr-16572	275	82	the	the	DET
ihlr-16572	275	83	incentive	incentive	NOUN
ihlr-16572	275	84	to	to	PART
ihlr-16572	275	85	innovate	innovate	VERB
ihlr-16572	275	86	.	.	PUNCT
ihlr-16572	276	1	8	8	NUM
ihlr-16572	276	2	"	"	PUNCT
ihlr-16572	276	3	biotechnology	biotechnology	NOUN
ihlr-16572	276	4	companies	company	NOUN
ihlr-16572	276	5	must	must	AUX
ihlr-16572	276	6	have	have	VERB
ihlr-16572	276	7	some	some	DET
ihlr-16572	276	8	certainty	certainty	NOUN
ihlr-16572	276	9	that	that	SCONJ
ihlr-16572	276	10	they	they	PRON
ihlr-16572	276	11	can	can	AUX
ihlr-16572	276	12	protect	protect	VERB
ihlr-16572	276	13	their	their	PRON
ihlr-16572	276	14	investment	investment	NOUN
ihlr-16572	276	15	in	in	ADP
ihlr-16572	276	16	the	the	DET
ihlr-16572	276	17	development	development	NOUN
ihlr-16572	276	18	of	of	ADP
ihlr-16572	276	19	new	new	ADJ
ihlr-16572	276	20	breakthrough	breakthrough	NOUN
ihlr-16572	276	21	therapies	therapy	NOUN
ihlr-16572	276	22	for	for	ADP
ihlr-16572	276	23	a	a	DET
ihlr-16572	276	24	substantial	substantial	ADJ
ihlr-16572	276	25	period	period	NOUN
ihlr-16572	276	26	of	of	ADP
ihlr-16572	276	27	time	time	NOUN
ihlr-16572	276	28	in	in	ADP
ihlr-16572	276	29	order	order	NOUN
ihlr-16572	276	30	to	to	PART
ihlr-16572	276	31	secure	secure	VERB
ihlr-16572	276	32	the	the	DET
ihlr-16572	276	33	necessary	necessary	ADJ
ihlr-16572	276	34	resources	resource	NOUN
ihlr-16572	276	35	from	from	ADP
ihlr-16572	276	36	venture	venture	NOUN
ihlr-16572	276	37	capital	capital	NOUN
ihlr-16572	276	38	firms	firm	NOUN
ihlr-16572	276	39	and	and	CCONJ
ihlr-16572	276	40	other	other	ADJ
ihlr-16572	276	41	funding	funding	NOUN
ihlr-16572	276	42	sources	source	NOUN
ihlr-16572	276	43	.	.	PUNCT
ihlr-16572	277	1	"87	"87	PROPN
ihlr-16572	277	2	bio	bio	PROPN
ihlr-16572	277	3	further	far	ADV
ihlr-16572	277	4	,	,	PUNCT
ihlr-16572	277	5	expresses	express	VERB
ihlr-16572	277	6	·	·	PUNCT
ihlr-16572	277	7	its	its	PRON
ihlr-16572	277	8	concern	concern	NOUN
ihlr-16572	277	9	that	that	SCONJ
ihlr-16572	277	10	an	an	DET
ihlr-16572	277	11	"	"	PUNCT
ihlr-16572	277	12	uncertain	uncertain	ADJ
ihlr-16572	277	13	'	'	PUNCT
ihlr-16572	277	14	similarity	similarity	NOUN
ihlr-16572	277	15	"	"	PUNCT
ihlr-16572	277	16	standard	standard	NOUN
ihlr-16572	277	17	with	with	ADP
ihlr-16572	277	18	respect	respect	NOUN
ihlr-16572	277	19	to	to	ADP
ihlr-16572	277	20	biologics	biologic	NOUN
ihlr-16572	277	21	will	will	AUX
ihlr-16572	277	22	create	create	VERB
ihlr-16572	277	23	"	"	PUNCT
ihlr-16572	277	24	a	a	DET
ihlr-16572	277	25	greater	great	ADJ
ihlr-16572	277	26	potential	potential	NOUN
ihlr-16572	277	27	for	for	ADP
ihlr-16572	277	28	biologic	biologic	ADJ
ihlr-16572	277	29	patents	patent	NOUN
ihlr-16572	277	30	to	to	PART
ihlr-16572	277	31	be	be	AUX
ihlr-16572	277	32	designed	design	VERB
ihlr-16572	277	33	around	around	ADV
ihlr-16572	277	34	,	,	PUNCT
ihlr-16572	277	35	particularly	particularly	ADV
ihlr-16572	277	36	given	give	VERB
ihlr-16572	277	37	some	some	PRON
ihlr-16572	277	38	of	of	ADP
ihlr-16572	277	39	the	the	DET
ihlr-16572	277	40	available	available	ADJ
ihlr-16572	277	41	case	case	NOUN
ihlr-16572	277	42	law	law	NOUN
ihlr-16572	277	43	involv­	involv­	VERB
ihlr-16572	277	44	ing	e	VERB
ihlr-16572	277	45	the	the	DET
ihlr-16572	277	46	scope	scope	NOUN
ihlr-16572	277	47	of	of	ADP
ihlr-16572	277	48	biologic	biologic	NOUN
ihlr-16572	277	49	patents	patent	NOUN
ihlr-16572	277	50	.	.	PUNCT
ihlr-16572	278	1	"88	"88	PROPN
ihlr-16572	278	2	bio	bio	PROPN
ihlr-16572	278	3	claims	claim	VERB
ihlr-16572	278	4	these	these	DET
ihlr-16572	278	5	uncertain	uncertain	ADJ
ihlr-16572	278	6	standards	standard	NOUN
ihlr-16572	278	7	will	will	AUX
ihlr-16572	278	8	result	result	VERB
ihlr-16572	278	9	in	in	ADP
ihlr-16572	278	10	difficulty	difficulty	NOUN
ihlr-16572	278	11	justifying	justify	VERB
ihlr-16572	278	12	commitment	commitment	NOUN
ihlr-16572	278	13	of	of	ADP
ihlr-16572	278	14	the	the	DET
ihlr-16572	278	15	resources	resource	NOUN
ihlr-16572	278	16	necessary	necessary	ADJ
ihlr-16572	278	17	to	to	PART
ihlr-16572	278	18	·	·	VERB
ihlr-16572	278	19	bring	bring	VERB
ihlr-16572	278	20	a	a	DET
ihlr-16572	278	21	biologic	biologic	NOUN
ihlr-16572	278	22	to	to	ADP
ihlr-16572	278	23	market	market	VERB
ihlr-16572	278	24	"	"	PUNCT
ihlr-16572	278	25	[	[	X
ihlr-16572	278	26	b]ecause	b]ecause	ADP
ihlr-16572	278	27	fobs	fobs	PROPN
ihlr-16572	278	28	will	will	AUX
ihlr-16572	278	29	not	not	PART
ihlr-16572	278	30	have	have	VERB
ihlr-16572	278	31	to	to	PART
ihlr-16572	278	32	comply	comply	VERB
ihlr-16572	278	33	with	with	ADP
ihlr-16572	278	34	rigorous	rigorous	ADJ
ihlr-16572	278	35	'	'	PUNCT
ihlr-16572	278	36	sameness	sameness	NOUN
ihlr-16572	278	37	'	'	PUNCT
ihlr-16572	278	38	standards	standard	NOUN
ihlr-16572	278	39	for	for	ADP
ihlr-16572	278	40	traditional	traditional	ADJ
ihlr-16572	278	41	pharmaceutical	pharmaceutical	ADJ
ihlr-16572	278	42	gener­	gener­	PROPN
ihlr-16572	278	43	ics	ic	NOUN
ihlr-16572	278	44	...	...	PUNCT
ihlr-16572	279	1	[	[	X
ihlr-16572	279	2	thus	thus	ADV
ihlr-16572	279	3	,	,	PUNCT
ihlr-16572	279	4	]	]	PUNCT
ihlr-16572	279	5	biologics	biologic	NOUN
ihlr-16572	279	6	patent	patent	NOUN
ihlr-16572	279	7	portfolios	portfolio	NOUN
ihlr-16572	279	8	will	will	AUX
ihlr-16572	279	9	not	not	PART
ihlr-16572	279	10	provide	provide	VERB
ihlr-16572	279	11	the	the	DET
ihlr-16572	279	12	same	same	ADJ
ihlr-16572	279	13	level	level	NOUN
ihlr-16572	279	14	of	of	ADP
ihlr-16572	279	15	certainty	certainty	NOUN
ihlr-16572	279	16	for	for	ADP
ihlr-16572	279	17	innovators	innovator	NOUN
ihlr-16572	279	18	and	and	CCONJ
ihlr-16572	279	19	investors	investor	NOUN
ihlr-16572	279	20	as	as	SCONJ
ihlr-16572	279	21	patents	patent	NOUN
ihlr-16572	279	22	do	do	AUX
ihlr-16572	279	23	for	for	ADP
ihlr-16572	279	24	traditional	traditional	ADJ
ihlr-16572	279	25	pharma­	pharma­	PUNCT
ihlr-16572	279	26	ceuticals	ceutical	NOUN
ihlr-16572	279	27	againstpremature	againstpremature	VERB
ihlr-16572	279	28	generic	generic	ADJ
ihlr-16572	279	29	entry	entry	NOUN
ihlr-16572	279	30	.	.	PUNCT
ihlr-16572	280	1	"89	"89	PUNCT
ihlr-16572	280	2	to	to	PART
ihlr-16572	280	3	illustrate	illustrate	VERB
ihlr-16572	280	4	the	the	DET
ihlr-16572	280	5	validity	validity	NOUN
ihlr-16572	280	6	of	of	ADP
ihlr-16572	280	7	their	their	PRON
ihlr-16572	280	8	stance	stance	NOUN
ihlr-16572	280	9	on	on	ADP
ihlr-16572	280	10	data	data	PROPN
ihlr-16572	280	11	exclusivi~	exclusivi~	PROPN
ihlr-16572	280	12	,	,	PUNCT
ihlr-16572	280	13	bio	bio	PROPN
ihlr-16572	280	14	cites	cite	VERB
ihlr-16572	280	15	a	a	DET
ihlr-16572	280	16	1990	1990	NUM
ihlr-16572	280	17	case	case	NOUN
ihlr-16572	280	18	involving	involve	VERB
ihlr-16572	280	19	two	two	NUM
ihlr-16572	280	20	leading	lead	VERB
ihlr-16572	280	21	biotechnology	biotechnology	NOUN
ihlr-16572	280	22	companies.9	companies.9	PROPN
ihlr-16572	280	23	there	there	ADV
ihlr-16572	280	24	,	,	PUNCT
ihlr-16572	280	25	ge­	ge­	PROPN
ihlr-16572	280	26	nentech	nentech	NOUN
ihlr-16572	280	27	was	be	AUX
ihlr-16572	280	28	sued·by	sued·by	PROPN
ihlr-16572	280	29	hormone	hormone	NOUN
ihlr-16572	280	30	research	research	NOUN
ihlr-16572	280	31	foundation	foundation	NOUN
ihlr-16572	280	32	in	in	ADP
ihlr-16572	280	33	a	a	DET
ihlr-16572	280	34	dispute	dispute	NOUN
ihlr-16572	280	35	regarding	regard	VERB
ihlr-16572	280	36	its	its	PRON
ihlr-16572	280	37	recombinant	recombinant	ADJ
ihlr-16572	280	38	human	human	ADJ
ihlr-16572	280	39	growth	growth	NOUN
ihlr-16572	280	40	hormone	hormone	NOUN
ihlr-16572	280	41	product.91	product.91	NOUN
ihlr-16572	280	42	the	the	DET
ihlr-16572	280	43	accused	accuse	VERB
ihlr-16572	280	44	·	·	PUNCT
ihlr-16572	280	45	product	product	NOUN
ihlr-16572	280	46	,	,	PUNCT
ihlr-16572	280	47	manufactured	manufacture	VERB
ihlr-16572	280	48	by	by	ADP
ihlr-16572	280	49	genentech	genentech	NOUN
ihlr-16572	280	50	,	,	PUNCT
ihlr-16572	280	51	differed	differ	VERB
ihlr-16572	280	52	from	from	ADP
ihlr-16572	280	53	hormone	hormone	NOUN
ihlr-16572	280	54	research	research	NOUN
ihlr-16572	280	55	f	f	PROPN
ihlr-16572	280	56	ounda­	ounda­	PROPN
ihlr-16572	280	57	tion	tion	NOUN
ihlr-16572	280	58	's	's	PART
ihlr-16572	280	59	patented	patent	VERB
ihlr-16572	280	60	human	human	ADJ
ihlr-16572	280	61	growth	growth	NOUN
ihlr-16572	280	62	hormone	hormone	NOUN
ihlr-16572	280	63	product	product	NOUN
ihlr-16572	280	64	by	by	ADP
ihlr-16572	280	65	only	only	ADV
ihlr-16572	280	66	two	two	NUM
ihlr-16572	280	67	amino	amino	ADJ
ihlr-16572	280	68	acids	acid	NOUN
ihlr-16572	280	69	.	.	PUNCT
ihlr-16572	281	1	notwithstanding	notwithstanding	ADP
ihlr-16572	281	2	the	the	DET
ihlr-16572	281	3	near	near	ADJ
ihlr-16572	281	4	identical	identical	ADJ
ihlr-16572	281	5	nature	nature	NOUN
ihlr-16572	281	6	of	of	ADP
ihlr-16572	281	7	the	the	DET
ihlr-16572	281	8	products	product	NOUN
ihlr-16572	281	9	,	,	PUNCT
ihlr-16572	281	10	the	the	DET
ihlr-16572	281	11	u.s	u.s	PROPN
ihlr-16572	281	12	.	.	PROPN
ihlr-16572	281	13	court	court	PROPN
ihlr-16572	281	14	of	of	ADP
ihlr-16572	281	15	appeals	appeal	NOUN
ihlr-16572	281	16	for	for	ADP
ihlr-16572	281	17	the	the	DET
ihlr-16572	281	18	federal	federal	ADJ
ihlr-16572	281	19	circuit	circuit	NOUN
ihlr-16572	281	20	found	find	VERB
ihlr-16572	281	21	that	that	SCONJ
ihlr-16572	281	22	hormone	hormone	NOUN
ihlr-16572	281	23	research	research	NOUN
ihlr-16572	281	24	foundation	foundation	NOUN
ihlr-16572	281	25	's	's	PART
ihlr-16572	281	26	patent	patent	NOUN
ihlr-16572	281	27	did	do	AUX
ihlr-16572	281	28	not	not	PART
ihlr-16572	281	29	cover	cover	VERB
ihlr-16572	281	30	the	the	DET
ihlr-16572	281	31	accused	accuse	VERB
ihlr-16572	281	32	product.92	product.92	NOUN
ihlr-16572	281	33	.	.	PUNCT
ihlr-16572	282	1	bio	bio	PROPN
ihlr-16572	282	2	's	's	PART
ihlr-16572	282	3	statement	statement	NOUN
ihlr-16572	282	4	contains	contain	VERB
ihlr-16572	282	5	a	a	DET
ihlr-16572	282	6	narrow	narrow	ADJ
ihlr-16572	282	7	,	,	PUNCT
ihlr-16572	282	8	and	and	CCONJ
ihlr-16572	282	9	perhaps	perhaps	ADV
ihlr-16572	282	10	even	even	ADV
ihlr-16572	282	11	misleading	mislead	VERB
ihlr-16572	282	12	view	view	NOUN
ihlr-16572	282	13	,	,	PUNCT
ihlr-16572	282	14	of	of	ADP
ihlr-16572	282	15	the	the	DET
ihlr-16572	282	16	genentech	genentech	NOUN
ihlr-16572	282	17	decision	decision	NOUN
ihlr-16572	282	18	.	.	PUNCT
ihlr-16572	283	1	the	the	DET
ihlr-16572	283	2	court	court	NOUN
ihlr-16572	283	3	implies	imply	VERB
ihlr-16572	283	4	that	that	SCONJ
ihlr-16572	283	5	if	if	SCONJ
ihlr-16572	283	6	it	it	PRON
ihlr-16572	283	7	were	be	AUX
ihlr-16572	283	8	not	not	PART
ihlr-16572	283	9	for	for	ADP
ihlr-16572	283	10	limiting	limit	VERB
ihlr-16572	283	11	language	language	NOUN
ihlr-16572	283	12	in	in	ADP
ihlr-16572	283	13	hormone	hormone	NOUN
ihlr-16572	283	14	research	research	NOUN
ihlr-16572	283	15	foundation	foundation	NOUN
ihlr-16572	283	16	's	's	PART
ihlr-16572	283	17	patent	patent	NOUN
ihlr-16572	283	18	,	,	PUNCT
ihlr-16572	283	19	the	the	DET
ihlr-16572	283	20	genentech	genentech	NOUN
ihlr-16572	283	21	83	83	NUM
ihlr-16572	283	22	.	.	PUNCT
ihlr-16572	284	1	see	see	VERB
ihlr-16572	284	2	e.g.	e.g.	ADV
ihlr-16572	284	3	,	,	PUNCT
ihlr-16572	284	4	schacht	schacht	NOUN
ihlr-16572	284	5	,	,	PUNCT
ihlr-16572	284	6	supra	supra	PROPN
ihlr-16572	284	7	note	note	NOUN
ihlr-16572	284	8	10	10	NUM
ihlr-16572	284	9	,	,	PUNCT
ihlr-16572	284	10	at	at	ADP
ihlr-16572	284	11	13	13	NUM
ihlr-16572	284	12	-	-	SYM
ihlr-16572	284	13	14	14	NUM
ihlr-16572	284	14	.	.	PUNCT
ihlr-16572	285	1	84	84	NUM
ihlr-16572	285	2	.	.	PUNCT
ihlr-16572	286	1	i	i	PRON
ihlr-16572	286	2	d.	d.	PROPN
ihlr-16572	286	3	at	at	ADP
ihlr-16572	286	4	14	14	NUM
ihlr-16572	286	5	.	.	PUNCT
ihlr-16572	286	6	85	85	NUM
ihlr-16572	286	7	.	.	PUNCT
ihlr-16572	287	1	/d	/d	PUNCT
ihlr-16572	287	2	.	.	PUNCT
ihlr-16572	288	1	86	86	NUM
ihlr-16572	288	2	.	.	PUNCT
ihlr-16572	288	3	letter	letter	NOUN
ihlr-16572	288	4	from	from	ADP
ihlr-16572	288	5	john	john	PROPN
ihlr-16572	288	6	taylor	taylor	PROPN
ihlr-16572	288	7	,	,	PUNCT
ihlr-16572	288	8	supra	supra	PROPN
ihlr-16572	288	9	note	note	NOUN
ihlr-16572	288	10	7	7	NUM
ihlr-16572	288	11	.	.	NOUN
ihlr-16572	288	12	87	87	NUM
ihlr-16572	288	13	.	.	PUNCT
ihlr-16572	289	1	i	i	PRON
ihlr-16572	289	2	d.	d.	PROPN
ihlr-16572	289	3	88	88	NUM
ihlr-16572	289	4	.	.	PUNCT
ihlr-16572	290	1	/d	/d	INTJ
ihlr-16572	290	2	.	.	PUNCT
ihlr-16572	290	3	89	89	NUM
ihlr-16572	290	4	.	.	PUNCT
ihlr-16572	291	1	/d	/d	INTJ
ihlr-16572	291	2	.	.	PUNCT
ihlr-16572	292	1	90	90	NUM
ihlr-16572	292	2	.	.	PUNCT
ihlr-16572	292	3	letter	letter	NOUN
ihlr-16572	292	4	from	from	ADP
ihlr-16572	292	5	john	john	PROPN
ihlr-16572	292	6	taylor	taylor	PROPN
ihlr-16572	292	7	,	,	PUNCT
ihlr-16572	292	8	supra	supra	PROPN
ihlr-16572	292	9	note	note	PROPN
ihlr-16572	292	10	7	7	NUM
ihlr-16572	292	11	(	(	PUNCT
ihlr-16572	292	12	citing	cite	VERB
ihlr-16572	292	13	hormone	hormone	NOUN
ihlr-16572	292	14	res	re	NOUN
ihlr-16572	292	15	.	.	PUNCT
ihlr-16572	293	1	found	find	VERB
ihlr-16572	293	2	.	.	PUNCT
ihlr-16572	294	1	v.	v.	ADP
ihlr-16572	294	2	genentech	genentech	PROPN
ihlr-16572	294	3	,	,	PUNCT
ihlr-16572	294	4	904	904	NUM
ihlr-16572	294	5	f.2d	f.2d	X
ihlr-16572	294	6	1558	1558	NUM
ihlr-16572	294	7	(	(	PUNCT
ihlr-16572	294	8	fed	fed	PROPN
ihlr-16572	294	9	.	.	PUNCT
ihlr-16572	294	10	cir	cir	PROPN
ihlr-16572	294	11	.	.	PROPN
ihlr-16572	294	12	1990	1990	NUM
ihlr-16572	294	13	)	)	PUNCT
ihlr-16572	294	14	)	)	PUNCT
ihlr-16572	294	15	.	.	PUNCT
ihlr-16572	295	1	91	91	NUM
ihlr-16572	295	2	.	.	PUNCT
ihlr-16572	295	3	letter	letter	NOUN
ihlr-16572	295	4	from	from	ADP
ihlr-16572	295	5	john	john	PROPN
ihlr-16572	295	6	taylor	taylor	PROPN
ihlr-16572	295	7	,	,	PUNCT
ihlr-16572	295	8	supra	supra	PROPN
ihlr-16572	295	9	note	note	NOUN
ihlr-16572	295	10	7	7	NUM
ihlr-16572	295	11	.	.	NOUN
ihlr-16572	295	12	92	92	NUM
ihlr-16572	295	13	.	.	PUNCT
ihlr-16572	296	1	honnone	honnone	PROPN
ihlr-16572	296	2	res	re	NOUN
ihlr-16572	296	3	.	.	PUNCT
ihlr-16572	296	4	found	find	VERB
ihlr-16572	296	5	.	.	PUNCT
ihlr-16572	297	1	v.	v.	ADP
ihlr-16572	297	2	genentech	genentech	PROPN
ihlr-16572	297	3	,	,	PUNCT
ihlr-16572	297	4	904	904	NUM
ihlr-16572	297	5	f.2d	f.2d	X
ihlr-16572	297	6	1558	1558	NUM
ihlr-16572	297	7	(	(	PUNCT
ihlr-16572	297	8	fed	fed	PROPN
ihlr-16572	297	9	.	.	PUNCT
ihlr-16572	297	10	cir	cir	PROPN
ihlr-16572	297	11	.	.	PROPN
ihlr-16572	297	12	1990	1990	NUM
ihlr-16572	297	13	)	)	PUNCT
ihlr-16572	297	14	.	.	PUNCT
ihlr-16572	298	1	380	380	NUM
ihlr-16572	298	2	indiana	indiana	PROPN
ihlr-16572	298	3	heal	heal	PROPN
ihlr-16572	298	4	til	til	SCONJ
ihlr-16572	298	5	law	law	NOUN
ihlr-16572	298	6	review	review	NOUN
ihlr-16572	298	7	[	[	X
ihlr-16572	298	8	vol	vol	NOUN
ihlr-16572	298	9	.	.	PUNCT
ihlr-16572	299	1	7:367	7:367	NUM
ihlr-16572	299	2	product	product	NOUN
ihlr-16572	299	3	rna~	rna~	NOUN
ihlr-16572	299	4	have	have	AUX
ihlr-16572	299	5	been	be	AUX
ihlr-16572	299	6	found	find	VERB
ihlr-16572	299	7	to	to	PART
ihlr-16572	299	8	be	be	AUX
ihlr-16572	299	9	infringing	infringe	VERB
ihlr-16572	299	10	based	base	VERB
ihlr-16572	299	11	on	on	ADP
ihlr-16572	299	12	the	the	DET
ihlr-16572	299	13	doctrine	doctrine	NOUN
ihlr-16572	299	14	of	of	ADP
ihlr-16572	299	15	equivalents	equivalent	NOUN
ihlr-16572	299	16	.	.	PUNCT
ihlr-16572	300	1	3	3	NUM
ihlr-16572	300	2	concern	concern	NOUN
ihlr-16572	300	3	that	that	SCONJ
ihlr-16572	300	4	biologics	biologic	NOUN
ihlr-16572	300	5	.	.	PUNCT
ihlr-16572	301	1	man	man	NOUN
ihlr-16572	301	2	:	:	PUNCT
ihlr-16572	301	3	ufacturej.:s	ufacturej.:s	ADJ
ihlr-16572	301	4	may	may	AUX
ihlr-16572	301	5	have	have	AUX
ihlr-16572	301	6	over	over	ADP
ihlr-16572	301	7	the	the	DET
ihlr-16572	301	8	stability	stability	NOUN
ihlr-16572	301	9	of	of	ADP
ihlr-16572	301	10	theit	theit	NOUN
ihlr-16572	301	11	patents	patent	NOUN
ihlr-16572	301	12	should	should	AUX
ihlr-16572	301	13	be	be	AUX
ihlr-16572	301	14	mitigated	mitigate	VERB
ihlr-16572	301	15	by	by	ADP
ihlr-16572	301	16	the	the	DET
ihlr-16572	301	17	.	.	PUNCT
ihlr-16572	301	18	doctrine	doctrine	NOUN
ihlr-16572	301	19	of	of	ADP
ihlr-16572	301	20	equivalents	equivalent	NOUN
ihlr-16572	301	21	,	,	PUNCT
ihlr-16572	301	22	an	an	DET
ihlr-16572	301	23	equitable	equitable	ADJ
ihlr-16572	301	24	doctrine	doctrine	NOUN
ihlr-16572	301	25	intended	intend	VERB
ihlr-16572	301	26	''	''	PUNCT
ihlr-16572	301	27	in	in	ADP
ihlr-16572	301	28	situations	situation	NOUN
ihlr-16572	301	29	where	where	SCONJ
ihlr-16572	301	30	there	there	PRON
ihlr-16572	301	31	is	be	VERB
ihlr-16572	301	32	no	no	DET
ihlr-16572	301	33	literal	literal	ADJ
ihlr-16572	301	34	in­	in­	NOUN
ihlr-16572	301	35	fringement	fringement	NOUN
ihlr-16572	301	36	but	but	CCONJ
ihlr-16572	301	37	liability	liability	NOUN
ihlr-16572	301	38	is	be	AUX
ihlr-16572	301	39	nevertheless	nevertheless	ADV
ihlr-16572	301	40	appropriate	appropriate	ADJ
ihlr-16572	301	41	[	[	X
ihlr-16572	301	42	,	,	PUNCT
ihlr-16572	301	43	]	]	PUNCT
ihlr-16572	301	44	to	to	PART
ihlr-16572	301	45	prevent	prevent	VERB
ihlr-16572	301	46	what	what	PRON
ihlr-16572	301	47	is	be	AUX
ihlr-16572	301	48	in	in	ADP
ihlr-16572	301	49	essence	essence	NOUN
ihlr-16572	301	50	a	a	DET
ihlr-16572	301	51	pirating	pirating	NOUN
ihlr-16572	301	52	of	of	ADP
ihlr-16572	301	53	the	the	DET
ihlr-16572	301	54	patentee	patentee	NOUN
ihlr-16572	301	55	's	's	PART
ihlr-16572	301	56	invention	invention	NOUN
ihlr-16572	301	57	.	.	PUNCT
ihlr-16572	302	1	"94	"94	ADV
ihlr-16572	302	2	under	under	ADP
ihlr-16572	302	3	this	this	DET
ihlr-16572	302	4	doctrine	doctrine	NOUN
ihlr-16572	302	5	,	,	PUNCT
ihlr-16572	302	6	a	a	DET
ihlr-16572	302	7	product	product	NOUN
ihlr-16572	302	8	may	may	AUX
ihlr-16572	302	9	infringe	infringe	VERB
ihlr-16572	302	10	an	an	DET
ihlr-16572	302	11	existing	exist	VERB
ihlr-16572	302	12	patent	patent	NOUN
ihlr-16572	302	13	if	if	SCONJ
ihlr-16572	302	14	it	it	PRON
ihlr-16572	302	15	performs	perform	VERB
ihlr-16572	302	16	"	"	PUNCT
ihlr-16572	302	17	substantially	substantially	ADV
ihlr-16572	302	18	the	the	DET
ihlr-16572	302	19	same	same	ADJ
ihlr-16572	302	20	function	function	NOUN
ihlr-16572	302	21	in	in	ADP
ihlr-16572	302	22	substantially	substantially	ADV
ihlr-16572	302	23	the	the	DET
ihlr-16572	302	24	same	same	ADJ
ihlr-16572	302	25	way	way	NOUN
ihlr-16572	302	26	to	to	PART
ihlr-16572	302	27	give	give	VERB
ihlr-16572	302	28	substantially	substantially	ADV
ihlr-16572	302	29	the	the	DET
ihlr-16572	302	30	same	same	ADJ
ihlr-16572	302	31	result	result	NOUN
ihlr-16572	302	32	.	.	PUNCT
ihlr-16572	303	1	"95	"95	VERB
ihlr-16572	304	1	so	so	ADV
ihlr-16572	304	2	,	,	PUNCT
ihlr-16572	304	3	while	while	SCONJ
ihlr-16572	304	4	brand	brand	NOUN
ihlr-16572	304	5	dame	dame	PROPN
ihlr-16572	304	6	manufacturers	manufacturer	NOUN
ihlr-16572	304	7	'	'	PART
ihlr-16572	304	8	concern	concern	NOUN
ihlr-16572	304	9	regarding	regard	VERB
ihlr-16572	304	10	the	the	DET
ihlr-16572	304	11	simi­	simi­	ADJ
ihlr-16572	304	12	larity	larity	NOUN
ihlr-16572	304	13	requirement	requirement	NOUN
ihlr-16572	304	14	for	for	ADP
ihlr-16572	304	15	generic	generic	ADJ
ihlr-16572	304	16	biologics	biologic	NOUN
ihlr-16572	304	17	is	be	AUX
ihlr-16572	304	18	not	not	PART
ihlr-16572	304	19	unreasonable	unreasonable	ADJ
ihlr-16572	304	20	,	,	PUNCT
ihlr-16572	304	21	it	it	PRON
ihlr-16572	304	22	may	may	AUX
ihlr-16572	304	23	be	be	AUX
ihlr-16572	304	24	over­	over­	PROPN
ihlr-16572	304	25	stated	state	VERB
ihlr-16572	304	26	:	:	PUNCT
ihlr-16572	304	27	it	it	PRON
ihlr-16572	304	28	is	be	AUX
ihlr-16572	304	29	important	important	ADJ
ihlr-16572	304	30	to	to	PART
ihlr-16572	304	31	note	note	VERB
ihlr-16572	304	32	that	that	SCONJ
ihlr-16572	304	33	exclusivity	exclusivity	NOUN
ihlr-16572	304	34	right$	right$	NOUN
ihlr-16572	304	35	are	be	AUX
ihlr-16572	304	36	entirely	entirely	ADV
ihlr-16572	304	37	separate	separate	ADJ
ihlr-16572	304	38	from	from	ADP
ihlr-16572	304	39	patent	patent	NOUN
ihlr-16572	304	40	protection.96	protection.96	NOUN
ihlr-16572	304	41	these	these	DET
ihlr-16572	304	42	types	type	NOUN
ihlr-16572	304	43	of	of	ADP
ihlr-16572	304	44	protection	protection	NOUN
ihlr-16572	304	45	are	be	AUX
ihlr-16572	304	46	not	not	PART
ihlr-16572	304	47	on	on	ADP
ihlr-16572	304	48	the	the	DET
ihlr-16572	304	49	same	same	ADJ
ihlr-16572	304	50	timetable	timetable	NOUN
ihlr-16572	304	51	~	~	PUNCT
ihlr-16572	304	52	exclusivity	exclusivity	NOUN
ihlr-16572	304	53	periods	period	NOUN
ihlr-16572	304	54	begin	begin	VERB
ihlr-16572	304	55	with	with	ADP
ihlr-16572	304	56	fda	fda	PROPN
ihlr-16572	304	57	approval	approval	NOUN
ihlr-16572	304	58	of	of	ADP
ihlr-16572	304	59	the	the	DET
ihlr-16572	304	60	brand	brand	NOUN
ihlr-16572	304	61	drug	drug	NOUN
ihlr-16572	304	62	,	,	PUNCT
ihlr-16572	304	63	whereas	whereas	SCONJ
ihlr-16572	304	64	patent	patent	NOUN
ihlr-16572	304	65	protection	protection	NOUN
ihlr-16572	304	66	begins	begin	VERB
ihlr-16572	304	67	after	after	SCONJ
ihlr-16572	304	68	the	the	DET
ihlr-16572	304	69	new	new	ADJ
ihlr-16572	304	70	discovery	discovery	NOUN
ihlr-16572	304	71	is	be	AUX
ihlr-16572	304	72	made	make	VERB
ihlr-16572	304	73	and	and	CCONJ
ihlr-16572	304	74	a	a	DET
ihlr-16572	304	75	patent	patent	NOUN
ihlr-16572	304	76	appli­	appli­	NOUN
ihlr-16572	304	77	cation	cation	NOUN
ihlr-16572	304	78	is	be	AUX
ihlr-16572	304	79	approved	approve	VERB
ihlr-16572	304	80	by	by	ADP
ihlr-16572	304	81	the	the	DET
ihlr-16572	304	82	united	united	PROPN
ihlr-16572	304	83	states	states	PROPN
ihlr-16572	304	84	patent	patent	NOUN
ihlr-16572	304	85	and	and	CCONJ
ihlr-16572	304	86	trademark	trademark	NOUN
ihlr-16572	304	87	office.97	office.97	NOUN
ihlr-16572	304	88	''	''	PUNCT
ihlr-16572	304	89	the	the	DET
ihlr-16572	304	90	upshot	upshot	NOUN
ihlr-16572	304	91	here	here	ADV
ihlr-16572	304	92	is	be	AUX
ihlr-16572	304	93	that	that	SCONJ
ihlr-16572	304	94	if	if	SCONJ
ihlr-16572	304	95	the	the	DET
ihlr-16572	304	96	total	total	ADJ
ihlr-16572	304	97	period	period	NOUN
ihlr-16572	304	98	of	of	ADP
ihlr-16572	304	99	.	.	PUNCT
ihlr-16572	304	100	exclusivity	exclusivity	NOUN
ihlr-16572	304	101	exceeds	exceed	VERB
ihlr-16572	304	102	the	the	DET
ihlr-16572	304	103	amount	amount	NOUN
ihlr-16572	304	104	of	of	ADP
ihlr-16572	304	105	patent	patent	NOUN
ihlr-16572	304	106	protection	protection	NOUN
ihlr-16572	304	107	left	leave	VERB
ihlr-16572	304	108	at	at	ADP
ihlr-16572	304	109	the	the	DET
ihlr-16572	304	110	time	time	NOUN
ihlr-16572	304	111	of	of	ADP
ihlr-16572	304	112	fda	fda	PROPN
ihlr-16572	304	113	nda	nda	PROPN
ihlr-16572	304	114	approval	approval	PROPN
ihlr-16572	304	115	,	,	PUNCT
ihlr-16572	304	116	mono­	mono­	ADP
ihlr-16572	304	117	poly	poly	ADJ
ihlr-16572	304	118	protection	protection	NOUN
ihlr-16572	304	119	will	will	AUX
ihlr-16572	304	120	be	be	AUX
ihlr-16572	304	121	expanded	expand	VERB
ihlr-16572	304	122	by	by	ADP
ihlr-16572	304	123	the	the	DET
ihlr-16572	304	124	number	number	NOUN
ihlr-16572	304	125	of	of	ADP
ihlr-16572	304	126	years	year	NOUN
ihlr-16572	304	127	that	that	SCONJ
ihlr-16572	304	128	exclusivity	exclusivity	NOUN
ihlr-16572	304	129	exceeds	exceed	VERB
ihlr-16572	304	130	remaining	remain	VERB
ihlr-16572	304	131	patent	patent	NOUN
ihlr-16572	304	132	life	life	NOUN
ihlr-16572	304	133	.	.	PUNCT
ihlr-16572	305	1	"98	"98	PROPN
ihlr-16572	305	2	1	1	NUM
ihlr-16572	305	3	.	.	PUNCT
ihlr-16572	305	4	general	general	ADJ
ihlr-16572	305	5	agreement	agreement	NOUN
ihlr-16572	305	6	on	on	ADP
ihlr-16572	305	7	tariffs	tariff	NOUN
ihlr-16572	305	8	and	and	CCONJ
ihlr-16572	305	9	trade	trade	NOUN
ihlr-16572	305	10	(	(	PUNCT
ihlr-16572	305	11	ga1	ga1	NOUN
ihlr-16572	305	12	t	t	PROPN
ihlr-16572	305	13	)	)	PUNCT
ihlr-16572	305	14	some	some	DET
ihlr-16572	305	15	legislation	legislation	NOUN
ihlr-16572	305	16	allow~	allow~	VERB
ihlr-16572	305	17	;	;	PUNCT
ihlr-16572	305	18	for	for	SCONJ
ihlr-16572	305	19	innovators	innovator	NOUN
ihlr-16572	305	20	to	to	PART
ihlr-16572	305	21	evergreen	evergreen	VERB
ihlr-16572	305	22	its	its	PRON
ihlr-16572	305	23	drugs	drug	NOUN
ihlr-16572	305	24	.	.	PUNCT
ihlr-16572	306	1	ever­	ever­	PROPN
ihlr-16572	306	2	greening	greening	NOUN
ihlr-16572	306	3	refers	refer	VERB
ihlr-16572	306	4	to	to	ADP
ihlr-16572	306	5	the	the	DET
ihlr-16572	306	6	process	process	NOUN
ihlr-16572	306	7	whereby	whereby	SCONJ
ihlr-16572	306	8	patent	patent	NOUN
ihlr-16572	306	9	holders	holder	NOUN
ihlr-16572	306	10	use	use	VERB
ihlr-16572	306	11	the	the	DET
ihlr-16572	306	12	time	time	NOUN
ihlr-16572	306	13	afforded	afford	VERB
ihlr-16572	306	14	by	by	ADP
ihlr-16572	306	15	initial	initial	ADJ
ihlr-16572	306	16	monopoly	monopoly	NOUN
ihlr-16572	306	17	protection	protection	NOUN
ihlr-16572	306	18	to	to	PART
ihlr-16572	306	19	make	make	VERB
ihlr-16572	306	20	minor	minor	ADJ
ihlr-16572	306	21	modifications	modification	NOUN
ihlr-16572	306	22	to	to	ADP
ihlr-16572	306	23	the	the	DET
ihlr-16572	306	24	biologics	biologic	NOUN
ihlr-16572	306	25	formulation	formulation	NOUN
ihlr-16572	306	26	in	in	ADP
ihlr-16572	306	27	order	order	NOUN
ihlr-16572	306	28	to	to	PART
ihlr-16572	306	29	gamer	gamer	VERB
ihlr-16572	306	30	extended	extend	VERB
ihlr-16572	306	31	periods	period	NOUN
ihlr-16572	306	32	of	of	ADP
ihlr-16572	306	33	exclusivity	exclusivity	NOUN
ihlr-16572	306	34	.	.	PUNCT
ihlr-16572	307	1	99	99	NUM
ihlr-16572	307	2	when	when	SCONJ
ihlr-16572	307	3	pursuing	pursue	VERB
ihlr-16572	307	4	this	this	DET
ihlr-16572	307	5	strategy	strategy	NOUN
ihlr-16572	307	6	,	,	PUNCT
ihlr-16572	307	7	innovators	innovator	NOUN
ihlr-16572	307	8	make	make	VERB
ihlr-16572	307	9	changes	change	NOUN
ihlr-16572	307	10	which	which	PRON
ihlr-16572	307	11	are	be	AUX
ihlr-16572	307	12	significant	significant	ADJ
ihlr-16572	307	13	enough	enough	ADV
ihlr-16572	307	14	to	to	PART
ihlr-16572	307	15	lengthen	lengthen	VERB
ihlr-16572	307	16	statutory	statutory	ADJ
ihlr-16572	307	17	exclusivity	exclusivity	NOUN
ihlr-16572	307	18	,	,	PUNCT
ihlr-16572	307	19	but	but	CCONJ
ihlr-16572	307	20	not	not	PART
ihlr-16572	307	21	so	so	ADV
ihlr-16572	307	22	significant	significant	ADJ
ihlr-16572	307	23	that	that	SCONJ
ihlr-16572	307	24	they	they	PRON
ihlr-16572	307	25	affect	affect	VERB
ihlr-16572	307	26	a	a	DET
ihlr-16572	307	27	drug	drug	NOUN
ihlr-16572	307	28	's	's	PART
ihlr-16572	307	29	function	function	NOUN
ihlr-16572	307	30	or	or	CCONJ
ihlr-16572	307	31	require	require	VERB
ihlr-16572	307	32	extensive	extensive	ADJ
ihlr-16572	307	33	investment	investment	NOUN
ihlr-16572	307	34	.	.	PUNCT
ihlr-16572	308	1	some	some	DET
ihlr-16572	308	2	trivial	trivial	ADJ
ihlr-16572	308	3	mod­	mod­	NOUN
ihlr-16572	308	4	ifications	ification	NOUN
ihlr-16572	308	5	typically	typically	ADV
ihlr-16572	308	6	made	make	VERB
ihlr-16572	308	7	in	in	ADP
ihlr-16572	308	8	an	an	DET
ihlr-16572	308	9	effort	effort	NOUN
ihlr-16572	308	10	to	to	PART
ihlr-16572	308	11	evergreen	evergreen	VERB
ihlr-16572	308	12	drugs	drug	NOUN
ihlr-16572	308	13	include	include	VERB
ihlr-16572	308	14	the	the	DET
ihlr-16572	308	15	follow­	follow­	NOUN
ihlr-16572	308	16	ing	ing	NOUN
ihlr-16572	308	17	:	:	PUNCT
ihlr-16572	308	18	changing	change	VERB
ihlr-16572	308	19	the	the	DET
ihlr-16572	308	20	medication	medication	NOUN
ihlr-16572	308	21	strength	strength	NOUN
ihlr-16572	308	22	of	of	ADP
ihlr-16572	308	23	pills	pill	NOUN
ihlr-16572	308	24	(	(	PUNCT
ihlr-16572	308	25	e.g.	e.g.	ADV
ihlr-16572	308	26	,	,	PUNCT
ihlr-16572	308	27	chang­	chang­	NOUN
ihlr-16572	308	28	ing	e	VERB
ihlr-16572	308	29	the	the	DET
ihlr-16572	308	30	pills	pill	NOUN
ihlr-16572	308	31	from	from	ADP
ihlr-16572	308	32	.1	.1	NUM
ihlr-16572	308	33	0	0	PUNCT
ihlr-16572	309	1	mg	mg	NOUN
ihlr-16572	309	2	to	to	ADP
ihlr-16572	309	3	.15	.15	NUM
ihlr-16572	309	4	mg	mg	NOUN
ihlr-16572	309	5	)	)	PUNCT
ihlr-16572	309	6	,	,	PUNCT
ihlr-16572	309	7	changing	change	VERB
ihlr-16572	309	8	the	the	DET
ihlr-16572	309	9	form	form	NOUN
ihlr-16572	309	10	of	of	ADP
ihlr-16572	309	11	medication	medication	NOUN
ihlr-16572	309	12	(	(	PUNCT
ihlr-16572	309	13	e.g.	e.g.	ADV
ihlr-16572	309	14	,	,	PUNCT
ihlr-16572	309	15	switching	switch	VERB
ihlr-16572	309	16	from	from	ADP
ihlr-16572	309	17	pill	pill	NOUN
ihlr-16572	309	18	to	to	ADP
ihlr-16572	309	19	cap93	cap93	PROPN
ihlr-16572	309	20	.	.	PROPN
ihlr-16572	310	1	genentech	genentech	PROPN
ihlr-16572	310	2	,	,	PUNCT
ihlr-16572	310	3	904	904	NUM
ihlr-16572	310	4	f.2d	f.2d	X
ihlr-16572	310	5	at	at	ADP
ihlr-16572	310	6	1564	1564	NUM
ihlr-16572	310	7	.	.	PUNCT
ihlr-16572	311	1	94	94	NUM
ihlr-16572	311	2	.	.	PUNCT
ihlr-16572	312	1	loctite	loctite	PROPN
ihlr-16572	312	2	corp	corp	PROPN
ihlr-16572	312	3	v.	v.	ADP
ihlr-16572	312	4	ultra	ultra	ADJ
ihlr-16572	312	5	-	-	ADJ
ihlr-16572	312	6	seal	seal	ADJ
ihlr-16572	312	7	ltd	ltd	PROPN
ihlr-16572	312	8	.	.	PROPN
ihlr-16572	312	9	,	,	PUNCT
ihlr-16572	312	10	781	781	NUM
ihlr-16572	312	11	f.2d	f.2d	NUM
ihlr-16572	312	12	861,870	861,870	NUM
ihlr-16572	312	13	(	(	PUNCT
ihlr-16572	312	14	fed	fed	PROPN
ihlr-16572	312	15	.	.	PUNCT
ihlr-16572	313	1	cir.l985	cir.l985	NUM
ihlr-16572	313	2	)	)	PUNCT
ihlr-16572	313	3	.	.	PUNCT
ihlr-16572	314	1	95	95	NUM
ihlr-16572	314	2	.	.	PUNCT
ihlr-16572	315	1	/d	/d	INTJ
ihlr-16572	315	2	.	.	PUNCT
ihlr-16572	316	1	96	96	NUM
ihlr-16572	316	2	.	.	PUNCT
ihlr-16572	316	3	drug	drug	NOUN
ihlr-16572	316	4	price	price	NOUN
ihlr-16572	316	5	competition	competition	NOUN
ihlr-16572	316	6	and	and	CCONJ
ihlr-16572	316	7	patent	patent	NOUN
ihlr-16572	316	8	term	term	NOUN
ihlr-16572	316	9	restoration	restoration	NOUN
ihlr-16572	316	10	act	act	NOUN
ihlr-16572	316	11	,	,	PUNCT
ihlr-16572	316	12	pub	pub	NOUN
ihlr-16572	316	13	.	.	PUNCT
ihlr-16572	317	1	l.	l.	PROPN
ihlr-16572	317	2	no	no	INTJ
ihlr-16572	317	3	.	.	PROPN
ihlr-16572	318	1	98	98	NUM
ihlr-16572	318	2	-	-	SYM
ihlr-16572	318	3	417	417	NUM
ihlr-16572	318	4	(	(	PUNCT
ihlr-16572	318	5	1984	1984	NUM
ihlr-16572	318	6	)	)	PUNCT
ihlr-16572	318	7	,	,	PUNCT
ihlr-16572	318	8	98	98	NUM
ihlr-16572	318	9	stat	stat	NOUN
ihlr-16572	318	10	.	.	PUNCT
ihlr-16572	319	1	1585	1585	NUM
ihlr-16572	319	2	(	(	PUNCT
ihlr-16572	319	3	1984	1984	NUM
ihlr-16572	319	4	)	)	PUNCT
ihlr-16572	319	5	.	.	PUNCT
ihlr-16572	320	1	97	97	NUM
ihlr-16572	320	2	.	.	PUNCT
ihlr-16572	321	1	/d	/d	INTJ
ihlr-16572	321	2	.	.	PUNCT
ihlr-16572	322	1	98	98	NUM
ihlr-16572	322	2	.	.	PUNCT
ihlr-16572	322	3	kotlikoff	kotlikoff	PROPN
ihlr-16572	322	4	,	,	PUNCT
ihlr-16572	322	5	supra	supra	PROPN
ihlr-16572	322	6	note	note	PROPN
ihlr-16572	322	7	28	28	NUM
ihlr-16572	322	8	,	,	PUNCT
ihlr-16572	322	9	at	at	ADP
ihlr-16572	322	10	6	6	NUM
ihlr-16572	322	11	.	.	SYM
ihlr-16572	322	12	99	99	NUM
ihlr-16572	322	13	.	.	PUNCT
ihlr-16572	323	1	i	i	PROPN
ihlr-16572	323	2	d	d	PROPN
ihlr-16572	323	3	at9	at9	PROPN
ihlr-16572	323	4	.	.	PROPN
ihlr-16572	323	5	2010	2010	NUM
ihlr-16572	323	6	]	]	PUNCT
ihlr-16572	324	1	follow	follow	VERB
ihlr-16572	324	2	~	~	PUNCT
ihlr-16572	324	3	on	on	ADP
ihlr-16572	324	4	biologics	biologic	NOUN
ihlr-16572	324	5	legislation	legislation	NOUN
ihlr-16572	324	6	sule	sule	PROPN
ihlr-16572	324	7	)	)	PUNCT
ihlr-16572	324	8	,	,	PUNCT
ihlr-16572	324	9	modifying	modify	VERB
ihlr-16572	324	10	the	the	DET
ihlr-16572	324	11	method	method	NOUN
ihlr-16572	324	12	of	of	ADP
ihlr-16572	324	13	delivery	delivery	NOUN
ihlr-16572	324	14	(	(	PUNCT
ihlr-16572	324	15	e.g.	e.g.	ADV
ihlr-16572	324	16	,	,	PUNCT
ihlr-16572	324	17	from	from	ADP
ihlr-16572	324	18	in­	in­	NOUN
ihlr-16572	324	19	jection	jection	NOUN
ihlr-16572	324	20	to	to	ADP
ihlr-16572	324	21	inhalation	inhalation	NOUN
ihlr-16572	324	22	)	)	PUNCT
ihlr-16572	324	23	,	,	PUNCT
ihlr-16572	324	24	expanding	expand	VERB
ihlr-16572	324	25	indications	indication	NOUN
ihlr-16572	324	26	(	(	PUNCT
ihlr-16572	324	27	applying	apply	VERB
ihlr-16572	324	28	the	the	DET
ihlr-16572	324	29	medicine	medicine	NOUN
ihlr-16572	324	30	to	to	ADP
ihlr-16572	324	31	additional	additional	ADJ
ihlr-16572	324	32	conditions	condition	NOUN
ihlr-16572	324	33	)	)	PUNCT
ihlr-16572	324	34	,	,	PUNCT
ihlr-16572	324	35	pegylation	pegylation	NOUN
ihlr-16572	324	36	(	(	PUNCT
ihlr-16572	324	37	which	which	PRON
ihlr-16572	324	38	has	have	VERB
ihlr-16572	324	39	the	the	DET
ihlr-16572	324	40	effect	effect	NOUN
ihlr-16572	324	41	of	of	ADP
ihlr-16572	324	42	reducing	reduce	VERB
ihlr-16572	324	43	doses	dose	NOUN
ihlr-16572	324	44	per	per	ADP
ihlr-16572	324	45	time	time	NOUN
ihlr-16572	324	46	pe­	pe­	NOUN
ihlr-16572	324	47	riod	riod	NOUN
ihlr-16572	324	48	via	via	ADP
ihlr-16572	324	49	time	time	NOUN
ihlr-16572	324	50	-	-	PUNCT
ihlr-16572	324	51	release	release	NOUN
ihlr-16572	324	52	mechanisms	mechanism	NOUN
ihlr-16572	324	53	)	)	PUNCT
ihlr-16572	324	54	,	,	PUNCT
ihlr-16572	324	55	and	and	CCONJ
ihlr-16572	324	56	glycosolation	glycosolation	NOUN
ihlr-16572	324	57	(	(	PUNCT
ihlr-16572	324	58	adding	add	VERB
ihlr-16572	324	59	sugar	sugar	NOUN
ihlr-16572	324	60	molecules	molecule	NOUN
ihlr-16572	324	61	to	to	ADP
ihlr-16572	324	62	the	the	DET
ihlr-16572	324	63	medication	medication	NOUN
ihlr-16572	324	64	)	)	PUNCT
ihlr-16572	325	1	.1	.1	NUM
ihlr-16572	325	2	00	00	NUM
ihlr-16572	326	1	381	381	NUM
ihlr-16572	326	2	the	the	DET
ihlr-16572	326	3	existence	existence	NOUN
ihlr-16572	326	4	of	of	ADP
ihlr-16572	326	5	these	these	DET
ihlr-16572	326	6	provisions	provision	NOUN
ihlr-16572	326	7	,	,	PUNCT
ihlr-16572	326	8	as	as	ADV
ihlr-16572	326	9	well	well	ADV
ihlr-16572	326	10	as	as	ADP
ihlr-16572	326	11	the	the	DET
ihlr-16572	326	12	varying	vary	VERB
ihlr-16572	326	13	degrees	degree	NOUN
ihlr-16572	326	14	of	of	ADP
ihlr-16572	326	15	latitude	latitude	NOUN
ihlr-16572	326	16	they	they	PRON
ihlr-16572	326	17	give	give	VERB
ihlr-16572	326	18	innovators	innovator	NOUN
ihlr-16572	326	19	to	to	PART
ihlr-16572	326	20	extend	extend	VERB
ihlr-16572	326	21	their	their	PRON
ihlr-16572	326	22	monopoly	monopoly	NOUN
ihlr-16572	326	23	,	,	PUNCT
ihlr-16572	326	24	is	be	AUX
ihlr-16572	326	25	important	important	ADJ
ihlr-16572	326	26	when	when	SCONJ
ihlr-16572	326	27	assessing	assess	VERB
ihlr-16572	326	28	the	the	DET
ihlr-16572	326	29	fairness	fairness	NOUN
ihlr-16572	326	30	of	of	ADP
ihlr-16572	326	31	proposed	propose	VERB
ihlr-16572	326	32	legislation	legislation	NOUN
ihlr-16572	326	33	.	.	PUNCT
ihlr-16572	327	1	2	2	X
ihlr-16572	327	2	.	.	X
ihlr-16572	327	3	the	the	DET
ihlr-16572	327	4	inhibitory	inhibitory	ADJ
ihlr-16572	327	5	effect	effect	NOUN
ihlr-16572	327	6	of	of	ADP
ihlr-16572	327	7	exclusivity	exclusivity	NOUN
ihlr-16572	327	8	provisions	provision	NOUN
ihlr-16572	327	9	on	on	ADP
ihlr-16572	327	10	innovation	innovation	NOUN
ihlr-16572	327	11	innovators	innovator	NOUN
ihlr-16572	327	12	build	build	VERB
ihlr-16572	327	13	on	on	ADP
ihlr-16572	327	14	others	other	NOUN
ihlr-16572	327	15	'	'	PART
ihlr-16572	327	16	achievements	achievement	NOUN
ihlr-16572	327	17	in	in	ADP
ihlr-16572	327	18	making	make	VERB
ihlr-16572	327	19	new	new	ADJ
ihlr-16572	327	20	discoveries	discovery	NOUN
ihlr-16572	327	21	.	.	PUNCT
ihlr-16572	328	1	sir	sir	PROPN
ihlr-16572	328	2	isaac	isaac	PROPN
ihlr-16572	328	3	newton	newton	PROPN
ihlr-16572	328	4	referred	refer	VERB
ihlr-16572	328	5	to	to	ADP
ihlr-16572	328	6	this	this	DET
ihlr-16572	328	7	age	age	NOUN
ihlr-16572	328	8	-	-	PUNCT
ihlr-16572	328	9	old	old	ADJ
ihlr-16572	328	10	process	process	NOUN
ihlr-16572	328	11	,	,	PUNCT
ihlr-16572	328	12	stating	state	VERB
ihlr-16572	328	13	"	"	PUNCT
ihlr-16572	328	14	[	[	X
ihlr-16572	328	15	i]f	i]f	X
ihlr-16572	328	16	i	i	PRON
ihlr-16572	328	17	have	have	AUX
ihlr-16572	328	18	seen	see	VERB
ihlr-16572	328	19	further	far	ADV
ihlr-16572	328	20	it	it	PRON
ihlr-16572	328	21	is	be	AUX
ihlr-16572	328	22	by	by	ADP
ihlr-16572	328	23	standing	stand	VERB
ihlr-16572	328	24	on	on	ADP
ihlr-16572	328	25	ye	ye	NOUN
ihlr-16572	328	26	shoulders	shoulder	NOUN
ihlr-16572	328	27	of	of	ADP
ihlr-16572	328	28	giants	giant	NOUN
ihlr-16572	328	29	.	.	PUNCT
ihlr-16572	329	1	''101	''101	PROPN
ihlr-16572	329	2	any	any	DET
ihlr-16572	329	3	policy	policy	NOUN
ihlr-16572	329	4	which	which	PRON
ihlr-16572	329	5	effectively	effectively	ADV
ihlr-16572	329	6	lengthens	lengthen	VERB
ihlr-16572	329	7	the	the	DET
ihlr-16572	329	8	time	time	NOUN
ihlr-16572	329	9	between	between	ADP
ihlr-16572	329	10	innovations	innovation	NOUN
ihlr-16572	329	11	may	may	AUX
ihlr-16572	329	12	result	result	VERB
ihlr-16572	329	13	in	in	ADP
ihlr-16572	329	14	decreased	decrease	VERB
ihlr-16572	329	15	innovation	innovation	NOUN
ihlr-16572	329	16	over	over	ADP
ihlr-16572	329	17	time	time	NOUN
ihlr-16572	329	18	.	.	PUNCT
ihlr-16572	330	1	decreased	decrease	VERB
ihlr-16572	330	2	innovation	innovation	NOUN
ihlr-16572	330	3	in	in	ADP
ihlr-16572	330	4	general	general	ADJ
ihlr-16572	330	5	has	have	VERB
ihlr-16572	330	6	a	a	DET
ihlr-16572	330	7	profound	profound	ADJ
ihlr-16572	330	8	ef­	ef­	NOUN
ihlr-16572	330	9	fect	fect	NOUN
ihlr-16572	330	10	on	on	ADP
ihlr-16572	330	11	our	our	PRON
ihlr-16572	330	12	economy	economy	NOUN
ihlr-16572	330	13	,	,	PUNCT
ihlr-16572	330	14	but	but	CCONJ
ihlr-16572	330	15	decreased	decrease	VERB
ihlr-16572	330	16	innovation	innovation	NOUN
ihlr-16572	330	17	of	of	ADP
ihlr-16572	330	18	life	life	NOUN
ihlr-16572	330	19	-	-	PUNCT
ihlr-16572	330	20	saving	save	VERB
ihlr-16572	330	21	drugs	drug	NOUN
ihlr-16572	330	22	reaches	reach	VERB
ihlr-16572	330	23	much	much	ADV
ihlr-16572	330	24	further	far	ADV
ihlr-16572	330	25	than	than	ADP
ihlr-16572	330	26	the	the	DET
ihlr-16572	330	27	bottom	bottom	ADJ
ihlr-16572	330	28	line	line	NOUN
ihlr-16572	330	29	it	it	PRON
ihlr-16572	330	30	negatively	negatively	ADV
ihlr-16572	330	31	impacts	impact	VERB
ihlr-16572	330	32	our	our	PRON
ihlr-16572	330	33	health	health	NOUN
ihlr-16572	330	34	.	.	PUNCT
ihlr-16572	331	1	once	once	ADV
ihlr-16572	331	2	a	a	DET
ihlr-16572	331	3	drug	drug	NOUN
ihlr-16572	331	4	company	company	NOUN
ihlr-16572	331	5	has	have	AUX
ihlr-16572	331	6	received	receive	VERB
ihlr-16572	331	7	approval	approval	NOUN
ihlr-16572	331	8	for	for	ADP
ihlr-16572	331	9	a	a	DET
ihlr-16572	331	10	blockbuster	blockbuster	ADJ
ihlr-16572	331	11	biologic	biologic	NOUN
ihlr-16572	331	12	,	,	PUNCT
ihlr-16572	331	13	the	the	DET
ihlr-16572	331	14	com­	com­	NOUN
ihlr-16572	331	15	pany	pany	NOUN
ihlr-16572	331	16	is	be	AUX
ihlr-16572	331	17	typically	typically	ADV
ihlr-16572	331	18	less	less	ADV
ihlr-16572	331	19	inclined	inclined	ADJ
ihlr-16572	331	20	to	to	PART
ihlr-16572	331	21	promote	promote	VERB
ihlr-16572	331	22	discovery	discovery	NOUN
ihlr-16572	331	23	of	of	ADP
ihlr-16572	331	24	new	new	ADJ
ihlr-16572	331	25	drugs	drug	NOUN
ihlr-16572	331	26	to	to	ADP
ihlr-16572	331	27	the	the	DET
ihlr-16572	331	28	same	same	ADJ
ihlr-16572	331	29	extent	extent	NOUN
ihlr-16572	331	30	it	it	PRON
ihlr-16572	331	31	had	have	VERB
ihlr-16572	331	32	prior	prior	ADV
ihlr-16572	331	33	to	to	ADP
ihlr-16572	331	34	approval	approval	NOUN
ihlr-16572	331	35	of	of	ADP
ihlr-16572	331	36	that	that	DET
ihlr-16572	331	37	drug	drug	NOUN
ihlr-16572	331	38	.	.	PUNCT
ihlr-16572	332	1	"	"	PUNCT
ihlr-16572	332	2	[	[	X
ihlr-16572	332	3	y]esterday	y]esterday	NOUN
ihlr-16572	332	4	's	's	PART
ihlr-16572	332	5	inventors	inventor	NOUN
ihlr-16572	332	6	are	be	AUX
ihlr-16572	332	7	much	much	ADV
ihlr-16572	332	8	less	less	ADV
ihlr-16572	332	9	likely	likely	ADJ
ihlr-16572	332	10	to	to	PART
ihlr-16572	332	11	be	be	AUX
ihlr-16572	332	12	either	either	DET
ihlr-16572	332	13	today	today	NOUN
ihlr-16572	332	14	's	's	PART
ihlr-16572	332	15	innovators	innovator	NOUN
ihlr-16572	332	16	or	or	CCONJ
ihlr-16572	332	17	tomorrow's	tomorrow's	PROPN
ihlr-16572	332	18	.	.	PUNCT
ihlr-16572	333	1	"102	"102	VERB
ihlr-16572	334	1	once	once	SCONJ
ihlr-16572	334	2	an	an	DET
ihlr-16572	334	3	innovator	innovator	NOUN
ihlr-16572	334	4	has	have	AUX
ihlr-16572	334	5	made	make	VERB
ihlr-16572	334	6	a	a	DET
ihlr-16572	334	7	discovery	discovery	NOUN
ihlr-16572	334	8	,	,	PUNCT
ihlr-16572	334	9	he	he	PRON
ihlr-16572	334	10	or	or	CCONJ
ihlr-16572	334	11	she	she	PRON
ihlr-16572	334	12	is	be	AUX
ihlr-16572	334	13	faced	face	VERB
ihlr-16572	334	14	with	with	ADP
ihlr-16572	334	15	different	different	ADJ
ihlr-16572	334	16	incentives	incentive	NOUN
ihlr-16572	334	17	than	than	ADP
ihlr-16572	334	18	those	those	PRON
ihlr-16572	334	19	that	that	PRON
ihlr-16572	334	20	may	may	AUX
ihlr-16572	334	21	have	have	AUX
ihlr-16572	334	22	prompted	prompt	VERB
ihlr-16572	334	23	the	the	DET
ihlr-16572	334	24	discovery	discovery	NOUN
ihlr-16572	334	25	.	.	PUNCT
ihlr-16572	335	1	the	the	DET
ihlr-16572	335	2	brand	brand	NOUN
ihlr-16572	335	3	company	company	NOUN
ihlr-16572	335	4	diverts	divert	VERB
ihlr-16572	335	5	resources	resource	NOUN
ihlr-16572	335	6	from	from	ADP
ihlr-16572	335	7	innovation	innovation	NOUN
ihlr-16572	335	8	towards	towards	ADP
ihlr-16572	335	9	building	building	NOUN
ihlr-16572	335	10	and	and	CCONJ
ihlr-16572	335	11	sustaining	sustain	VERB
ihlr-16572	335	12	the	the	DET
ihlr-16572	335	13	profitability	profitability	NOUN
ihlr-16572	335	14	of	of	ADP
ihlr-16572	335	15	its	its	PRON
ihlr-16572	335	16	new	new	ADJ
ihlr-16572	335	17	discovery	discovery	NOUN
ihlr-16572	335	18	.	.	PUNCT
ihlr-16572	336	1	consider	consider	VERB
ihlr-16572	336	2	for	for	ADP
ihlr-16572	336	3	example	example	NOUN
ihlr-16572	336	4	,	,	PUNCT
ihlr-16572	336	5	genetico	genetico	PROPN
ihlr-16572	336	6	,	,	PUNCT
ihlr-16572	336	7	a	a	DET
ihlr-16572	336	8	hypothetical	hypothetical	ADJ
ihlr-16572	336	9	biologics	biologic	NOUN
ihlr-16572	336	10	manufac­	manufac­	PROPN
ihlr-16572	336	11	turer	turer	PROPN
ihlr-16572	336	12	which	which	PRON
ihlr-16572	336	13	spends	spend	VERB
ihlr-16572	336	14	millions	million	NOUN
ihlr-16572	336	15	of	of	ADP
ihlr-16572	336	16	dollars	dollar	NOUN
ihlr-16572	336	17	to	to	PART
ihlr-16572	336	18	make	make	VERB
ihlr-16572	336	19	an	an	DET
ihlr-16572	336	20	initial	initial	ADJ
ihlr-16572	336	21	discovery	discovery	NOUN
ihlr-16572	336	22	of	of	ADP
ihlr-16572	336	23	a	a	DET
ihlr-16572	336	24	pro­	pro­	NOUN
ihlr-16572	336	25	tein	tein	NOUN
ihlr-16572	336	26	-	-	PUNCT
ihlr-16572	336	27	based	base	VERB
ihlr-16572	336	28	compound	compound	NOUN
ihlr-16572	336	29	which	which	PRON
ihlr-16572	336	30	can	can	AUX
ihlr-16572	336	31	be	be	AUX
ihlr-16572	336	32	developed	develop	VERB
ihlr-16572	336	33	into	into	ADP
ihlr-16572	336	34	a	a	DET
ihlr-16572	336	35	lifesaving	lifesaving	NOUN
ihlr-16572	336	36	cancer	cancer	NOUN
ihlr-16572	336	37	drug	drug	NOUN
ihlr-16572	336	38	.	.	PUNCT
ihlr-16572	337	1	after	after	SCONJ
ihlr-16572	337	2	the	the	DET
ihlr-16572	337	3	discovery	discovery	NOUN
ihlr-16572	337	4	is	be	AUX
ihlr-16572	337	5	made	make	VERB
ihlr-16572	337	6	,	,	PUNCT
ihlr-16572	337	7	genetico	genetico	PROPN
ihlr-16572	337	8	's	's	PART
ihlr-16572	337	9	main	main	ADJ
ihlr-16572	337	10	goals	goal	NOUN
ihlr-16572	337	11	include	include	VERB
ihlr-16572	337	12	protecting	protect	VERB
ihlr-16572	337	13	this	this	DET
ihlr-16572	337	14	intellectual	intellectual	ADJ
ihlr-16572	337	15	property	property	NOUN
ihlr-16572	337	16	,	,	PUNCT
ihlr-16572	337	17	developing	develop	VERB
ihlr-16572	337	18	the	the	DET
ihlr-16572	337	19	drug	drug	NOUN
ihlr-16572	337	20	,	,	PUNCT
ihlr-16572	337	21	conducting	conduct	VERB
ihlr-16572	337	22	clinical	clinical	ADJ
ihlr-16572	337	23	trials	trial	NOUN
ihlr-16572	337	24	,	,	PUNCT
ihlr-16572	337	25	gaining	gain	VERB
ihlr-16572	337	26	fda	fda	PROPN
ihlr-16572	337	27	approval	approval	NOUN
ihlr-16572	337	28	for	for	ADP
ihlr-16572	337	29	the	the	DET
ihlr-16572	337	30	drug	drug	NOUN
ihlr-16572	337	31	;	;	PUNCT
ihlr-16572	337	32	and	and	CCONJ
ihlr-16572	337	33	finally	finally	ADV
ihlr-16572	337	34	manufacturing	manufacture	VERB
ihlr-16572	337	35	,	,	PUNCT
ihlr-16572	337	36	marketing	marketing	NOUN
ihlr-16572	337	37	,	,	PUNCT
ihlr-16572	337	38	and	and	CCONJ
ihlr-16572	337	39	sell­	sell­	PRON
ihlr-16572	337	40	ing	e	VERB
ihlr-16572	337	41	the	the	DET
ihlr-16572	337	42	drug	drug	NOUN
ihlr-16572	337	43	.	.	PUNCT
ihlr-16572	338	1	these	these	DET
ihlr-16572	338	2	goals	goal	NOUN
ihlr-16572	338	3	do	do	AUX
ihlr-16572	338	4	not	not	PART
ihlr-16572	338	5	coincide	coincide	VERB
ihlr-16572	338	6	with	with	ADP
ihlr-16572	338	7	the	the	DET
ihlr-16572	338	8	devotion	devotion	NOUN
ihlr-16572	338	9	of	of	ADP
ihlr-16572	338	10	significant	significant	ADJ
ihlr-16572	338	11	resources	resource	NOUN
ihlr-16572	338	12	towards	towards	ADP
ihlr-16572	338	13	building	build	VERB
ihlr-16572	338	14	on	on	ADP
ihlr-16572	338	15	the	the	DET
ihlr-16572	338	16	discovery	discovery	NOUN
ihlr-16572	338	17	.	.	PUNCT
ihlr-16572	339	1	if	if	SCONJ
ihlr-16572	339	2	genetico	genetico	PROPN
ihlr-16572	339	3	were	be	AUX
ihlr-16572	339	4	to	to	PART
ihlr-16572	339	5	build	build	VERB
ihlr-16572	339	6	on	on	ADP
ihlr-16572	339	7	the	the	DET
ihlr-16572	339	8	discovery	discovery	NOUN
ihlr-16572	339	9	and	and	CCONJ
ihlr-16572	339	10	essentially	essentially	ADV
ihlr-16572	339	11	produce	produce	VERB
ihlr-16572	339	12	a	a	DET
ihlr-16572	339	13	better	well	ADJ
ihlr-16572	339	14	version	version	NOUN
ihlr-16572	339	15	of	of	ADP
ihlr-16572	339	16	the	the	DET
ihlr-16572	339	17	current	current	ADJ
ihlr-16572	339	18	prod100	prod100	PROPN
ihlr-16572	339	19	.	.	PUNCT
ihlr-16572	340	1	i	i	PROPN
ihlr-16572	340	2	d	d	PROPN
ihlr-16572	340	3	101	101	NUM
ihlr-16572	340	4	.	.	PUNCT
ihlr-16572	340	5	letter	letter	NOUN
ihlr-16572	340	6	from	from	ADP
ihlr-16572	340	7	sir	sir	PROPN
ihlr-16572	340	8	isaac	isaac	PROPN
ihlr-16572	340	9	newton	newton	PROPN
ihlr-16572	340	10	to	to	ADP
ihlr-16572	340	11	robert	robert	PROPN
ihlr-16572	340	12	hooke	hooke	PROPN
ihlr-16572	340	13	(	(	PUNCT
ihlr-16572	340	14	feb	feb	PROPN
ihlr-16572	340	15	.	.	PROPN
ihlr-16572	340	16	15	15	NUM
ihlr-16572	340	17	,	,	PUNCT
ihlr-16572	340	18	1676	1676	NUM
ihlr-16572	340	19	)	)	PUNCT
ihlr-16572	340	20	.	.	PUNCT
ihlr-16572	341	1	this	this	DET
ihlr-16572	341	2	letter	letter	NOUN
ihlr-16572	341	3	was	be	AUX
ihlr-16572	341	4	originally	originally	ADV
ihlr-16572	341	5	dated	date	VERB
ihlr-16572	341	6	feb	feb	NOUN
ihlr-16572	341	7	.	.	PROPN
ihlr-16572	341	8	5	5	NUM
ihlr-16572	341	9	,	,	PUNCT
ihlr-16572	341	10	1675	1675	NUM
ihlr-16572	341	11	using	use	VERB
ihlr-16572	341	12	the	the	DET
ihlr-16572	341	13	julian	julian	PROPN
ihlr-16572	341	14	calendar	calendar	NOUN
ihlr-16572	341	15	with	with	ADP
ihlr-16572	341	16	march	march	PROPN
ihlr-16572	341	17	25th	25th	PROPN
ihlr-16572	341	18	rather	rather	ADV
ihlr-16572	341	19	than	than	ADP
ihlr-16572	341	20	january	january	PROPN
ihlr-16572	341	21	1st	1st	NOUN
ihlr-16572	341	22	as	as	ADP
ihlr-16572	341	23	new	new	ADJ
ihlr-16572	341	24	years	year	NOUN
ihlr-16572	341	25	day	day	NOUN
ihlr-16572	341	26	.	.	PUNCT
ihlr-16572	342	1	according	accord	VERB
ihlr-16572	342	2	to	to	ADP
ihlr-16572	342	3	gregorian	gregorian	ADJ
ihlr-16572	342	4	theorists	theorist	NOUN
ihlr-16572	342	5	,	,	PUNCT
ihlr-16572	342	6	the	the	DET
ihlr-16572	342	7	original	original	ADJ
ihlr-16572	342	8	date	date	NOUN
ihlr-16572	342	9	is	be	AUX
ihlr-16572	342	10	equivalent	equivalent	ADJ
ihlr-16572	342	11	to	to	ADP
ihlr-16572	342	12	feb	feb	PROPN
ihlr-16572	342	13	.	.	PROPN
ihlr-16572	342	14	15	15	NUM
ihlr-16572	342	15	,	,	PUNCT
ihlr-16572	342	16	1676	1676	NUM
ihlr-16572	342	17	.	.	PUNCT
ihlr-16572	343	1	102	102	NUM
ihlr-16572	343	2	.	.	PUNCT
ihlr-16572	343	3	kotlikoff	kotlikoff	PROPN
ihlr-16572	343	4	,	,	PUNCT
ihlr-16572	343	5	supra	supra	PROPN
ihlr-16572	343	6	note	note	PROPN
ihlr-16572	343	7	28	28	NUM
ihlr-16572	343	8	,	,	PUNCT
ihlr-16572	343	9	at	at	ADP
ihlr-16572	343	10	4	4	NUM
ihlr-16572	343	11	.	.	NUM
ihlr-16572	343	12	382	382	NUM
ihlr-16572	343	13	indiana	indiana	PROPN
ihlr-16572	343	14	heal1h	heal1h	PROPN
ihlr-16572	343	15	law	law	NOUN
ihlr-16572	343	16	review	review	NOUN
ihlr-16572	343	17	.	.	PUNCT
ihlr-16572	344	1	[	[	X
ihlr-16572	344	2	vol	vol	NOUN
ihlr-16572	344	3	.	.	PUNCT
ihlr-16572	345	1	7:367	7:367	NUM
ihlr-16572	345	2	uct	uct	NOUN
ihlr-16572	345	3	,	,	PUNCT
ihlr-16572	345	4	it	it	PRON
ihlr-16572	345	5	would	would	AUX
ihlr-16572	345	6	be	be	AUX
ihlr-16572	345	7	diminishing	diminish	VERB
ihlr-16572	345	8	much	much	ADJ
ihlr-16572	345	9	of	of	ADP
ihlr-16572	345	10	the	the	DET
ihlr-16572	345	11	value	value	NOUN
ihlr-16572	345	12	of	of	ADP
ihlr-16572	345	13	the	the	DET
ihlr-16572	345	14	initial	initial	NOUN
ihlr-16572	345	15	invention.103	invention.103	VERB
ihlr-16572	345	16	many	many	ADJ
ihlr-16572	345	17	economists	economist	NOUN
ihlr-16572	345	18	have	have	AUX
ihlr-16572	345	19	concurred	concur	VERB
ihlr-16572	345	20	with	with	ADP
ihlr-16572	345	21	nobellaureate	nobellaureate	NOUN
ihlr-16572	345	22	kenneth	kenneth	PROPN
ihlr-16572	345	23	ar­	ar­	PROPN
ihlr-16572	345	24	row	row	NOUN
ihlr-16572	345	25	's	's	PART
ihlr-16572	345	26	contention	contention	NOUN
ihlr-16572	345	27	that	that	SCONJ
ihlr-16572	345	28	''	''	PUNCT
ihlr-16572	345	29	the	the	DET
ihlr-16572	345	30	incentive	incentive	NOUN
ihlr-16572	345	31	to	to	PART
ihlr-16572	345	32	invent	invent	VERB
ihlr-16572	345	33	is	be	AUX
ihlr-16572	345	34	less	less	ADJ
ihlr-16572	345	35	·	·	PUNCT
ihlr-16572	345	36	under	under	ADP
ihlr-16572	345	37	monopolistic	monopolistic	ADJ
ihlr-16572	345	38	than	than	ADP
ihlr-16572	345	39	under	under	ADP
ihlr-16572	345	40	competitive	competitive	ADJ
ihlr-16572	345	41	conditions!'104	conditions!'104	NOUN
ihlr-16572	345	42	monopolists	monopolist	NOUN
ihlr-16572	345	43	are	be	AUX
ihlr-16572	345	44	less	less	ADV
ihlr-16572	345	45	likely	likely	ADJ
ihlr-16572	345	46	to	to	PART
ihlr-16572	345	47	inno­	inno­	VERB
ihlr-16572	345	48	vate	vate	ADJ
ihlr-16572	345	49	for	for	ADP
ihlr-16572	345	50	a	a	DET
ihlr-16572	345	51	simple	simple	ADJ
ihlr-16572	345	52	,	,	PUNCT
ihlr-16572	345	53	though	though	SCONJ
ihlr-16572	345	54	not	not	PART
ihlr-16572	345	55	necessarily	necessarily	ADV
ihlr-16572	345	56	obvious	obvious	ADJ
ihlr-16572	345	57	reason	reason	NOUN
ihlr-16572	345	58	:	:	PUNCT
ihlr-16572	345	59	,	,	PUNCT
ihlr-16572	345	60	if	if	SCONJ
ihlr-16572	345	61	a	a	DET
ihlr-16572	345	62	company	company	NOUN
ihlr-16572	345	63	in­	in­	NOUN
ihlr-16572	345	64	troduces	troduce	NOUN
ihlr-16572	345	65	an	an	DET
ihlr-16572	345	66	improved	improved	ADJ
ihlr-16572	345	67	version	version	NOUN
ihlr-16572	345	68	of	of	ADP
ihlr-16572	345	69	their	their	PRON
ihlr-16572	345	70	existing	exist	VERB
ihlr-16572	345	71	product	product	NOUN
ihlr-16572	345	72	into	into	ADP
ihlr-16572	345	73	the	the	DET
ihlr-16572	345	74	market	market	NOUN
ihlr-16572	345	75	they	they	PRON
ihlr-16572	345	76	diminish	diminish	VERB
ihlr-16572	345	77	their	their	PRON
ihlr-16572	345	78	own	own	ADJ
ihlr-16572	345	79	revenue	revenue	NOUN
ihlr-16572	345	80	on	on	ADP
ihlr-16572	345	81	their	their	PRON
ihlr-16572	345	82	existing	exist	VERB
ihlr-16572	345	83	product	product	NOUN
ihlr-16572	345	84	.	.	PUNCT
ihlr-16572	346	1	so	so	ADV
ihlr-16572	346	2	long	long	ADV
ihlr-16572	346	3	·	·	PUNCT
ihlr-16572	346	4	as	as	ADP
ihlr-16572	346	5	a	a	DET
ihlr-16572	346	6	particu­	particu­	NUM
ihlr-16572	346	7	lar	lar	ADJ
ihlr-16572	346	8	product	product	NOUN
ihlr-16572	346	9	is	be	AUX
ihlr-16572	346	10	the	the	DET
ihlr-16572	346	11	only	only	ADJ
ihlr-16572	346	12	option	option	NOUN
ihlr-16572	346	13	for	for	ADP
ihlr-16572	346	14	consumers	consumer	NOUN
ihlr-16572	346	15	,	,	PUNCT
ihlr-16572	346	16	brand	brand	NOUN
ihlr-16572	346	17	companies	company	NOUN
ihlr-16572	346	18	have	have	VERB
ihlr-16572	346	19	no	no	DET
ihlr-16572	346	20	in­	in­	NOUN
ihlr-16572	346	21	centive	centive	NOUN
ihlr-16572	346	22	to	to	PART
ihlr-16572	346	23	expend	expend	VERB
ihlr-16572	346	24	resources	resource	NOUN
ihlr-16572	346	25	in	in	ADP
ihlr-16572	346	26	an	an	DET
ihlr-16572	346	27	effort	effort	NOUN
ihlr-16572	346	28	to	to	PART
ihlr-16572	346	29	improve	improve	VERB
ihlr-16572	346	30	their	their	PRON
ihlr-16572	346	31	own	own	ADJ
ihlr-16572	346	32	product	product	NOUN
ihlr-16572	346	33	.	.	PUNCT
ihlr-16572	347	1	as	as	ADP
ihlr-16572	347	2	·	·	PUNCT
ihlr-16572	347	3	expiration	expiration	NOUN
ihlr-16572	347	4	of	of	ADP
ihlr-16572	347	5	the	the	DET
ihlr-16572	347	6	monopoly	monopoly	NOUN
ihlr-16572	347	7	approaches	approach	NOUN
ihlr-16572	347	8	and	and	CCONJ
ihlr-16572	347	9	the	the	DET
ihlr-16572	347	10	prospect	prospect	NOUN
ihlr-16572	347	11	of	of	ADP
ihlr-16572	347	12	competition	competition	NOUN
ihlr-16572	347	13	re­	re­	NOUN
ihlr-16572	347	14	surfaces	surface	NOUN
ihlr-16572	347	15	,	,	PUNCT
ihlr-16572	347	16	the	the	DET
ihlr-16572	347	17	wheels	wheel	NOUN
ihlr-16572	347	18	of	of	ADP
ihlr-16572	347	19	innovation	innovation	NOUN
ihlr-16572	347	20	begin	begin	VERB
ihlr-16572	347	21	to	to	PART
ihlr-16572	347	22	churn	churn	VERB
ihlr-16572	347	23	again	again	ADV
ihlr-16572	347	24	as	as	SCONJ
ihlr-16572	347	25	the	the	DET
ihlr-16572	347	26	·	·	SYM
ihlr-16572	347	27	original	original	ADJ
ihlr-16572	347	28	inno­	inno­	PRON
ihlr-16572	347	29	vator	vator	NOUN
ihlr-16572	347	30	and	and	CCONJ
ihlr-16572	347	31	hopeful	hopeful	ADJ
ihlr-16572	347	32	competitors	competitor	NOUN
ihlr-16572	347	33	strive	strive	VERB
ihlr-16572	347	34	to	to	PART
ihlr-16572	347	35	produce	produce	VERB
ihlr-16572	347	36	the	the	DET
ihlr-16572	347	37	superior	superior	ADJ
ihlr-16572	347	38	version	version	NOUN
ihlr-16572	347	39	of	of	ADP
ihlr-16572	347	40	a	a	DET
ihlr-16572	347	41	product	product	NOUN
ihlr-16572	347	42	.	.	PUNCT
ihlr-16572	348	1	of	of	ADP
ihlr-16572	348	2	course	course	ADV
ihlr-16572	348	3	,	,	PUNCT
ihlr-16572	348	4	brand	brand	NOUN
ihlr-16572	348	5	name	name	NOUN
ihlr-16572	348	6	drug	drug	NOUN
ihlr-16572	348	7	companies	company	NOUN
ihlr-16572	348	8	need	need	VERB
ihlr-16572	348	9	to	to	PART
ihlr-16572	348	10	be	be	AUX
ihlr-16572	348	11	provided	provide	VERB
ihlr-16572	348	12	assurance	assurance	NOUN
ihlr-16572	348	13	that	that	SCONJ
ihlr-16572	348	14	they	they	PRON
ihlr-16572	348	15	will	will	AUX
ihlr-16572	348	16	not	not	PART
ihlr-16572	348	17	only	only	ADV
ihlr-16572	348	18	be	be	AUX
ihlr-16572	348	19	able	able	ADJ
ihlr-16572	348	20	to	to	PART
ihlr-16572	348	21	recoup	recoup	VERB
ihlr-16572	348	22	their	their	PRON
ihlr-16572	348	23	investment	investment	NOUN
ihlr-16572	348	24	in	in	ADP
ihlr-16572	348	25	a	a	DET
ihlr-16572	348	26	given	give	VERB
ihlr-16572	348	27	drug	drug	NOUN
ihlr-16572	348	28	,	,	PUNCT
ihlr-16572	348	29	but	but	CCONJ
ihlr-16572	348	30	that	that	SCONJ
ihlr-16572	348	31	the	the	DET
ihlr-16572	348	32	drug	drug	NOUN
ihlr-16572	348	33	will	will	AUX
ihlr-16572	348	34	be	be	AUX
ihlr-16572	348	35	profitable	profitable	ADJ
ihlr-16572	348	36	.	.	PUNCT
ihlr-16572	349	1	when	when	SCONJ
ihlr-16572	349	2	these	these	DET
ihlr-16572	349	3	companies	company	NOUN
ihlr-16572	349	4	are	be	AUX
ihlr-16572	349	5	afforded	afford	VERB
ihlr-16572	349	6	monopolies	monopoly	NOUN
ihlr-16572	349	7	for	for	ADP
ihlr-16572	349	8	time	time	NOUN
ihlr-16572	349	9	periods	period	NOUN
ihlr-16572	349	10	beyond	beyond	ADP
ihlr-16572	349	11	what	what	PRON
ihlr-16572	349	12	is	be	AUX
ihlr-16572	349	13	necessary	necessary	ADJ
ihlr-16572	349	14	,	,	PUNCT
ihlr-16572	349	15	however	however	ADV
ihlr-16572	349	16	,	,	PUNCT
ihlr-16572	349	17	the	the	DET
ihlr-16572	349	18	sacri­	sacri­	VERB
ihlr-16572	349	19	fice	fice	NOUN
ihlr-16572	349	20	in	in	ADP
ihlr-16572	349	21	innovation	innovation	NOUN
ihlr-16572	349	22	and	and	CCONJ
ihlr-16572	349	23	increased	increase	VERB
ihlr-16572	349	24	c	c	PROPN
ihlr-16572	349	25	~	~	SYM
ihlr-16572	349	26	st	st	PROPN
ihlr-16572	349	27	become	become	VERB
ihlr-16572	349	28	more	more	ADV
ihlr-16572	349	29	difficult	difficult	ADJ
ihlr-16572	349	30	to	to	PART
ihlr-16572	349	31	justify	justify	VERB
ihlr-16572	349	32	.	.	PUNCT
ihlr-16572	350	1	ap­	ap­	PROPN
ihlr-16572	350	2	propriate	propriate	PROPN
ihlr-16572	350	3	..	..	PUNCT
ihlr-16572	350	4	legislation	legislation	NOUN
ihlr-16572	350	5	will	will	AUX
ihlr-16572	350	6	·	·	PUNCT
ihlr-16572	350	7	·	·	PUNCT
ihlr-16572	350	8	limit	limit	VERB
ihlr-16572	350	9	monopoly	monopoly	NOUN
ihlr-16572	350	10	protection	protection	NOUN
ihlr-16572	350	11	for	for	ADP
ihlr-16572	350	12	biologics	biologic	NOUN
ihlr-16572	350	13	manufacturers	manufacturer	NOUN
ihlr-16572	350	14	to	to	ADP
ihlr-16572	350	15	the	the	DET
ihlr-16572	350	16	length	length	NOUN
ihlr-16572	350	17	necessary	necessary	ADJ
ihlr-16572	350	18	to	to	PART
ihlr-16572	350	19	·	·	PUNCT
ihlr-16572	350	20	maintain	maintain	VERB
ihlr-16572	350	21	the	the	DET
ihlr-16572	350	22	incentive	incentive	NOUN
ihlr-16572	350	23	to	to	PART
ihlr-16572	350	24	.	.	PUNCT
ihlr-16572	351	1	discover	discover	VERB
ihlr-16572	351	2	new	new	ADJ
ihlr-16572	351	3	drugs	drug	NOUN
ihlr-16572	351	4	.	.	PUNCT
ihlr-16572	352	1	3	3	X
ihlr-16572	352	2	.	.	X
ihlr-16572	352	3	access	access	NOUN
ihlr-16572	352	4	distortion	distortion	NOUN
ihlr-16572	352	5	the	the	DET
ihlr-16572	352	6	high	high	ADJ
ihlr-16572	352	7	price	price	NOUN
ihlr-16572	352	8	ofbiologics	ofbiologic	NOUN
ihlr-16572	352	9	,	,	PUNCT
ihlr-16572	352	10	coupled	couple	VERB
ihlr-16572	352	11	with	with	ADP
ihlr-16572	352	12	the	the	DET
ihlr-16572	352	13	increasing	increase	VERB
ihlr-16572	352	14	number	number	NOUN
ihlr-16572	352	15	of	of	ADP
ihlr-16572	352	16	un­	un­	PUNCT
ihlr-16572	352	17	insured	insured	ADJ
ihlr-16572	352	18	and	and	CCONJ
ihlr-16572	352	19	underinsured	underinsured	ADJ
ihlr-16572	352	20	americans	americans	PROPN
ihlr-16572	352	21	,	,	PUNCT
ihlr-16572	352	22	·	·	PUNCT
ihlr-16572	352	23	results	result	NOUN
ihlr-16572	352	24	in	in	ADP
ihlr-16572	352	25	distorted	distorted	ADJ
ihlr-16572	352	26	access	access	NOUN
ihlr-16572	352	27	:	:	PUNCT
ihlr-16572	352	28	those	those	DET
ihlr-16572	352	29	for­	for­	PROPN
ihlr-16572	352	30	tunate	tunate	PROPN
ihlr-16572	352	31	enough	enough	ADV
ihlr-16572	352	32	to	to	PART
ihlr-16572	352	33	have	have	VERB
ihlr-16572	352	34	access	access	NOUN
ihlr-16572	352	35	to	to	ADP
ihlr-16572	352	36	these	these	DET
ihlr-16572	352	37	drugs	drug	NOUN
ihlr-16572	352	38	may	may	AUX
ihlr-16572	352	39	not	not	PART
ihlr-16572	352	40	·	·	VERB
ihlr-16572	352	41	have	have	VERB
ihlr-16572	352	42	the	the	DET
ihlr-16572	352	43	greatest	great	ADJ
ihlr-16572	352	44	need.105	need.105	NOUN
ihlr-16572	352	45	aside	aside	ADV
ihlr-16572	352	46	from	from	ADP
ihlr-16572	352	47	the	the	DET
ihlr-16572	352	48	obvious	obvious	ADJ
ihlr-16572	352	49	equity	equity	NOUN
ihlr-16572	352	50	issues	issue	NOUN
ihlr-16572	352	51	associated	associate	VERB
ihlr-16572	352	52	with	with	ADP
ihlr-16572	352	53	this	this	DET
ihlr-16572	352	54	access	access	NOUN
ihlr-16572	352	55	distortion	distortion	NOUN
ihlr-16572	352	56	,	,	PUNCT
ihlr-16572	352	57	efficiency	efficiency	NOUN
ihlr-16572	352	58	concerns	concern	NOUN
ihlr-16572	352	59	exist	exist	VERB
ihlr-16572	352	60	as	as	ADV
ihlr-16572	352	61	well	well	ADV
ihlr-16572	352	62	.	.	PUNCT
ihlr-16572	352	63	·	·	PUNCT
ihlr-16572	353	1	·	·	PUNCT
ihlr-16572	353	2	markets	market	NOUN
ihlr-16572	353	3	in	in	ADP
ihlr-16572	353	4	which	which	PRON
ihlr-16572	353	5	some	some	DET
ihlr-16572	353	6	people	people	NOUN
ihlr-16572	353	7	face	face	VERB
ihlr-16572	353	8	one	one	NUM
ihlr-16572	353	9	set	set	NOUN
ihlr-16572	353	10	of	of	ADP
ihlr-16572	353	11	prices	price	NOUN
ihlr-16572	353	12	for	for	ADP
ihlr-16572	353	13	goods	good	NOUN
ihlr-16572	353	14	and	and	CCONJ
ihlr-16572	353	15	services	service	NOUN
ihlr-16572	353	16	and	and	CCONJ
ihlr-16572	353	17	other	other	ADJ
ihlr-16572	353	18	people	people	NOUN
ihlr-16572	353	19	face	face	VERB
ihlr-16572	353	20	another	another	DET
ihlr-16572	353	21	set	set	NOUN
ihlr-16572	353	22	are	be	AUX
ihlr-16572	353	23	inefficient	inefficient	ADJ
ihlr-16572	353	24	for	for	ADP
ihlr-16572	353	25	a	a	DET
ihlr-16572	353	26	simple	simple	ADJ
ihlr-16572	353	27	reason	reason	NOUN
ihlr-16572	353	28	.	.	PUNCT
ihlr-16572	354	1	,	,	PUNCT
ihlr-16572	354	2	..	..	PUNCT
ihlr-16572	354	3	there	there	PRON
ihlr-16572	354	4	are	be	VERB
ihlr-16572	354	5	bene­	bene­	NUM
ihlr-16572	354	6	ficial	ficial	ADJ
ihlr-16572	354	7	economic	economic	ADJ
ihlr-16572	354	8	trades	trade	NOUN
ihlr-16572	354	9	between	between	ADP
ihlr-16572	354	10	the	the	DET
ihlr-16572	354	11	two	two	NUM
ihlr-16572	354	12	sets	set	NOUN
ihlr-16572	354	13	of	of	ADP
ihlr-16572	354	14	people	people	NOUN
ihlr-16572	354	15	that	that	PRON
ihlr-16572	354	16	are	be	AUX
ihlr-16572	354	17	not	not	PART
ihlr-16572	354	18	occurring	occur	VERB
ihlr-16572	354	19	*	*	PUNCT
ihlr-16572	354	20	*	*	PUNCT
ihlr-16572	354	21	*	*	NOUN
ihlr-16572	354	22	concern	concern	NOUN
ihlr-16572	354	23	about	about	ADP
ihlr-16572	354	24	these	these	DET
ihlr-16572	354	25	efficiency	efficiency	NOUN
ihlr-16572	354	26	costs	cost	NOUN
ihlr-16572	354	27	explains	explain	VERB
ihlr-16572	354	28	why	why	SCONJ
ihlr-16572	354	29	we	we	PRON
ihlr-16572	354	30	103	103	NUM
ihlr-16572	354	31	.	.	PUNCT
ihlr-16572	355	1	/d	/d	INTJ
ihlr-16572	355	2	.	.	PUNCT
ihlr-16572	356	1	at	at	ADP
ihlr-16572	356	2	4	4	NUM
ihlr-16572	356	3	-	-	SYM
ihlr-16572	356	4	5	5	NUM
ihlr-16572	356	5	(	(	PUNCT
ihlr-16572	356	6	discussing	discuss	VERB
ihlr-16572	356	7	mechanisms	mechanism	NOUN
ihlr-16572	356	8	by	by	ADP
ihlr-16572	356	9	which	which	PRON
ihlr-16572	356	10	a	a	DET
ihlr-16572	356	11	biologics	biologic	NOUN
ihlr-16572	356	12	manufacturer	manufacturer	NOUN
ihlr-16572	356	13	prolongs	prolong	VERB
ihlr-16572	356	14	its	its	PRON
ihlr-16572	356	15	monopoly	monopoly	NOUN
ihlr-16572	356	16	)	)	PUNCT
ihlr-16572	356	17	.	.	PUNCT
ihlr-16572	357	1	104	104	NUM
ihlr-16572	357	2	.	.	PUNCT
ihlr-16572	357	3	kenneth	kenneth	PROPN
ihlr-16572	357	4	j.	j.	PROPN
ihlr-16572	357	5	arrow	arrow	PROPN
ihlr-16572	357	6	,	,	PUNCT
ihlr-16572	357	7	economic	economic	ADJ
ihlr-16572	357	8	welfare	welfare	NOUN
ihlr-16572	357	9	and	and	CCONJ
ihlr-16572	357	10	the	the	DET
ihlr-16572	357	11	allocation	allocation	NOUN
ihlr-16572	357	12	of	of	ADP
ihlr-16572	357	13	resources	resource	NOUN
ihlr-16572	357	14	for	for	ADP
ihlr-16572	357	15	inven­	inven­	PART
ihlr-16572	357	16	tion	tion	NOUN
ihlr-16572	357	17	(	(	PUNCT
ihlr-16572	357	18	rand	rand	PROPN
ihlr-16572	357	19	corp	corp	PROPN
ihlr-16572	357	20	.	.	PROPN
ihlr-16572	357	21	working	working	PROPN
ihlr-16572	357	22	paper	paper	PROPN
ihlr-16572	357	23	no	no	INTJ
ihlr-16572	357	24	.	.	PUNCT
ihlr-16572	358	1	p-1856	p-1856	PROPN
ihlr-16572	358	2	-	-	PROPN
ihlr-16572	358	3	rc	rc	PROPN
ihlr-16572	358	4	,	,	PUNCT
ihlr-16572	358	5	1959	1959	NUM
ihlr-16572	358	6	)	)	PUNCT
ihlr-16572	358	7	.	.	PUNCT
ihlr-16572	359	1	105	105	NUM
ihlr-16572	359	2	.	.	PUNCT
ihlr-16572	359	3	kotlikoff	kotlikoff	PROPN
ihlr-16572	359	4	,	,	PUNCT
ihlr-16572	359	5	supra	supra	PROPN
ihlr-16572	359	6	note	note	PROPN
ihlr-16572	359	7	28	28	NUM
ihlr-16572	359	8	,	,	PUNCT
ihlr-16572	359	9	at	at	ADP
ihlr-16572	359	10	5	5	NUM
ihlr-16572	359	11	.	.	PUNCT
ihlr-16572	359	12	2010	2010	NUM
ihlr-16572	359	13	]	]	PUNCT
ihlr-16572	359	14	follow	follow	VERB
ihlr-16572	359	15	-	-	PUNCT
ihlr-16572	359	16	on	on	ADP
ihlr-16572	359	17	biologics	biologic	NOUN
ihlr-16572	359	18	legislation	legislation	NOUN
ihlr-16572	359	19	restrict	restrict	VERB
ihlr-16572	359	20	monopolies	monopoly	NOUN
ihlr-16572	359	21	,	,	PUNCT
ihlr-16572	359	22	why	why	SCONJ
ihlr-16572	359	23	we	we	PRON
ihlr-16572	359	24	have	have	VERB
ihlr-16572	359	25	patent	patent	NOUN
ihlr-16572	359	26	limits	limit	NOUN
ihlr-16572	359	27	,	,	PUNCT
ihlr-16572	359	28	why	why	SCONJ
ihlr-16572	359	29	we	we	PRON
ihlr-16572	359	30	have	have	VERB
ihlr-16572	359	31	free	free	ADJ
ihlr-16572	359	32	domestic	domestic	ADJ
ihlr-16572	359	33	trade	trade	NOUN
ihlr-16572	359	34	,	,	PUNCT
ihlr-16572	359	35	and	and	CCONJ
ihlr-16572	359	36	why	why	SCONJ
ihlr-16572	359	37	we	we	PRON
ihlr-16572	359	38	form	form	VERB
ihlr-16572	359	39	free	free	ADJ
ihlr-16572	359	40	trade	trade	NOUN
ihlr-16572	359	41	agreements	agreement	NOUN
ihlr-16572	359	42	.	.	PUNCT
ihlr-16572	360	1	106	106	NUM
ihlr-16572	360	2	383	383	NUM
ihlr-16572	360	3	excessively	excessively	ADV
ihlr-16572	360	4	lengthy	lengthy	ADJ
ihlr-16572	360	5	protection	protection	NOUN
ihlr-16572	360	6	monopolies	monopoly	NOUN
ihlr-16572	360	7	enjoyed	enjoy	VERB
ihlr-16572	360	8	by	by	ADP
ihlr-16572	360	9	name	name	NOUN
ihlr-16572	360	10	-	-	PUNCT
ihlr-16572	360	11	brand	brand	NOUN
ihlr-16572	360	12	biolog­	biolog­	PROPN
ihlr-16572	360	13	ics	ics	NOUN
ihlr-16572	360	14	manufacturers	manufacturer	NOUN
ihlr-16572	360	15	result	result	VERB
ihlr-16572	360	16	in	in	ADP
ihlr-16572	360	17	decreased	decrease	VERB
ihlr-16572	360	18	competition	competition	NOUN
ihlr-16572	360	19	and	and	CCONJ
ihlr-16572	360	20	in	in	ADP
ihlr-16572	360	21	inefficient	inefficient	ADJ
ihlr-16572	360	22	delivery	delivery	NOUN
ihlr-16572	360	23	of	of	ADP
ihlr-16572	360	24	biologics	biologic	NOUN
ihlr-16572	360	25	to	to	ADP
ihlr-16572	360	26	patients	patient	NOUN
ihlr-16572	360	27	.	.	PUNCT
ihlr-16572	361	1	4	4	X
ihlr-16572	361	2	.	.	X
ihlr-16572	361	3	hatch	hatch	NOUN
ihlr-16572	361	4	-	-	PUNCT
ihlr-16572	361	5	waxman	waxman	PROPN
ihlr-16572	361	6	actvery	actvery	PROPN
ihlr-16572	361	7	limited	limited	PROPN
ihlr-16572	361	8	exclusivity	exclusivity	NOUN
ihlr-16572	361	9	generic	generic	ADJ
ihlr-16572	361	10	drugs	drug	NOUN
ihlr-16572	361	11	are	be	AUX
ihlr-16572	361	12	"	"	PUNCT
ihlr-16572	361	13	identical	identical	ADJ
ihlr-16572	361	14	,	,	PUNCT
ihlr-16572	361	15	or	or	CCONJ
ihlr-16572	361	16	bioequivalent	bioequivalent	VERB
ihlr-16572	361	17	to	to	ADP
ihlr-16572	361	18	a	a	DET
ihlr-16572	361	19	brand	brand	NOUN
ihlr-16572	361	20	-	-	PUNCT
ihlr-16572	361	21	name	name	NOUN
ihlr-16572	361	22	drug	drug	NOUN
ihlr-16572	361	23	in	in	ADP
ihlr-16572	361	24	dosage	dosage	NOUN
ihlr-16572	361	25	form	form	NOUN
ihlr-16572	361	26	,	,	PUNCT
ihlr-16572	361	27	safety	safety	NOUN
ihlr-16572	361	28	,	,	PUNCT
ihlr-16572	361	29	strength	strength	NOUN
ihlr-16572	361	30	,	,	PUNCT
ihlr-16572	361	31	route	route	NOUN
ihlr-16572	361	32	of	of	ADP
ihlr-16572	361	33	administration	administration	NOUN
ihlr-16572	361	34	,	,	PUNCT
ihlr-16572	361	35	quality	quality	NOUN
ihlr-16572	361	36	,	,	PUNCT
ihlr-16572	361	37	performance	performance	NOUN
ihlr-16572	361	38	characteristics	characteristic	NOUN
ihlr-16572	361	39	,	,	PUNCT
ihlr-16572	361	40	and	and	CCONJ
ihlr-16572	361	41	intended	intend	VERB
ihlr-16572	361	42	use	use	NOUN
ihlr-16572	361	43	.	.	PUNCT
ihlr-16572	362	1	"	"	PUNCT
ihlr-16572	362	2	1	1	NUM
ihlr-16572	362	3	07	07	NUM
ihlr-16572	362	4	a.	a.	NOUN
ihlr-16572	362	5	potential	potential	ADJ
ihlr-16572	362	6	savings	saving	NOUN
ihlr-16572	362	7	associated	associate	VERB
ihlr-16572	362	8	with	with	ADP
ihlr-16572	362	9	follow	follow	NOUN
ihlr-16572	362	10	-	-	PUNCT
ihlr-16572	362	11	on	on	ADP
ihlr-16572	362	12	biologics	biologic	NOUN
ihlr-16572	362	13	.	.	PUNCT
ihlr-16572	363	1	proponents	proponent	NOUN
ihlr-16572	363	2	of	of	ADP
ihlr-16572	363	3	lengthy	lengthy	ADJ
ihlr-16572	363	4	exclusivity	exclusivity	NOUN
ihlr-16572	363	5	provisions	provision	NOUN
ihlr-16572	363	6	assert	assert	VERB
ihlr-16572	363	7	that	that	SCONJ
ihlr-16572	363	8	such	such	ADJ
ihlr-16572	363	9	provi-	provi-	NOUN
ihlr-16572	363	10	'	'	PART
ihlr-16572	363	11	sions	sion	NOUN
ihlr-16572	363	12	are	be	AUX
ihlr-16572	363	13	essential	essential	ADJ
ihlr-16572	363	14	to	to	PART
ihlr-16572	363	15	ensure	ensure	VERB
ihlr-16572	363	16	profitability	profitability	NOUN
ihlr-16572	363	17	as	as	ADP
ihlr-16572	363	18	an	an	DET
ihlr-16572	363	19	incentive	incentive	NOUN
ihlr-16572	363	20	to	to	AUX
ihlr-16572	363	21	innovate.108	innovate.108	ADV
ihlr-16572	363	22	conversely	conversely	ADV
ihlr-16572	363	23	,	,	PUNCT
ihlr-16572	363	24	some	some	DET
ihlr-16572	363	25	economists	economist	NOUN
ihlr-16572	363	26	contend	contend	VERB
ihlr-16572	363	27	that	that	SCONJ
ihlr-16572	363	28	lengthy	lengthy	ADJ
ihlr-16572	363	29	exclusivity	exclusivity	NOUN
ihlr-16572	363	30	periods	period	NOUN
ihlr-16572	363	31	pose	pose	VERB
ihlr-16572	363	32	a	a	DET
ihlr-16572	363	33	serious	serious	ADJ
ihlr-16572	363	34	threat	threat	NOUN
ihlr-16572	363	35	to	to	ADP
ihlr-16572	363	36	innovation	innovation	NOUN
ihlr-16572	363	37	.	.	PUNCT
ihlr-16572	364	1	109	109	NUM
ihlr-16572	364	2	the	the	DET
ihlr-16572	364	3	latter	latter	ADJ
ihlr-16572	364	4	of	of	ADP
ihlr-16572	364	5	these	these	DET
ihlr-16572	364	6	views	view	NOUN
ihlr-16572	364	7	militates	militate	VERB
ihlr-16572	364	8	in	in	ADP
ihlr-16572	364	9	favor	favor	NOUN
ihlr-16572	364	10	of	of	ADP
ihlr-16572	364	11	applying	apply	VERB
ihlr-16572	364	12	a	a	DET
ihlr-16572	364	13	modified	modify	VERB
ihlr-16572	364	14	version	version	NOUN
ihlr-16572	364	15	of	of	ADP
ihlr-16572	364	16	the	the	DET
ihlr-16572	364	17	hatch	hatch	NOUN
ihlr-16572	364	18	-	-	PUNCT
ihlr-16572	364	19	waxman	waxman	PROPN
ihlr-16572	364	20	act	act	PROPN
ihlr-16572	364	21	,	,	PUNCT
ihlr-16572	364	22	with	with	ADP
ihlr-16572	364	23	its	its	PRON
ihlr-16572	364	24	limited	limited	ADJ
ihlr-16572	364	25	exclusivity	exclusivity	NOUN
ihlr-16572	364	26	,	,	PUNCT
ihlr-16572	364	27	to	to	PART
ihlr-16572	364	28	promote	promote	VERB
ihlr-16572	364	29	biologic	biologic	NOUN
ihlr-16572	364	30	competition	competition	NOUN
ihlr-16572	364	31	and	and	CCONJ
ihlr-16572	364	32	innovation.110	innovation.110	NOUN
ihlr-16572	364	33	"	"	PUNCT
ihlr-16572	364	34	[	[	X
ihlr-16572	364	35	t]he	t]he	ADV
ihlr-16572	364	36	effects	effect	VERB
ihlr-16572	364	37	ofwaxman	ofwaxman	ADJ
ihlr-16572	364	38	-	-	PUNCT
ihlr-16572	364	39	hatch	hatch	NOUN
ihlr-16572	364	40	and	and	CCONJ
ihlr-16572	364	41	gatt	gatt	NOUN
ihlr-16572	364	42	on	on	ADP
ihlr-16572	364	43	[	[	X
ihlr-16572	364	44	effective	effective	ADJ
ihlr-16572	364	45	patent	patent	NOUN
ihlr-16572	364	46	life	life	NOUN
ihlr-16572	364	47	]	]	PUNCT
ihlr-16572	364	48	have	have	AUX
ihlr-16572	364	49	been	be	AUX
ihlr-16572	364	50	modest	modest	ADJ
ihlr-16572	364	51	to	to	ADP
ihlr-16572	364	52	date	date	NOUN
ihlr-16572	364	53	.	.	PUNCT
ihlr-16572	365	1	"n	"n	NOUN
ihlr-16572	365	2	1	1	NUM
ihlr-16572	365	3	while	while	SCONJ
ihlr-16572	365	4	the	the	DET
ihlr-16572	365	5	hatch	hatch	NOUN
ihlr-16572	365	6	-	-	PUNCT
ihlr-16572	365	7	waxman	waxman	PROPN
ihlr-16572	365	8	act	act	NOUN
ihlr-16572	365	9	does	do	AUX
ihlr-16572	365	10	grant	grant	VERB
ihlr-16572	365	11	data	datum	NOUN
ihlr-16572	365	12	and	and	CCONJ
ihlr-16572	365	13	approval	approval	NOUN
ihlr-16572	365	14	exclusivity	exclusivity	NOUN
ihlr-16572	365	15	for	for	ADP
ihlr-16572	365	16	chemical	chemical	NOUN
ihlr-16572	365	17	-	-	PUNCT
ihlr-16572	365	18	based	base	VERB
ihlr-16572	365	19	drugs	drug	NOUN
ihlr-16572	365	20	,	,	PUNCT
ihlr-16572	365	21	this	this	DET
ihlr-16572	365	22	exclusivity	exclusivity	NOUN
ihlr-16572	365	23	is	be	AUX
ihlr-16572	365	24	very	very	ADV
ihlr-16572	365	25	limited	limited	ADJ
ihlr-16572	365	26	compared	compare	VERB
ihlr-16572	365	27	to	to	ADP
ihlr-16572	365	28	the	the	DET
ihlr-16572	365	29	provisions	provision	NOUN
ihlr-16572	365	30	in	in	ADP
ihlr-16572	365	31	many	many	ADJ
ihlr-16572	365	32	of	of	ADP
ihlr-16572	365	33	the	the	DET
ihlr-16572	365	34	proposed	propose	VERB
ihlr-16572	365	35	biogenetic	biogenetic	ADJ
ihlr-16572	365	36	bills	bill	NOUN
ihlr-16572	365	37	before	before	ADP
ihlr-16572	365	38	congress.112	congress.112	PROPN
ihlr-16572	365	39	106	106	NUM
ihlr-16572	365	40	.	.	PUNCT
ihlr-16572	365	41	!	!	PUNCT
ihlr-16572	366	1	d.	d.	PROPN
ihlr-16572	366	2	instead	instead	ADV
ihlr-16572	366	3	of	of	ADP
ihlr-16572	366	4	the	the	DET
ihlr-16572	366	5	combined	combine	VERB
ihlr-16572	366	6	data	datum	NOUN
ihlr-16572	366	7	plus	plus	CCONJ
ihlr-16572	366	8	approvalexclusivi­	approvalexclusivi­	PRON
ihlr-16572	366	9	ty	ty	PRON
ihlr-16572	366	10	periods	period	NOUN
ihlr-16572	366	11	of	of	ADP
ihlr-16572	366	12	twelve	twelve	NUM
ihlr-16572	366	13	years	year	NOUN
ihlr-16572	366	14	(	(	PUNCT
ihlr-16572	366	15	four	four	NUM
ihlr-16572	366	16	data	datum	NOUN
ihlr-16572	366	17	plus	plus	CCONJ
ihlr-16572	366	18	eight	eight	NUM
ihlr-16572	366	19	ap­	ap­	NOUN
ihlr-16572	366	20	proval	proval	NOUN
ihlr-16572	366	21	)	)	PUNCT
ihlr-16572	366	22	years	year	NOUN
ihlr-16572	366	23	proposed	propose	VERB
ihlr-16572	366	24	in	in	ADP
ihlr-16572	366	25	the	the	DET
ihlr-16572	366	26	kennedy	kennedy	PROPN
ihlr-16572	366	27	bill	bill	PROPN
ihlr-16572	366	28	and	and	CCONJ
ihlr-16572	366	29	fourteen	fourteen	NUM
ihlr-16572	366	30	years	year	NOUN
ihlr-16572	366	31	(	(	PUNCT
ihlr-16572	366	32	twelve	twelve	NUM
ihlr-16572	366	33	data	datum	NOUN
ihlr-16572	366	34	and	and	CCONJ
ihlr-16572	366	35	two	two	NUM
ihlr-16572	366	36	approval	approval	NOUN
ihlr-16572	366	37	)	)	PUNCT
ihlr-16572	366	38	pro­	pro­	NOUN
ihlr-16572	366	39	posed	pose	VERB
ihlr-16572	366	40	in	in	ADP
ihlr-16572	366	41	both	both	CCONJ
ihlr-16572	366	42	the	the	DET
ihlr-16572	366	43	eshoo	eshoo	ADJ
ihlr-16572	366	44	-	-	PUNCT
ihlr-16572	366	45	barton	barton	NOUN
ihlr-16572	366	46	and	and	CCONJ
ihlr-16572	366	47	inslee	inslee	PROPN
ihlr-16572	366	48	follow	follow	VERB
ihlr-16572	366	49	-	-	PUNCT
ihlr-16572	366	50	on	on	ADP
ihlr-16572	366	51	107	107	NUM
ihlr-16572	366	52	.	.	PUNCT
ihlr-16572	367	1	u.s	u.s	PROPN
ihlr-16572	367	2	.	.	PROPN
ihlr-16572	367	3	food	food	PROPN
ihlr-16572	367	4	and	and	CCONJ
ihlr-16572	367	5	drug	drug	NOUN
ihlr-16572	367	6	admin	admin	PROPN
ihlr-16572	367	7	.	.	PUNCT
ihlr-16572	367	8	,	,	PUNCT
ihlr-16572	367	9	generic	generic	ADJ
ihlr-16572	367	10	drugs	drug	NOUN
ihlr-16572	367	11	:	:	PUNCT
ihlr-16572	367	12	questions	question	NOUN
ihlr-16572	367	13	and	and	CCONJ
ihlr-16572	367	14	answers	answer	NOUN
ihlr-16572	367	15	,	,	PUNCT
ihlr-16572	367	16	http://www.fda.gov/drugs/resroucesforyour/consumerslquestionsanswerslucml	http://www.fda.gov/drugs/resroucesforyour/consumerslquestionsanswerslucml	PROPN
ihlr-16572	367	17	00	00	PUNCT
ihlr-16572	368	1	i	i	PRON
ihlr-16572	368	2	oo.htm	oo.htm	INTJ
ihlr-16572	368	3	(	(	PUNCT
ihlr-16572	368	4	last	last	ADJ
ihlr-16572	368	5	visited	visit	VERB
ihlr-16572	368	6	oct	oct	PROPN
ihlr-16572	368	7	.	.	PROPN
ihlr-16572	368	8	21	21	NUM
ihlr-16572	368	9	,	,	PUNCT
ihlr-16572	368	10	2009	2009	NUM
ihlr-16572	368	11	)	)	PUNCT
ihlr-16572	368	12	.	.	PUNCT
ihlr-16572	369	1	108	108	NUM
ihlr-16572	369	2	.	.	PUNCT
ihlr-16572	369	3	drug	drug	NOUN
ihlr-16572	369	4	price	price	NOUN
ihlr-16572	369	5	competition	competition	NOUN
ihlr-16572	369	6	and	and	CCONJ
ihlr-16572	369	7	patent	patent	NOUN
ihlr-16572	369	8	term	term	NOUN
ihlr-16572	369	9	restoration	restoration	NOUN
ihlr-16572	369	10	act	act	NOUN
ihlr-16572	369	11	,	,	PUNCT
ihlr-16572	369	12	pub	pub	NOUN
ihlr-16572	369	13	.	.	PUNCT
ihlr-16572	370	1	l.	l.	PROPN
ihlr-16572	370	2	no	no	INTJ
ihlr-16572	370	3	.	.	PROPN
ihlr-16572	371	1	98	98	NUM
ihlr-16572	371	2	-	-	SYM
ihlr-16572	371	3	417	417	NUM
ihlr-16572	371	4	(	(	PUNCT
ihlr-16572	371	5	1984	1984	NUM
ihlr-16572	371	6	)	)	PUNCT
ihlr-16572	371	7	,	,	PUNCT
ihlr-16572	371	8	98	98	NUM
ihlr-16572	371	9	stat	stat	NOUN
ihlr-16572	371	10	.	.	PUNCT
ihlr-16572	372	1	1585	1585	NUM
ihlr-16572	372	2	(	(	PUNCT
ihlr-16572	372	3	1984	1984	NUM
ihlr-16572	372	4	)	)	PUNCT
ihlr-16572	372	5	.	.	PUNCT
ihlr-16572	373	1	109	109	NUM
ihlr-16572	373	2	.	.	PUNCT
ihlr-16572	373	3	kotlikoff	kotlikoff	PROPN
ihlr-16572	373	4	,	,	PUNCT
ihlr-16572	373	5	supra	supra	PROPN
ihlr-16572	373	6	note	note	PROPN
ihlr-16572	373	7	28	28	NUM
ihlr-16572	373	8	,	,	PUNCT
ihlr-16572	373	9	at	at	ADP
ihlr-16572	373	10	4	4	NUM
ihlr-16572	373	11	.	.	NOUN
ihlr-16572	373	12	110	110	NUM
ihlr-16572	373	13	.	.	PUNCT
ihlr-16572	374	1	see	see	VERB
ihlr-16572	374	2	generally	generally	ADV
ihlr-16572	374	3	drug	drug	NOUN
ihlr-16572	374	4	price	price	NOUN
ihlr-16572	374	5	competition	competition	NOUN
ihlr-16572	374	6	and	and	CCONJ
ihlr-16572	374	7	patent	patent	NOUN
ihlr-16572	374	8	term	term	NOUN
ihlr-16572	374	9	restoration	restoration	NOUN
ihlr-16572	374	10	act	act	NOUN
ihlr-16572	374	11	,	,	PUNCT
ihlr-16572	374	12	pub	pub	NOUN
ihlr-16572	374	13	.	.	PUNCT
ihlr-16572	375	1	l.	l.	PROPN
ihlr-16572	375	2	no	no	INTJ
ihlr-16572	375	3	.	.	PROPN
ihlr-16572	376	1	98	98	NUM
ihlr-16572	376	2	-	-	SYM
ihlr-16572	376	3	417	417	NUM
ihlr-16572	376	4	,	,	PUNCT
ihlr-16572	376	5	98	98	NUM
ihlr-16572	376	6	stat	stat	NOUN
ihlr-16572	376	7	.	.	PUNCT
ihlr-16572	377	1	1585	1585	NUM
ihlr-16572	377	2	(	(	PUNCT
ihlr-16572	377	3	1984	1984	NUM
ihlr-16572	377	4	)	)	PUNCT
ihlr-16572	377	5	.	.	PUNCT
ihlr-16572	378	1	ill	ill	PROPN
ihlr-16572	378	2	.	.	PUNCT
ihlr-16572	379	1	henry	henry	PROPN
ihlr-16572	379	2	g.	g.	PROPN
ihlr-16572	379	3	grabowski	grabowski	PROPN
ihlr-16572	379	4	and	and	CCONJ
ihlr-16572	379	5	john	john	PROPN
ihlr-16572	379	6	m.	m.	PROPN
ihlr-16572	379	7	vernon	vernon	PROPN
ihlr-16572	379	8	,	,	PUNCT
ihlr-16572	379	9	effective	effective	ADJ
ihlr-16572	379	10	patent	patent	NOUN
ihlr-16572	379	11	life	life	NOUN
ihlr-16572	379	12	in	in	ADP
ihlr-16572	379	13	pharmaceuti­	pharmaceuti­	NOUN
ihlr-16572	379	14	cals	cal	NOUN
ihlr-16572	379	15	,	,	PUNCT
ihlr-16572	379	16	19	19	NUM
ihlr-16572	379	17	int'lj	int'lj	NOUN
ihlr-16572	379	18	.	.	PUNCT
ihlr-16572	379	19	tech	tech	NOUN
ihlr-16572	379	20	.	.	PUNCT
ihlr-16572	380	1	mm.p	mm.p	NOUN
ihlr-16572	380	2	"	"	PUNCT
ihlr-16572	380	3	.	.	PUNCT
ihlr-16572	381	1	98	98	NUM
ihlr-16572	381	2	,	,	PUNCT
ihlr-16572	381	3	116	116	NUM
ihlr-16572	381	4	(	(	PUNCT
ihlr-16572	381	5	2000	2000	NUM
ihlr-16572	381	6	)	)	PUNCT
ihlr-16572	381	7	.	.	PUNCT
ihlr-16572	382	1	112	112	NUM
ihlr-16572	382	2	.	.	PUNCT
ihlr-16572	382	3	drug	drug	NOUN
ihlr-16572	382	4	price	price	NOUN
ihlr-16572	382	5	com	com	NOUN
ihlr-16572	382	6	~	~	NOUN
ihlr-16572	382	7	tition	tition	NOUN
ihlr-16572	382	8	and	and	CCONJ
ihlr-16572	382	9	patent	patent	PROPN
ihlr-16572	382	10	tenn	tenn	PROPN
ihlr-16572	382	11	restoration	restoration	PROPN
ihlr-16572	382	12	act	act	PROPN
ihlr-16572	382	13	,	,	PUNCT
ihlr-16572	382	14	pub	pub	NOUN
ihlr-16572	382	15	.	.	PUNCT
ihlr-16572	383	1	l.	l.	PROPN
ihlr-16572	383	2	no	no	INTJ
ihlr-16572	383	3	.	.	PROPN
ihlr-16572	384	1	98	98	NUM
ihlr-16572	384	2	-	-	SYM
ihlr-16572	384	3	417	417	NUM
ihlr-16572	384	4	(	(	PUNCT
ihlr-16572	384	5	1984	1984	NUM
ihlr-16572	384	6	)	)	PUNCT
ihlr-16572	384	7	,	,	PUNCT
ihlr-16572	384	8	98	98	NUM
ihlr-16572	384	9	stat	stat	NOUN
ihlr-16572	384	10	.	.	PUNCT
ihlr-16572	385	1	1585	1585	NUM
ihlr-16572	385	2	(	(	PUNCT
ihlr-16572	385	3	1984	1984	NUM
ihlr-16572	385	4	)	)	PUNCT
ihlr-16572	385	5	.	.	PUNCT
ihlr-16572	386	1	384	384	NUM
ihlr-16572	386	2	indiana	indiana	PROPN
ihlr-16572	386	3	heal	heal	PROPN
ihlr-16572	386	4	til	til	PROPN
ihlr-16572	386	5	law	law	NOUN
ihlr-16572	386	6	review	review	NOUN
ihlr-16572	386	7	biologics	biologic	NOUN
ihlr-16572	386	8	bills	bill	NOUN
ihlr-16572	386	9	,	,	PUNCT
ihlr-16572	386	10	hatch	hatch	NOUN
ihlr-16572	386	11	-	-	PUNCT
ihlr-16572	386	12	waxman	waxman	NOUN
ihlr-16572	386	13	offers	offer	VERB
ihlr-16572	386	14	five	five	NUM
ihlr-16572	386	15	years	year	NOUN
ihlr-16572	386	16	of	of	ADP
ihlr-16572	386	17	exclusivity	exclusivity	NOUN
ihlr-16572	386	18	generally	generally	ADV
ihlr-16572	386	19	,	,	PUNCT
ihlr-16572	386	20	with	with	ADP
ihlr-16572	386	21	four	four	NUM
ihlr-16572	386	22	years	year	NOUN
ihlr-16572	386	23	of	of	ADP
ihlr-16572	386	24	data	datum	NOUN
ihlr-16572	386	25	exclu­	exclu­	PROPN
ihlr-16572	386	26	sivity	sivity	NOUN
ihlr-16572	386	27	followed	follow	VERB
ihlr-16572	386	28	by	by	ADP
ihlr-16572	386	29	one	one	NUM
ihlr-16572	386	30	year	year	NOUN
ihlr-16572	386	31	of	of	ADP
ihlr-16572	386	32	approval	approval	NOUN
ihlr-16572	386	33	exclusivity	exclusivity	NOUN
ihlr-16572	386	34	if	if	SCONJ
ihlr-16572	386	35	an	an	DET
ihlr-16572	386	36	applicant	applicant	ADJ
ihlr-16572	386	37	files	file	NOUN
ihlr-16572	386	38	.	.	PUNCT
ihlr-16572	387	1	a	a	DET
ihlr-16572	387	2	patent	patent	NOUN
ihlr-16572	387	3	challenge	challenge	NOUN
ihlr-16572	387	4	in	in	ADP
ihlr-16572	387	5	the	the	DET
ihlr-16572	387	6	fourth	fourth	ADJ
ihlr-16572	387	7	year	year	NOUN
ihlr-16572	387	8	.	.	PUNCT
ihlr-16572	388	1	the	the	DET
ihlr-16572	388	2	waxman	waxman	NOUN
ihlr-16572	388	3	follow	follow	VERB
ihlr-16572	388	4	-	-	PUNCT
ihlr-16572	388	5	on	on	ADP
ihlr-16572	388	6	biologics	biologic	NOUN
ihlr-16572	388	7	bill	bill	NOUN
ihlr-16572	388	8	does	do	VERB
ihlr-16572	388	9	not	not	PART
ihlr-16572	388	10	ad­	ad­	ADV
ihlr-16572	388	11	dress	dress	NOUN
ihlr-16572	388	12	data	datum	NOUN
ihlr-16572	388	13	or	or	CCONJ
ihlr-16572	389	1	approval	approval	NOUN
ihlr-16572	389	2	exclusivity	exclusivity	NOUN
ihlr-16572	389	3	whatsoever.113	whatsoever.113	ADJ
ihlr-16572	389	4	[	[	X
ihlr-16572	389	5	vol	vol	NOUN
ihlr-16572	389	6	.	.	PUNCT
ihlr-16572	390	1	7:367	7:367	NUM
ihlr-16572	390	2	"	"	PUNCT
ihlr-16572	390	3	the	the	DET
ihlr-16572	390	4	hatch	hatch	NOUN
ihlr-16572	390	5	-	-	PUNCT
ihlr-16572	390	6	waxman	waxman	PROPN
ihlr-16572	390	7	act	act	NOUN
ihlr-16572	390	8	also	also	ADV
ihlr-16572	390	9	provides	provide	VERB
ihlr-16572	390	10	forpatent	forpatent	ADJ
ihlr-16572	390	11	restoration	restoration	NOUN
ihlr-16572	390	12	;	;	PUNCT
ihlr-16572	390	13	the	the	DET
ihlr-16572	390	14	act	act	NOUN
ihlr-16572	390	15	restores	restore	VERB
ihlr-16572	390	16	to	to	ADP
ihlr-16572	390	17	a	a	DET
ihlr-16572	390	18	new	new	ADJ
ihlr-16572	390	19	chemical	chemical	NOUN
ihlr-16572	390	20	entity	entity	NOUN
ihlr-16572	390	21	's	's	PART
ihlr-16572	390	22	patent	patent	NOUN
ihlr-16572	390	23	life	life	NOUN
ihlr-16572	390	24	half	half	NOUN
ihlr-16572	390	25	of	of	ADP
ihlr-16572	390	26	the	the	DET
ihlr-16572	390	27	time	time	NOUN
ihlr-16572	390	28	spent	spend	VERB
ihlr-16572	390	29	in	in	ADP
ihlr-16572	390	30	clini­	clini­	X
ihlr-16572	390	31	cal	cal	ADJ
ihlr-16572	390	32	testing	testing	NOUN
ihlr-16572	390	33	.and	.and	PUNCT
ihlr-16572	391	1	all	all	PRON
ihlr-16572	391	2	of	of	ADP
ihlr-16572	391	3	the	the	DET
ihlr-16572	391	4	time	time	NOUN
ihlr-16572	391	5	spent	spend	VERB
ihlr-16572	391	6	securing	secure	VERB
ihlr-16572	391	7	fda	fda	PROPN
ihlr-16572	391	8	approval	approval	NOUN
ihlr-16572	391	9	,	,	PUNCT
ihlr-16572	391	10	up	up	ADP
ihlr-16572	391	11	to	to	ADP
ihlr-16572	391	12	a	a	DET
ihlr-16572	391	13	maxi­	maxi­	NOUN
ihlr-16572	391	14	mum	mum	NOUN
ihlr-16572	391	15	of	of	ADP
ihlr-16572	391	16	five	five	NUM
ihlr-16572	391	17	years	year	NOUN
ihlr-16572	391	18	.	.	PUNCT
ihlr-16572	391	19	"114	"114	PROPN
ihlr-16572	392	1	a	a	DET
ihlr-16572	392	2	result	result	NOUN
ihlr-16572	392	3	of	of	ADP
ihlr-16572	392	4	hatch	hatch	NOUN
ihlr-16572	392	5	-	-	PUNCT
ihlr-16572	392	6	waxman	waxman	NOUN
ihlr-16572	392	7	's	's	PART
ihlr-16572	392	8	patent	patent	NOUN
ihlr-16572	392	9	restoration	restoration	NOUN
ihlr-16572	392	10	provision	provision	NOUN
ihlr-16572	392	11	is	be	AUX
ihlr-16572	392	12	that	that	SCONJ
ihlr-16572	392	13	the	the	DET
ihlr-16572	392	14	exclusivi7,_provision	exclusivi7,_provision	PROPN
ihlr-16572	392	15	is	be	AUX
ihlr-16572	392	16	not	not	PART
ihlr-16572	392	17	likely	likely	ADJ
ihlr-16572	392	18	to	to	PART
ihlr-16572	392	19	extend	extend	VERB
ihlr-16572	392	20	the	the	DET
ihlr-16572	392	21	total	total	ADJ
ihlr-16572	392	22	length	length	NOUN
ihlr-16572	392	23	of	of	ADP
ihlr-16572	392	24	monopoly	monopoly	NOUN
ihlr-16572	392	25	protection	protection	NOUN
ihlr-16572	392	26	.	.	PUNCT
ihlr-16572	393	1	1	1	NUM
ihlr-16572	394	1	the	the	DET
ihlr-16572	394	2	exclusivity	exclusivity	NOUN
ihlr-16572	394	3	provision	provision	NOUN
ihlr-16572	394	4	,	,	PUNCT
ihlr-16572	394	5	however	however	ADV
ihlr-16572	394	6	,	,	PUNCT
ihlr-16572	394	7	does	do	AUX
ihlr-16572	394	8	serve	serve	VERB
ihlr-16572	394	9	to	to	ADP
ihlr-16572	394	10	delai	delai	ADJ
ihlr-16572	394	11	competitors	competitor	NOUN
ihlr-16572	394	12	'	'	PART
ihlr-16572	394	13	ability	ability	NOUN
ihlr-16572	394	14	to	to	PART
ihlr-16572	394	15	contest	contest	VERB
ihlr-16572	394	16	innovators	innovator	NOUN
ihlr-16572	394	17	'	'	PART
ihlr-16572	394	18	patents	patent	NOUN
ihlr-16572	394	19	by	by	ADP
ihlr-16572	394	20	at	at	ADV
ihlr-16572	394	21	least	least	ADV
ihlr-16572	394	22	four	four	NUM
ihlr-16572	394	23	years.11	years.11	NOUN
ihlr-16572	394	24	the	the	DET
ihlr-16572	394	25	hatch	hatch	NOUN
ihlr-16572	394	26	-	-	PUNCT
ihlr-16572	394	27	waxman	waxman	PROPN
ihlr-16572	394	28	act	act	NOUN
ihlr-16572	394	29	has	have	AUX
ihlr-16572	394	30	saved	save	VERB
ihlr-16572	394	31	americans	americans	PROPN
ihlr-16572	394	32	billions	billion	NOUN
ihlr-16572	394	33	of	of	ADP
ihlr-16572	394	34	dollars	dollar	NOUN
ihlr-16572	394	35	in	in	ADP
ihlr-16572	394	36	prescription	prescription	NOUN
ihlr-16572	394	37	drug	drug	NOUN
ihlr-16572	394	38	expensesy7	expensesy7	NOUN
ihlr-16572	395	1	generic	generic	ADJ
ihlr-16572	395	2	drugs	drug	NOUN
ihlr-16572	395	3	provide	provide	VERB
ihlr-16572	395	4	safe	safe	ADJ
ihlr-16572	395	5	and	and	CCONJ
ihlr-16572	395	6	effective	effective	ADJ
ihlr-16572	395	7	alternatives	alternative	NOUN
ihlr-16572	395	8	to	to	ADP
ihlr-16572	395	9	their	their	PRON
ihlr-16572	395	10	name	name	NOUN
ihlr-16572	395	11	brand	brand	NOUN
ihlr-16572	395	12	counterparts	counterpart	NOUN
ihlr-16572	395	13	,	,	PUNCT
ihlr-16572	395	14	and	and	CCONJ
ihlr-16572	395	15	often	often	ADV
ihlr-16572	395	16	cost	cost	VERB
ihlr-16572	395	17	eighty	eighty	NUM
ihlr-16572	395	18	percent	percent	NOUN
ihlr-16572	395	19	less.u8	less.u8	PROPN
ihlr-16572	395	20	·	·	PUNCT
ihlr-16572	395	21	b.	b.	PROPN
ihlr-16572	395	22	hatch	hatch	PROPN
ihlr-16572	395	23	-	-	PUNCT
ihlr-16572	395	24	waxman	waxman	NOUN
ihlr-16572	395	25	's	's	PART
ihlr-16572	395	26	effect	effect	NOUN
ihlr-16572	395	27	on	on	ADP
ihlr-16572	395	28	follow	follow	VERB
ihlr-16572	395	29	-	-	PUNCT
ihlr-16572	395	30	on	on	ADP
ihlr-16572	395	31	biologics	biologic	NOUN
ihlr-16572	395	32	there	there	PRON
ihlr-16572	395	33	is	be	VERB
ihlr-16572	395	34	·	·	PUNCT
ihlr-16572	395	35	one	one	NUM
ihlr-16572	395	36	provision	provision	NOUN
ihlr-16572	395	37	of	of	ADP
ihlr-16572	395	38	the	the	DET
ihlr-16572	395	39	hatch	hatch	PROPN
ihlr-16572	395	40	-	-	PUNCT
ihlr-16572	395	41	waxman	waxman	PROPN
ihlr-16572	395	42	act	act	PROPN
ihlr-16572	395	43	,	,	PUNCT
ihlr-16572	395	44	patent	patent	NOUN
ihlr-16572	395	45	-	-	PUNCT
ihlr-16572	395	46	term	term	NOUN
ihlr-16572	395	47	restora­	restora­	NOUN
ihlr-16572	395	48	tion	tion	NOUN
ihlr-16572	395	49	,	,	PUNCT
ihlr-16572	395	50	which	which	PRON
ihlr-16572	395	51	currently	currently	ADV
ihlr-16572	395	52	applies	apply	VERB
ihlr-16572	395	53	to	to	ADP
ihlr-16572	395	54	biologics	biologic	NOUN
ihlr-16572	395	55	as	as	ADV
ihlr-16572	395	56	well	well	ADV
ihlr-16572	395	57	as	as	ADP
ihlr-16572	395	58	chemical	chemical	ADJ
ihlr-16572	395	59	drugs	drug	NOUN
ihlr-16572	395	60	}	}	PUNCT
ihlr-16572	395	61	19	19	NUM
ihlr-16572	395	62	un­	un­	PUNCT
ihlr-16572	395	63	fortunately	fortunately	ADV
ihlr-16572	395	64	,	,	PUNCT
ihlr-16572	395	65	this	this	DET
ihlr-16572	395	66	provision	provision	NOUN
ihlr-16572	395	67	does	do	AUX
ihlr-16572	395	68	not	not	PART
ihlr-16572	395	69	yet	yet	ADV
ihlr-16572	395	70	have	have	VERB
ihlr-16572	395	71	any	any	DET
ihlr-16572	395	72	substantive	substantive	ADJ
ihlr-16572	395	73	force	force	NOUN
ihlr-16572	395	74	because	because	SCONJ
ihlr-16572	395	75	there	there	PRON
ihlr-16572	395	76	is	be	VERB
ihlr-16572	395	77	currentltc	currentltc	ADJ
ihlr-16572	395	78	no	no	DET
ihlr-16572	395	79	regulatory	regulatory	ADJ
ihlr-16572	395	80	pathway	pathway	NOUN
ihlr-16572	395	81	for	for	ADP
ihlr-16572	395	82	follow	follow	VERB
ihlr-16572	395	83	-	-	PUNCT
ihlr-16572	395	84	on	on	ADP
ihlr-16572	395	85	biologics	biologic	NOUN
ihlr-16572	395	86	to	to	PART
ihlr-16572	395	87	receive	receive	VERB
ihlr-16572	395	88	fda	fda	PROPN
ihlr-16572	395	89	approval.1	approval.1	PROPN
ihlr-16572	395	90	0	0	PUNCT
ihlr-16572	396	1	since	since	SCONJ
ihlr-16572	396	2	none	none	NOUN
ihlr-16572	396	3	of	of	ADP
ihlr-16572	396	4	the	the	DET
ihlr-16572	396	5	proposed	propose	VERB
ihlr-16572	396	6	bills121	bills121	PROPN
ihlr-16572	396	7	would	would	AUX
ihlr-16572	396	8	affect	affect	VERB
ihlr-16572	396	9	this	this	DET
ihlr-16572	396	10	por­	por­	NOUN
ihlr-16572	396	11	tion	tion	NOUN
ihlr-16572	396	12	of	of	ADP
ihlr-16572	396	13	the	the	DET
ihlr-16572	396	14	·	·	PUNCT
ihlr-16572	396	15	hatch	hatch	NOUN
ihlr-16572	396	16	-	-	PUNCT
ihlr-16572	396	17	waxman	waxman	PROPN
ihlr-16572	396	18	act	act	PROPN
ihlr-16572	396	19	,	,	PUNCT
ihlr-16572	396	20	brand	brand	NOUN
ihlr-16572	396	21	name	name	NOUN
ihlr-16572	396	22	drug	drug	NOUN
ihlr-16572	396	23	companies	company	NOUN
ihlr-16572	396	24	would	would	AUX
ihlr-16572	396	25	still	still	ADV
ihlr-16572	396	26	receive	receive	VERB
ihlr-16572	396	27	significant	significant	ADJ
ihlr-16572	396	28	protection	protection	NOUN
ihlr-16572	396	29	of	of	ADP
ihlr-16572	396	30	their	their	PRON
ihlr-16572	396	31	patents	patent	NOUN
ihlr-16572	396	32	through	through	ADP
ihlr-16572	396	33	~·four	~·four	DET
ihlr-16572	396	34	legislated	legislate	VERB
ihlr-16572	396	35	types	type	NOUN
ihlr-16572	396	36	of	of	ADP
ihlr-16572	396	37	monopoly	monopoly	NOUN
ihlr-16572	396	38	protection	protection	PROPN
ihlr-16572	396	39	gatt	gatt	PROPN
ihlr-16572	396	40	,	,	PUNCT
ihlr-16572	396	41	data	datum	NOUN
ihlr-16572	396	42	exclusivity	exclusivity	NOUN
ihlr-16572	396	43	,	,	PUNCT
ihlr-16572	396	44	approval	approval	NOUN
ihlr-16572	396	45	exclusivity	exclusivity	NOUN
ihlr-16572	396	46	,	,	PUNCT
ihlr-16572	396	47	and	and	CCONJ
ihlr-16572	396	48	patent	patent	NOUN
ihlr-16572	396	49	restoration	restoration	NOUN
ihlr-16572	396	50	.	.	PUNCT
ihlr-16572	397	1	each	each	PRON
ihlr-16572	397	2	of	of	ADP
ihlr-16572	397	3	these	these	DET
ihlr-16572	397	4	protections	protection	NOUN
ihlr-16572	397	5	can	can	AUX
ihlr-16572	397	6	impact	impact	VERB
ihlr-16572	397	7	the	the	DET
ihlr-16572	397	8	total	total	ADJ
ihlr-16572	397	9	length	length	NOUN
ihlr-16572	397	10	of	of	ADP
ihlr-16572	397	11	monopoly	monopoly	NOUN
ihlr-16572	397	12	protection	protection	NOUN
ihlr-16572	397	13	depending	depend	VERB
ihlr-16572	397	14	on	on	ADP
ihlr-16572	397	15	the	the	DET
ihlr-16572	397	16	particular	particular	ADJ
ihlr-16572	397	17	circumstances	circumstance	NOUN
ihlr-16572	397	18	involved	involve	VERB
ihlr-16572	397	19	.	.	PUNCT
ihlr-16572	398	1	under	under	ADV
ihlr-16572	398	2	.	.	PUNCT
ihlr-16572	399	1	the	the	DET
ihlr-16572	399	2	waxman	waxman	PROPN
ihlr-16572	399	3	bill	bill	PROPN
ihlr-16572	399	4	,	,	PUNCT
ihlr-16572	399	5	brand	brand	NOUN
ihlr-16572	399	6	biologics	biologic	NOUN
ihlr-16572	399	7	would	would	AUX
ihlr-16572	399	8	enjoy	enjoy	VERB
ihlr-16572	399	9	gatt	gatt	NOUN
ihlr-16572	399	10	and	and	CCONJ
ihlr-16572	399	11	patent	patent	NOUN
ihlr-16572	399	12	res113	res113	PROPN
ihlr-16572	399	13	.	.	PUNCT
ihlr-16572	400	1	i	i	PRON
ihlr-16572	400	2	d.	d.	PROPN
ihlr-16572	400	3	114	114	NUM
ihlr-16572	400	4	.	.	PUNCT
ihlr-16572	401	1	kotlikoff	kotlikoff	PROPN
ihlr-16572	401	2	,	,	PUNCT
ihlr-16572	401	3	supra	supra	PROPN
ihlr-16572	401	4	note	note	PROPN
ihlr-16572	401	5	28	28	NUM
ihlr-16572	401	6	,	,	PUNCT
ihlr-16572	401	7	at	at	ADP
ihlr-16572	401	8	6	6	NUM
ihlr-16572	401	9	.	.	NOUN
ihlr-16572	401	10	115	115	NUM
ihlr-16572	401	11	.	.	PUNCT
ihlr-16572	402	1	see	see	VERB
ihlr-16572	402	2	e.g.	e.g.	ADV
ihlr-16572	402	3	,	,	PUNCT
ihlr-16572	402	4	grabowski	grabowski	PROPN
ihlr-16572	402	5	and	and	CCONJ
ihlr-16572	402	6	vernon	vernon	PROPN
ihlr-16572	402	7	,	,	PUNCT
ihlr-16572	402	8	supra	supra	PROPN
ihlr-16572	402	9	note	note	PROPN
ihlr-16572	402	10	ll1	ll1	ADV
ihlr-16572	402	11	,	,	PUNCT
ihlr-16572	402	12	at	at	ADP
ihlr-16572	402	13	ll6	ll6	NOUN
ihlr-16572	402	14	(	(	PUNCT
ihlr-16572	402	15	stating	state	VERB
ihlr-16572	402	16	that	that	SCONJ
ihlr-16572	402	17	the	the	DET
ihlr-16572	402	18	hatch­	hatch­	PROPN
ihlr-16572	402	19	waxman	waxman	PROPN
ihlr-16572	402	20	act	act	PROPN
ihlr-16572	402	21	's	's	PART
ihlr-16572	402	22	effect	effect	NOUN
ihlr-16572	402	23	on	on	ADP
ihlr-16572	402	24	patent	patent	NOUN
ihlr-16572	402	25	life	life	NOUN
ihlr-16572	402	26	has	have	AUX
ihlr-16572	402	27	been	be	AUX
ihlr-16572	402	28	"	"	PUNCT
ihlr-16572	402	29	modest	modest	ADJ
ihlr-16572	402	30	''	''	PUNCT
ihlr-16572	402	31	)	)	PUNCT
ihlr-16572	402	32	.	.	PUNCT
ihlr-16572	403	1	116	116	NUM
ihlr-16572	403	2	.	.	PUNCT
ihlr-16572	403	3	drug	drug	NOUN
ihlr-16572	403	4	price	price	NOUN
ihlr-16572	403	5	competition	competition	NOUN
ihlr-16572	403	6	and	and	CCONJ
ihlr-16572	403	7	patent	patent	NOUN
ihlr-16572	403	8	term	term	NOUN
ihlr-16572	403	9	restoration	restoration	NOUN
ihlr-16572	403	10	act	act	NOUN
ihlr-16572	403	11	,	,	PUNCT
ihlr-16572	403	12	pub	pub	NOUN
ihlr-16572	403	13	.	.	PUNCT
ihlr-16572	404	1	l.	l.	PROPN
ihlr-16572	404	2	no	no	INTJ
ihlr-16572	404	3	.	.	PROPN
ihlr-16572	405	1	98	98	NUM
ihlr-16572	405	2	-	-	SYM
ihlr-16572	405	3	417	417	NUM
ihlr-16572	405	4	(	(	PUNCT
ihlr-16572	405	5	1984	1984	NUM
ihlr-16572	405	6	)	)	PUNCT
ihlr-16572	405	7	,	,	PUNCT
ihlr-16572	405	8	98	98	NUM
ihlr-16572	405	9	stat	stat	NOUN
ihlr-16572	405	10	.	.	PUNCT
ihlr-16572	406	1	1585	1585	NUM
ihlr-16572	406	2	(	(	PUNCT
ihlr-16572	406	3	1984	1984	NUM
ihlr-16572	406	4	)	)	PUNCT
ihlr-16572	406	5	.	.	PUNCT
ihlr-16572	407	1	117	117	NUM
ihlr-16572	407	2	.	.	PUNCT
ihlr-16572	407	3	alan	alan	PROPN
ihlr-16572	407	4	j.	j.	PROPN
ihlr-16572	407	5	morrison	morrison	PROPN
ihlr-16572	407	6	,	,	PUNCT
ihlr-16572	407	7	biosimilars	biosimilar	VERB
ihlr-16572	407	8	in	in	ADP
ihlr-16572	407	9	the	the	DET
ihlr-16572	407	10	united	united	PROPN
ihlr-16572	407	11	states	states	PROPN
ihlr-16572	407	12	:	:	PUNCT
ihlr-16572	407	13	a	a	DET
ihlr-16572	407	14	brief	brief	ADJ
ihlr-16572	407	15	look	look	NOUN
ihlr-16572	407	16	at	at	ADP
ihlr-16572	407	17	where	where	SCONJ
ihlr-16572	407	18	we	we	PRON
ihlr-16572	407	19	are	be	AUX
ihlr-16572	407	20	and	and	CCONJ
ihlr-16572	407	21	the	the	DET
ihlr-16572	407	22	road	road	NOUN
ihlr-16572	407	23	ahead	ahead	ADV
ihlr-16572	407	24	,	,	PUNCT
ihlr-16572	407	25	26	26	NUM
ihlr-16572	407	26	biotechnolooy	biotechnolooy	NOUN
ihlr-16572	407	27	l.	l.	PROPN
ihlr-16572	407	28	rep	rep	PROPN
ihlr-16572	407	29	.	.	PROPN
ihlr-16572	407	30	463	463	NUM
ihlr-16572	407	31	,	,	PUNCT
ihlr-16572	407	32	464	464	NUM
ihlr-16572	407	33	(	(	PUNCT
ihlr-16572	407	34	2007	2007	NUM
ihlr-16572	407	35	)	)	PUNCT
ihlr-16572	407	36	(	(	PUNCT
ihlr-16572	407	37	citation	citation	NOUN
ihlr-16572	407	38	omitted	omit	VERB
ihlr-16572	407	39	)	)	PUNCT
ihlr-16572	407	40	.	.	PUNCT
ihlr-16572	408	1	118	118	NUM
ihlr-16572	408	2	.	.	PUNCT
ihlr-16572	409	1	i	i	PRON
ihlr-16572	409	2	d.	d.	PROPN
ihlr-16572	409	3	119	119	NUM
ihlr-16572	409	4	.	.	PUNCT
ihlr-16572	410	1	drug	drug	NOUN
ihlr-16572	410	2	price	price	NOUN
ihlr-16572	410	3	competition	competition	NOUN
ihlr-16572	410	4	and	and	CCONJ
ihlr-16572	410	5	patent	patent	NOUN
ihlr-16572	410	6	term	term	NOUN
ihlr-16572	410	7	restoration	restoration	NOUN
ihlr-16572	410	8	act	act	NOUN
ihlr-16572	410	9	,	,	PUNCT
ihlr-16572	410	10	pub	pub	NOUN
ihlr-16572	410	11	.	.	PUNCT
ihlr-16572	411	1	l	l	NOUN
ihlr-16572	411	2	..	..	PUNCT
ihlr-16572	412	1	no	no	INTJ
ihlr-16572	412	2	.	.	NOUN
ihlr-16572	413	1	98	98	NUM
ihlr-16572	413	2	-	-	SYM
ihlr-16572	413	3	417	417	NUM
ihlr-16572	413	4	(	(	PUNCT
ihlr-16572	413	5	1984	1984	NUM
ihlr-16572	413	6	)	)	PUNCT
ihlr-16572	413	7	,	,	PUNCT
ihlr-16572	413	8	98	98	NUM
ihlr-16572	413	9	stat	stat	NOUN
ihlr-16572	413	10	.	.	PUNCT
ihlr-16572	414	1	1585	1585	NUM
ihlr-16572	414	2	(	(	PUNCT
ihlr-16572	414	3	1984	1984	NUM
ihlr-16572	414	4	)	)	PUNCT
ihlr-16572	414	5	.	.	PUNCT
ihlr-16572	415	1	120	120	NUM
ihlr-16572	415	2	.	.	PUNCT
ihlr-16572	415	3	ld	ld	PROPN
ihlr-16572	415	4	121	121	NUM
ihlr-16572	415	5	.	.	PUNCT
ihlr-16572	416	1	see	see	VERB
ihlr-16572	416	2	e.g.	e.g.	ADV
ihlr-16572	416	3	,	,	PUNCT
ihlr-16572	416	4	biologics	biologic	NOUN
ihlr-16572	416	5	price	price	NOUN
ihlr-16572	416	6	competition	competition	NOUN
ihlr-16572	416	7	and	and	CCONJ
ihlr-16572	416	8	innovation	innovation	NOUN
ihlr-16572	416	9	act	act	NOUN
ihlr-16572	416	10	of2007	of2007	PROPN
ihlr-16572	416	11	,	,	PUNCT
ihlr-16572	416	12	s.	s.	PROPN
ihlr-16572	416	13	1695	1695	NUM
ihlr-16572	416	14	,	,	PUNCT
ihlr-16572	416	15	110th	110th	ADJ
ihlr-16572	416	16	cong	cong	NOUN
ihlr-16572	416	17	.	.	PUNCT
ihlr-16572	417	1	(	(	PUNCT
ihlr-16572	417	2	2007	2007	NUM
ihlr-16572	417	3	)	)	PUNCT
ihlr-16572	417	4	.	.	PUNCT
ihlr-16572	418	1	2010	2010	NUM
ihlr-16572	418	2	]	]	PUNCT
ihlr-16572	418	3	follow	follow	VERB
ihlr-16572	418	4	-	-	PUNCT
ihlr-16572	418	5	on	on	ADP
ihlr-16572	418	6	biologics	biologic	NOUN
ihlr-16572	418	7	legislation	legislation	NOUN
ihlr-16572	418	8	385	385	NUM
ihlr-16572	418	9	toration	toration	NOUN
ihlr-16572	418	10	protections	protection	NOUN
ihlr-16572	418	11	.	.	PUNCT
ihlr-16572	419	1	"122	"122	PROPN
ihlr-16572	420	1	three	three	NUM
ihlr-16572	420	2	of	of	ADP
ihlr-16572	420	3	the	the	DET
ihlr-16572	420	4	four	four	NUM
ihlr-16572	420	5	biogenetic	biogenetic	ADJ
ihlr-16572	420	6	bills	bill	NOUN
ihlr-16572	420	7	entail	entail	VERB
ihlr-16572	420	8	expansion	expansion	NOUN
ihlr-16572	420	9	of	of	ADP
ihlr-16572	420	10	monopoly	monopoly	NOUN
ihlr-16572	420	11	pro­	pro­	NOUN
ihlr-16572	420	12	tection	tection	NOUN
ihlr-16572	420	13	for	for	ADP
ihlr-16572	420	14	biologics.123	biologics.123	NOUN
ihlr-16572	420	15	because	because	SCONJ
ihlr-16572	420	16	new	new	ADJ
ihlr-16572	420	17	innovators	innovator	NOUN
ihlr-16572	420	18	rely	rely	VERB
ihlr-16572	420	19	on	on	ADP
ihlr-16572	420	20	pre	pre	ADJ
ihlr-16572	420	21	-	-	ADJ
ihlr-16572	420	22	existing	existing	ADJ
ihlr-16572	420	23	scien­	scien­	NOUN
ihlr-16572	420	24	tific	tific	ADJ
ihlr-16572	420	25	advances	advance	NOUN
ihlr-16572	420	26	,	,	PUNCT
ihlr-16572	420	27	the	the	DET
ihlr-16572	420	28	extension	extension	NOUN
ihlr-16572	420	29	of	of	ADP
ihlr-16572	420	30	monopoly	monopoly	NOUN
ihlr-16572	420	31	protection	protection	NOUN
ihlr-16572	420	32	has	have	VERB
ihlr-16572	420	33	an	an	DET
ihlr-16572	420	34	exponential	exponential	ADJ
ihlr-16572	420	35	deleterious	deleterious	ADJ
ihlr-16572	420	36	effect	effect	NOUN
ihlr-16572	420	37	.	.	PUNCT
ihlr-16572	421	1	for	for	ADP
ihlr-16572	421	2	example	example	NOUN
ihlr-16572	421	3	,	,	PUNCT
ihlr-16572	421	4	increasing	increase	VERB
ihlr-16572	421	5	monopoly	monopoly	NOUN
ihlr-16572	421	6	protection	protection	NOUN
ihlr-16572	421	7	from	from	ADP
ihlr-16572	421	8	twenty	twenty	NUM
ihlr-16572	421	9	to	to	PART
ihlr-16572	421	10	twenty	twenty	NUM
ihlr-16572	421	11	-	-	PUNCT
ihlr-16572	421	12	five	five	NUM
ihlr-16572	421	13	years	year	NOUN
ihlr-16572	421	14	results	result	NOUN
ihlr-16572	421	15	in	in	ADP
ihlr-16572	421	16	a	a	DET
ihlr-16572	421	17	twenty	twenty	NUM
ihlr-16572	421	18	-	-	PUNCT
ihlr-16572	421	19	five	five	NUM
ihlr-16572	421	20	percent	percent	NOUN
ihlr-16572	421	21	delay	delay	NOUN
ihlr-16572	421	22	in	in	ADP
ihlr-16572	421	23	the	the	DET
ihlr-16572	421	24	on­	on­	NOUN
ihlr-16572	421	25	set	set	NOUN
ihlr-16572	421	26	of	of	ADP
ihlr-16572	421	27	the	the	DET
ihlr-16572	421	28	next	next	ADJ
ihlr-16572	421	29	innovation	innovation	NOUN
ihlr-16572	421	30	.	.	PUNCT
ihlr-16572	422	1	124	124	NUM
ihlr-16572	422	2	in	in	ADP
ihlr-16572	422	3	this	this	DET
ihlr-16572	422	4	case	case	NOUN
ihlr-16572	422	5	,	,	PUNCT
ihlr-16572	422	6	the	the	DET
ihlr-16572	422	7	second	second	ADJ
ihlr-16572	422	8	innovation	innovation	NOUN
ihlr-16572	422	9	arrives	arrive	VERB
ihlr-16572	422	10	five	five	NUM
ihlr-16572	422	11	years	year	NOUN
ihlr-16572	422	12	late	late	ADV
ihlr-16572	422	13	,	,	PUNCT
ihlr-16572	422	14	the	the	DET
ihlr-16572	422	15	third	third	ADJ
ihlr-16572	422	16	1	1	NUM
ihlr-16572	422	17	0	0	NUM
ihlr-16572	422	18	years	year	NOUN
ihlr-16572	422	19	late	late	ADV
ihlr-16572	422	20	,	,	PUNCT
ihlr-16572	422	21	the	the	DET
ihlr-16572	422	22	fourth	fourth	ADJ
ihlr-16572	422	23	15	15	NUM
ihlr-16572	422	24	years	year	NOUN
ihlr-16572	422	25	late	late	ADV
ihlr-16572	422	26	,	,	PUNCT
ihlr-16572	422	27	the	the	DET
ihlr-16572	422	28	third	third	ADJ
ihlr-16572	422	29	1	1	NUM
ihlr-16572	422	30	0	0	NUM
ihlr-16572	422	31	years	year	NOUN
ihlr-16572	422	32	late	late	ADV
ihlr-16572	422	33	,	,	PUNCT
ihlr-16572	422	34	the	the	DET
ihlr-16572	422	35	fourth	fourth	ADJ
ihlr-16572	422	36	15	15	NUM
ihlr-16572	422	37	years	year	NOUN
ihlr-16572	422	38	late	late	ADV
ihlr-16572	422	39	,	,	PUNCT
ihlr-16572	422	40	etc	etc	X
ihlr-16572	422	41	.	.	X
ihlr-16572	423	1	over	over	ADP
ihlr-16572	423	2	the	the	DET
ihlr-16572	423	3	course	course	NOUN
ihlr-16572	423	4	of	of	ADP
ihlr-16572	423	5	a	a	DET
ihlr-16572	423	6	century	century	NOUN
ihlr-16572	423	7	,	,	PUNCT
ihlr-16572	423	8	the	the	DET
ihlr-16572	423	9	country	country	NOUN
ihlr-16572	423	10	experiences	experience	VERB
ihlr-16572	423	11	not	not	PART
ihlr-16572	423	12	five	five	NUM
ihlr-16572	423	13	innovations	innovation	NOUN
ihlr-16572	423	14	,	,	PUNCT
ihlr-16572	423	15	but	but	CCONJ
ihlr-16572	423	16	four	four	NUM
ihlr-16572	423	17	.	.	PUNCT
ihlr-16572	423	18	"125	"125	NOUN
ihlr-16572	424	1	the	the	DET
ihlr-16572	424	2	decision	decision	NOUN
ihlr-16572	424	3	to	to	PART
ihlr-16572	424	4	permanently	permanently	ADV
ihlr-16572	424	5	extend	extend	VERB
ihlr-16572	424	6	monopoly	monopoly	NOUN
ihlr-16572	424	7	protection	protection	NOUN
ihlr-16572	424	8	has	have	VERB
ihlr-16572	424	9	far	far	ADV
ihlr-16572	424	10	greater	great	ADJ
ihlr-16572	424	11	consequences	consequence	NOUN
ihlr-16572	424	12	as	as	SCONJ
ihlr-16572	424	13	time	time	NOUN
ihlr-16572	424	14	progresses	progress	VERB
ihlr-16572	424	15	,	,	PUNCT
ihlr-16572	424	16	causing	cause	VERB
ihlr-16572	424	17	a	a	DET
ihlr-16572	424	18	greater	great	ADJ
ihlr-16572	424	19	decrease	decrease	NOUN
ihlr-16572	424	20	in	in	ADP
ihlr-16572	424	21	innovation	innovation	NOUN
ihlr-16572	424	22	with	with	ADP
ihlr-16572	424	23	each	each	DET
ihlr-16572	424	24	succes­	succes­	ADJ
ihlr-16572	424	25	sive	sive	ADJ
ihlr-16572	424	26	generation	generation	NOUN
ihlr-16572	424	27	.	.	PUNCT
ihlr-16572	425	1	e.	e.	PROPN
ihlr-16572	425	2	proposed	propose	VERB
ihlr-16572	425	3	legislation	legislation	NOUN
ihlr-16572	425	4	all	all	PRON
ihlr-16572	425	5	of	of	ADP
ihlr-16572	425	6	the	the	DET
ihlr-16572	425	7	proposed	propose	VERB
ihlr-16572	425	8	legislation	legislation	NOUN
ihlr-16572	425	9	purports	purport	VERB
ihlr-16572	425	10	to	to	PART
ihlr-16572	425	11	allow	allow	VERB
ihlr-16572	425	12	for	for	ADP
ihlr-16572	425	13	e	e	NOUN
ihlr-16572	425	14	~	~	NOUN
ihlr-16572	425	15	enditure	enditure	NOUN
ihlr-16572	425	16	relief	relief	NOUN
ihlr-16572	425	17	for	for	ADP
ihlr-16572	425	18	the	the	DET
ihlr-16572	425	19	public	public	NOUN
ihlr-16572	425	20	while	while	SCONJ
ihlr-16572	425	21	protecting	protect	VERB
ihlr-16572	425	22	the	the	DET
ihlr-16572	425	23	innovator	innovator	NOUN
ihlr-16572	425	24	's	's	PART
ihlr-16572	425	25	interests.12	interests.12	PROPN
ihlr-16572	425	26	these	these	DET
ihlr-16572	425	27	abbre­	abbre­	PROPN
ihlr-16572	425	28	viated	viate	VERB
ihlr-16572	425	29	regulatory	regulatory	ADJ
ihlr-16572	425	30	procedures	procedure	NOUN
ihlr-16572	425	31	would	would	AUX
ihlr-16572	425	32	allow	allow	VERB
ihlr-16572	425	33	the	the	DET
ihlr-16572	425	34	manufacturers	manufacturer	NOUN
ihlr-16572	425	35	of	of	ADP
ihlr-16572	425	36	follow	follow	VERB
ihlr-16572	425	37	-	-	PUNCT
ihlr-16572	425	38	on	on	ADP
ihlr-16572	425	39	biologics	biologic	NOUN
ihlr-16572	425	40	"	"	PUNCT
ihlr-16572	425	41	to	to	PART
ihlr-16572	425	42	sell	sell	VERB
ihlr-16572	425	43	the	the	DET
ihlr-16572	425	44	competing	compete	VERB
ihlr-16572	425	45	version	version	NOUN
ihlr-16572	425	46	at	at	ADP
ihlr-16572	425	47	a	a	DET
ihlr-16572	425	48	discounted	discount	VERB
ihlr-16572	425	49	price	price	NOUN
ihlr-16572	425	50	by	by	ADP
ihlr-16572	425	51	avoiding	avoid	VERB
ihlr-16572	425	52	the	the	DET
ihlr-16572	425	53	substantial	substantial	ADJ
ihlr-16572	425	54	research	research	NOUN
ihlr-16572	425	55	and	and	CCONJ
ihlr-16572	425	56	development	development	NOUN
ihlr-16572	425	57	expenses	expense	NOUN
ihlr-16572	425	58	incurred	incur	VERB
ihlr-16572	425	59	by	by	ADP
ihlr-16572	425	60	the	the	DET
ihlr-16572	425	61	brand­	brand­	PROPN
ihlr-16572	425	62	name	name	NOUN
ihlr-16572	425	63	company	company	NOUN
ihlr-16572	425	64	to	to	PART
ihlr-16572	425	65	bring	bring	VERB
ihlr-16572	425	66	an	an	DET
ihlr-16572	425	67	innovator	innovator	NOUN
ihlr-16572	425	68	biological	biological	ADJ
ihlr-16572	425	69	product	product	NOUN
ihlr-16572	425	70	to	to	ADP
ihlr-16572	425	71	market	market	NOUN
ihlr-16572	425	72	,	,	PUNCT
ihlr-16572	425	73	includ­	includ­	PROPN
ihlr-16572	425	74	ing	ing	ADJ
ihlr-16572	425	75	costs	cost	NOUN
ihlr-16572	425	76	associated	associate	VERB
ihlr-16572	425	77	with	with	ADP
ihlr-16572	425	78	large	large	ADJ
ihlr-16572	425	79	,	,	PUNCT
ihlr-16572	425	80	clinical	clinical	ADJ
ihlr-16572	425	81	trials	trial	NOUN
ihlr-16572	425	82	necessary	necessary	ADJ
ihlr-16572	425	83	to	to	PART
ihlr-16572	425	84	demonstrate	demonstrate	VERB
ihlr-16572	425	85	safe­	safe­	PROPN
ihlr-16572	425	86	ty	ty	INTJ
ihlr-16572	425	87	and	and	CCONJ
ihlr-16572	425	88	effectiveness	effectiveness	NOUN
ihlr-16572	425	89	of	of	ADP
ihlr-16572	425	90	the	the	DET
ihlr-16572	425	91	treatment	treatment	NOUN
ihlr-16572	425	92	in	in	ADP
ihlr-16572	425	93	humans	human	NOUN
ihlr-16572	425	94	.	.	PUNCT
ihlr-16572	426	1	"	"	PUNCT
ihlr-16572	426	2	127	127	NUM
ihlr-16572	426	3	the	the	DET
ihlr-16572	426	4	bipartisan	bipartisan	ADJ
ihlr-16572	426	5	biologics	biologic	NOUN
ihlr-16572	426	6	price	price	NOUN
ihlr-16572	426	7	competition	competition	NOUN
ihlr-16572	426	8	and	and	CCONJ
ihlr-16572	426	9	innovation	innovation	NOUN
ihlr-16572	426	10	act	act	NOUN
ihlr-16572	426	11	of	of	ADP
ihlr-16572	426	12	2007	2007	NUM
ihlr-16572	426	13	,	,	PUNCT
ihlr-16572	426	14	introduced	introduce	VERB
ihlr-16572	426	15	by	by	ADP
ihlr-16572	426	16	senator	senator	PROPN
ihlr-16572	426	17	ted	ted	PROPN
ihlr-16572	426	18	kennedy	kennedy	PROPN
ihlr-16572	426	19	(	(	PUNCT
ihlr-16572	426	20	d	d	PROPN
ihlr-16572	426	21	,	,	PUNCT
ihlr-16572	426	22	mass	mass	PROPN
ihlr-16572	426	23	.	.	PUNCT
ihlr-16572	426	24	)	)	PUNCT
ihlr-16572	426	25	,	,	PUNCT
ihlr-16572	426	26	would	would	AUX
ihlr-16572	426	27	provide	provide	VERB
ihlr-16572	426	28	inno­	inno­	NUM
ihlr-16572	426	29	vators	vator	NOUN
ihlr-16572	426	30	twelve	twelve	NUM
ihlr-16572	426	31	years	year	NOUN
ihlr-16572	426	32	of	of	ADP
ihlr-16572	426	33	exclusivity	exclusivity	NOUN
ihlr-16572	426	34	and	and	CCONJ
ihlr-16572	426	35	allow	allow	VERB
ihlr-16572	426	36	interchangeability	interchangeability	NOUN
ihlr-16572	426	37	upon	upon	SCONJ
ihlr-16572	426	38	the	the	DET
ihlr-16572	426	39	satisfaction	satisfaction	NOUN
ihlr-16572	426	40	of	of	ADP
ihlr-16572	426	41	certain	certain	ADJ
ihlr-16572	426	42	requirements.128	requirements.128	NOUN
ihlr-16572	426	43	once	once	SCONJ
ihlr-16572	426	44	a	a	DET
ihlr-16572	426	45	drug	drug	NOUN
ihlr-16572	426	46	is	be	AUX
ihlr-16572	426	47	classified	classify	VERB
ihlr-16572	426	48	as	as	ADP
ihlr-16572	426	49	inter­	inter­	NUM
ihlr-16572	426	50	changeable	changeable	NOUN
ihlr-16572	426	51	,	,	PUNCT
ihlr-16572	426	52	a	a	DET
ihlr-16572	426	53	generic	generic	ADJ
ihlr-16572	426	54	drug	drug	NOUN
ihlr-16572	426	55	can	can	AUX
ihlr-16572	426	56	be	be	AUX
ihlr-16572	426	57	substituted	substitute	VERB
ihlr-16572	426	58	for	for	ADP
ihlr-16572	426	59	the	the	DET
ihlr-16572	426	60	original	original	ADJ
ihlr-16572	426	61	without	without	ADP
ihlr-16572	426	62	phy­	phy­	NOUN
ihlr-16572	426	63	sician	sician	ADJ
ihlr-16572	426	64	approval	approval	NOUN
ihlr-16572	426	65	.	.	PUNCT
ihlr-16572	427	1	129	129	NUM
ihlr-16572	427	2	in	in	ADP
ihlr-16572	427	3	june	june	PROPN
ihlr-16572	427	4	2008	2008	NUM
ihlr-16572	427	5	,	,	PUNCT
ihlr-16572	427	6	the	the	DET
ihlr-16572	427	7	congressional	congressional	ADJ
ihlr-16572	427	8	budget	budget	NOUN
ihlr-16572	427	9	office	office	NOUN
ihlr-16572	427	10	released	release	VERB
ihlr-16572	427	11	findings	finding	NOUN
ihlr-16572	427	12	that	that	PRON
ihlr-16572	427	13	reflected	reflect	VERB
ihlr-16572	427	14	this	this	DET
ihlr-16572	427	15	bill	bill	NOUN
ihlr-16572	427	16	would	would	AUX
ihlr-16572	427	17	save	save	VERB
ihlr-16572	427	18	an	an	DET
ihlr-16572	427	19	estimated	estimate	VERB
ihlr-16572	427	20	$	$	SYM
ihlr-16572	427	21	25.2	25.2	NUM
ihlr-16572	427	22	billion	billion	NUM
ihlr-16572	427	23	in	in	ADP
ihlr-16572	427	24	bi­	bi­	PROPN
ihlr-16572	427	25	ologic	ologic	ADJ
ihlr-16572	427	26	drug	drug	NOUN
ihlr-16572	427	27	spending	spending	NOUN
ihlr-16572	427	28	over	over	ADP
ihlr-16572	427	29	ten	ten	NUM
ihlr-16572	427	30	years	year	NOUN
ihlr-16572	427	31	.	.	PUNCT
ihlr-16572	428	1	in	in	ADP
ihlr-16572	428	2	its	its	PRON
ihlr-16572	428	3	report	report	NOUN
ihlr-16572	428	4	,	,	PUNCT
ihlr-16572	428	5	the	the	DET
ihlr-16572	428	6	cbo	cbo	PROPN
ihlr-16572	428	7	estimates	estimate	VERB
ihlr-16572	428	8	that	that	SCONJ
ihlr-16572	428	9	:	:	PUNCT
ihlr-16572	428	10	122	122	NUM
ihlr-16572	428	11	.	.	PUNCT
ihlr-16572	428	12	kotlikoff	kotlikoff	PROPN
ihlr-16572	428	13	,	,	PUNCT
ihlr-16572	428	14	supra	supra	PROPN
ihlr-16572	428	15	note	note	PROPN
ihlr-16572	428	16	28	28	NUM
ihlr-16572	428	17	,	,	PUNCT
ihlr-16572	428	18	at	at	ADP
ihlr-16572	428	19	6	6	NUM
ihlr-16572	428	20	-	-	SYM
ihlr-16572	428	21	7	7	NUM
ihlr-16572	428	22	.	.	NUM
ihlr-16572	428	23	123	123	NUM
ihlr-16572	428	24	.	.	PUNCT
ihlr-16572	429	1	i	i	PRON
ihlr-16572	429	2	d.	d.	PROPN
ihlr-16572	429	3	at	at	ADP
ihlr-16572	429	4	7	7	NUM
ihlr-16572	429	5	.	.	NOUN
ihlr-16572	429	6	124	124	NUM
ihlr-16572	429	7	.	.	PUNCT
ihlr-16572	430	1	i	i	PRON
ihlr-16572	430	2	d	d	PROPN
ihlr-16572	430	3	125	125	NUM
ihlr-16572	430	4	.	.	PUNCT
ihlr-16572	431	1	i	i	PRON
ihlr-16572	431	2	d.	d.	PROPN
ihlr-16572	431	3	126	126	NUM
ihlr-16572	431	4	.	.	PUNCT
ihlr-16572	432	1	see	see	VERB
ihlr-16572	432	2	generally	generally	ADV
ihlr-16572	432	3	,	,	PUNCT
ihlr-16572	432	4	pathway	pathway	NOUN
ihlr-16572	432	5	for	for	ADP
ihlr-16572	432	6	biosimilars	biosimilars	PROPN
ihlr-16572	432	7	act	act	PROPN
ihlr-16572	432	8	,	,	PUNCT
ihlr-16572	432	9	h.r	h.r	PROPN
ihlr-16572	432	10	.	.	PROPN
ihlr-16572	432	11	5629	5629	NUM
ihlr-16572	432	12	,	,	PUNCT
ihlr-16572	432	13	i	i	PRON
ihlr-16572	432	14	10th	10th	ADJ
ihlr-16572	432	15	cong	cong	NOUN
ihlr-16572	432	16	.	.	PUNCT
ihlr-16572	433	1	(	(	PUNCT
ihlr-16572	433	2	2008	2008	NUM
ihlr-16572	433	3	)	)	PUNCT
ihlr-16572	433	4	.	.	PUNCT
ihlr-16572	434	1	127	127	NUM
ihlr-16572	434	2	.	.	PUNCT
ihlr-16572	435	1	congressional	congressional	ADJ
ihlr-16572	435	2	budget	budget	NOUN
ihlr-16572	435	3	office	office	NOUN
ihlr-16572	435	4	,	,	PUNCT
ihlr-16572	435	5	cost	cost	NOUN
ihlr-16572	435	6	estimate	estimate	NOUN
ihlr-16572	435	7	:	:	PUNCT
ihlr-16572	436	1	s.	s.	PROPN
ihlr-16572	436	2	1695	1695	NUM
ihlr-16572	436	3	-biologics	-biologic	NOUN
ihlr-16572	436	4	price	price	NOUN
ihlr-16572	436	5	competition	competition	NOUN
ihlr-16572	436	6	and	and	CCONJ
ihlr-16572	436	7	innovation	innovation	NOUN
ihlr-16572	436	8	act	act	NOUN
ihlr-16572	436	9	of	of	ADP
ihlr-16572	436	10	2007	2007	NUM
ihlr-16572	436	11	4	4	NUM
ihlr-16572	436	12	(	(	PUNCT
ihlr-16572	436	13	2008	2008	NUM
ihlr-16572	436	14	)	)	PUNCT
ihlr-16572	436	15	,	,	PUNCT
ihlr-16572	436	16	available	available	ADJ
ihlr-16572	436	17	at	at	ADP
ihlr-16572	436	18	http://www.cbo.gov/	http://www.cbo.gov/	NOUN
ihlr-16572	436	19	ftpdocs/94xx	ftpdocs/94xx	PROPN
ihlr-16572	436	20	/	/	SYM
ihlr-16572	436	21	doc	doc	PROPN
ihlr-16572	436	22	9496	9496	NUM
ihlr-16572	436	23	/	/	SYM
ihlr-16572	436	24	sl695.pdf	sl695.pdf	PROPN
ihlr-16572	436	25	(	(	PUNCT
ihlr-16572	436	26	last	last	ADV
ihlr-16572	436	27	visited	visit	VERB
ihlr-16572	436	28	mar	mar	PROPN
ihlr-16572	436	29	.	.	PROPN
ihlr-16572	436	30	7	7	NUM
ihlr-16572	436	31	,	,	PUNCT
ihlr-16572	436	32	2010	2010	NUM
ihlr-16572	436	33	)	)	PUNCT
ihlr-16572	437	1	[	[	X
ihlr-16572	437	2	hereinafter	hereinafter	NOUN
ihlr-16572	437	3	"	"	PUNCT
ihlr-16572	437	4	cbo	cbo	PROPN
ihlr-16572	437	5	cost	cost	PROPN
ihlr-16572	437	6	estimate	estimate	NOUN
ihlr-16572	437	7	"	"	PUNCT
ihlr-16572	437	8	]	]	PUNCT
ihlr-16572	437	9	.	.	PUNCT
ihlr-16572	438	1	128	128	NUM
ihlr-16572	438	2	.	.	PUNCT
ihlr-16572	439	1	biologics	biologic	NOUN
ihlr-16572	439	2	price	price	NOUN
ihlr-16572	439	3	competition	competition	NOUN
ihlr-16572	439	4	and	and	CCONJ
ihlr-16572	439	5	innovation	innovation	NOUN
ihlr-16572	439	6	act	act	NOUN
ihlr-16572	439	7	of	of	ADP
ihlr-16572	439	8	2007	2007	NUM
ihlr-16572	439	9	,	,	PUNCT
ihlr-16572	439	10	8.1695	8.1695	NUM
ihlr-16572	439	11	,	,	PUNCT
ihlr-16572	439	12	i	i	PRON
ihlr-16572	439	13	loth	loth	PROPN
ihlr-16572	439	14	cong	cong	PROPN
ihlr-16572	439	15	.	.	PUNCT
ihlr-16572	440	1	§	§	PROPN
ihlr-16572	440	2	7(a	7(a	NUM
ihlr-16572	440	3	)	)	PUNCT
ihlr-16572	440	4	(	(	PUNCT
ihlr-16572	440	5	2007	2007	NUM
ihlr-16572	440	6	)	)	PUNCT
ihlr-16572	440	7	.	.	PUNCT
ihlr-16572	441	1	129	129	NUM
ihlr-16572	441	2	.	.	PUNCT
ihlr-16572	442	1	s.	s.	PROPN
ihlr-16572	442	2	1695	1695	NUM
ihlr-16572	442	3	.	.	PUNCT
ihlr-16572	443	1	386	386	NUM
ihlr-16572	443	2	indiana	indiana	PROPN
ihlr-16572	443	3	health	health	PROPN
ihlr-16572	443	4	law	law	NOUN
ihlr-16572	443	5	review	review	NOUN
ihlr-16572	443	6	•	•	NOUN
ihlr-16572	443	7	enacting	enact	VERB
ihlr-16572	443	8	s.	s.	PROPN
ihlr-16572	443	9	1695	1695	NUM
ihlr-16572	443	10	would	would	AUX
ihlr-16572	443	11	reduce	reduce	VERB
ihlr-16572	443	12	total	total	ADJ
ihlr-16572	443	13	expenditures	expenditure	NOUN
ihlr-16572	443	14	on	on	ADP
ihlr-16572	443	15	biologics	biologic	NOUN
ihlr-16572	443	16	in	in	ADP
ihlr-16572	443	17	the	the	DET
ihlr-16572	443	18	united	united	PROPN
ihlr-16572	443	19	states	states	PROPN
ihlr-16572	443	20	by	by	ADP
ihlr-16572	443	21	$	$	SYM
ihlr-16572	443	22	0.2	0.2	NUM
ihlr-16572	443	23	billion	billion	NUM
ihlr-16572	443	24	over	over	ADP
ihlr-16572	443	25	the	the	DET
ihlr-16572	443	26	2009	2009	NUM
ihlr-16572	443	27	-	-	SYM
ihlr-16572	443	28	2013	2013	NUM
ihlr-16572	443	29	period	period	NOUN
ihlr-16572	443	30	and	and	CCONJ
ihlr-16572	443	31	by	by	ADP
ihlr-16572	443	32	about	about	ADV
ihlr-16572	443	33	$	$	SYM
ihlr-16572	443	34	25	25	NUM
ihlr-16572	443	35	billion	billion	NUM
ihlr-16572	443	36	over	over	ADP
ihlr-16572	443	37	the	the	DET
ihlr-16572	443	38	2009	2009	NUM
ihlr-16572	443	39	-	-	SYM
ihlr-16572	443	40	2018	2018	NUM
ihlr-16572	443	41	period	period	NOUN
ihlr-16572	443	42	.	.	PUNCT
ihlr-16572	444	1	(	(	PUNCT
ihlr-16572	444	2	over	over	ADP
ihlr-16572	444	3	that	that	DET
ihlr-16572	444	4	10	10	NUM
ihlr-16572	444	5	-	-	PUNCT
ihlr-16572	444	6	year	year	NOUN
ihlr-16572	444	7	period	period	NOUN
ihlr-16572	444	8	,	,	PUNCT
ihlr-16572	444	9	such	such	ADJ
ihlr-16572	444	10	savings	saving	NOUN
ihlr-16572	444	11	would	would	AUX
ihlr-16572	444	12	equal	equal	VERB
ihlr-16572	444	13	roughly	roughly	ADV
ihlr-16572	444	14	0.5	0.5	NUM
ihlr-16572	444	15	percent	percent	NOUN
ihlr-16572	444	16	of	of	ADP
ihlr-16572	444	17	national	national	ADJ
ihlr-16572	444	18	spendinft	spendinft	NOUN
ihlr-16572	444	19	on	on	ADP
ihlr-16572	444	20	prescription	prescription	NOUN
ihlr-16572	444	21	drugs	drug	NOUN
ihlr-16572	444	22	,	,	PUNCT
ihlr-16572	444	23	valued	value	VERB
ihlr-16572	444	24	at	at	ADP
ihlr-16572	444	25	wholesale	wholesale	ADJ
ihlr-16572	444	26	prices	price	NOUN
ihlr-16572	444	27	.	.	PUNCT
ihlr-16572	444	28	)	)	PUNCT
ihlr-16572	445	1	0	0	NUM
ihlr-16572	446	1	•	•	NUM
ihlr-16572	446	2	direct	direct	ADJ
ihlr-16572	446	3	spending	spending	NOUN
ihlr-16572	446	4	by	by	ADP
ihlr-16572	446	5	the	the	DET
ihlr-16572	446	6	federal	federal	ADJ
ihlr-16572	446	7	government	government	NOUN
ihlr-16572	446	8	would	would	AUX
ihlr-16572	446	9	decrease	decrease	VERB
ihlr-16572	446	10	by	by	ADP
ihlr-16572	446	11	$	$	SYM
ihlr-16572	446	12	46	46	NUM
ihlr-16572	446	13	million	million	NUM
ihlr-16572	446	14	over	over	ADP
ihlr-16572	446	15	the	the	DET
ihlr-16572	446	16	2009	2009	NUM
ihlr-16572	446	17	-	-	SYM
ihlr-16572	446	18	2013	2013	NUM
ihlr-16572	446	19	period	period	NOUN
ihlr-16572	446	20	,	,	PUNCT
ihlr-16572	446	21	and	and	CCONJ
ihlr-16572	446	22	by	by	ADP
ihlr-16572	446	23	$	$	SYM
ihlr-16572	446	24	5.9	5.9	NUM
ihlr-16572	446	25	billion	billion	NUM
ihlr-16572	446	26	over	over	ADP
ihlr-16572	446	27	the	the	DET
ihlr-16572	446	28	2009	2009	NUM
ihlr-16572	446	29	-	-	SYM
ihlr-16572	446	30	2018	2018	NUM
ihlr-16572	446	31	period	period	NOUN
ihlr-16572	446	32	.	.	PUNCT
ihlr-16572	447	1	feder­	feder­	PROPN
ihlr-16572	447	2	al	al	PROPN
ihlr-16572	447	3	revenues	revenue	NOUN
ihlr-16572	447	4	would	would	AUX
ihlr-16572	447	5	increase	increase	VERB
ihlr-16572	447	6	by	by	ADP
ihlr-16572	447	7	$	$	SYM
ihlr-16572	447	8	6	6	NUM
ihlr-16572	447	9	million	million	NUM
ihlr-16572	447	10	over	over	ADP
ihlr-16572	447	11	the	the	DET
ihlr-16572	447	12	2009	2009	NUM
ihlr-16572	447	13	-	-	SYM
ihlr-16572	447	14	2013	2013	NUM
ihlr-16572	447	15	period	period	NOUN
ihlr-16572	447	16	and	and	CCONJ
ihlr-16572	447	17	by	by	ADP
ihlr-16572	447	18	$	$	SYM
ihlr-16572	447	19	0.8	0.8	NUM
ihlr-16572	447	20	billion	billion	NUM
ihlr-16572	447	21	over	over	ADP
ihlr-16572	447	22	the	the	DET
ihlr-16572	447	23	20092018	20092018	NUM
ihlr-16572	447	24	period	period	NOUN
ihlr-16572	447	25	.	.	PUNCT
ihlr-16572	448	1	as	as	ADP
ihlr-16572	448	2	a	a	DET
ihlr-16572	448	3	result	result	NOUN
ihlr-16572	448	4	of	of	ADP
ihlr-16572	448	5	those	those	DET
ihlr-16572	448	6	changes	change	NOUN
ihlr-16572	448	7	,	,	PUNCT
ihlr-16572	448	8	cbo	cbo	PROPN
ihlr-16572	448	9	esti­	esti­	PROPN
ihlr-16572	448	10	mates	mate	NOUN
ihlr-16572	448	11	that	that	SCONJ
ihlr-16572	448	12	enacting	enact	VERB
ihlr-16572	448	13	the	the	DET
ihlr-16572	448	14	bill	bill	NOUN
ihlr-16572	448	15	would	would	AUX
ihlr-16572	448	16	reduce	reduce	VERB
ihlr-16572	448	17	budget	budget	NOUN
ihlr-16572	448	18	defi­	defi­	PROPN
ihlr-16572	448	19	cits	cit	NOUN
ihlr-16572	448	20	(	(	PUNCT
ihlr-16572	448	21	or	or	CCONJ
ihlr-16572	448	22	increase	increase	VERB
ihlr-16572	448	23	surpluses	surplus	NOUN
ihlr-16572	448	24	)	)	PUNCT
ihlr-16572	448	25	by	by	ADP
ihlr-16572	448	26	a	a	DET
ihlr-16572	448	27	total	total	NOUN
ihlr-16572	448	28	of	of	ADP
ihlr-16572	448	29	$	$	SYM
ihlr-16572	448	30	52	52	NUM
ihlr-16572	448	31	million	million	NUM
ihlr-16572	448	32	over	over	ADP
ihlr-16572	448	33	the2009	the2009	NOUN
ihlr-16572	448	34	-	-	SYM
ihlr-16572	448	35	2013	2013	NUM
ihlr-16572	448	36	~riod	~riod	PUNCT
ihlr-16572	448	37	and	and	CCONJ
ihlr-16572	448	38	by	by	ADP
ihlr-16572	448	39	$	$	SYM
ihlr-16572	448	40	6.6	6.6	NUM
ihlr-16572	448	41	billion	billion	NUM
ihlr-16572	448	42	over	over	ADP
ihlr-16572	448	43	the	the	DET
ihlr-16572	448	44	2009	2009	NUM
ihlr-16572	448	45	-	-	SYM
ihlr-16572	448	46	2018	2018	NUM
ihlr-16572	448	47	period.1	period.1	NOUN
ihlr-16572	449	1	i	i	PRON
ihlr-16572	449	2	•	•	ADV
ihlr-16572	449	3	implementing	implement	VERB
ihlr-16572	449	4	s.	s.	PROPN
ihlr-16572	449	5	1695	1695	NUM
ihlr-16572	449	6	would	would	AUX
ihlr-16572	449	7	increase	increase	VERB
ihlr-16572	449	8	federal	federal	ADJ
ihlr-16572	449	9	dis­	dis­	ADJ
ihlr-16572	449	10	cretionary	cretionary	NOUN
ihlr-16572	449	11	costs	cost	NOUN
ihlr-16572	449	12	,	,	PUNCT
ihlr-16572	449	13	on	on	ADP
ihlr-16572	449	14	net	net	NOUN
ihlr-16572	449	15	,	,	PUNCT
ihlr-16572	449	16	by	by	ADP
ihlr-16572	449	17	nearly	nearly	ADV
ihlr-16572	449	18	$	$	SYM
ihlr-16572	449	19	30	30	NUM
ihlr-16572	449	20	million	million	NUM
ihlr-16572	449	21	over	over	ADP
ihlr-16572	449	22	the	the	DET
ihlr-16572	449	23	2009	2009	NUM
ihlr-16572	449	24	-	-	SYM
ihlr-16572	449	25	2013	2013	NUM
ihlr-16572	449	26	period	period	NOUN
ihlr-16572	449	27	and	and	CCONJ
ihlr-16572	449	28	by	by	ADP
ihlr-16572	449	29	$	$	SYM
ihlr-16572	449	30	5.3	5.3	NUM
ihlr-16572	449	31	billion	billion	NUM
ihlr-16572	449	32	over	over	ADP
ihlr-16572	449	33	the	the	DET
ihlr-16572	449	34	2009	2009	NUM
ihlr-16572	449	35	-	-	SYM
ihlr-16572	449	36	2018	2018	NUM
ihlr-16572	449	37	period	period	NOUN
ihlr-16572	449	38	,	,	PUNCT
ihlr-16572	449	39	assuming	assume	VERB
ihlr-16572	449	40	appropriation	appropriation	NOUN
ihlr-16572	449	41	of	of	ADP
ihlr-16572	449	42	the	the	DET
ihlr-16572	449	43	ne­	ne­	PUNCT
ihlr-16572	449	44	cessary	cessary	ADJ
ihlr-16572	449	45	amounts	amount	NOUN
ihlr-16572	449	46	,	,	PUNCT
ihlr-16572	449	47	mostly	mostly	ADV
ihlr-16572	449	48	because	because	SCONJ
ihlr-16572	449	49	the	the	DET
ihlr-16572	449	50	bill	bill	NOUN
ihlr-16572	449	51	w.ould	w.ould	AUX
ihlr-16572	449	52	au­	au­	PART
ihlr-16572	449	53	thorize	thorize	VERB
ihlr-16572	449	54	discretionary	discretionary	ADJ
ihlr-16572	449	55	spending	spending	NOUN
ihlr-16572	449	56	equal	equal	ADJ
ihlr-16572	449	57	to	to	ADP
ihlr-16572	449	58	the	the	DET
ihlr-16572	449	59	estimated	estimate	VERB
ihlr-16572	449	60	amount	amount	NOUN
ihlr-16572	449	61	of	of	ADP
ihlr-16572	449	62	savings	saving	NOUN
ihlr-16572	449	63	to	to	ADP
ihlr-16572	449	64	the	the	DET
ihlr-16572	449	65	federal	federal	ADJ
ihlr-16572	449	66	government	government	NOUN
ihlr-16572	449	67	under	under	ADP
ihlr-16572	449	68	the	the	DET
ihlr-16572	449	69	legislation	legislation	NOUN
ihlr-16572	449	70	.	.	PUNCT
ihlr-16572	450	1	these	these	DET
ihlr-16572	450	2	sums	sum	NOUN
ihlr-16572	450	3	exclude	exclude	VERB
ihlr-16572	450	4	fda	fda	PROPN
ihlr-16572	450	5	's	's	PART
ihlr-16572	450	6	costs	cost	NOUN
ihlr-16572	450	7	to	to	PART
ihlr-16572	450	8	administer	administer	VERB
ihlr-16572	450	9	the	the	DET
ihlr-16572	450	10	new	new	ADJ
ihlr-16572	450	11	regulatory	regulatory	ADJ
ihlr-16572	450	12	program	program	NOUN
ihlr-16572	450	13	established	establish	VERB
ihlr-16572	450	14	under	under	ADP
ihlr-16572	450	15	the	the	DET
ihlr-16572	450	16	bill.132	bill.132	NOUN
ihlr-16572	450	17	[	[	X
ihlr-16572	450	18	vol	vol	NOUN
ihlr-16572	450	19	.	.	PUNCT
ihlr-16572	451	1	7:367	7:367	NUM
ihlr-16572	451	2	the	the	DET
ihlr-16572	451	3	bill	bill	NOUN
ihlr-16572	451	4	would	would	AUX
ihlr-16572	451	5	also	also	ADV
ihlr-16572	451	6	significantly	significantly	ADV
ihlr-16572	451	7	decrease	decrease	VERB
ihlr-16572	451	8	medicaid	medicaid	PROPN
ihlr-16572	451	9	expenditures	expenditure	NOUN
ihlr-16572	451	10	.	.	PUNCT
ihlr-16572	452	1	"	"	PUNCT
ihlr-16572	452	2	cbo	cbo	PROPN
ihlr-16572	452	3	estimates	estimate	VERB
ihlr-16572	452	4	that	that	SCONJ
ihlr-16572	452	5	state	state	NOUN
ihlr-16572	452	6	spending	spending	NOUN
ihlr-16572	452	7	for	for	ADP
ihlr-16572	452	8	medicaid	medicaid	PROPN
ihlr-16572	452	9	would	would	AUX
ihlr-16572	452	10	decrease	decrease	VERB
ihlr-16572	452	11	by	by	ADP
ihlr-16572	452	12	about	about	ADV
ihlr-16572	452	13	$	$	SYM
ihlr-16572	452	14	4	4	NUM
ihlr-16572	452	15	bil­	bil­	NOUN
ihlr-16572	452	16	lion	lion	NOUN
ihlr-16572	452	17	over	over	ADP
ihlr-16572	452	18	the	the	DET
ihlr-16572	452	19	2009	2009	NUM
ihlr-16572	452	20	-	-	SYM
ihlr-16572	452	21	2013	2013	NUM
ihlr-16572	452	22	period	period	NOUN
ihlr-16572	452	23	.	.	PUNCT
ihlr-16572	452	24	"133	"133	PROPN
ihlr-16572	453	1	bio	bio	PROPN
ihlr-16572	453	2	is	be	AUX
ihlr-16572	453	3	a	a	DET
ihlr-16572	453	4	proponent	proponent	NOUN
ihlr-16572	453	5	of	of	ADP
ihlr-16572	453	6	the	the	DET
ihlr-16572	453	7	pathway	pathway	NOUN
ihlr-16572	453	8	for	for	ADP
ihlr-16572	453	9	biosimilars	biosimilar	NOUN
ihlr-16572	453	10	act	act	PROPN
ihlr-16572	453	11	(	(	PUNCT
ihlr-16572	453	12	h.r	h.r	PROPN
ihlr-16572	453	13	.	.	PROPN
ihlr-16572	453	14	5629	5629	NUM
ihlr-16572	453	15	)	)	PUNCT
ihlr-16572	453	16	,	,	PUNCT
ihlr-16572	453	17	in1roduced	in1roduce	VERB
ihlr-16572	453	18	in	in	ADP
ihlr-16572	453	19	march	march	PROPN
ihlr-16572	453	20	of2008	of2008	NOUN
ihlr-16572	453	21	by	by	ADP
ihlr-16572	453	22	reps	rep	NOUN
ihlr-16572	453	23	.	.	PROPN
ihlr-16572	453	24	anna	anna	PROPN
ihlr-16572	453	25	eshoo	eshoo	PROPN
ihlr-16572	453	26	(	(	PUNCT
ihlr-16572	453	27	d	d	PROPN
ihlr-16572	453	28	,	,	PUNCT
ihlr-16572	453	29	calif	calif	PROPN
ihlr-16572	453	30	.	.	PUNCT
ihlr-16572	453	31	)	)	PUNCT
ihlr-16572	454	1	and	and	CCONJ
ihlr-16572	454	2	joe	joe	PROPN
ihlr-16572	454	3	bar­	bar­	PROPN
ihlr-16572	454	4	ton	ton	PROPN
ihlr-16572	454	5	(	(	PUNCT
ihlr-16572	454	6	r	r	NOUN
ihlr-16572	454	7	,	,	PUNCT
ihlr-16572	454	8	texas).134	texas).134	PROPN
ihlr-16572	454	9	this	this	DET
ihlr-16572	454	10	bill	bill	NOUN
ihlr-16572	454	11	would	would	AUX
ihlr-16572	454	12	provide	provide	VERB
ihlr-16572	454	13	innovators	innovator	NOUN
ihlr-16572	454	14	twelve	twelve	NUM
ihlr-16572	454	15	years	year	NOUN
ihlr-16572	454	16	of	of	ADP
ihlr-16572	454	17	ex­	ex­	NOUN
ihlr-16572	454	18	clusivity	clusivity	NOUN
ihlr-16572	454	19	,	,	PUNCT
ihlr-16572	454	20	and	and	CCONJ
ihlr-16572	454	21	a	a	DET
ihlr-16572	454	22	possible	possible	ADJ
ihlr-16572	454	23	two	two	NUM
ihlr-16572	454	24	-	-	PUNCT
ihlr-16572	454	25	year	year	NOUN
ihlr-16572	454	26	extension	extension	NOUN
ihlr-16572	454	27	if	if	SCONJ
ihlr-16572	454	28	a	a	DET
ihlr-16572	454	29	newly	newly	ADV
ihlr-16572	454	30	approved	approve	VERB
ihlr-16572	454	31	use	use	NOUN
ihlr-16572	454	32	of	of	ADP
ihlr-16572	454	33	the	the	DET
ihlr-16572	454	34	drug	drug	NOUN
ihlr-16572	454	35	is	be	AUX
ihlr-16572	454	36	discovered.135	discovered.135	PROPN
ihlr-16572	454	37	bio	bio	NOUN
ihlr-16572	454	38	contends	contend	VERB
ihlr-16572	454	39	that	that	SCONJ
ihlr-16572	454	40	fourteen	fourteen	NUM
ihlr-16572	454	41	years	year	NOUN
ihlr-16572	454	42	of	of	ADP
ihlr-16572	454	43	exclusivity	exclusivity	NOUN
ihlr-16572	454	44	is	be	AUX
ihlr-16572	454	45	130	130	NUM
ihlr-16572	454	46	.	.	PUNCT
ihlr-16572	455	1	cbo	cbo	PROPN
ihlr-16572	455	2	cost	cost	PROPN
ihlr-16572	455	3	estimate	estimate	NOUN
ihlr-16572	455	4	,	,	PUNCT
ihlr-16572	455	5	supra	supra	PROPN
ihlr-16572	455	6	note	note	PROPN
ihlr-16572	455	7	127	127	NUM
ihlr-16572	455	8	,	,	PUNCT
ihlr-16572	455	9	at	at	ADP
ihlr-16572	455	10	1	1	NUM
ihlr-16572	455	11	.	.	PUNCT
ihlr-16572	455	12	131	131	NUM
ihlr-16572	455	13	.	.	PUNCT
ihlr-16572	456	1	i	i	PRON
ihlr-16572	456	2	d.	d.	PROPN
ihlr-16572	456	3	132	132	NUM
ihlr-16572	456	4	.	.	PUNCT
ihlr-16572	457	1	i	i	PRON
ihlr-16572	457	2	d.	d.	PROPN
ihlr-16572	457	3	at	at	ADP
ihlr-16572	457	4	2	2	NUM
ihlr-16572	457	5	.	.	PUNCT
ihlr-16572	457	6	133	133	NUM
ihlr-16572	457	7	.	.	PUNCT
ihlr-16572	458	1	i	i	PRON
ihlr-16572	458	2	d.	d.	PROPN
ihlr-16572	458	3	at	at	ADP
ihlr-16572	458	4	10	10	NUM
ihlr-16572	458	5	.	.	PUNCT
ihlr-16572	458	6	134	134	NUM
ihlr-16572	458	7	.	.	PUNCT
ihlr-16572	459	1	doug	doug	PROPN
ihlr-16572	459	2	trapp	trapp	PROPN
ihlr-16572	459	3	,	,	PUNCT
ihlr-16572	459	4	disagreements	disagreement	VERB
ihlr-16572	459	5	slow	slow	ADJ
ihlr-16572	459	6	progress	progress	NOUN
ihlr-16572	459	7	on	on	ADP
ihlr-16572	459	8	biogenerics	biogeneric	NOUN
ihlr-16572	459	9	legislation	legislation	NOUN
ihlr-16572	459	10	,	,	PUNCT
ihlr-16572	459	11	american	american	PROPN
ihlr-16572	459	12	medical	medical	PROPN
ihlr-16572	459	13	news	news	PROPN
ihlr-16572	459	14	,	,	PUNCT
ihlr-16572	459	15	aug	aug	PROPN
ihlr-16572	459	16	.	.	PROPN
ihlr-16572	459	17	11	11	NUM
ihlr-16572	459	18	,	,	PUNCT
ihlr-16572	459	19	2008	2008	NUM
ihlr-16572	459	20	,	,	PUNCT
ihlr-16572	459	21	http://www.ama	http://www.ama	PROPN
ihlr-16572	459	22	-	-	PUNCT
ihlr-16572	459	23	assn.orglamednewsl2008/08/11	assn.orglamednewsl2008/08/11	NOUN
ihlr-16572	459	24	/	/	SYM
ihlr-16572	459	25	gvsa0811	gvsa0811	PROPN
ihlr-16572	459	26	.	.	PUNCT
ihlr-16572	460	1	htm	htm	PROPN
ihlr-16572	460	2	(	(	PUNCT
ihlr-16572	460	3	last	last	ADV
ihlr-16572	460	4	visited	visit	VERB
ihlr-16572	460	5	mar	mar	PROPN
ihlr-16572	460	6	.	.	PROPN
ihlr-16572	460	7	6	6	NUM
ihlr-16572	460	8	,	,	PUNCT
ihlr-16572	460	9	20	20	NUM
ihlr-16572	460	10	i	i	NOUN
ihlr-16572	460	11	0	0	NUM
ihlr-16572	460	12	)	)	PUNCT
ihlr-16572	460	13	.	.	PUNCT
ihlr-16572	461	1	135	135	NUM
ihlr-16572	461	2	.	.	PUNCT
ihlr-16572	462	1	i	i	PRON
ihlr-16572	462	2	d.	d.	PROPN
ihlr-16572	462	3	2010	2010	NUM
ihlr-16572	462	4	]	]	PUNCT
ihlr-16572	462	5	'	'	PUNCT
ihlr-16572	462	6	follow	follow	VERB
ihlr-16572	462	7	-	-	PUNCT
ihlr-16572	462	8	on	on	ADP
ihlr-16572	462	9	biologics	biologic	NOUN
ihlr-16572	462	10	legislation	legislation	NOUN
ihlr-16572	462	11	387	387	NUM
ihlr-16572	462	12	necessary	necessary	ADJ
ihlr-16572	462	13	to	to	PART
ihlr-16572	462	14	maintain	maintain	VERB
ihlr-16572	462	15	the	the	DET
ihlr-16572	462	16	requisite	requisite	ADJ
ihlr-16572	462	17	incentives	incentive	NOUN
ihlr-16572	462	18	to	to	PART
ihlr-16572	462	19	research	research	VERB
ihlr-16572	462	20	and	and	CCONJ
ihlr-16572	462	21	develop	develop	VERB
ihlr-16572	462	22	new	new	ADJ
ihlr-16572	462	23	biologics.136	biologics.136	PROPN
ihlr-16572	462	24	the	the	DET
ihlr-16572	462	25	generic	generic	ADJ
ihlr-16572	462	26	pharmaceutical	pharmaceutical	PROPN
ihlr-16572	462	27	association	association	NOUN
ihlr-16572	462	28	(	(	PUNCT
ihlr-16572	462	29	"	"	PUNCT
ihlr-16572	462	30	gpha	gpha	NOUN
ihlr-16572	462	31	"	"	PUNCT
ihlr-16572	462	32	)	)	PUNCT
ihlr-16572	462	33	opposes	oppose	VERB
ihlr-16572	462	34	the	the	DET
ihlr-16572	462	35	pathway	pathway	NOUN
ihlr-16572	462	36	for	for	ADP
ihlr-16572	462	37	biosimilars	biosimilar	NOUN
ihlr-16572	462	38	act	act	PROPN
ihlr-16572	462	39	.	.	PUNCT
ihlr-16572	463	1	137	137	NUM
ihlr-16572	463	2	gpha	gpha	PROPN
ihlr-16572	463	3	spokeswoman	spokeswoman	NOUN
ihlr-16572	463	4	andrea	andrea	PROPN
ihlr-16572	463	5	hofelich	hofelich	PROPN
ihlr-16572	463	6	stated	state	VERB
ihlr-16572	463	7	that	that	SCONJ
ihlr-16572	463	8	this	this	DET
ihlr-16572	463	9	legislation	legislation	NOUN
ihlr-16572	463	10	is	be	AUX
ihlr-16572	463	11	"	"	PUNCT
ihlr-16572	463	12	will	will	AUX
ihlr-16572	463	13	needlessly	needlessly	ADV
ihlr-16572	463	14	delay	delay	VERB
ihlr-16572	463	15	affordable	affordable	ADJ
ihlr-16572	463	16	.	.	PUNCT
ihlr-16572	464	1	lifesaving	lifesave	VERB
ihlr-16572	464	2	biogenerics	biogeneric	NOUN
ihlr-16572	464	3	form	form	NOUN
ihlr-16572	464	4	getting	get	VERB
ihlr-16572	464	5	to	to	ADP
ihlr-16572	464	6	[	[	X
ihlr-16572	464	7	patients]."138	patients]."138	PROPN
ihlr-16572	464	8	the	the	DET
ihlr-16572	464	9	most	most	ADJ
ihlr-16572	464	10	imgortant	imgortant	NOUN
ihlr-16572	464	11	of	of	ADP
ihlr-16572	464	12	these	these	DET
ihlr-16572	464	13	roadblocks	roadblock	NOUN
ihlr-16572	464	14	is	be	AUX
ihlr-16572	464	15	the	the	DET
ihlr-16572	464	16	potential	potential	NOUN
ihlr-16572	464	17	of	of	ADP
ihlr-16572	464	18	fourteen	fourteen	NUM
ihlr-16572	464	19	years	year	NOUN
ihlr-16572	464	20	of	of	ADP
ihlr-16572	464	21	exclusivity	exclusivity	NOUN
ihlr-16572	464	22	.	.	PUNCT
ihlr-16572	465	1	39	39	NUM
ihlr-16572	465	2	this	this	DET
ihlr-16572	465	3	lengthy	lengthy	ADJ
ihlr-16572	465	4	monopoly	monopoly	NOUN
ihlr-16572	465	5	protection	protection	NOUN
ihlr-16572	465	6	is	be	AUX
ihlr-16572	465	7	in	in	ADP
ihlr-16572	465	8	stark	stark	ADJ
ihlr-16572	465	9	contrast	contrast	NOUN
ihlr-16572	465	10	to	to	ADP
ihlr-16572	465	11	the	the	DET
ihlr-16572	465	12	five	five	NUM
ihlr-16572	465	13	years	year	NOUN
ihlr-16572	465	14	of	of	ADP
ihlr-16572	465	15	exclusivity	exclusivity	NOUN
ihlr-16572	465	16	chemical	chemical	NOUN
ihlr-16572	465	17	drugs	drug	NOUN
ihlr-16572	465	18	are	be	AUX
ihlr-16572	465	19	afforded	afford	VERB
ihlr-16572	465	20	under	under	ADP
ihlr-16572	465	21	hatch	hatch	NOUN
ihlr-16572	465	22	-	-	NOUN
ihlr-16572	465	23	waxman.140	waxman.140	NOUN
ihlr-16572	465	24	"	"	PUNCT
ihlr-16572	465	25	the	the	DET
ihlr-16572	465	26	eshoo	eshoo	ADJ
ihlr-16572	465	27	-	-	PUNCT
ihlr-16572	465	28	barton	barton	NOUN
ihlr-16572	465	29	legislation	legislation	NOUN
ihlr-16572	465	30	has	have	AUX
ihlr-16572	465	31	been	be	AUX
ihlr-16572	465	32	endorsed	endorse	VERB
ihlr-16572	465	33	by	by	ADP
ihlr-16572	465	34	the	the	DET
ihlr-16572	465	35	pharmaceuti­	pharmaceuti­	NOUN
ihlr-16572	465	36	cal	cal	X
ihlr-16572	465	37	research	research	NOUN
ihlr-16572	465	38	and	and	CCONJ
ihlr-16572	465	39	manufacturers	manufacturer	NOUN
ihlr-16572	465	40	of	of	ADP
ihlr-16572	465	41	america	america	PROPN
ihlr-16572	465	42	and	and	CCONJ
ihlr-16572	465	43	the	the	DET
ihlr-16572	465	44	[	[	X
ihlr-16572	465	45	association	association	NOUN
ihlr-16572	465	46	]	]	PUNCT
ihlr-16572	465	47	of	of	ADP
ihlr-16572	465	48	amer­	amer­	PROPN
ihlr-16572	465	49	ican	ican	ADJ
ihlr-16572	465	50	universities	university	NOUN
ihlr-16572	465	51	.	.	PUNCT
ihlr-16572	465	52	"141	"141	PUNCT
ihlr-16572	466	1	the	the	DET
ihlr-16572	466	2	gpha	gpha	NOUN
ihlr-16572	466	3	prefers	prefer	VERB
ihlr-16572	466	4	the	the	DET
ihlr-16572	466	5	promoting	promote	VERB
ihlr-16572	466	6	innovation	innovation	NOUN
ihlr-16572	466	7	and	and	CCONJ
ihlr-16572	466	8	access	access	NOUN
ihlr-16572	466	9	to	to	ADP
ihlr-16572	466	10	life	life	NOUN
ihlr-16572	466	11	-	-	PUNCT
ihlr-16572	466	12	saving	save	VERB
ihlr-16572	466	13	medicine	medicine	NOUN
ihlr-16572	466	14	act	act	NOUN
ihlr-16572	466	15	,	,	PUNCT
ihlr-16572	466	16	sponsored	sponsor	VERB
ihlr-16572	466	17	by	by	ADP
ihlr-16572	466	18	representative	representative	ADJ
ihlr-16572	466	19	henry	henry	PROPN
ihlr-16572	466	20	waxman.142	waxman.142	PROPN
ihlr-16572	466	21	this	this	DET
ihlr-16572	466	22	bill	bill	NOUN
ihlr-16572	466	23	is	be	AUX
ihlr-16572	466	24	very	very	ADV
ihlr-16572	466	25	similar	similar	ADJ
ihlr-16572	466	26	to	to	ADP
ihlr-16572	466	27	the	the	DET
ihlr-16572	466	28	hatch	hatch	NOUN
ihlr-16572	466	29	-	-	PUNCT
ihlr-16572	466	30	waxman	waxman	PROPN
ihlr-16572	466	31	act	act	PROPN
ihlr-16572	466	32	,	,	PUNCT
ihlr-16572	466	33	and	and	CCONJ
ihlr-16572	466	34	would	would	AUX
ihlr-16572	466	35	require	require	VERB
ihlr-16572	466	36	similar	similar	ADJ
ihlr-16572	466	37	steps	step	NOUN
ihlr-16572	466	38	to	to	PART
ihlr-16572	466	39	be	be	AUX
ihlr-16572	466	40	taken	take	VERB
ihlr-16572	466	41	for	for	ADP
ihlr-16572	466	42	biogeneric	biogeneric	ADJ
ihlr-16572	466	43	approval	approval	NOUN
ihlr-16572	466	44	as	as	SCONJ
ihlr-16572	466	45	would	would	AUX
ihlr-16572	466	46	be	be	AUX
ihlr-16572	466	47	taken	take	VERB
ihlr-16572	466	48	for	for	ADP
ihlr-16572	466	49	chemical	chemical	ADJ
ihlr-16572	466	50	generic	generic	ADJ
ihlr-16572	466	51	drug	drug	NOUN
ihlr-16572	466	52	approval	approval	NOUN
ihlr-16572	466	53	.	.	PUNCT
ihlr-16572	467	1	143	143	NUM
ihlr-16572	467	2	proponents	proponent	NOUN
ihlr-16572	467	3	of	of	ADP
ihlr-16572	467	4	the	the	DET
ihlr-16572	467	5	promoting	promote	VERB
ihlr-16572	467	6	inno­	inno­	PRON
ihlr-16572	467	7	vation	vation	NOUN
ihlr-16572	467	8	and	and	CCONJ
ihlr-16572	467	9	access	access	NOUN
ihlr-16572	467	10	to	to	ADP
ihlr-16572	467	11	life	life	NOUN
ihlr-16572	467	12	-	-	PUNCT
ihlr-16572	467	13	saving	save	VERB
ihlr-16572	467	14	medicine	medicine	NOUN
ihlr-16572	467	15	act	act	NOUN
ihlr-16572	467	16	cite	cite	VERB
ihlr-16572	467	17	a	a	DET
ihlr-16572	467	18	2007	2007	NUM
ihlr-16572	467	19	study	study	NOUN
ihlr-16572	467	20	by	by	ADP
ihlr-16572	467	21	duke	duke	PROPN
ihlr-16572	467	22	university	university	PROPN
ihlr-16572	467	23	economist	economist	NOUN
ihlr-16572	467	24	henry	henry	PROPN
ihlr-16572	467	25	grabowski	grabowski	PROPN
ihlr-16572	467	26	which	which	PRON
ihlr-16572	467	27	concluded	conclude	VERB
ihlr-16572	467	28	that	that	SCONJ
ihlr-16572	467	29	the	the	DET
ihlr-16572	467	30	average	average	ADJ
ihlr-16572	467	31	time	time	NOUN
ihlr-16572	467	32	to	to	PART
ihlr-16572	467	33	develop	develop	VERB
ihlr-16572	467	34	a	a	DET
ihlr-16572	467	35	new	new	ADJ
ihlr-16572	467	36	biologic	biologic	NOUN
ihlr-16572	467	37	was	be	AUX
ihlr-16572	467	38	97.7	97.7	NUM
ihlr-16572	467	39	months	month	NOUN
ihlr-16572	467	40	,	,	PUNCT
ihlr-16572	467	41	while	while	SCONJ
ihlr-16572	467	42	the	the	DET
ihlr-16572	467	43	development	development	NOUN
ihlr-16572	467	44	of	of	ADP
ihlr-16572	467	45	new	new	ADJ
ihlr-16572	467	46	chemical	chemical	NOUN
ihlr-16572	467	47	drugs	drug	NOUN
ihlr-16572	467	48	averaged	average	VERB
ihlr-16572	467	49	90.3	90.3	NUM
ihlr-16572	467	50	months.144	months.144	ADJ
ihlr-16572	467	51	gpha	gpha	NOUN
ihlr-16572	467	52	asserts	assert	VERB
ihlr-16572	467	53	that	that	SCONJ
ihlr-16572	467	54	this	this	PRON
ihlr-16572	467	55	is	be	AUX
ihlr-16572	467	56	not	not	PART
ihlr-16572	467	57	a	a	DET
ihlr-16572	467	58	significantly	significantly	ADV
ihlr-16572	467	59	different	different	ADJ
ihlr-16572	467	60	timetable	timetable	NOUN
ihlr-16572	467	61	,	,	PUNCT
ihlr-16572	467	62	and	and	CCONJ
ihlr-16572	467	63	that	that	DET
ihlr-16572	467	64	regulation	regulation	NOUN
ihlr-16572	467	65	of	of	ADP
ihlr-16572	467	66	follow	follow	NOUN
ihlr-16572	467	67	-	-	PUNCT
ihlr-16572	467	68	on	on	ADP
ihlr-16572	467	69	biolog­	biolog­	NOUN
ihlr-16572	467	70	ics	ics	NOUN
ihlr-16572	467	71	should	should	AUX
ihlr-16572	467	72	closely	closely	ADV
ihlr-16572	467	73	mirror	mirror	VERB
ihlr-16572	467	74	that	that	PRON
ihlr-16572	467	75	of	of	ADP
ihlr-16572	467	76	chemical	chemical	ADJ
ihlr-16572	467	77	generic	generic	ADJ
ihlr-16572	467	78	drugs	drug	NOUN
ihlr-16572	467	79	.	.	PUNCT
ihlr-16572	468	1	145	145	NUM
ihlr-16572	468	2	f.	f.	PROPN
ihlr-16572	468	3	shorter	short	ADJ
ihlr-16572	468	4	exclusivity	exclusivity	NOUN
ihlr-16572	468	5	periods	period	NOUN
ihlr-16572	468	6	may	may	AUX
ihlr-16572	468	7	actually	actually	ADV
ihlr-16572	468	8	promote	promote	VERB
ihlr-16572	468	9	innovation	innovation	NOUN
ihlr-16572	468	10	.	.	PUNCT
ihlr-16572	469	1	a	a	DET
ihlr-16572	469	2	recent	recent	ADJ
ihlr-16572	469	3	study	study	NOUN
ihlr-16572	469	4	by	by	ADP
ihlr-16572	469	5	dr	dr	PROPN
ihlr-16572	469	6	.	.	PROPN
ihlr-16572	469	7	laurence	laurence	PROPN
ihlr-16572	469	8	j.	j.	PROPN
ihlr-16572	469	9	kotlikoff	kotlikoff	PROPN
ihlr-16572	469	10	,	,	PUNCT
ihlr-16572	469	11	professor	professor	NOUN
ihlr-16572	469	12	of	of	ADP
ihlr-16572	469	13	economics	economic	NOUN
ihlr-16572	469	14	at	at	ADP
ihlr-16572	469	15	boston	boston	PROPN
ihlr-16572	469	16	university	university	PROPN
ihlr-16572	469	17	,	,	PUNCT
ihlr-16572	469	18	suggests	suggest	VERB
ihlr-16572	469	19	that	that	SCONJ
ihlr-16572	469	20	length	length	NOUN
ihlr-16572	469	21	exclusivity	exclusivity	NOUN
ihlr-16572	469	22	projections	projection	NOUN
ihlr-16572	469	23	for	for	ADP
ihlr-16572	469	24	manu­	manu­	PROPN
ihlr-16572	469	25	facturers	facturer	NOUN
ihlr-16572	469	26	of	of	ADP
ihlr-16572	469	27	biologics	biologic	NOUN
ihlr-16572	469	28	not	not	PART
ihlr-16572	469	29	only	only	ADV
ihlr-16572	469	30	results	result	NOUN
ihlr-16572	469	31	in	in	ADP
ihlr-16572	469	32	these	these	DET
ihlr-16572	469	33	drugs	drug	NOUN
ihlr-16572	469	34	'	'	PART
ihlr-16572	469	35	high	high	ADJ
ihlr-16572	469	36	price	price	NOUN
ihlr-16572	469	37	,	,	PUNCT
ihlr-16572	469	38	but	but	CCONJ
ihlr-16572	469	39	also	also	ADV
ihlr-16572	469	40	136	136	NUM
ihlr-16572	469	41	.	.	PUNCT
ihlr-16572	470	1	letter	letter	NOUN
ihlr-16572	470	2	from	from	ADP
ihlr-16572	470	3	john	john	PROPN
ihlr-16572	470	4	taylor	taylor	PROPN
ihlr-16572	470	5	,	,	PUNCT
ihlr-16572	470	6	supra	supra	PROPN
ihlr-16572	470	7	note	note	NOUN
ihlr-16572	470	8	7	7	NUM
ihlr-16572	470	9	.	.	NOUN
ihlr-16572	470	10	13	13	NUM
ihlr-16572	470	11	7	7	NUM
ihlr-16572	470	12	.	.	PUNCT
ihlr-16572	470	13	press	press	NOUN
ihlr-16572	470	14	release	release	NOUN
ihlr-16572	470	15	,	,	PUNCT
ihlr-16572	470	16	the	the	DET
ihlr-16572	470	17	generic	generic	ADJ
ihlr-16572	470	18	pharmaceutical	pharmaceutical	PROPN
ihlr-16572	470	19	association	association	PROPN
ihlr-16572	470	20	,	,	PUNCT
ihlr-16572	470	21	gpha	gpha	PROPN
ihlr-16572	470	22	says	say	VERB
ihlr-16572	470	23	new	new	ADJ
ihlr-16572	470	24	study	study	NOUN
ihlr-16572	470	25	shows	show	VERB
ihlr-16572	470	26	that	that	SCONJ
ihlr-16572	470	27	hatch	hatch	NOUN
ihlr-16572	470	28	-	-	PUNCT
ihlr-16572	470	29	waxman	waxman	NOUN
ihlr-16572	470	30	is	be	AUX
ihlr-16572	470	31	a	a	DET
ihlr-16572	470	32	successful	successful	ADJ
ihlr-16572	470	33	model	model	NOUN
ihlr-16572	470	34	for	for	ADP
ihlr-16572	470	35	biogenerics	biogeneric	NOUN
ihlr-16572	470	36	legislation	legislation	NOUN
ihlr-16572	470	37	exclusivity	exclusivity	NOUN
ihlr-16572	470	38	provisions	provision	NOUN
ihlr-16572	470	39	similar	similar	ADJ
ihlr-16572	470	40	to	to	ADP
ihlr-16572	470	41	those	those	PRON
ihlr-16572	470	42	in	in	ADP
ihlr-16572	470	43	hatch	hatch	NOUN
ihlr-16572	470	44	-	-	PUNCT
ihlr-16572	470	45	waxman	waxman	NOUN
ihlr-16572	470	46	would	would	AUX
ihlr-16572	470	47	promote	promote	VERB
ihlr-16572	470	48	competition	competition	NOUN
ihlr-16572	470	49	and	and	CCONJ
ihlr-16572	470	50	innovation	innovation	NOUN
ihlr-16572	470	51	(	(	PUNCT
ihlr-16572	470	52	september	september	PROPN
ihlr-16572	470	53	17	17	NUM
ihlr-16572	470	54	,	,	PUNCT
ihlr-16572	470	55	2008	2008	NUM
ihlr-16572	470	56	)	)	PUNCT
ihlr-16572	470	57	,	,	PUNCT
ihlr-16572	470	58	available	available	ADJ
ihlr-16572	470	59	at	at	ADP
ihlr-16572	470	60	ht1p://www.gphaonline.org/media/press-releases/2009/02/12/gpha-says-new­	ht1p://www.gphaonline.org/media/press-releases/2009/02/12/gpha-says-new­	PROPN
ihlr-16572	470	61	study	study	NOUN
ihlr-16572	470	62	-	-	PUNCT
ihlr-16572	470	63	shows	show	NOUN
ihlr-16572	470	64	-	-	PUNCT
ihlr-16572	470	65	hatch	hatch	NOUN
ihlr-16572	470	66	-	-	PUNCT
ihlr-16572	470	67	waxman	waxman	NOUN
ihlr-16572	470	68	-	-	PUNCT
ihlr-16572	470	69	successful	successful	ADJ
ihlr-16572	470	70	-	-	PUNCT
ihlr-16572	470	71	model	model	NOUN
ihlr-16572	470	72	-	-	PUNCT
ihlr-16572	470	73	biogenerics(last	biogenerics(last	NOUN
ihlr-16572	470	74	visited	visit	VERB
ihlr-16572	470	75	mar	mar	PROPN
ihlr-16572	470	76	.	.	PROPN
ihlr-16572	470	77	7	7	NUM
ihlr-16572	470	78	,	,	PUNCT
ihlr-16572	470	79	201	201	NUM
ihlr-16572	470	80	0	0	NUM
ihlr-16572	470	81	)	)	PUNCT
ihlr-16572	471	1	[	[	X
ihlr-16572	471	2	hereinafter	hereinafter	NOUN
ihlr-16572	471	3	"	"	PUNCT
ihlr-16572	471	4	gpha	gpha	ADJ
ihlr-16572	471	5	press	press	NOUN
ihlr-16572	471	6	release	release	NOUN
ihlr-16572	471	7	ii	ii	NOUN
ihlr-16572	471	8	"	"	PUNCT
ihlr-16572	471	9	]	]	X
ihlr-16572	471	10	.	.	PUNCT
ihlr-16572	471	11	138	138	NUM
ihlr-16572	471	12	.	.	PUNCT
ihlr-16572	471	13	!	!	PUNCT
ihlr-16572	472	1	d.	d.	PROPN
ihlr-16572	472	2	139	139	NUM
ihlr-16572	472	3	.	.	PUNCT
ihlr-16572	473	1	h.r	h.r	PROPN
ihlr-16572	473	2	.	.	PROPN
ihlr-16572	473	3	5629	5629	NUM
ihlr-16572	473	4	,	,	PUNCT
ihlr-16572	473	5	§	§	NOUN
ihlr-16572	473	6	7(a	7(a	NUM
ihlr-16572	473	7	)	)	PUNCT
ihlr-16572	473	8	.	.	PUNCT
ihlr-16572	474	1	140	140	NUM
ihlr-16572	474	2	.	.	PUNCT
ihlr-16572	474	3	drug	drug	NOUN
ihlr-16572	474	4	price	price	NOUN
ihlr-16572	474	5	competition	competition	NOUN
ihlr-16572	474	6	and	and	CCONJ
ihlr-16572	474	7	patent	patent	NOUN
ihlr-16572	474	8	term	term	NOUN
ihlr-16572	474	9	restoration	restoration	NOUN
ihlr-16572	474	10	act	act	NOUN
ihlr-16572	474	11	,	,	PUNCT
ihlr-16572	474	12	pub	pub	NOUN
ihlr-16572	474	13	.	.	PUNCT
ihlr-16572	475	1	l.	l.	PROPN
ihlr-16572	475	2	no	no	INTJ
ihlr-16572	475	3	.	.	PROPN
ihlr-16572	476	1	98	98	NUM
ihlr-16572	476	2	-	-	SYM
ihlr-16572	476	3	417	417	NUM
ihlr-16572	476	4	(	(	PUNCT
ihlr-16572	476	5	1984	1984	NUM
ihlr-16572	476	6	)	)	PUNCT
ihlr-16572	476	7	,	,	PUNCT
ihlr-16572	476	8	98	98	NUM
ihlr-16572	476	9	stat	stat	NOUN
ihlr-16572	476	10	.	.	PUNCT
ihlr-16572	477	1	1585	1585	NUM
ihlr-16572	477	2	(	(	PUNCT
ihlr-16572	477	3	1984	1984	NUM
ihlr-16572	477	4	)	)	PUNCT
ihlr-16572	477	5	.	.	PUNCT
ihlr-16572	478	1	141	141	NUM
ihlr-16572	478	2	.	.	X
ihlr-16572	479	1	trapp	trapp	PROPN
ihlr-16572	479	2	,	,	PUNCT
ihlr-16572	479	3	supra	supra	PROPN
ihlr-16572	479	4	note	note	PROPN
ihlr-16572	479	5	134	134	NUM
ihlr-16572	479	6	.	.	PUNCT
ihlr-16572	479	7	142	142	NUM
ihlr-16572	479	8	.	.	PUNCT
ihlr-16572	480	1	i	i	PRON
ihlr-16572	480	2	d	d	PROPN
ihlr-16572	480	3	143	143	PROPN
ihlr-16572	480	4	.	.	PUNCT
ihlr-16572	481	1	see	see	VERB
ihlr-16572	481	2	promoting	promote	VERB
ihlr-16572	481	3	innovation	innovation	NOUN
ihlr-16572	481	4	and	and	CCONJ
ihlr-16572	481	5	access	access	NOUN
ihlr-16572	481	6	to	to	ADP
ihlr-16572	481	7	life	life	NOUN
ihlr-16572	481	8	-	-	PUNCT
ihlr-16572	481	9	saving	save	VERB
ihlr-16572	481	10	medicine	medicine	NOUN
ihlr-16572	481	11	act	act	PROPN
ihlr-16572	481	12	,	,	PUNCT
ihlr-16572	481	13	h.r	h.r	PROPN
ihlr-16572	481	14	.	.	PROPN
ihlr-16572	481	15	1427	1427	NUM
ihlr-16572	481	16	,	,	PUNCT
ihlr-16572	481	17	ill	ill	ADJ
ihlr-16572	481	18	th	th	X
ihlr-16572	481	19	con	con	X
ihlr-16572	481	20	g.	g.	PROPN
ihlr-16572	481	21	(	(	PUNCT
ihlr-16572	481	22	2009	2009	NUM
ihlr-16572	481	23	)	)	PUNCT
ihlr-16572	481	24	.	.	PUNCT
ihlr-16572	482	1	this	this	DET
ihlr-16572	482	2	piece	piece	NOUN
ihlr-16572	482	3	of	of	ADP
ihlr-16572	482	4	legislation	legislation	NOUN
ihlr-16572	482	5	was	be	AUX
ihlr-16572	482	6	first	first	ADV
ihlr-16572	482	7	introduced	introduce	VERB
ihlr-16572	482	8	on	on	ADP
ihlr-16572	482	9	march	march	PROPN
ihlr-16572	482	10	11	11	NUM
ihlr-16572	482	11	,	,	PUNCT
ihlr-16572	482	12	2007	2007	NUM
ihlr-16572	482	13	and	and	CCONJ
ihlr-16572	482	14	was	be	AUX
ihlr-16572	482	15	entitled	entitle	VERB
ihlr-16572	482	16	the	the	DET
ihlr-16572	482	17	access	access	NOUN
ihlr-16572	482	18	to	to	ADP
ihlr-16572	482	19	life	life	NOUN
ihlr-16572	482	20	-	-	PUNCT
ihlr-16572	482	21	saving	save	VERB
ihlr-16572	482	22	medicine	medicine	NOUN
ihlr-16572	482	23	act	act	NOUN
ihlr-16572	482	24	.	.	PUNCT
ihlr-16572	483	1	it	it	PRON
ihlr-16572	483	2	was	be	AUX
ihlr-16572	483	3	later	later	ADV
ihlr-16572	483	4	modified	modify	VERB
ihlr-16572	483	5	to	to	ADP
ihlr-16572	483	6	its	its	PRON
ihlr-16572	483	7	current	current	ADJ
ihlr-16572	483	8	form	form	NOUN
ihlr-16572	483	9	.	.	PUNCT
ihlr-16572	484	1	144	144	NUM
ihlr-16572	484	2	.	.	PUNCT
ihlr-16572	485	1	henry	henry	PROPN
ihlr-16572	485	2	grabowski	grabowski	PROPN
ihlr-16572	485	3	,	,	PUNCT
ihlr-16572	485	4	follow	follow	VERB
ihlr-16572	485	5	-	-	PUNCT
ihlr-16572	485	6	on	on	ADP
ihlr-16572	485	7	biologics	biologic	NOUN
ihlr-16572	485	8	:	:	PUNCT
ihlr-16572	485	9	data	datum	NOUN
ihlr-16572	485	10	exclusivity	exclusivity	NOUN
ihlr-16572	485	11	and	and	CCONJ
ihlr-16572	485	12	the	the	DET
ihlr-16572	485	13	balance	balance	NOUN
ihlr-16572	485	14	be­	be­	PUNCT
ihlr-16572	485	15	tween	tween	NOUN
ihlr-16572	485	16	innovation	innovation	NOUN
ihlr-16572	485	17	and	and	CCONJ
ihlr-16572	485	18	competition	competition	NOUN
ihlr-16572	485	19	,	,	PUNCT
ihlr-16572	485	20	7	7	NUM
ihlr-16572	485	21	nature	nature	NOUN
ihlr-16572	485	22	reviews	review	NOUN
ihlr-16572	485	23	:	:	PUNCT
ihlr-16572	485	24	drug	drug	NOUN
ihlr-16572	485	25	discovery	discovery	NOUN
ihlr-16572	485	26	4	4	NUM
ihlr-16572	485	27	79	79	NUM
ihlr-16572	485	28	,	,	PUNCT
ihlr-16572	485	29	481	481	NUM
ihlr-16572	485	30	(	(	PUNCT
ihlr-16572	485	31	2008	2008	NUM
ihlr-16572	485	32	)	)	PUNCT
ihlr-16572	485	33	.	.	PUNCT
ihlr-16572	486	1	145	145	NUM
ihlr-16572	486	2	.	.	PUNCT
ihlr-16572	487	1	gpha	gpha	PROPN
ihlr-16572	487	2	press	press	PROPN
ihlr-16572	487	3	release	release	PROPN
ihlr-16572	487	4	ii	ii	PROPN
ihlr-16572	487	5	,	,	PUNCT
ihlr-16572	487	6	supra	supra	PROPN
ihlr-16572	487	7	note	note	VERB
ihlr-16572	487	8	13	13	NUM
ihlr-16572	487	9	7	7	NUM
ihlr-16572	487	10	.	.	X
ihlr-16572	487	11	388	388	NUM
ihlr-16572	487	12	indiana	indiana	PROPN
ihlr-16572	487	13	health	health	PROPN
ihlr-16572	487	14	law	law	PROPN
ihlr-16572	487	15	review	review	NOUN
ihlr-16572	487	16	actually	actually	ADV
ihlr-16572	487	17	stifles	stifle	VERB
ihlr-16572	487	18	innovation	innovation	NOUN
ihlr-16572	487	19	:	:	PUNCT
ihlr-16572	487	20	four	four	NUM
ihlr-16572	487	21	bills	bill	NOUN
ihlr-16572	487	22	pending	pende	VERB
ihlr-16572	487	23	in	in	ADP
ihlr-16572	487	24	congress	congress	PROPN
ihlr-16572	487	25	propose	propose	VERB
ihlr-16572	487	26	to	to	PART
ihlr-16572	487	27	do	do	VERB
ihlr-16572	487	28	for	for	ADP
ihlr-16572	487	29	bi­	bi­	NOUN
ihlr-16572	487	30	ologic	ologic	ADJ
ihlr-16572	487	31	medications	medication	NOUN
ihlr-16572	487	32	what	what	PRON
ihlr-16572	487	33	the	the	DET
ihlr-16572	487	34	1984	1984	NUM
ihlr-16572	487	35	landmark	landmark	PROPN
ihlr-16572	487	36	hatch­	hatch­	PROPN
ihlr-16572	487	37	waxman	waxman	PROPN
ihlr-16572	487	38	bill	bill	PROPN
ihlr-16572	487	39	did	do	VERB
ihlr-16572	487	40	for	for	ADP
ihlr-16572	487	41	chemical	chemical	NOUN
ihlr-16572	487	42	medications	medication	NOUN
ihlr-16572	487	43	,	,	PUNCT
ihlr-16572	487	44	namely	namely	ADV
ihlr-16572	487	45	,	,	PUNCT
ihlr-16572	487	46	promote	promote	VERB
ihlr-16572	487	47	a	a	DET
ihlr-16572	487	48	competitive	competitive	ADJ
ihlr-16572	487	49	marketplace	marketplace	NOUN
ihlr-16572	487	50	that	that	PRON
ihlr-16572	487	51	would	would	AUX
ihlr-16572	487	52	dra­	dra­	VERB
ihlr-16572	487	53	matically	matically	ADV
ihlr-16572	487	54	lower	low	ADJ
ihlr-16572	487	55	prices	price	NOUN
ihlr-16572	487	56	while	while	SCONJ
ihlr-16572	487	57	also	also	ADV
ihlr-16572	487	58	ensuring	ensure	VERB
ihlr-16572	487	59	strong	strong	ADJ
ihlr-16572	487	60	in­	in­	NOUN
ihlr-16572	487	61	centives	centive	NOUN
ihlr-16572	487	62	to	to	PART
ihlr-16572	487	63	innovate	innovate	VERB
ihlr-16572	487	64	.	.	PUNCT
ihlr-16572	488	1	yet	yet	ADV
ihlr-16572	488	2	three	three	NUM
ihlr-16572	488	3	of	of	ADP
ihlr-16572	488	4	the	the	DET
ihlr-16572	488	5	four	four	NUM
ihlr-16572	488	6	bills	bill	NOUN
ihlr-16572	488	7	contain	contain	VERB
ihlr-16572	488	8	exclusivity	exclusivity	NOUN
ihlr-16572	488	9	provisions	provision	NOUN
ihlr-16572	488	10	that	that	PRON
ihlr-16572	488	11	run	run	VERB
ihlr-16572	488	12	the	the	DET
ihlr-16572	488	13	danger	danger	NOUN
ihlr-16572	488	14	of	of	ADP
ihlr-16572	488	15	overextending	overextend	VERB
ihlr-16572	488	16	monopoly	monopoly	NOUN
ihlr-16572	488	17	protection	protection	NOUN
ihlr-16572	488	18	.	.	PUNCT
ihlr-16572	489	1	doing	do	VERB
ihlr-16572	489	2	so	so	ADV
ihlr-16572	489	3	would	would	AUX
ihlr-16572	489	4	,	,	PUNCT
ihlr-16572	489	5	paradoxically	paradoxically	ADV
ihlr-16572	489	6	,	,	PUNCT
ihlr-16572	489	7	undermine	undermine	ADJ
ihlr-16572	489	8	innovation	innovation	NOUN
ihlr-16572	489	9	and	and	CCONJ
ihlr-16572	489	10	the	the	DET
ihlr-16572	489	11	bills	bill	NOUN
ihlr-16572	489	12	'	'	PART
ihlr-16572	489	13	own	own	ADJ
ihlr-16572	489	14	objectives	objective	NOUN
ihlr-16572	489	15	.	.	PUNCT
ihlr-16572	490	1	bestowing	bestow	VERB
ihlr-16572	490	2	lengthy	lengthy	ADJ
ihlr-16572	490	3	monopolies	monopoly	NOUN
ihlr-16572	490	4	by	by	ADP
ihlr-16572	490	5	statute	statute	NOUN
ihlr-16572	490	6	on	on	ADP
ihlr-16572	490	7	brand	brand	NOUN
ihlr-16572	490	8	biologic	biologic	NOUN
ihlr-16572	490	9	companies	company	NOUN
ihlr-16572	490	10	not	not	PART
ihlr-16572	490	11	only	only	ADV
ihlr-16572	490	12	greatly	greatly	ADV
ihlr-16572	490	13	delays	delay	VERB
ihlr-16572	490	14	entry	entry	NOUN
ihlr-16572	490	15	by	by	ADP
ihlr-16572	490	16	competitors	competitor	NOUN
ihlr-16572	490	17	with	with	ADP
ihlr-16572	490	18	low	low	ADJ
ihlr-16572	490	19	-	-	PUNCT
ihlr-16572	490	20	cost	cost	NOUN
ihlr-16572	490	21	alterna­	alterna­	NOUN
ihlr-16572	490	22	tives	tive	NOUN
ihlr-16572	490	23	,	,	PUNCT
ihlr-16572	490	24	but	but	CCONJ
ihlr-16572	490	25	also	also	ADV
ihlr-16572	490	26	excludes	exclude	VERB
ihlr-16572	490	27	other	other	ADJ
ihlr-16572	490	28	innovators	innovator	NOUN
ihlr-16572	490	29	from	from	ADP
ihlr-16572	490	30	build­	build­	NOUN
ihlr-16572	490	31	ing	ing	NOUN
ihlr-16572	490	32	in	in	ADP
ihlr-16572	490	33	a	a	DET
ihlr-16572	490	34	timely	timely	ADJ
ihlr-16572	490	35	manner	manner	NOUN
ihlr-16572	490	36	on	on	ADP
ihlr-16572	490	37	the	the	DET
ihlr-16572	490	38	stock	stock	NOUN
ihlr-16572	490	39	of	of	ADP
ihlr-16572	490	40	prior	prior	ADJ
ihlr-16572	490	41	knowledge	knowledge	NOUN
ihlr-16572	490	42	much	much	ADJ
ihlr-16572	490	43	of	of	ADP
ihlr-16572	490	44	which	which	PRON
ihlr-16572	490	45	was	be	AUX
ihlr-16572	490	46	accumulated	accumulate	VERB
ihlr-16572	490	47	at	at	ADP
ihlr-16572	490	48	bl	bl	PROPN
ihlr-16572	490	49	.	.	PROPN
ihlr-16572	490	50	146	146	NUM
ihlr-16572	490	51	pu	pu	PROPN
ihlr-16572	490	52	tc	tc	NUM
ihlr-16572	490	53	expense	expense	NOUN
ihlr-16572	490	54	.	.	PUNCT
ihlr-16572	491	1	[	[	X
ihlr-16572	491	2	vol	vol	NOUN
ihlr-16572	491	3	.	.	PUNCT
ihlr-16572	492	1	7:367	7:367	NUM
ihlr-16572	492	2	this	this	DET
ihlr-16572	492	3	study	study	NOUN
ihlr-16572	492	4	represents	represent	VERB
ihlr-16572	492	5	a	a	DET
ihlr-16572	492	6	favorable	favorable	ADJ
ihlr-16572	492	7	viewpoint	viewpoint	NOUN
ihlr-16572	492	8	for	for	ADP
ihlr-16572	492	9	generic	generic	ADJ
ihlr-16572	492	10	manufacturers	manufacturer	NOUN
ihlr-16572	492	11	.	.	PUNCT
ihlr-16572	493	1	while	while	SCONJ
ihlr-16572	493	2	it	it	PRON
ihlr-16572	493	3	is	be	AUX
ihlr-16572	493	4	readily	readily	ADV
ihlr-16572	493	5	apparent	apparent	ADJ
ihlr-16572	493	6	that	that	SCONJ
ihlr-16572	493	7	lengthy	lengthy	ADJ
ihlr-16572	493	8	exclusivity	exclusivity	NOUN
ihlr-16572	493	9	periods	period	NOUN
ihlr-16572	493	10	allow	allow	VERB
ihlr-16572	493	11	manufac­	manufac­	PROPN
ihlr-16572	493	12	turers	turer	NOUN
ihlr-16572	493	13	'	'	PART
ihlr-16572	493	14	to	to	PART
ihlr-16572	493	15	charge	charge	VERB
ihlr-16572	493	16	higher	high	ADJ
ihlr-16572	493	17	prices	price	NOUN
ihlr-16572	493	18	,	,	PUNCT
ihlr-16572	493	19	the	the	DET
ihlr-16572	493	20	observation	observation	NOUN
ihlr-16572	493	21	that	that	SCONJ
ihlr-16572	493	22	these	these	DET
ihlr-16572	493	23	monopolies	monopoly	NOUN
ihlr-16572	493	24	may	may	AUX
ihlr-16572	493	25	actually	actually	ADV
ihlr-16572	493	26	inhibit	inhibit	VERB
ihlr-16572	493	27	innovation	innovation	NOUN
ihlr-16572	493	28	is	be	AUX
ihlr-16572	493	29	much	much	ADV
ihlr-16572	493	30	less	less	ADJ
ihlr-16572	493	31	obvious.147	obvious.147	PROPN
ihlr-16572	493	32	dr	dr	PROPN
ihlr-16572	493	33	.	.	PROPN
ihlr-16572	493	34	kotlikoff	kotlikoff	PROPN
ihlr-16572	493	35	contends	contend	VERB
ihlr-16572	493	36	that	that	SCONJ
ihlr-16572	493	37	"	"	PUNCT
ihlr-16572	493	38	competition	competition	NOUN
ihlr-16572	493	39	,	,	PUNCT
ihlr-16572	493	40	not	not	PART
ihlr-16572	493	41	protection	protection	NOUN
ihlr-16572	493	42	,	,	PUNCT
ihlr-16572	493	43	is	be	AUX
ihlr-16572	493	44	the	the	DET
ihlr-16572	493	45	true	true	ADJ
ihlr-16572	493	46	source	source	NOUN
ihlr-16572	493	47	of	of	ADP
ihlr-16572	493	48	innovation	innovation	NOUN
ihlr-16572	493	49	and	and	CCONJ
ihlr-16572	493	50	that	that	SCONJ
ihlr-16572	493	51	overextending	overextend	VERB
ihlr-16572	493	52	monopoly	monopoly	NOUN
ihlr-16572	493	53	protection	protection	NOUN
ihlr-16572	493	54	can	can	AUX
ihlr-16572	493	55	be	be	AUX
ihlr-16572	493	56	counterproductive	counterproductive	ADJ
ihlr-16572	493	57	.	.	PUNCT
ihlr-16572	493	58	"148	"148	PUNCT
ihlr-16572	494	1	"	"	PUNCT
ihlr-16572	494	2	this	this	PRON
ihlr-16572	494	3	is	be	AUX
ihlr-16572	494	4	particularly	particularly	ADV
ihlr-16572	494	5	true	true	ADJ
ihlr-16572	494	6	given	give	VERB
ihlr-16572	494	7	the	the	DET
ihlr-16572	494	8	potential	potential	NOUN
ihlr-16572	494	9	to	to	PART
ihlr-16572	494	10	use	use	VERB
ihlr-16572	494	11	exclusivity	exclusivity	NOUN
ihlr-16572	494	12	periods	period	NOUN
ihlr-16572	494	13	to	to	PART
ihlr-16572	494	14	'	'	PUNCT
ihlr-16572	494	15	evergreen	evergreen	VERB
ihlr-16572	494	16	'	'	PUNCT
ihlr-16572	494	17	one	one	NUM
ihlr-16572	494	18	's	's	PART
ihlr-16572	494	19	productsto	productsto	NOUN
ihlr-16572	494	20	secure	secure	VERB
ihlr-16572	494	21	additional	additional	ADJ
ihlr-16572	494	22	long	long	ADJ
ihlr-16572	494	23	periods	period	NOUN
ihlr-16572	494	24	of	of	ADP
ihlr-16572	494	25	monopoly	monopoly	NOUN
ihlr-16572	494	26	based	base	VERB
ihlr-16572	494	27	on	on	ADP
ihlr-16572	494	28	minor	minor	ADJ
ihlr-16572	494	29	product	product	NOUN
ihlr-16572	494	30	modifications	modification	NOUN
ihlr-16572	494	31	.	.	PUNCT
ihlr-16572	495	1	"149	"149	PROPN
ihlr-16572	495	2	dr	dr	PROPN
ihlr-16572	495	3	.	.	PROPN
ihlr-16572	495	4	kotlikoff	kotlikoff	PROPN
ihlr-16572	495	5	cites	cite	VERB
ihlr-16572	495	6	the	the	DET
ihlr-16572	495	7	success	success	NOUN
ihlr-16572	495	8	of	of	ADP
ihlr-16572	495	9	the	the	DET
ihlr-16572	495	10	hatch	hatch	NOUN
ihlr-16572	495	11	-	-	PUNCT
ihlr-16572	495	12	waxman	waxman	PROPN
ihlr-16572	495	13	act	act	NOUN
ihlr-16572	495	14	in	in	ADP
ihlr-16572	495	15	balancing	balance	VERB
ihlr-16572	495	16	innovation	innovation	NOUN
ihlr-16572	495	17	with	with	ADP
ihlr-16572	495	18	affordability	affordability	NOUN
ihlr-16572	495	19	,	,	PUNCT
ihlr-16572	495	20	as	as	ADV
ihlr-16572	495	21	well	well	ADV
ihlr-16572	495	22	as	as	ADP
ihlr-16572	495	23	the	the	DET
ihlr-16572	495	24	"	"	PUNCT
ihlr-16572	495	25	absence	absence	NOUN
ihlr-16572	495	26	of	of	ADP
ihlr-16572	495	27	any	any	DET
ihlr-16572	495	28	material	material	ADJ
ihlr-16572	495	29	differ­	differ­	PROPN
ihlr-16572	495	30	ences	ence	NOUN
ihlr-16572	495	31	between	between	ADP
ihlr-16572	495	32	the	the	DET
ihlr-16572	495	33	biologics	biologic	NOUN
ihlr-16572	495	34	and	and	CCONJ
ihlr-16572	495	35	chemical	chemical	PROPN
ihlr-16572	495	36	medical	medical	ADJ
ihlr-16572	495	37	industries	industry	NOUN
ihlr-16572	495	38	arguing	argue	VERB
ihlr-16572	495	39	for	for	ADP
ihlr-16572	495	40	longer	long	ADJ
ihlr-16572	495	41	monopoly	monopoly	NOUN
ihlr-16572	495	42	protection	protection	NOUN
ihlr-16572	495	43	,	,	PUNCT
ihlr-16572	495	44	"	"	PUNCT
ihlr-16572	495	45	when	when	SCONJ
ihlr-16572	495	46	recommending	recommend	VERB
ihlr-16572	495	47	that	that	SCONJ
ihlr-16572	495	48	congress	congress	PROPN
ihlr-16572	495	49	"	"	PUNCT
ihlr-16572	495	50	consider	consider	VERB
ihlr-16572	495	51	the	the	DET
ihlr-16572	495	52	hatch	hatch	NOUN
ihlr-16572	495	53	-	-	PUNCT
ihlr-16572	495	54	waxman	waxman	NOUN
ihlr-16572	495	55	model	model	NOUN
ihlr-16572	495	56	for	for	ADP
ihlr-16572	495	57	exclusivity	exclusivity	NOUN
ihlr-16572	495	58	rather	rather	ADV
ihlr-16572	495	59	than	than	ADP
ihlr-16572	495	60	proposals	proposal	NOUN
ihlr-16572	495	61	that	that	PRON
ihlr-16572	495	62	would	would	AUX
ihlr-16572	495	63	distort	distort	VERB
ihlr-16572	495	64	the	the	DET
ihlr-16572	495	65	market	market	NOUN
ihlr-16572	495	66	and	and	CCONJ
ihlr-16572	495	67	undercut	undercut	ADJ
ihlr-16572	495	68	innovation	innovation	NOUN
ihlr-16572	495	69	.	.	PUNCT
ihlr-16572	496	1	"150	"150	PROPN
ihlr-16572	497	1	1	1	NUM
ihlr-16572	497	2	.	.	PUNCT
ihlr-16572	498	1	the	the	DET
ihlr-16572	498	2	generic	generic	PROPN
ihlr-16572	498	3	pharmaceutical	pharmaceutical	PROPN
ihlr-16572	498	4	association	association	NOUN
ihlr-16572	498	5	's	's	PART
ihlr-16572	498	6	response	response	NOUN
ihlr-16572	498	7	to	to	ADP
ihlr-16572	498	8	the	the	DET
ihlr-16572	498	9	kotlikoff	kotlikoff	NOUN
ihlr-16572	498	10	study	study	NOUN
ihlr-16572	498	11	:	:	PUNCT
ihlr-16572	498	12	gpha	gpha	PROPN
ihlr-16572	498	13	endorsed	endorse	VERB
ihlr-16572	498	14	the	the	DET
ihlr-16572	498	15	findings	finding	NOUN
ihlr-16572	498	16	of	of	ADP
ihlr-16572	498	17	dr	dr	PROPN
ihlr-16572	498	18	.	.	PROPN
ihlr-16572	498	19	kotlikoff	kotlikoff	PROPN
ihlr-16572	498	20	's	's	PART
ihlr-16572	498	21	study	study	NOUN
ihlr-16572	498	22	in	in	ADP
ihlr-16572	498	23	a	a	DET
ihlr-16572	498	24	september	september	PROPN
ihlr-16572	498	25	146	146	NUM
ihlr-16572	498	26	.	.	PUNCT
ihlr-16572	498	27	kotlikoff	kotlikoff	PROPN
ihlr-16572	498	28	,	,	PUNCT
ihlr-16572	498	29	supra	supra	PROPN
ihlr-16572	498	30	note	note	PROPN
ihlr-16572	498	31	28	28	NUM
ihlr-16572	498	32	,	,	PUNCT
ihlr-16572	498	33	at	at	ADP
ihlr-16572	498	34	1	1	NUM
ihlr-16572	498	35	.	.	PUNCT
ihlr-16572	498	36	147	147	NUM
ihlr-16572	498	37	.	.	PUNCT
ihlr-16572	499	1	/d	/d	INTJ
ihlr-16572	499	2	.	.	PUNCT
ihlr-16572	500	1	148	148	NUM
ihlr-16572	500	2	.	.	PUNCT
ihlr-16572	501	1	/d	/d	INTJ
ihlr-16572	501	2	.	.	PUNCT
ihlr-16572	502	1	149	149	NUM
ihlr-16572	502	2	.	.	PUNCT
ihlr-16572	503	1	/d	/d	INTJ
ihlr-16572	503	2	.	.	PUNCT
ihlr-16572	504	1	150	150	NUM
ihlr-16572	504	2	.	.	PUNCT
ihlr-16572	505	1	/d	/d	PUNCT
ihlr-16572	505	2	.	.	PUNCT
ihlr-16572	506	1	2010	2010	NUM
ihlr-16572	506	2	]	]	PUNCT
ihlr-16572	506	3	follow	follow	VERB
ihlr-16572	506	4	-	-	PUNCT
ihlr-16572	506	5	on	on	ADP
ihlr-16572	506	6	biologics	biologic	NOUN
ihlr-16572	506	7	legislation	legislation	NOUN
ihlr-16572	506	8	389	389	NUM
ihlr-16572	506	9	17	17	NUM
ihlr-16572	506	10	,	,	PUNCT
ihlr-16572	506	11	2008	2008	NUM
ihlr-16572	506	12	press	press	PROPN
ihlr-16572	506	13	release}51	release}51	PROPN
ihlr-16572	506	14	kathleen	kathleen	PROPN
ihlr-16572	506	15	jaeger	jaeger	PROPN
ihlr-16572	506	16	,	,	PUNCT
ihlr-16572	506	17	president	president	NOUN
ihlr-16572	506	18	and	and	CCONJ
ihlr-16572	506	19	ceo	ceo	PROPN
ihlr-16572	506	20	of	of	ADP
ihlr-16572	506	21	gpha	gpha	PROPN
ihlr-16572	506	22	stated	state	VERB
ihlr-16572	506	23	:	:	PUNCT
ihlr-16572	506	24	dr	dr	PROPN
ihlr-16572	506	25	.	.	PROPN
ihlr-16572	506	26	kotlikoffs	kotlikoffs	PROPN
ihlr-16572	506	27	economic	economic	ADJ
ihlr-16572	506	28	analysis	analysis	NOUN
ihlr-16572	506	29	strongly	strongly	ADV
ihlr-16572	506	30	supports	support	VERB
ihlr-16572	506	31	the	the	DET
ihlr-16572	506	32	value	value	NOUN
ihlr-16572	506	33	of	of	ADP
ihlr-16572	506	34	biogenetic	biogenetic	ADJ
ihlr-16572	506	35	competition	competition	NOUN
ihlr-16572	506	36	.	.	PUNCT
ihlr-16572	507	1	first	first	ADV
ihlr-16572	507	2	,	,	PUNCT
ihlr-16572	507	3	creating	create	VERB
ihlr-16572	507	4	an	an	DET
ihlr-16572	507	5	approval	approval	NOUN
ihlr-16572	507	6	pathway	pathway	NOUN
ihlr-16572	507	7	for	for	ADP
ihlr-16572	507	8	biogenetic	biogenetic	ADJ
ihlr-16572	507	9	competition	competition	NOUN
ihlr-16572	507	10	will	will	AUX
ihlr-16572	507	11	create	create	VERB
ihlr-16572	507	12	substantial	substantial	ADJ
ihlr-16572	507	13	savings	saving	NOUN
ihlr-16572	507	14	for	for	ADP
ihlr-16572	507	15	struggling	struggle	VERB
ihlr-16572	507	16	consumers	consumer	NOUN
ihlr-16572	507	17	,	,	PUNCT
ihlr-16572	507	18	and	and	CCONJ
ihlr-16572	507	19	a	a	DET
ihlr-16572	507	20	challenged	challenge	VERB
ihlr-16572	507	21	economy	economy	NOUN
ihlr-16572	507	22	.	.	PUNCT
ihlr-16572	508	1	our	our	PRON
ihlr-16572	508	2	nation	nation	NOUN
ihlr-16572	508	3	needs	need	VERB
ihlr-16572	508	4	to	to	ADP
ihlr-16572	508	5	deliv­	deliv­	PROPN
ihlr-16572	508	6	er	er	INTJ
ihlr-16572	508	7	these	these	DET
ihlr-16572	508	8	savings	saving	NOUN
ihlr-16572	508	9	today	today	NOUN
ihlr-16572	508	10	,	,	PUNCT
ihlr-16572	508	11	for	for	ADP
ihlr-16572	508	12	those	those	PRON
ihlr-16572	508	13	who	who	PRON
ihlr-16572	508	14	n	n	CCONJ
ihlr-16572	508	15	~	~	SYM
ihlr-16572	508	16	d	d	PROPN
ihlr-16572	508	17	,	,	PUNCT
ihlr-16572	508	18	but	but	CCONJ
ihlr-16572	508	19	can	can	AUX
ihlr-16572	508	20	not	not	PART
ihlr-16572	508	21	afford	afford	VERB
ihlr-16572	508	22	expensive	expensive	ADJ
ihlr-16572	508	23	biologic	biologic	NOUN
ihlr-16572	508	24	medicines	medicine	NOUN
ihlr-16572	508	25	.	.	PUNCT
ihlr-16572	508	26	.	.	PUNCT
ihlr-16572	508	27	.	.	PUNCT
ihlr-16572	508	28	.	.	PUNCT
ihlr-16572	509	1	second	second	ADV
ihlr-16572	509	2	,	,	PUNCT
ihlr-16572	509	3	ba­	ba­	NOUN
ihlr-16572	509	4	lancing	lance	VERB
ihlr-16572	509	5	brand	brand	NOUN
ihlr-16572	509	6	exclusivity	exclusivity	NOUN
ihlr-16572	509	7	and	and	CCONJ
ihlr-16572	509	8	rewarding	rewarding	ADJ
ihlr-16572	509	9	innovation	innovation	NOUN
ihlr-16572	509	10	,	,	PUNCT
ihlr-16572	509	11	while	while	SCONJ
ihlr-16572	509	12	permitting	permit	VERB
ihlr-16572	509	13	generic	generic	ADJ
ihlr-16572	509	14	competition	competition	NOUN
ihlr-16572	509	15	,	,	PUNCT
ihlr-16572	509	16	is	be	AUX
ihlr-16572	509	17	simply	simply	ADV
ihlr-16572	509	18	good	good	ADJ
ihlr-16572	509	19	medicine	medicine	NOUN
ihlr-16572	509	20	for	for	ADP
ihlr-16572	509	21	our	our	PRON
ihlr-16572	509	22	healthcare	healthcare	NOUN
ihlr-16572	509	23	system	system	NOUN
ihlr-16572	509	24	.	.	PUNCT
ihlr-16572	510	1	for	for	ADP
ihlr-16572	510	2	nearly	nearly	ADV
ihlr-16572	510	3	25	25	NUM
ihlr-16572	510	4	years	year	NOUN
ihlr-16572	510	5	,	,	PUNCT
ihlr-16572	510	6	hatch	hatch	NOUN
ihlr-16572	510	7	-	-	PUNCT
ihlr-16572	510	8	waxman	waxman	NOUN
ihlr-16572	510	9	has	have	AUX
ihlr-16572	510	10	demonstrated	demonstrate	VERB
ihlr-16572	510	11	that	that	SCONJ
ihlr-16572	510	12	when	when	SCONJ
ihlr-16572	510	13	competition	competition	NOUN
ihlr-16572	510	14	for	for	ADP
ihlr-16572	510	15	pharmaceutical	pharmaceutical	ADJ
ihlr-16572	510	16	products	product	NOUN
ihlr-16572	510	17	exists	exist	VERB
ihlr-16572	510	18	from	from	ADP
ihlr-16572	510	19	generics	generic	NOUN
ihlr-16572	510	20	,	,	PUNCT
ihlr-16572	510	21	the	the	DET
ihlr-16572	510	22	marketplace	marketplace	NOUN
ihlr-16572	510	23	incentive	incentive	NOUN
ihlr-16572	510	24	to	to	PART
ihlr-16572	510	25	create	create	VERB
ihlr-16572	510	26	new	new	ADJ
ihlr-16572	510	27	products	product	NOUN
ihlr-16572	510	28	with	with	ADP
ihlr-16572	510	29	exclusivity	exclusivity	NOUN
ihlr-16572	510	30	spurs	spur	VERB
ihlr-16572	510	31	innovation	innovation	NOUN
ihlr-16572	510	32	.	.	PUNCT
ihlr-16572	511	1	dr	dr	PROPN
ihlr-16572	511	2	.	.	PROPN
ihlr-16572	512	1	kotli­	kotli­	PROPN
ihlr-16572	512	2	koff	koff	PROPN
ihlr-16572	512	3	s	s	PROPN
ihlr-16572	512	4	study	study	NOUN
ihlr-16572	512	5	notes	note	VERB
ihlr-16572	512	6	that	that	SCONJ
ihlr-16572	512	7	'	'	PUNCT
ihlr-16572	512	8	research	research	NOUN
ihlr-16572	512	9	and	and	CCONJ
ihlr-16572	512	10	development	development	NOUN
ihlr-16572	512	11	in	in	ADP
ihlr-16572	512	12	pharmaceuticals	pharmaceutical	NOUN
ihlr-16572	512	13	,	,	PUNCT
ihlr-16572	512	14	measured	measure	VERB
ihlr-16572	512	15	relative	relative	ADJ
ihlr-16572	512	16	to	to	ADP
ihlr-16572	512	17	sales	sale	NOUN
ihlr-16572	512	18	,	,	PUNCT
ihlr-16572	512	19	increased	increase	VERB
ihlr-16572	512	20	dramatically	dramatically	ADV
ihlr-16572	512	21	after	after	ADP
ihlr-16572	512	22	1984	1984	NUM
ihlr-16572	512	23	'	'	PUNCT
ihlr-16572	512	24	and	and	CCONJ
ihlr-16572	512	25	further	further	ADJ
ihlr-16572	512	26	notes	note	NOUN
ihlr-16572	512	27	that	that	SCONJ
ihlr-16572	512	28	'	'	PUNCT
ihlr-16572	512	29	nce	nce	NOUN
ihlr-16572	512	30	approvals	approval	NOUN
ihlr-16572	512	31	increased	increase	VERB
ihlr-16572	512	32	by	by	ADP
ihlr-16572	512	33	one	one	NUM
ihlr-16572	512	34	-	-	PUNCT
ihlr-16572	512	35	third	third	NOUN
ihlr-16572	512	36	in	in	ADP
ihlr-16572	512	37	the	the	DET
ihlr-16572	512	38	decade	decade	NOUN
ihlr-16572	512	39	fol­	fol­	NOUN
ihlr-16572	512	40	lowing	low	VERB
ihlr-16572	512	41	the	the	DET
ihlr-16572	512	42	bill	bill	NOUN
ihlr-16572	512	43	's	's	PART
ihlr-16572	512	44	(	(	PUNCT
ihlr-16572	512	45	hatch	hatch	NOUN
ihlr-16572	512	46	-	-	PUNCT
ihlr-16572	512	47	waxman	waxman	NOUN
ihlr-16572	512	48	)	)	PUNCT
ihlr-16572	512	49	passage	passage	NOUN
ihlr-16572	512	50	.	.	PUNCT
ihlr-16572	512	51	'	'	PUNCT
ihlr-16572	513	1	these	these	DET
ihlr-16572	513	2	statistics	statistic	NOUN
ihlr-16572	513	3	clearly	clearly	ADV
ihlr-16572	513	4	show	show	VERB
ihlr-16572	513	5	that	that	SCONJ
ihlr-16572	513	6	competition	competition	NOUN
ihlr-16572	513	7	is	be	AUX
ihlr-16572	513	8	good	good	ADJ
ihlr-16572	513	9	for	for	ADP
ihlr-16572	513	10	in­	in­	NOUN
ihlr-16572	513	11	novation	novation	NOUN
ihlr-16572	513	12	.	.	PUNCT
ihlr-16572	513	13	.	.	PUNCT
ihlr-16572	513	14	.	.	PUNCT
ihlr-16572	513	15	.	.	PUNCT
ihlr-16572	514	1	third	third	ADJ
ihlr-16572	514	2	,	,	PUNCT
ihlr-16572	514	3	excessive	excessive	ADJ
ihlr-16572	514	4	market	market	NOUN
ihlr-16572	514	5	exclusivity	exclusivity	NOUN
ihlr-16572	514	6	or	or	CCONJ
ihlr-16572	514	7	the	the	DET
ihlr-16572	514	8	ability	ability	NOUN
ihlr-16572	514	9	to	to	PART
ihlr-16572	514	10	evergreen	evergreen	VERB
ihlr-16572	514	11	products	product	NOUN
ihlr-16572	514	12	poses	pose	VERB
ihlr-16572	514	13	a	a	DET
ihlr-16572	514	14	significant	significant	ADJ
ihlr-16572	514	15	risk	risk	NOUN
ihlr-16572	514	16	to	to	ADP
ihlr-16572	514	17	innovation	innovation	NOUN
ihlr-16572	514	18	.	.	PUNCT
ihlr-16572	515	1	dr	dr	PROPN
ihlr-16572	515	2	.	.	PROPN
ihlr-16572	515	3	kotlikoffs	kotlikoffs	PROPN
ihlr-16572	515	4	study	study	NOUN
ihlr-16572	515	5	states	state	NOUN
ihlr-16572	515	6	that	that	SCONJ
ihlr-16572	515	7	'	'	PUNCT
ihlr-16572	515	8	over	over	ADV
ihlr-16572	515	9	-	-	PUNCT
ihlr-16572	515	10	extending	extend	VERB
ihlr-16572	515	11	monopoly	monopoly	NOUN
ihlr-16572	515	12	protection	protection	NOUN
ihlr-16572	515	13	...	...	PUNCT
ihlr-16572	515	14	may	may	AUX
ihlr-16572	515	15	do	do	VERB
ihlr-16572	515	16	little	little	ADJ
ihlr-16572	515	17	or	or	CCONJ
ihlr-16572	515	18	nothing	nothing	PRON
ihlr-16572	515	19	to	to	PART
ihlr-16572	515	20	incentivize	incentivize	VERB
ihlr-16572	515	21	new	new	ADJ
ihlr-16572	515	22	discovery	discovery	NOUN
ihlr-16572	515	23	and	and	CCONJ
ihlr-16572	515	24	simply	simply	ADV
ihlr-16572	515	25	delay	delay	VERB
ihlr-16572	515	26	when	when	SCONJ
ihlr-16572	515	27	the	the	DET
ihlr-16572	515	28	next	next	ADJ
ihlr-16572	515	29	discovery	discovery	NOUN
ihlr-16572	515	30	comes	come	VERB
ihlr-16572	515	31	on	on	ADP
ihlr-16572	515	32	board	board	NOUN
ihlr-16572	515	33	.	.	PUNCT
ihlr-16572	515	34	'	'	PUNCT
ihlr-16572	516	1	gpha	gpha	PROPN
ihlr-16572	516	2	believes	believe	VERB
ihlr-16572	516	3	that	that	SCONJ
ihlr-16572	516	4	a	a	DET
ihlr-16572	516	5	vibrant	vibrant	ADJ
ihlr-16572	516	6	biopharmaceutical	biopharmaceutical	NOUN
ihlr-16572	516	7	in­	in­	PROPN
ihlr-16572	516	8	dustry	dustry	NOUN
ihlr-16572	516	9	,	,	PUNCT
ihlr-16572	516	10	with	with	ADP
ihlr-16572	516	11	the	the	DET
ihlr-16572	516	12	incentive	incentive	NOUN
ihlr-16572	516	13	to	to	PART
ihlr-16572	516	14	create	create	VERB
ihlr-16572	516	15	new	new	ADJ
ihlr-16572	516	16	medicines	medicine	NOUN
ihlr-16572	516	17	,	,	PUNCT
ihlr-16572	516	18	is	be	AUX
ihlr-16572	516	19	pro	pro	ADJ
ihlr-16572	516	20	-	-	ADJ
ihlr-16572	516	21	consumer	consumer	ADJ
ihlr-16572	516	22	and	and	CCONJ
ihlr-16572	516	23	pro	pro	ADJ
ihlr-16572	516	24	-	-	ADJ
ihlr-16572	516	25	healthcare	healthcare	ADJ
ihlr-16572	516	26	.	.	PUNCT
ihlr-16572	517	1	without	without	ADP
ihlr-16572	517	2	the	the	DET
ihlr-16572	517	3	incen­	incen­	NOUN
ihlr-16572	517	4	tive	tive	NOUN
ihlr-16572	517	5	that	that	SCONJ
ihlr-16572	517	6	competition	competition	NOUN
ihlr-16572	517	7	from	from	ADP
ihlr-16572	517	8	generics	generic	NOUN
ihlr-16572	517	9	will	will	AUX
ihlr-16572	517	10	create	create	VERB
ihlr-16572	517	11	to	to	PART
ihlr-16572	517	12	de­	de­	VERB
ihlr-16572	517	13	velop	velop	ADJ
ihlr-16572	517	14	new	new	ADJ
ihlr-16572	517	15	and	and	CCONJ
ihlr-16572	517	16	more	more	ADV
ihlr-16572	517	17	innovative	innovative	ADJ
ihlr-16572	517	18	products	product	NOUN
ihlr-16572	517	19	,	,	PUNCT
ihlr-16572	517	20	patients	patient	NOUN
ihlr-16572	517	21	suffer.152	suffer.152	PROPN
ihlr-16572	517	22	gpha	gpha	NOUN
ihlr-16572	517	23	strongly	strongly	ADV
ihlr-16572	517	24	supports	support	VERB
ihlr-16572	517	25	dr	dr	PROPN
ihlr-16572	517	26	.	.	PROPN
ihlr-16572	517	27	kotlikoff	kotlikoff	PROPN
ihlr-16572	517	28	's	's	PART
ihlr-16572	517	29	conclusion	conclusion	NOUN
ihlr-16572	517	30	that	that	SCONJ
ihlr-16572	517	31	excessive	excessive	ADJ
ihlr-16572	517	32	ex­	ex­	NOUN
ihlr-16572	517	33	clusivity	clusivity	NOUN
ihlr-16572	517	34	'	'	PUNCT
ihlr-16572	517	35	reduces	reduce	VERB
ihlr-16572	517	36	the	the	DET
ihlr-16572	517	37	pace	pace	NOUN
ihlr-16572	517	38	of	of	ADP
ihlr-16572	517	39	innovation	innovation	NOUN
ihlr-16572	517	40	'	'	PUNCT
ihlr-16572	517	41	,	,	PUNCT
ihlr-16572	517	42	and	and	CCONJ
ihlr-16572	517	43	that	that	SCONJ
ihlr-16572	517	44	exclusivity	exclusivity	NOUN
ihlr-16572	517	45	provisions	provision	NOUN
ihlr-16572	517	46	similar	similar	ADJ
ihlr-16572	517	47	to	to	ADP
ihlr-16572	517	48	those	those	PRON
ihlr-16572	517	49	applied	apply	VERB
ihlr-16572	517	50	to	to	ADP
ihlr-16572	517	51	chemical	chemical	ADJ
ihlr-16572	517	52	drugs	drug	NOUN
ihlr-16572	517	53	through	through	ADP
ihlr-16572	517	54	the	the	DET
ihlr-16572	517	55	hatch	hatch	NOUN
ihlr-16572	517	56	-	-	PUNCT
ihlr-16572	517	57	waxman	waxman	NOUN
ihlr-16572	517	58	act3	act3	PROPN
ihlr-16572	517	59	provide	provide	VERB
ihlr-16572	517	60	sufficient	sufficient	ADJ
ihlr-16572	517	61	incentive	incentive	NOUN
ihlr-16572	517	62	to	to	PART
ihlr-16572	517	63	innovate	innovate	VERB
ihlr-16572	517	64	while	while	SCONJ
ihlr-16572	517	65	encouraging	encourage	VERB
ihlr-16572	517	66	competition.15	competition.15	NOUN
ihlr-16572	517	67	151	151	NUM
ihlr-16572	517	68	.	.	PUNCT
ihlr-16572	518	1	gpha	gpha	PROPN
ihlr-16572	518	2	press	press	NOUN
ihlr-16572	518	3	release	release	NOUN
ihlr-16572	518	4	ll	ll	NOUN
ihlr-16572	518	5	,	,	PUNCT
ihlr-16572	518	6	supra	supra	PROPN
ihlr-16572	518	7	note	note	VERB
ihlr-16572	518	8	137	137	NUM
ihlr-16572	518	9	.	.	PUNCT
ihlr-16572	518	10	152	152	NUM
ihlr-16572	518	11	.	.	PUNCT
ihlr-16572	518	12	!	!	PUNCT
ihlr-16572	519	1	d.	d.	PROPN
ihlr-16572	519	2	153	153	NUM
ihlr-16572	519	3	.	.	PUNCT
ihlr-16572	520	1	ld	ld	PROPN
ihlr-16572	520	2	390	390	NUM
ihlr-16572	520	3	indiana	indiana	PROPN
ihlr-16572	520	4	health	health	PROPN
ihlr-16572	520	5	law	law	PROPN
ihlr-16572	520	6	review	review	NOUN
ihlr-16572	521	1	[	[	X
ihlr-16572	521	2	vol	vol	NOUN
ihlr-16572	521	3	.	.	PUNCT
ihlr-16572	522	1	7:367	7:367	NUM
ihlr-16572	522	2	gpha	gpha	NOUN
ihlr-16572	522	3	·	·	PUNCT
ihlr-16572	522	4	contends	contend	VERB
ihlr-16572	522	5	that	that	SCONJ
ihlr-16572	522	6	excessive	excessive	ADJ
ihlr-16572	522	7	exclusivity	exclusivity	NOUN
ihlr-16572	522	8	results	result	VERB
ihlr-16572	522	9	in	in	ADP
ihlr-16572	522	10	harm	harm	NOUN
ihlr-16572	522	11	to	to	ADP
ihlr-16572	522	12	the	the	DET
ihlr-16572	522	13	consumer	consumer	NOUN
ihlr-16572	522	14	by	by	ADP
ihlr-16572	522	15	limiting	limit	VERB
ihlr-16572	522	16	access	access	NOUN
ihlr-16572	522	17	to	to	ADP
ihlr-16572	522	18	affordable	affordable	ADJ
ihlr-16572	522	19	biogenerics	biogeneric	NOUN
ihlr-16572	522	20	and	and	CCONJ
ihlr-16572	522	21	by	by	ADP
ihlr-16572	522	22	decreasing	decrease	VERB
ihlr-16572	522	23	the	the	DET
ihlr-16572	522	24	·	·	SYM
ihlr-16572	522	25	likelih­	likelih­	NOUN
ihlr-16572	522	26	ood	ood	PROPN
ihlr-16572	522	27	of	of	ADP
ihlr-16572	522	28	new	new	ADJ
ihlr-16572	522	29	innovator	innovator	NOUN
ihlr-16572	522	30	products	product	NOUN
ihlr-16572	522	31	being	be	AUX
ihlr-16572	522	32	introduced	introduce	VERB
ihlr-16572	522	33	due	due	ADJ
ihlr-16572	522	34	to	to	ADP
ihlr-16572	522	35	increased	increase	VERB
ihlr-16572	522	36	competi­	competi­	PROPN
ihlr-16572	522	37	tion.154	tion.154	PROPN
ihlr-16572	522	38	gpha	gpha	PROPN
ihlr-16572	522	39	notes	note	VERB
ihlr-16572	522	40	the	the	DET
ihlr-16572	522	41	growing	grow	VERB
ihlr-16572	522	42	support	support	NOUN
ihlr-16572	522	43	for	for	ADP
ihlr-16572	522	44	biogenerics	biogeneric	NOUN
ihlr-16572	522	45	legislation	legislation	NOUN
ihlr-16572	522	46	,	,	PUNCT
ihlr-16572	522	47	stating	state	VERB
ihlr-16572	522	48	that	that	SCONJ
ihlr-16572	522	49	''	''	PUNCT
ihlr-16572	522	50	[	[	X
ihlr-16572	522	51	n]early	n]early	ADV
ihlr-16572	522	52	70	70	NUM
ihlr-16572	522	53	organizations	organization	NOUN
ihlr-16572	522	54	representing	represent	VERB
ihlr-16572	522	55	tens	ten	NOUN
ihlr-16572	522	56	of	of	ADP
ihlr-16572	522	57	millions	million	NOUN
ihlr-16572	522	58	of	of	ADP
ihlr-16572	522	59	americans	americans	PROPN
ihlr-16572	522	60	,	,	PUNCT
ihlr-16572	522	61	including	include	VERB
ihlr-16572	522	62	aarp	aarp	NOUN
ihlr-16572	522	63	,	,	PUNCT
ihlr-16572	522	64	major	major	ADJ
ihlr-16572	522	65	corporations	corporation	NOUN
ihlr-16572	522	66	like	like	ADP
ihlr-16572	522	67	gm	gm	PROPN
ihlr-16572	522	68	and	and	CCONJ
ihlr-16572	522	69	caterpillar	caterpillar	PROPN
ihlr-16572	522	70	,	,	PUNCT
ihlr-16572	522	71	the	the	DET
ihlr-16572	522	72	consum­	consum­	PROPN
ihlr-16572	522	73	er	er	INTJ
ihlr-16572	522	74	federation	federation	PROPN
ihlr-16572	522	75	of	of	ADP
ihlr-16572	522	76	america	america	PROPN
ihlr-16572	522	77	,	,	PUNCT
ihlr-16572	522	78	the	the	DET
ihlr-16572	522	79	afl	afl	PROPN
ihlr-16572	522	80	-	-	PUNCT
ihlr-16572	522	81	cio	cio	PROPN
ihlr-16572	522	82	and	and	CCONJ
ihlr-16572	522	83	more	more	ADJ
ihlr-16572	522	84	than	than	ADP
ihlr-16572	522	85	20	20	NUM
ihlr-16572	522	86	state	state	NOUN
ihlr-16572	522	87	governors	governor	NOUN
ihlr-16572	522	88	support	support	VERB
ihlr-16572	522	89	the	the	DET
ihlr-16572	522	90	creation	creation	NOUN
ihlr-16572	522	91	of	of	ADP
ihlr-16572	522	92	a	a	DET
ihlr-16572	522	93	pathway	pathway	NOUN
ihlr-16572	522	94	for	for	ADP
ihlr-16572	522	95	biogenerics	biogeneric	NOUN
ihlr-16572	522	96	.	.	PUNCT
ihlr-16572	523	1	"	"	PUNCT
ihlr-16572	523	2	155	155	NUM
ihlr-16572	523	3	·	·	PUNCT
ihlr-16572	523	4	in	in	ADP
ihlr-16572	523	5	a	a	DET
ihlr-16572	523	6	press	press	NOUN
ihlr-16572	523	7	release	release	NOUN
ihlr-16572	523	8	,	,	PUNCT
ihlr-16572	523	9	bio	bio	PROPN
ihlr-16572	523	10	argues	argue	VERB
ihlr-16572	523	11	that	that	SCONJ
ihlr-16572	523	12	an	an	DET
ihlr-16572	523	13	approval	approval	NOUN
ihlr-16572	523	14	pathway	pathway	NOUN
ihlr-16572	523	15	for	for	ADP
ihlr-16572	523	16	follow	follow	VERB
ihlr-16572	523	17	-	-	PUNCT
ihlr-16572	523	18	on	on	ADP
ihlr-16572	523	19	biologics	biologic	NOUN
ihlr-16572	523	20	should	should	AUX
ihlr-16572	523	21	include	include	VERB
ihlr-16572	523	22	a	a	DET
ihlr-16572	523	23	fourteen	fourteen	NUM
ihlr-16572	523	24	year	year	NOUN
ihlr-16572	523	25	period	period	NOUN
ihlr-16572	523	26	of	of	ADP
ihlr-16572	523	27	data	datum	NOUN
ihlr-16572	523	28	exclusivity	exclusivity	NOUN
ihlr-16572	523	29	.	.	PUNCT
ihlr-16572	524	1	to	to	PART
ihlr-16572	524	2	en­	en­	PROPN
ihlr-16572	524	3	courage	courage	NOUN
ihlr-16572	524	4	investment	investment	NOUN
ihlr-16572	524	5	in	in	ADP
ihlr-16572	524	6	biopharmaceuticals	biopharmaceutical	NOUN
ihlr-16572	524	7	and	and	CCONJ
ihlr-16572	524	8	promote	promote	VERB
ihlr-16572	524	9	the	the	DET
ihlr-16572	524	10	development	development	NOUN
ihlr-16572	524	11	of	of	ADP
ihlr-16572	524	12	new	new	ADJ
ihlr-16572	524	13	therapies.156	therapies.156	PROPN
ihlr-16572	524	14	biologics	biologic	NOUN
ihlr-16572	524	15	research	research	NOUN
ihlr-16572	524	16	and	and	CCONJ
ihlr-16572	524	17	development	development	NOUN
ihlr-16572	524	18	entails	entail	VERB
ihlr-16572	524	19	higher	high	ADJ
ihlr-16572	524	20	costs	cost	NOUN
ihlr-16572	524	21	,	,	PUNCT
ihlr-16572	524	22	longer	long	ADJ
ihlr-16572	524	23	development	development	PROPN
ihlr-16572	524	24	times	time	NOUN
ihlr-16572	524	25	,	,	PUNCT
ihlr-16572	524	26	and	and	CCONJ
ihlr-16572	524	27	lower	low	ADJ
ihlr-16572	524	28	late	late	ADJ
ihlr-16572	524	29	-	-	PUNCT
ihlr-16572	524	30	stage	stage	NOUN
ihlr-16572	524	31	success	success	NOUN
ihlr-16572	524	32	rates	rate	NOUN
ihlr-16572	524	33	than	than	SCONJ
ihlr-16572	524	34	small­	small­	NOUN
ihlr-16572	524	35	molecule	molecule	NOUN
ihlr-16572	524	36	drugs	drug	NOUN
ihlr-16572	524	37	.	.	PUNCT
ihlr-16572	525	1	157	157	NUM
ihlr-16572	525	2	the	the	DET
ihlr-16572	525	3	majority	majority	NOUN
ihlr-16572	525	4	of	of	ADP
ihlr-16572	525	5	biopharmaceutical	biopharmaceutical	ADJ
ihlr-16572	525	6	companies	company	NOUN
ihlr-16572	525	7	are	be	AUX
ihlr-16572	525	8	small	small	ADJ
ihlr-16572	525	9	startups	startup	NOUN
ihlr-16572	525	10	,	,	PUNCT
ihlr-16572	525	11	and	and	CCONJ
ihlr-16572	525	12	an	an	DET
ihlr-16572	525	13	appropriate	appropriate	ADJ
ihlr-16572	525	14	period	period	NOUN
ihlr-16572	525	15	of	of	ADP
ihlr-16572	525	16	data	datum	NOUN
ihlr-16572	525	17	exclusivity	exclusivity	NOUN
ihlr-16572	525	18	would	would	AUX
ihlr-16572	525	19	encourage	encourage	VERB
ihlr-16572	525	20	the	the	DET
ihlr-16572	525	21	venture	venture	NOUN
ihlr-16572	525	22	-	-	PUNCT
ihlr-16572	525	23	capital	capital	NOUN
ihlr-16572	525	24	investment	investment	NOUN
ihlr-16572	525	25	that	that	PRON
ihlr-16572	525	26	these	these	DET
ihlr-16572	525	27	companies	company	NOUN
ihlr-16572	525	28	need	need	VERB
ihlr-16572	525	29	,	,	PUNCT
ihlr-16572	525	30	according	accord	VERB
ihlr-16572	525	31	to	to	ADP
ihlr-16572	525	32	the	the	DET
ihlr-16572	525	33	statement	statement	NOUN
ihlr-16572	525	34	.	.	PUNCT
ihlr-16572	526	1	158	158	NUM
ihlr-16572	526	2	iii	iii	NOUN
ihlr-16572	526	3	.	.	PUNCT
ihlr-16572	526	4	analysis	analysis	NOUN
ihlr-16572	526	5	:	:	PUNCT
ihlr-16572	526	6	modified	modify	VERB
ihlr-16572	526	7	version	version	NOUN
ihlr-16572	526	8	of	of	ADP
ihlr-16572	526	9	hatch	hatch	NOUN
ihlr-16572	526	10	-	-	PUNCT
ihlr-16572	526	11	waxman	waxman	NOUN
ihlr-16572	526	12	applicable	applicable	ADJ
ihlr-16572	526	13	to	to	ADP
ihlr-16572	526	14	biologics	biologic	NOUN
ihlr-16572	526	15	a.	a.	NOUN
ihlr-16572	526	16	downfalls	downfall	NOUN
ihlr-16572	526	17	of	of	ADP
ihlr-16572	526	18	proposed	propose	VERB
ihlr-16572	526	19	biogenerics	biogeneric	NOUN
ihlr-16572	526	20	bills	bill	NOUN
ihlr-16572	526	21	remarkably	remarkably	ADV
ihlr-16572	526	22	,	,	PUNCT
ihlr-16572	526	23	the	the	DET
ihlr-16572	526	24	kennedy	kennedy	PROPN
ihlr-16572	526	25	,	,	PUNCT
ihlr-16572	526	26	eshoo	eshoo	ADJ
ihlr-16572	526	27	-	-	PUNCT
ihlr-16572	526	28	barton	barton	NOUN
ihlr-16572	526	29	,	,	PUNCT
ihlr-16572	526	30	and	and	CCONJ
ihlr-16572	526	31	inslee	inslee	PROPN
ihlr-16572	526	32	bills	bill	NOUN
ihlr-16572	526	33	reward	reward	VERB
ihlr-16572	526	34	delay	delay	NOUN
ihlr-16572	526	35	in	in	ADP
ihlr-16572	526	36	getting	get	VERB
ihlr-16572	526	37	to	to	ADP
ihlr-16572	526	38	market	market	NOUN
ihlr-16572	526	39	with	with	ADP
ihlr-16572	526	40	longer	long	ADJ
ihlr-16572	526	41	monopoly	monopoly	NOUN
ihlr-16572	526	42	protection	protection	NOUN
ihlr-16572	526	43	,	,	PUNCT
ihlr-16572	526	44	with	with	ADP
ihlr-16572	526	45	each	each	DET
ihlr-16572	526	46	year	year	NOUN
ihlr-16572	526	47	of	of	ADP
ihlr-16572	526	48	delay	delay	NOUN
ihlr-16572	526	49	beyond	beyond	ADP
ihlr-16572	526	50	twelve	twelve	NUM
ihlr-16572	526	51	leading	lead	VERB
ihlr-16572	526	52	to	to	ADP
ihlr-16572	526	53	roughly	roughly	ADV
ihlr-16572	526	54	one	one	NUM
ihlr-16572	526	55	more	more	ADJ
ihlr-16572	526	56	year	year	NOUN
ihlr-16572	526	57	of	of	ADP
ihlr-16572	526	58	protec­	protec­	ADJ
ihlr-16572	526	59	tion	tion	NOUN
ihlr-16572	526	60	.	.	PUNCT
ihlr-16572	526	61	·	·	PUNCT
ihlr-16572	527	1	one	one	NUM
ihlr-16572	527	2	wonders	wonder	VERB
ihlr-16572	527	3	why	why	SCONJ
ihlr-16572	527	4	legislators	legislator	NOUN
ihlr-16572	527	5	would	would	AUX
ihlr-16572	527	6	want	want	VERB
ihlr-16572	527	7	to	to	PART
ihlr-16572	527	8	en­	en­	VERB
ihlr-16572	527	9	courage	courage	NOUN
ihlr-16572	527	10	delay	delay	NOUN
ihlr-16572	527	11	in	in	ADP
ihlr-16572	527	12	the	the	DET
ihlr-16572	527	13	pace	pace	NOUN
ihlr-16572	527	14	at	at	ADP
ihlr-16572	527	15	which	which	PRON
ihlr-16572	527	16	innovative	innovative	ADJ
ihlr-16572	527	17	drugs	drug	NOUN
ihlr-16572	527	18	are	be	AUX
ihlr-16572	527	19	brought	bring	VERB
ihlr-16572	527	20	to	to	ADP
ihlr-16572	527	21	market	market	NOUN
ihlr-16572	527	22	and	and	CCONJ
ihlr-16572	527	23	lower	lower	VERB
ihlr-16572	527	24	the	the	DET
ihlr-16572	527	25	speed	speed	NOUN
ihlr-16572	527	26	at	at	ADP
ihlr-16572	527	27	which	which	PRON
ihlr-16572	527	28	today	today	NOUN
ihlr-16572	527	29	's	's	PART
ihlr-16572	527	30	innovations	innovation	NOUN
ihlr-16572	527	31	are	be	AUX
ihlr-16572	527	32	incorporated	incorporate	VERB
ihlr-16572	527	33	in	in	ADP
ihlr-16572	527	34	tomorrow	tomorrow	NOUN
ihlr-16572	527	35	's	's	PART
ihlr-16572	527	36	discoveries.159	discoveries.159	NOUN
ihlr-16572	527	37	.	.	PUNCT
ihlr-16572	528	1	conversely	conversely	ADV
ihlr-16572	528	2	,	,	PUNCT
ihlr-16572	528	3	the	the	DET
ihlr-16572	528	4	hatch	hatch	NOUN
ihlr-16572	528	5	-	-	PUNCT
ihlr-16572	528	6	waxman	waxman	PROPN
ihlr-16572	528	7	and	and	CCONJ
ihlr-16572	528	8	waxman	waxman	PROPN
ihlr-16572	528	9	biologics	biologics	PROPN
ihlr-16572	528	10	bills	bill	NOUN
ihlr-16572	528	11	discourage	discourage	VERB
ihlr-16572	528	12	"	"	PUNCT
ihlr-16572	528	13	delays	delay	NOUN
ihlr-16572	528	14	in	in	ADP
ihlr-16572	528	15	reaching	reach	VERB
ihlr-16572	528	16	the	the	DET
ihlr-16572	528	17	market	market	NOUN
ihlr-16572	528	18	b~	b~	ADP
ihlr-16572	528	19	reducing	reduce	VERB
ihlr-16572	528	20	monopoly	monopoly	NOUN
ihlr-16572	528	21	protection	protection	NOUN
ihlr-16572	528	22	by	by	ADP
ihlr-16572	528	23	roughly	roughly	ADV
ihlr-16572	528	24	one	one	NUM
ihlr-16572	528	25	year	year	NOUN
ihlr-16572	528	26	for	for	ADP
ihlr-16572	528	27	each	each	DET
ihlr-16572	528	28	year	year	NOUN
ihlr-16572	528	29	of	of	ADP
ihlr-16572	528	30	delay	delay	NOUN
ihlr-16572	528	31	.	.	PUNCT
ihlr-16572	528	32	"	"	PUNCT
ihlr-16572	529	1	60	60	NUM
ihlr-16572	529	2	proponents	proponent	NOUN
ihlr-16572	529	3	of	of	ADP
ihlr-16572	529	4	increased	increase	VERB
ihlr-16572	529	5	monopoly	monopoly	NOUN
ihlr-16572	529	6	protection	protection	NOUN
ihlr-16572	529	7	for	for	ADP
ihlr-16572	529	8	biologics	biologic	NOUN
ihlr-16572	529	9	compared	compare	VERB
ihlr-16572	529	10	154	154	NUM
ihlr-16572	529	11	.	.	PUNCT
ihlr-16572	530	1	i	i	PRON
ihlr-16572	530	2	d	d	PROPN
ihlr-16572	530	3	155	155	NUM
ihlr-16572	530	4	.	.	PUNCT
ihlr-16572	531	1	i	i	PRON
ihlr-16572	531	2	d	d	PROPN
ihlr-16572	531	3	156	156	NUM
ihlr-16572	531	4	.	.	PUNCT
ihlr-16572	532	1	bio	bio	PROPN
ihlr-16572	532	2	press	press	PROPN
ihlr-16572	532	3	release	release	NOUN
ihlr-16572	532	4	i	i	PROPN
ihlr-16572	532	5	,	,	PUNCT
ihlr-16572	532	6	supra	supra	PROPN
ihlr-16572	532	7	note	note	NOUN
ihlr-16572	532	8	29	29	NUM
ihlr-16572	532	9	.	.	PUNCT
ihlr-16572	533	1	157	157	NUM
ihlr-16572	533	2	.	.	PUNCT
ihlr-16572	534	1	bio	bio	PROPN
ihlr-16572	534	2	press	press	PROPN
ihlr-16572	534	3	release	release	PROPN
ihlr-16572	534	4	ii	ii	PROPN
ihlr-16572	534	5	,	,	PUNCT
ihlr-16572	534	6	supra	supra	PROPN
ihlr-16572	534	7	note	note	PROPN
ihlr-16572	534	8	53	53	NUM
ihlr-16572	534	9	.	.	NOUN
ihlr-16572	535	1	158	158	NUM
ihlr-16572	535	2	.	.	PUNCT
ihlr-16572	536	1	bio	bio	PROPN
ihlr-16572	536	2	press	press	PROPN
ihlr-16572	536	3	release	release	PROPN
ihlr-16572	536	4	iii	iii	PROPN
ihlr-16572	536	5	,	,	PUNCT
ihlr-16572	536	6	supra	supra	PROPN
ihlr-16572	536	7	note	note	NOUN
ihlr-16572	536	8	55	55	NUM
ihlr-16572	536	9	.	.	X
ihlr-16572	536	10	159	159	NUM
ihlr-16572	536	11	.	.	PUNCT
ihlr-16572	537	1	kotlikoft	kotlikoft	PROPN
ihlr-16572	537	2	supra	supra	PROPN
ihlr-16572	537	3	note	note	PROPN
ihlr-16572	537	4	28	28	NUM
ihlr-16572	537	5	,	,	PUNCT
ihlr-16572	537	6	at	at	ADP
ihlr-16572	537	7	8	8	NUM
ihlr-16572	537	8	.	.	PUNCT
ihlr-16572	537	9	160	160	NUM
ihlr-16572	537	10	.	.	PUNCT
ihlr-16572	538	1	/d	/d	PUNCT
ihlr-16572	538	2	.	.	PUNCT
ihlr-16572	539	1	2010	2010	NUM
ihlr-16572	539	2	]	]	PUNCT
ihlr-16572	539	3	follow	follow	VERB
ihlr-16572	539	4	-	-	PUNCT
ihlr-16572	539	5	on	on	ADP
ihlr-16572	539	6	biologics	biologic	NOUN
ihlr-16572	539	7	legislation	legislation	NOUN
ihlr-16572	539	8	391	391	NUM
ihlr-16572	539	9	to	to	ADP
ihlr-16572	539	10	chemical	chemical	ADJ
ihlr-16572	539	11	drugs	drug	NOUN
ihlr-16572	539	12	contend	contend	VERB
ihlr-16572	539	13	that	that	SCONJ
ihlr-16572	539	14	the	the	DET
ihlr-16572	539	15	longer	long	ADJ
ihlr-16572	539	16	time	time	NOUN
ihlr-16572	539	17	necessary	necessary	ADJ
ihlr-16572	539	18	for	for	SCONJ
ihlr-16572	539	19	development	development	NOUN
ihlr-16572	539	20	of	of	ADP
ihlr-16572	539	21	biologics	biologic	NOUN
ihlr-16572	539	22	justifies	justify	VERB
ihlr-16572	539	23	extended	extend	VERB
ihlr-16572	539	24	protection.161	protection.161	NOUN
ihlr-16572	539	25	while	while	SCONJ
ihlr-16572	539	26	this	this	DET
ihlr-16572	539	27	argument	argument	NOUN
ihlr-16572	539	28	has	have	VERB
ihlr-16572	539	29	some	some	DET
ihlr-16572	539	30	merit	merit	NOUN
ihlr-16572	539	31	,	,	PUNCT
ihlr-16572	539	32	the	the	DET
ihlr-16572	539	33	increase	increase	NOUN
ihlr-16572	539	34	in	in	ADP
ihlr-16572	539	35	monopoly	monopoly	NOUN
ihlr-16572	539	36	protection	protection	NOUN
ihlr-16572	539	37	of	of	ADP
ihlr-16572	539	38	biologics	biologic	NOUN
ihlr-16572	539	39	over	over	ADP
ihlr-16572	539	40	chemical	chemical	ADJ
ihlr-16572	539	41	drugs	drug	NOUN
ihlr-16572	539	42	should	should	AUX
ihlr-16572	539	43	closely	closely	ADV
ihlr-16572	539	44	correlate	correlate	VERB
ihlr-16572	539	45	to	to	ADP
ihlr-16572	539	46	the	the	DET
ihlr-16572	539	47	difference	difference	NOUN
ihlr-16572	539	48	in	in	ADP
ihlr-16572	539	49	time	time	NOUN
ihlr-16572	539	50	it	it	PRON
ihlr-16572	539	51	takes	take	VERB
ihlr-16572	539	52	to	to	PART
ihlr-16572	539	53	develop	develop	VERB
ihlr-16572	539	54	biolog­	biolog­	PRON
ihlr-16572	539	55	ics	ics	NOUN
ihlr-16572	539	56	than	than	ADP
ihlr-16572	539	57	chemical	chemical	NOUN
ihlr-16572	539	58	drug	drug	NOUN
ihlr-16572	539	59	development	development	NOUN
ihlr-16572	539	60	.	.	PUNCT
ihlr-16572	540	1	biolo	biolo	ADJ
ihlr-16572	540	2	:	:	PUNCT
ihlr-16572	540	3	fics	fic	NOUN
ihlr-16572	540	4	take	take	VERB
ihlr-16572	540	5	on	on	ADP
ihlr-16572	540	6	average	average	ADJ
ihlr-16572	540	7	7.4	7.4	NUM
ihlr-16572	540	8	months	month	NOUN
ihlr-16572	540	9	longer	long	ADV
ihlr-16572	540	10	to	to	PART
ihlr-16572	540	11	develop	develop	VERB
ihlr-16572	540	12	than	than	ADP
ihlr-16572	540	13	chemical	chemical	NOUN
ihlr-16572	540	14	entities.16	entities.16	PROPN
ihlr-16572	540	15	the	the	DET
ihlr-16572	540	16	eshoo	eshoo	PROPN
ihlr-16572	540	17	-	-	PUNCT
ihlr-16572	540	18	barton	barton	NOUN
ihlr-16572	540	19	and	and	CCONJ
ihlr-16572	540	20	inslee	inslee	PROPN
ihlr-16572	540	21	bills	bill	NOUN
ihlr-16572	540	22	go	go	VERB
ihlr-16572	540	23	well	well	ADV
ihlr-16572	540	24	beyond	beyond	ADP
ihlr-16572	540	25	compensating	compensate	VERB
ihlr-16572	540	26	for	for	ADP
ihlr-16572	540	27	this	this	DET
ihlr-16572	540	28	increased	increase	VERB
ihlr-16572	540	29	development	development	NOUN
ihlr-16572	540	30	time	time	NOUN
ihlr-16572	540	31	,	,	PUNCT
ihlr-16572	540	32	providing	provide	VERB
ihlr-16572	540	33	innovators	innovator	NOUN
ihlr-16572	540	34	between	between	ADP
ihlr-16572	540	35	12	12	NUM
ihlr-16572	540	36	months	month	NOUN
ihlr-16572	540	37	and	and	CCONJ
ihlr-16572	540	38	120	120	NUM
ihlr-16572	540	39	months	month	NOUN
ihlr-16572	540	40	of	of	ADP
ihlr-16572	540	41	extra	extra	ADJ
ihlr-16572	540	42	monopo­	monopo­	PRON
ihlr-16572	540	43	ly	ly	ADP
ihlr-16572	540	44	protection	protection	NOUN
ihlr-16572	540	45	the	the	DET
ihlr-16572	540	46	variance	variance	NOUN
ihlr-16572	540	47	is	be	AUX
ihlr-16572	540	48	based	base	VERB
ihlr-16572	540	49	on	on	ADP
ihlr-16572	540	50	when	when	SCONJ
ihlr-16572	540	51	the	the	DET
ihlr-16572	540	52	biologic	biologic	NOUN
ihlr-16572	540	53	is	be	AUX
ihlr-16572	540	54	brought	bring	VERB
ihlr-16572	540	55	to	to	ADP
ihlr-16572	540	56	market.l63	market.l63	PROPN
ihlr-16572	540	57	1	1	NUM
ihlr-16572	540	58	.	.	PUNCT
ihlr-16572	540	59	cost	cost	NOUN
ihlr-16572	540	60	/	/	SYM
ihlr-16572	540	61	risk	risk	NOUN
ihlr-16572	540	62	justification	justification	NOUN
ihlr-16572	540	63	argument	argument	NOUN
ihlr-16572	540	64	the	the	DET
ihlr-16572	540	65	costs	cost	NOUN
ihlr-16572	540	66	associated	associate	VERB
ihlr-16572	540	67	with	with	ADP
ihlr-16572	540	68	introducing	introduce	VERB
ihlr-16572	540	69	a	a	DET
ihlr-16572	540	70	new	new	ADJ
ihlr-16572	540	71	biologic	biologic	NOUN
ihlr-16572	540	72	into	into	ADP
ihlr-16572	540	73	the	the	DET
ihlr-16572	540	74	market	market	NOUN
ihlr-16572	540	75	total	total	NOUN
ihlr-16572	540	76	an	an	DET
ihlr-16572	540	77	estimated	estimate	VERB
ihlr-16572	540	78	$	$	SYM
ihlr-16572	540	79	1.24	1.24	NUM
ihlr-16572	540	80	billion.164	billion.164	NOUN
ihlr-16572	540	81	while	while	SCONJ
ihlr-16572	540	82	this	this	DET
ihlr-16572	540	83	figure	figure	NOUN
ihlr-16572	540	84	is	be	AUX
ihlr-16572	540	85	staggering	staggering	ADJ
ihlr-16572	540	86	by	by	ADP
ihlr-16572	540	87	any	any	DET
ihlr-16572	540	88	standard	standard	NOUN
ihlr-16572	540	89	,	,	PUNCT
ihlr-16572	540	90	it	it	PRON
ihlr-16572	540	91	can	can	AUX
ihlr-16572	540	92	not	not	PART
ihlr-16572	540	93	be	be	AUX
ihlr-16572	540	94	looked	look	VERB
ihlr-16572	540	95	at	at	ADP
ihlr-16572	540	96	alone	alone	ADV
ihlr-16572	540	97	.	.	PUNCT
ihlr-16572	541	1	the	the	DET
ihlr-16572	541	2	cost	cost	NOUN
ihlr-16572	541	3	must	must	AUX
ihlr-16572	541	4	be	be	AUX
ihlr-16572	541	5	put	put	VERB
ihlr-16572	541	6	into	into	ADP
ihlr-16572	541	7	appropri­	appropri­	NOUN
ihlr-16572	541	8	ate	eat	VERB
ihlr-16572	541	9	context	context	NOUN
ihlr-16572	541	10	and	and	CCONJ
ihlr-16572	541	11	should	should	AUX
ihlr-16572	541	12	be	be	AUX
ihlr-16572	541	13	compared	compare	VERB
ihlr-16572	541	14	to	to	ADP
ihlr-16572	541	15	the	the	DET
ihlr-16572	541	16	potential	potential	ADJ
ihlr-16572	541	17	return	return	NOUN
ihlr-16572	541	18	on	on	ADP
ihlr-16572	541	19	the	the	DET
ihlr-16572	541	20	invest­	invest­	X
ihlr-16572	541	21	ment	ment	NOUN
ihlr-16572	541	22	.	.	PUNCT
ihlr-16572	542	1	"	"	PUNCT
ihlr-16572	542	2	invention	invention	NOUN
ihlr-16572	542	3	x	x	PUNCT
ihlr-16572	542	4	may	may	AUX
ihlr-16572	542	5	cost	cost	VERB
ihlr-16572	542	6	$	$	SYM
ihlr-16572	542	7	1	1	NUM
ihlr-16572	542	8	million	million	NUM
ihlr-16572	542	9	to	to	PART
ihlr-16572	542	10	bring	bring	VERB
ihlr-16572	542	11	to	to	ADP
ihlr-16572	542	12	market	market	NOUN
ihlr-16572	542	13	and	and	CCONJ
ihlr-16572	542	14	invention	invention	VERB
ihlr-16572	542	15	y	y	PROPN
ihlr-16572	542	16	$	$	SYM
ihlr-16572	542	17	1	1	NUM
ihlr-16572	542	18	billion	billion	NUM
ihlr-16572	542	19	,	,	PUNCT
ihlr-16572	542	20	but	but	CCONJ
ihlr-16572	542	21	the	the	DET
ihlr-16572	542	22	projected	project	VERB
ihlr-16572	542	23	revenues	revenue	NOUN
ihlr-16572	542	24	for	for	ADP
ihlr-16572	542	25	y	y	PROPN
ihlr-16572	542	26	may	may	AUX
ihlr-16572	542	27	exceed	exceed	VERB
ihlr-16572	542	28	those	those	PRON
ihlr-16572	542	29	for	for	ADP
ihlr-16572	542	30	x	x	PUNCT
ihlr-16572	542	31	by	by	ADP
ihlr-16572	542	32	far	far	ADV
ihlr-16572	542	33	more	more	ADJ
ihlr-16572	542	34	than	than	ADP
ihlr-16572	542	35	a	a	DET
ihlr-16572	542	36	factor	factor	NOUN
ihlr-16572	542	37	of	of	ADP
ihlr-16572	542	38	1,000	1,000	NUM
ihlr-16572	542	39	.	.	PUNCT
ihlr-16572	543	1	in	in	ADP
ihlr-16572	543	2	this	this	DET
ihlr-16572	543	3	case	case	NOUN
ihlr-16572	543	4	,	,	PUNCT
ihlr-16572	543	5	less	less	ADJ
ihlr-16572	543	6	monopoly	monopoly	NOUN
ihlr-16572	543	7	protection	protection	NOUN
ihlr-16572	543	8	is	be	AUX
ihlr-16572	543	9	needed	need	VERB
ihlr-16572	543	10	to	to	PART
ihlr-16572	543	11	promote	promote	VERB
ihlr-16572	543	12	invention	invention	NOUN
ihlr-16572	543	13	ofy	ofy	NOUN
ihlr-16572	543	14	than	than	ADP
ihlr-16572	543	15	ofx	ofx	NOUN
ihlr-16572	543	16	.	.	PUNCT
ihlr-16572	543	17	"165	"165	PROPN
ihlr-16572	544	1	b.	b.	PROPN
ihlr-16572	545	1	the	the	DET
ihlr-16572	545	2	hatch	hatch	PROPN
ihlr-16572	545	3	-	-	PUNCT
ihlr-16572	545	4	waxman	waxman	PROPN
ihlr-16572	545	5	act	act	NOUN
ihlr-16572	545	6	should	should	AUX
ihlr-16572	545	7	be	be	AUX
ihlr-16572	545	8	used	use	VERB
ihlr-16572	545	9	as	as	ADP
ihlr-16572	545	10	a	a	DET
ihlr-16572	545	11	template	template	NOUN
ihlr-16572	545	12	for	for	ADP
ihlr-16572	545	13	generic	generic	ADJ
ihlr-16572	545	14	bi­	bi­	PROPN
ihlr-16572	545	15	ologics	ologic	NOUN
ihlr-16572	545	16	legislation	legislation	NOUN
ihlr-16572	545	17	.	.	PUNCT
ihlr-16572	546	1	opponents	opponent	NOUN
ihlr-16572	546	2	of	of	ADP
ihlr-16572	546	3	generic	generic	ADJ
ihlr-16572	546	4	biologics	biologic	NOUN
ihlr-16572	546	5	contend	contend	VERB
ihlr-16572	546	6	that	that	SCONJ
ihlr-16572	546	7	allowing	allow	VERB
ihlr-16572	546	8	generic	generic	ADJ
ihlr-16572	546	9	produc­	produc­	ADP
ihlr-16572	546	10	tion	tion	NOUN
ihlr-16572	546	11	of	of	ADP
ihlr-16572	546	12	these	these	DET
ihlr-16572	546	13	drugs	drug	NOUN
ihlr-16572	546	14	will	will	AUX
ihlr-16572	546	15	stifle	stifle	VERB
ihlr-16572	546	16	innovation	innovation	NOUN
ihlr-16572	546	17	.	.	PUNCT
ihlr-16572	547	1	166	166	NUM
ihlr-16572	547	2	the	the	DET
ihlr-16572	547	3	hatch	hatch	NOUN
ihlr-16572	547	4	-	-	PUNCT
ihlr-16572	547	5	waxman	waxman	PROPN
ihlr-16572	547	6	act	act	NOUN
ihlr-16572	547	7	is	be	AUX
ihlr-16572	547	8	proof	proof	NOUN
ihlr-16572	547	9	that	that	SCONJ
ihlr-16572	547	10	generics	generic	NOUN
ihlr-16572	547	11	do	do	AUX
ihlr-16572	547	12	not	not	PART
ihlr-16572	547	13	stifle	stifle	VERB
ihlr-16572	547	14	innovation	innovation	NOUN
ihlr-16572	547	15	,	,	PUNCT
ihlr-16572	547	16	in	in	ADP
ihlr-16572	547	17	fact	fact	NOUN
ihlr-16572	547	18	they	they	PRON
ihlr-16572	547	19	stimulate	stimulate	VERB
ihlr-16572	547	20	innovat	innovat	NOUN
ihlr-16572	547	21	.	.	PUNCT
ihlr-16572	548	1	167	167	NUM
ihlr-16572	548	2	ton	ton	NOUN
ihlr-16572	548	3	.	.	PUNCT
ihlr-16572	549	1	hatch	hatch	NOUN
ihlr-16572	549	2	-	-	PUNCT
ihlr-16572	549	3	waxman	waxman	NOUN
ihlr-16572	549	4	's	's	PART
ihlr-16572	549	5	success	success	NOUN
ihlr-16572	549	6	did	do	AUX
ihlr-16572	549	7	not	not	PART
ihlr-16572	549	8	come	come	VERB
ihlr-16572	549	9	at	at	ADP
ihlr-16572	549	10	the	the	DET
ihlr-16572	549	11	price	price	NOUN
ihlr-16572	549	12	of	of	ADP
ihlr-16572	549	13	innovation	innovation	NOUN
ihlr-16572	549	14	.	.	PUNCT
ihlr-16572	550	1	on	on	ADP
ihlr-16572	550	2	the	the	DET
ihlr-16572	550	3	contrary	contrary	NOUN
ihlr-16572	550	4	,	,	PUNCT
ihlr-16572	550	5	the	the	DET
ihlr-16572	550	6	legislation	legislation	NOUN
ihlr-16572	550	7	appears	appear	VERB
ihlr-16572	550	8	to	to	PART
ihlr-16572	550	9	have	have	AUX
ihlr-16572	550	10	accelerated	accelerate	VERB
ihlr-16572	550	11	innovation	innovation	NOUN
ihlr-16572	550	12	.	.	PUNCT
ihlr-16572	550	13	.	.	PUNCT
ihlr-16572	550	14	.	.	PUNCT
ihlr-16572	550	15	.	.	PUNCT
ihlr-16572	551	1	research	research	NOUN
ihlr-16572	551	2	and	and	CCONJ
ihlr-16572	551	3	de­	de­	ADJ
ihlr-16572	551	4	velopment	velopment	NOUN
ihlr-16572	551	5	in	in	ADP
ihlr-16572	551	6	pharmaceuticals	pharmaceutical	NOUN
ihlr-16572	551	7	,	,	PUNCT
ihlr-16572	551	8	measured	measure	VERB
ihlr-16572	551	9	relative	relative	ADJ
ihlr-16572	551	10	to	to	ADP
ihlr-16572	551	11	sales	sale	NOUN
ihlr-16572	551	12	,	,	PUNCT
ihlr-16572	551	13	increased	increase	VERB
ihlr-16572	551	14	dramatically	dramatically	ADV
ihlr-16572	551	15	in	in	ADP
ihlr-16572	551	16	the	the	DET
ihlr-16572	551	17	years	year	NOUN
ihlr-16572	551	18	after	after	ADP
ihlr-16572	551	19	1984	1984	NUM
ihlr-16572	551	20	.	.	PUNCT
ihlr-16572	552	1	161	161	NUM
ihlr-16572	552	2	.	.	PUNCT
ihlr-16572	552	3	letter	letter	NOUN
ihlr-16572	552	4	from	from	ADP
ihlr-16572	552	5	john	john	PROPN
ihlr-16572	552	6	taylor	taylor	PROPN
ihlr-16572	552	7	,	,	PUNCT
ihlr-16572	552	8	supra	supra	PROPN
ihlr-16572	552	9	note	note	NOUN
ihlr-16572	552	10	7	7	NUM
ihlr-16572	552	11	.	.	NOUN
ihlr-16572	552	12	162	162	NUM
ihlr-16572	552	13	.	.	PUNCT
ihlr-16572	553	1	grabowski	grabowski	PROPN
ihlr-16572	553	2	,	,	PUNCT
ihlr-16572	553	3	supra	supra	PROPN
ihlr-16572	553	4	note	note	NOUN
ihlr-16572	553	5	144	144	NUM
ihlr-16572	553	6	,	,	PUNCT
ihlr-16572	553	7	at	at	ADP
ihlr-16572	553	8	481	481	NUM
ihlr-16572	553	9	.	.	PROPN
ihlr-16572	553	10	163	163	NUM
ihlr-16572	553	11	.	.	PUNCT
ihlr-16572	554	1	s.	s.	PROPN
ihlr-16572	554	2	1695	1695	NUM
ihlr-16572	554	3	,	,	PUNCT
ihlr-16572	554	4	supra	supra	PROPN
ihlr-16572	554	5	note	note	VERB
ihlr-16572	554	6	122	122	NUM
ihlr-16572	554	7	;	;	PUNCT
ihlr-16572	554	8	h.r	h.r	PROPN
ihlr-16572	554	9	.	.	PROPN
ihlr-16572	554	10	5629	5629	NUM
ihlr-16572	554	11	,	,	PUNCT
ihlr-16572	554	12	supra	supra	PROPN
ihlr-16572	554	13	note	note	NOUN
ihlr-16572	554	14	126	126	NUM
ihlr-16572	554	15	.	.	NOUN
ihlr-16572	554	16	164	164	NUM
ihlr-16572	554	17	.	.	PUNCT
ihlr-16572	555	1	see	see	VERB
ihlr-16572	555	2	kotlikoff	kotlikoff	NOUN
ihlr-16572	555	3	,	,	PUNCT
ihlr-16572	555	4	supra	supra	PROPN
ihlr-16572	555	5	note	note	PROPN
ihlr-16572	555	6	28	28	NUM
ihlr-16572	555	7	,	,	PUNCT
ihlr-16572	555	8	at	at	ADP
ihlr-16572	555	9	8	8	NUM
ihlr-16572	555	10	(	(	PUNCT
ihlr-16572	555	11	citing	cite	VERB
ihlr-16572	555	12	joseph	joseph	PROPN
ihlr-16572	555	13	a.	a.	PROPN
ihlr-16572	555	14	dimasi	dimasi	PROPN
ihlr-16572	555	15	,	,	PUNCT
ihlr-16572	555	16	ronald	ronald	PROPN
ihlr-16572	555	17	w.	w.	PROPN
ihlr-16572	555	18	hansen	hansen	PROPN
ihlr-16572	555	19	,	,	PUNCT
ihlr-16572	555	20	and	and	CCONJ
ihlr-16572	555	21	henry	henry	PROPN
ihlr-16572	555	22	g.	g.	PROPN
ihlr-16572	555	23	grabowski	grabowski	PROPN
ihlr-16572	555	24	,	,	PUNCT
ihlr-16572	555	25	the	the	DET
ihlr-16572	555	26	price	price	NOUN
ihlr-16572	555	27	of	of	ADP
ihlr-16572	555	28	innovation	innovation	NOUN
ihlr-16572	555	29	:	:	PUNCT
ihlr-16572	555	30	new	new	ADJ
ihlr-16572	555	31	estimates	estimate	NOUN
ihlr-16572	555	32	of	of	ADP
ihlr-16572	555	33	drug	drug	NOUN
ihlr-16572	555	34	development	development	NOUN
ihlr-16572	555	35	costs	cost	NOUN
ihlr-16572	555	36	,	,	PUNCT
ihlr-16572	555	37	22	22	NUM
ihlr-16572	555	38	j.healthecon.151	j.healthecon.151	NOUN
ihlr-16572	555	39	,	,	PUNCT
ihlr-16572	555	40	151	151	NUM
ihlr-16572	555	41	-	-	SYM
ihlr-16572	555	42	185	185	NUM
ihlr-16572	555	43	(	(	PUNCT
ihlr-16572	555	44	2003	2003	NUM
ihlr-16572	555	45	)	)	PUNCT
ihlr-16572	555	46	)	)	PUNCT
ihlr-16572	555	47	;	;	PUNCT
ihlr-16572	556	1	grabowski	grabowski	PROPN
ihlr-16572	556	2	,	,	PUNCT
ihlr-16572	556	3	supra	supra	PROPN
ihlr-16572	556	4	note	note	NOUN
ihlr-16572	556	5	144	144	NUM
ihlr-16572	556	6	,	,	PUNCT
ihlr-16572	556	7	at482	at482	PROPN
ihlr-16572	556	8	.	.	PUNCT
ihlr-16572	557	1	165	165	NUM
ihlr-16572	557	2	.	.	PUNCT
ihlr-16572	557	3	kotlikoff	kotlikoff	PROPN
ihlr-16572	557	4	,	,	PUNCT
ihlr-16572	557	5	supra	supra	PROPN
ihlr-16572	557	6	note	note	PROPN
ihlr-16572	557	7	28	28	NUM
ihlr-16572	557	8	,	,	PUNCT
ihlr-16572	557	9	at	at	ADP
ihlr-16572	557	10	9	9	NUM
ihlr-16572	557	11	.	.	NOUN
ihlr-16572	557	12	166	166	NUM
ihlr-16572	557	13	.	.	PUNCT
ihlr-16572	557	14	letter	letter	NOUN
ihlr-16572	557	15	from	from	ADP
ihlr-16572	557	16	john	john	PROPN
ihlr-16572	557	17	taylor	taylor	PROPN
ihlr-16572	557	18	,	,	PUNCT
ihlr-16572	557	19	supra	supra	PROPN
ihlr-16572	557	20	note	note	NOUN
ihlr-16572	558	1	7	7	NUM
ihlr-16572	558	2	.	.	NOUN
ihlr-16572	558	3	167	167	NUM
ihlr-16572	558	4	.	.	PUNCT
ihlr-16572	558	5	drug	drug	NOUN
ihlr-16572	558	6	price	price	NOUN
ihlr-16572	558	7	competition	competition	NOUN
ihlr-16572	558	8	and	and	CCONJ
ihlr-16572	558	9	patent	patent	NOUN
ihlr-16572	558	10	term	term	NOUN
ihlr-16572	558	11	restoration	restoration	NOUN
ihlr-16572	558	12	act	act	NOUN
ihlr-16572	558	13	,	,	PUNCT
ihlr-16572	558	14	pub	pub	NOUN
ihlr-16572	558	15	.	.	PUNCT
ihlr-16572	559	1	l.	l.	PROPN
ihlr-16572	559	2	no	no	INTJ
ihlr-16572	559	3	.	.	PROPN
ihlr-16572	560	1	98	98	NUM
ihlr-16572	560	2	-	-	SYM
ihlr-16572	560	3	417	417	NUM
ihlr-16572	560	4	(	(	PUNCT
ihlr-16572	560	5	1984	1984	NUM
ihlr-16572	560	6	)	)	PUNCT
ihlr-16572	560	7	,	,	PUNCT
ihlr-16572	560	8	98	98	NUM
ihlr-16572	560	9	stat	stat	NOUN
ihlr-16572	560	10	.	.	PUNCT
ihlr-16572	561	1	1585	1585	NUM
ihlr-16572	561	2	(	(	PUNCT
ihlr-16572	561	3	1984	1984	NUM
ihlr-16572	561	4	)	)	PUNCT
ihlr-16572	561	5	.	.	PUNCT
ihlr-16572	562	1	392	392	NUM
ihlr-16572	562	2	indiana	indiana	PROPN
ihlr-16572	562	3	health	health	PROPN
ihlr-16572	562	4	law	law	PROPN
ihlr-16572	562	5	review	review	NOUN
ihlr-16572	562	6	r&d	r&d	NOUN
ihlr-16572	562	7	is	be	AUX
ihlr-16572	562	8	now	now	ADV
ihlr-16572	562	9	running	run	VERB
ihlr-16572	562	10	between	between	ADP
ihlr-16572	562	11	16	16	NUM
ihlr-16572	562	12	percent	percent	NOUN
ihlr-16572	562	13	and	and	CCONJ
ihlr-16572	562	14	18	18	NUM
ihlr-16572	562	15	per­	per­	NOUN
ihlr-16572	562	16	cent	cent	NOUN
ihlr-16572	562	17	of	of	ADP
ihlr-16572	562	18	sales	sale	NOUN
ihlr-16572	562	19	,	,	PUNCT
ihlr-16572	562	20	on	on	ADP
ihlr-16572	562	21	an	an	DET
ihlr-16572	562	22	annual	annual	ADJ
ihlr-16572	562	23	basis	basis	NOUN
ihlr-16572	562	24	,	,	PUNCT
ihlr-16572	562	25	compared	compare	VERB
ihlr-16572	562	26	with	with	ADP
ihlr-16572	562	27	8	8	NUM
ihlr-16572	562	28	-	-	SYM
ihlr-16572	562	29	10	10	NUM
ihlr-16572	562	30	percent	percent	NOUN
ihlr-16572	562	31	of	of	ADP
ihlr-16572	562	32	sales	sale	NOUN
ihlr-16572	562	33	prior	prior	ADV
ihlr-16572	562	34	to	to	ADP
ihlr-16572	562	35	hatch	hatch	NOUN
ihlr-16572	562	36	-	-	PUNCT
ihlr-16572	562	37	waxman	waxman	NOUN
ihlr-16572	562	38	.	.	PUNCT
ihlr-16572	563	1	*	*	PUNCT
ihlr-16572	564	1	*	*	PUNCT
ihlr-16572	564	2	*	*	PUNCT
ihlr-16572	565	1	[	[	X
ihlr-16572	565	2	t]he	t]he	ADJ
ihlr-16572	565	3	number	number	NOUN
ihlr-16572	565	4	of	of	ADP
ihlr-16572	565	5	new	new	ADJ
ihlr-16572	565	6	drug	drug	NOUN
ihlr-16572	565	7	patents	patent	NOUN
ihlr-16572	565	8	issued	issue	VERB
ihlr-16572	565	9	by	by	ADP
ihlr-16572	565	10	the	the	DET
ihlr-16572	565	11	u.s	u.s	PROPN
ihlr-16572	565	12	.	.	PROPN
ihlr-16572	565	13	patent	patent	NOUN
ihlr-16572	565	14	office	office	NOUN
ihlr-16572	565	15	rose	rise	VERB
ihlr-16572	565	16	dramatically	dramatically	ADV
ihlr-16572	565	17	after	after	ADP
ihlr-16572	565	18	1984	1984	NUM
ihlr-16572	565	19	and	and	CCONJ
ihlr-16572	565	20	,	,	PUNCT
ihlr-16572	565	21	in­	in­	NOUN
ihlr-16572	565	22	deed	deed	NOUN
ihlr-16572	565	23	,	,	PUNCT
ihlr-16572	565	24	has	have	AUX
ihlr-16572	565	25	exceeded	exceed	VERB
ihlr-16572	565	26	the	the	DET
ihlr-16572	565	27	pre-1984	pre-1984	NOUN
ihlr-16572	565	28	levels	level	NOUN
ihlr-16572	565	29	in	in	ADP
ihlr-16572	565	30	each	each	DET
ihlr-16572	565	31	year	year	NOUN
ihlr-16572	565	32	since	since	SCONJ
ihlr-16572	565	33	the	the	DET
ihlr-16572	565	34	act	act	NOUN
ihlr-16572	565	35	was	be	AUX
ihlr-16572	565	36	promulgated.168	promulgated.168	NOUN
ihlr-16572	565	37	[	[	X
ihlr-16572	565	38	vol	vol	NOUN
ihlr-16572	565	39	.	.	PUNCT
ihlr-16572	566	1	7:367	7:367	NUM
ihlr-16572	566	2	any	any	DET
ihlr-16572	566	3	reduction	reduction	NOUN
ihlr-16572	566	4	in	in	ADP
ihlr-16572	566	5	profitability	profitability	NOUN
ihlr-16572	566	6	of	of	ADP
ihlr-16572	566	7	developing	develop	VERB
ihlr-16572	566	8	new	new	ADJ
ihlr-16572	566	9	drugs	drug	NOUN
ihlr-16572	566	10	as	as	ADP
ihlr-16572	566	11	a	a	DET
ihlr-16572	566	12	result	result	NOUN
ihlr-16572	566	13	ofhatch­	ofhatch­	VERB
ihlr-16572	566	14	w	w	PROPN
ihlr-16572	566	15	axman	axman	PROPN
ihlr-16572	566	16	was	be	AUX
ihlr-16572	566	17	mitigated	mitigate	VERB
ihlr-16572	566	18	by	by	ADP
ihlr-16572	566	19	other	other	ADJ
ihlr-16572	566	20	factors	factor	NOUN
ihlr-16572	566	21	,	,	PUNCT
ihlr-16572	566	22	including	include	VERB
ihlr-16572	566	23	an	an	DET
ihlr-16572	566	24	increased	increase	VERB
ihlr-16572	566	25	reliance	reliance	NOUN
ihlr-16572	566	26	on	on	ADP
ihlr-16572	566	27	medication	medication	NOUN
ihlr-16572	566	28	in	in	ADP
ihlr-16572	566	29	health	health	NOUN
ihlr-16572	566	30	care	care	NOUN
ihlr-16572	566	31	,	,	PUNCT
ihlr-16572	566	32	increased	increase	VERB
ihlr-16572	566	33	demand	demand	NOUN
ihlr-16572	566	34	resulting	result	VERB
ihlr-16572	566	35	from	from	ADP
ihlr-16572	566	36	an	an	DET
ihlr-16572	566	37	aging	age	VERB
ihlr-16572	566	38	socie­	socie­	NOUN
ihlr-16572	566	39	ty	ty	NOUN
ihlr-16572	566	40	,	,	PUNCT
ihlr-16572	566	41	and	and	CCONJ
ihlr-16572	566	42	an	an	DET
ihlr-16572	566	43	increased	increase	VERB
ihlr-16572	566	44	international	international	ADJ
ihlr-16572	566	45	demand	demand	NOUN
ihlr-16572	566	46	as	as	ADP
ihlr-16572	566	47	a	a	DET
ihlr-16572	566	48	result	result	NOUN
ihlr-16572	566	49	of	of	ADP
ihlr-16572	566	50	greater	great	ADJ
ihlr-16572	566	51	parity	parity	NOUN
ihlr-16572	566	52	amongst	amongst	ADP
ihlr-16572	566	53	industrial	industrial	ADJ
ihlr-16572	566	54	nations	nation	NOUN
ihlr-16572	566	55	.	.	PUNCT
ihlr-16572	567	1	"	"	PUNCT
ihlr-16572	567	2	for	for	ADP
ihlr-16572	567	3	all	all	DET
ihlr-16572	567	4	drugs	drug	NOUN
ihlr-16572	567	5	,	,	PUNCT
ihlr-16572	567	6	on	on	ADP
ihlr-16572	567	7	average	average	ADJ
ihlr-16572	567	8	,	,	PUNCT
ihlr-16572	567	9	the	the	DET
ihlr-16572	567	10	increase	increase	NOUN
ihlr-16572	567	11	in	in	ADP
ihlr-16572	567	12	ge­	ge­	PROPN
ihlr-16572	567	13	neric	neric	ADJ
ihlr-16572	567	14	sales	sale	NOUN
ihlr-16572	567	15	since	since	SCONJ
ihlr-16572	567	16	1984	1984	NUM
ihlr-16572	567	17	bas	bas	X
ihlr-16572	567	18	probably	probably	ADV
ihlr-16572	567	19	not	not	PART
ihlr-16572	567	20	reduced	reduce	VERB
ihlr-16572	567	21	expected	expect	VERB
ihlr-16572	567	22	returns	return	NOUN
ihlr-16572	567	23	below	below	ADP
ihlr-16572	567	24	the	the	DET
ihlr-16572	567	25	average	average	ADJ
ihlr-16572	567	26	capitalized	capitalize	VERB
ihlr-16572	567	27	costs	cost	NOUN
ihlr-16572	567	28	of	of	ADP
ihlr-16572	567	29	r&d	r&d	NOUN
ihlr-16572	567	30	.	.	PUNCT
ihlr-16572	568	1	on	on	ADP
ihlr-16572	568	2	the	the	DET
ihlr-16572	568	3	margin	margin	NOUN
ihlr-16572	568	4	,	,	PUNCT
ihlr-16572	568	5	however	however	ADV
ihlr-16572	568	6	,	,	PUNCT
ihlr-16572	568	7	it	it	PRON
ihlr-16572	568	8	is	be	AUX
ihlr-16572	568	9	possible	possible	ADJ
ihlr-16572	568	10	that	that	SCONJ
ihlr-16572	568	11	a	a	DET
ihlr-16572	568	12	few	few	ADJ
ihlr-16572	568	13	dru£s	dru£s	PROPN
ihlr-16572	568	14	that	that	PRON
ihlr-16572	568	15	were	be	AUX
ihlr-16572	568	16	barely	barely	ADV
ihlr-16572	568	17	profitable	profitable	ADJ
ihlr-16572	568	18	to	to	PART
ihlr-16572	568	19	develop	develop	VERB
ihlr-16572	568	20	before	before	ADP
ihlr-16572	568	21	may	may	AUX
ihlr-16572	568	22	no	no	ADV
ihlr-16572	568	23	longer	long	ADV
ihlr-16572	568	24	be	be	AUX
ihlr-16572	568	25	so	so	ADV
ihlr-16572	568	26	now	now	ADV
ihlr-16572	568	27	.	.	PUNCT
ihlr-16572	569	1	"1	"1	NOUN
ihlr-16572	569	2	while	while	SCONJ
ihlr-16572	569	3	generic	generic	ADJ
ihlr-16572	569	4	drugs	drug	NOUN
ihlr-16572	569	5	comprise	comprise	VERB
ihlr-16572	569	6	a	a	DET
ihlr-16572	569	7	large	large	ADJ
ihlr-16572	569	8	portion	portion	NOUN
ihlr-16572	569	9	of	of	ADP
ihlr-16572	569	10	all	all	DET
ihlr-16572	569	11	pre­	pre­	NOUN
ihlr-16572	569	12	scriptions	scription	NOUN
ihlr-16572	569	13	filled	fill	VERB
ihlr-16572	569	14	in	in	ADP
ihlr-16572	569	15	the	the	DET
ihlr-16572	569	16	u.s	u.s	PROPN
ihlr-16572	569	17	.	.	PROPN
ihlr-16572	569	18	;	;	PUNCT
ihlr-16572	569	19	the	the	DET
ihlr-16572	569	20	brand	brand	NOUN
ihlr-16572	569	21	companies	company	NOUN
ihlr-16572	569	22	'	'	PART
ihlr-16572	569	23	annual	annual	ADJ
ihlr-16572	569	24	revenue	revenue	NOUN
ihlr-16572	569	25	,	,	PUNCT
ihlr-16572	569	26	over	over	ADP
ihlr-16572	569	27	a	a	DET
ihlr-16572	569	28	quarter	quarter	NOUN
ihlr-16572	569	29	of	of	ADP
ihlr-16572	569	30	a	a	DET
ihlr-16572	569	31	trillion	trillion	NUM
ihlr-16572	569	32	dollars	dollar	NOUN
ihlr-16572	569	33	in	in	ADP
ihlr-16572	569	34	2007,170	2007,170	NUM
ihlr-16572	569	35	represents	represent	VERB
ihlr-16572	569	36	eighty	eighty	NUM
ihlr-16572	569	37	;	;	PUNCT
ihlr-16572	569	38	.	.	PUNCT
ihlr-16572	570	1	four	four	NUM
ihlr-16572	570	2	percent	percent	NOUN
ihlr-16572	570	3	of	of	ADP
ihlr-16572	570	4	all	all	DET
ihlr-16572	570	5	h	h	NOUN
ihlr-16572	570	6	.	.	PUNCT
ihlr-16572	571	1	1	1	NUM
ihlr-16572	571	2	171	171	NUM
ihlr-16572	571	3	p	p	PRON
ihlr-16572	571	4	armaceuttca	armaceuttca	ADJ
ihlr-16572	571	5	revenue	revenue	NOUN
ihlr-16572	571	6	.	.	PUNCT
ihlr-16572	572	1	c.	c.	PROPN
ihlr-16572	572	2	congress	congress	PROPN
ihlr-16572	572	3	should	should	AUX
ihlr-16572	572	4	assess	assess	VERB
ihlr-16572	572	5	the	the	DET
ihlr-16572	572	6	arguments	argument	NOUN
ihlr-16572	572	7	from	from	ADP
ihlr-16572	572	8	these	these	DET
ihlr-16572	572	9	two	two	NUM
ihlr-16572	572	10	inherently	inherently	ADV
ihlr-16572	572	11	bi­	bi­	ADJ
ihlr-16572	572	12	ased	ase	VERB
ihlr-16572	572	13	groups	group	NOUN
ihlr-16572	572	14	with	with	ADP
ihlr-16572	572	15	a	a	DET
ihlr-16572	572	16	focus	focus	NOUN
ihlr-16572	572	17	on	on	ADP
ihlr-16572	572	18	our	our	PRON
ihlr-16572	572	19	country	country	NOUN
ihlr-16572	572	20	's	's	PART
ihlr-16572	572	21	biotech	biotech	ADJ
ihlr-16572	572	22	consumers	consumer	NOUN
ihlr-16572	572	23	this	this	DET
ihlr-16572	572	24	debate	debate	NOUN
ihlr-16572	572	25	centers	center	NOUN
ihlr-16572	572	26	around	around	ADP
ihlr-16572	572	27	the	the	DET
ihlr-16572	572	28	feasibility	feasibility	NOUN
ihlr-16572	572	29	of	of	ADP
ihlr-16572	572	30	safe	safe	ADJ
ihlr-16572	572	31	and	and	CCONJ
ihlr-16572	572	32	effective	effective	ADJ
ihlr-16572	572	33	dupli­	dupli­	ADJ
ihlr-16572	572	34	cation	cation	NOUN
ihlr-16572	572	35	of	of	ADP
ihlr-16572	572	36	biologics	biologic	NOUN
ihlr-16572	572	37	,	,	PUNCT
ihlr-16572	572	38	and	and	CCONJ
ihlr-16572	572	39	the	the	DET
ihlr-16572	572	40	effect	effect	NOUN
ihlr-16572	572	41	that	that	SCONJ
ihlr-16572	572	42	an	an	DET
ihlr-16572	572	43	abbreviated	abbreviate	VERB
ihlr-16572	572	44	regulatory	regulatory	ADJ
ihlr-16572	572	45	pathway	pathway	NOUN
ihlr-16572	572	46	for	for	ADP
ihlr-16572	572	47	follow	follow	VERB
ihlr-16572	572	48	-	-	PUNCT
ihlr-16572	572	49	on	on	ADP
ihlr-16572	572	50	biologics	biologic	NOUN
ihlr-16572	572	51	will	will	AUX
ihlr-16572	572	52	have	have	AUX
ihlr-16572	572	53	on	on	ADP
ihlr-16572	572	54	innovation	innovation	NOUN
ihlr-16572	572	55	.	.	PUNCT
ihlr-16572	573	1	congress	congress	PROPN
ihlr-16572	573	2	and	and	CCONJ
ihlr-16572	573	3	fda	fda	PROPN
ihlr-16572	573	4	should	should	AUX
ihlr-16572	573	5	assess	assess	VERB
ihlr-16572	573	6	these	these	DET
ihlr-16572	573	7	areas	area	NOUN
ihlr-16572	573	8	of	of	ADP
ihlr-16572	573	9	contention	contention	NOUN
ihlr-16572	573	10	impartially	impartially	ADV
ihlr-16572	573	11	,	,	PUNCT
ihlr-16572	573	12	and	and	CCONJ
ihlr-16572	573	13	take	take	VERB
ihlr-16572	573	14	action	action	NOUN
ihlr-16572	573	15	commensurate	commensurate	ADJ
ihlr-16572	573	16	with	with	ADP
ihlr-16572	573	17	the	the	DET
ihlr-16572	573	18	urgency	urgency	NOUN
ihlr-16572	573	19	of	of	ADP
ihlr-16572	573	20	this	this	DET
ihlr-16572	573	21	highly	highly	ADV
ihlr-16572	573	22	important	important	ADJ
ihlr-16572	573	23	issue	issue	NOUN
ihlr-16572	573	24	.	.	PUNCT
ihlr-16572	574	1	the	the	DET
ihlr-16572	574	2	threshold	threshold	NOUN
ihlr-16572	574	3	question	question	NOUN
ihlr-16572	574	4	should	should	AUX
ihlr-16572	574	5	be	be	AUX
ihlr-16572	574	6	whether	whether	SCONJ
ihlr-16572	574	7	biologics	biologic	NOUN
ihlr-16572	574	8	are	be	AUX
ihlr-16572	574	9	amenable	amenable	ADJ
ihlr-16572	574	10	to	to	ADP
ihlr-16572	574	11	safe	safe	ADJ
ihlr-16572	574	12	duplication.172	duplication.172	NOUN
ihlr-16572	574	13	if	if	SCONJ
ihlr-16572	574	14	they	they	PRON
ihlr-16572	574	15	are	be	AUX
ihlr-16572	574	16	,	,	PUNCT
ihlr-16572	574	17	then	then	ADV
ihlr-16572	574	18	follow	follow	VERB
ihlr-16572	574	19	-	-	PUNCT
ihlr-16572	574	20	on	on	ADP
ihlr-16572	574	21	biologics	biologic	NOUN
ihlr-16572	574	22	legislation	legislation	NOUN
ihlr-16572	574	23	should	should	AUX
ihlr-16572	574	24	be	be	AUX
ihlr-16572	574	25	enacted	enact	VERB
ihlr-16572	574	26	which	which	PRON
ihlr-16572	574	27	strikes	strike	VERB
ihlr-16572	574	28	a	a	DET
ihlr-16572	574	29	balance	balance	NOUN
ihlr-16572	574	30	between	between	ADP
ihlr-16572	574	31	the	the	DET
ihlr-16572	574	32	necessary	necessary	ADJ
ihlr-16572	574	33	encouragement	encouragement	NOUN
ihlr-16572	574	34	of	of	ADP
ihlr-16572	574	35	innovation	innovation	NOUN
ihlr-16572	574	36	,	,	PUNCT
ihlr-16572	574	37	and	and	CCONJ
ihlr-16572	574	38	eventual	eventual	ADJ
ihlr-16572	574	39	relief	relief	NOUN
ihlr-16572	574	40	to	to	ADP
ihlr-16572	574	41	patients	patient	NOUN
ihlr-16572	574	42	'	'	PART
ihlr-16572	574	43	pocketbooks	pocketbook	NOUN
ihlr-16572	574	44	.	.	PUNCT
ihlr-16572	575	1	168	168	NUM
ihlr-16572	575	2	.	.	PUNCT
ihlr-16572	575	3	kotlikoff	kotlikoff	PROPN
ihlr-16572	575	4	,	,	PUNCT
ihlr-16572	575	5	supra	supra	PROPN
ihlr-16572	575	6	note	note	PROPN
ihlr-16572	575	7	28	28	NUM
ihlr-16572	575	8	,	,	PUNCT
ihlr-16572	575	9	at	at	ADP
ihlr-16572	575	10	10	10	NUM
ihlr-16572	575	11	.	.	NOUN
ihlr-16572	575	12	169	169	NUM
ihlr-16572	575	13	.	.	PUNCT
ihlr-16572	575	14	kotlikoff	kotlikoff	PROPN
ihlr-16572	575	15	,	,	PUNCT
ihlr-16572	575	16	supra	supra	PROPN
ihlr-16572	575	17	note	note	PROPN
ihlr-16572	575	18	28	28	NUM
ihlr-16572	575	19	,	,	PUNCT
ihlr-16572	575	20	at	at	ADP
ihlr-16572	575	21	ll(quoting	ll(quote	VERB
ihlr-16572	575	22	congressional	congressional	ADJ
ihlr-16572	575	23	budget	budget	NOUN
ihlr-16572	575	24	office	office	NOUN
ihlr-16572	575	25	,	,	PUNCT
ihlr-16572	575	26	study	study	NOUN
ihlr-16572	575	27	:	:	PUNCT
ihlr-16572	575	28	how	how	SCONJ
ihlr-16572	575	29	increased	increase	VERB
ihlr-16572	575	30	competition	competition	NOUN
ihlr-16572	575	31	from	from	ADP
ihlr-16572	575	32	generic	generic	ADJ
ihlr-16572	575	33	drugs	drug	NOUN
ihlr-16572	575	34	has	have	AUX
ihlr-16572	575	35	affected	affect	VERB
ihlr-16572	575	36	prices	price	NOUN
ihlr-16572	575	37	and	and	CCONJ
ihlr-16572	575	38	returns	return	NOUN
ihlr-16572	575	39	in	in	ADP
ihlr-16572	575	40	the	the	DET
ihlr-16572	575	41	pharmaceutical	pharmaceutical	NOUN
ihlr-16572	575	42	industry	industry	NOUN
ihlr-16572	575	43	(	(	PUNCT
ihlr-16572	575	44	1998	1998	NUM
ihlr-16572	575	45	)	)	PUNCT
ihlr-16572	575	46	)	)	PUNCT
ihlr-16572	575	47	.	.	PUNCT
ihlr-16572	576	1	170	170	NUM
ihlr-16572	576	2	.	.	PUNCT
ihlr-16572	577	1	generic	generic	ADJ
ihlr-16572	577	2	pharmaceutical	pharmaceutical	PROPN
ihlr-16572	577	3	association	association	NOUN
ihlr-16572	577	4	,	,	PUNCT
ihlr-16572	577	5	facts	fact	NOUN
ihlr-16572	577	6	at	at	ADP
ihlr-16572	577	7	a	a	DET
ihlr-16572	577	8	glance	glance	NOUN
ihlr-16572	577	9	,	,	PUNCT
ihlr-16572	577	10	http://www.gphaonline	http://www.gphaonline	NOUN
ihlr-16572	577	11	.	.	PUNCT
ihlr-16572	578	1	org!about	org!about	NOUN
ihlr-16572	578	2	-	-	PUNCT
ihlr-16572	578	3	gphalabout	gphalabout	NOUN
ihlr-16572	578	4	-	-	PUNCT
ihlr-16572	578	5	generics	generic	NOUN
ihlr-16572	578	6	/	/	SYM
ihlr-16572	578	7	facts	fact	NOUN
ihlr-16572	578	8	(	(	PUNCT
ihlr-16572	578	9	last	last	ADJ
ihlr-16572	578	10	visited	visit	VERB
ihlr-16572	578	11	mar	mar	PROPN
ihlr-16572	578	12	.	.	PROPN
ihlr-16572	578	13	11	11	NUM
ihlr-16572	578	14	,	,	PUNCT
ihlr-16572	578	15	2010	2010	NUM
ihlr-16572	578	16	)	)	PUNCT
ihlr-16572	578	17	.	.	PUNCT
ihlr-16572	579	1	171	171	NUM
ihlr-16572	579	2	.	.	PUNCT
ihlr-16572	580	1	ims	im	NOUN
ihlr-16572	580	2	health	health	NOUN
ihlr-16572	580	3	,	,	PUNCT
ihlr-16572	580	4	"	"	PUNCT
ihlr-16572	580	5	ims	ims	X
ihlr-16572	580	6	national	national	ADJ
ihlr-16572	580	7	prescription	prescription	NOUN
ihlr-16572	580	8	audit	audit	NOUN
ihlr-16572	580	9	plus	plus	CCONJ
ihlr-16572	580	10	,	,	PUNCT
ihlr-16572	580	11	national	national	ADJ
ihlr-16572	580	12	sales	sale	NOUN
ihlr-16572	580	13	perspectives	perspective	NOUN
ihlr-16572	580	14	,	,	PUNCT
ihlr-16572	580	15	"	"	PUNCT
ihlr-16572	580	16	december	december	PROPN
ihlr-16572	580	17	2007	2007	NUM
ihlr-16572	580	18	.	.	PUNCT
ihlr-16572	581	1	172	172	NUM
ihlr-16572	581	2	.	.	PUNCT
ihlr-16572	581	3	gpha	gpha	PROPN
ihlr-16572	581	4	press	press	NOUN
ihlr-16572	581	5	release	release	NOUN
ihlr-16572	581	6	ll	ll	NOUN
ihlr-16572	581	7	,	,	PUNCT
ihlr-16572	581	8	supra	supra	PROPN
ihlr-16572	581	9	note	note	VERB
ihlr-16572	581	10	137	137	NUM
ihlr-16572	581	11	.	.	PUNCT
ihlr-16572	582	1	2010	2010	NUM
ihlr-16572	582	2	]	]	PUNCT
ihlr-16572	582	3	follow	follow	VERB
ihlr-16572	582	4	-	-	PUNCT
ihlr-16572	582	5	on	on	ADP
ihlr-16572	582	6	biologics	biologic	NOUN
ihlr-16572	582	7	legislation	legislation	NOUN
ihlr-16572	582	8	393	393	NUM
ihlr-16572	582	9	an	an	DET
ihlr-16572	582	10	independent	independent	ADJ
ihlr-16572	582	11	research	research	NOUN
ihlr-16572	582	12	panel	panel	NOUN
ihlr-16572	582	13	should	should	AUX
ihlr-16572	582	14	be	be	AUX
ihlr-16572	582	15	used	use	VERB
ihlr-16572	582	16	to	to	PART
ihlr-16572	582	17	assess	assess	VERB
ihlr-16572	582	18	the	the	DET
ihlr-16572	582	19	true	true	ADJ
ihlr-16572	582	20	exclu­	exclu­	PROPN
ihlr-16572	582	21	sivity	sivity	NOUN
ihlr-16572	582	22	period	period	NOUN
ihlr-16572	582	23	necessary	necessary	ADJ
ihlr-16572	582	24	for	for	SCONJ
ihlr-16572	582	25	biotech	biotech	ADJ
ihlr-16572	582	26	companies	company	NOUN
ihlr-16572	582	27	to	to	PART
ihlr-16572	582	28	turn	turn	VERB
ihlr-16572	582	29	a	a	DET
ihlr-16572	582	30	profit	profit	NOUN
ihlr-16572	582	31	on	on	ADP
ihlr-16572	582	32	a	a	DET
ihlr-16572	582	33	given	give	VERB
ihlr-16572	582	34	drug	drug	NOUN
ihlr-16572	582	35	.	.	PUNCT
ihlr-16572	583	1	this	this	DET
ihlr-16572	583	2	data	datum	NOUN
ihlr-16572	583	3	should	should	AUX
ihlr-16572	583	4	be	be	AUX
ihlr-16572	583	5	compared	compare	VERB
ihlr-16572	583	6	to	to	ADP
ihlr-16572	583	7	corresponding	correspond	VERB
ihlr-16572	583	8	data	datum	NOUN
ihlr-16572	583	9	pertaining	pertain	VERB
ihlr-16572	583	10	to	to	ADP
ihlr-16572	583	11	chemical	chemical	ADJ
ihlr-16572	583	12	drugs	drug	NOUN
ihlr-16572	583	13	,	,	PUNCT
ihlr-16572	583	14	and	and	CCONJ
ihlr-16572	583	15	a	a	DET
ihlr-16572	583	16	bill	bill	NOUN
ihlr-16572	583	17	similar	similar	ADJ
ihlr-16572	583	18	to	to	ADP
ihlr-16572	583	19	the	the	DET
ihlr-16572	583	20	hatch	hatch	NOUN
ihlr-16572	583	21	-	-	PUNCT
ihlr-16572	583	22	waxman	waxman	PROPN
ihlr-16572	583	23	act	act	NOUN
ihlr-16572	583	24	should	should	AUX
ihlr-16572	583	25	be	be	AUX
ihlr-16572	583	26	con­	con­	NOUN
ihlr-16572	583	27	structed	structe	VERB
ihlr-16572	583	28	which	which	PRON
ihlr-16572	583	29	reflects	reflect	VERB
ihlr-16572	583	30	any	any	DET
ihlr-16572	583	31	differences	difference	NOUN
ihlr-16572	583	32	in	in	ADP
ihlr-16572	583	33	the	the	DET
ihlr-16572	583	34	data	datum	NOUN
ihlr-16572	583	35	.	.	PUNCT
ihlr-16572	584	1	while	while	SCONJ
ihlr-16572	584	2	a	a	DET
ihlr-16572	584	3	biologic	biologic	NOUN
ihlr-16572	584	4	may	may	AUX
ihlr-16572	584	5	be	be	AUX
ihlr-16572	584	6	more	more	ADV
ihlr-16572	584	7	expensive	expensive	ADJ
ihlr-16572	584	8	to	to	PART
ihlr-16572	584	9	produce	produce	VERB
ihlr-16572	584	10	,	,	PUNCT
ihlr-16572	584	11	there	there	PRON
ihlr-16572	584	12	is	be	VERB
ihlr-16572	584	13	no	no	DET
ihlr-16572	584	14	reason	reason	NOUN
ihlr-16572	584	15	why	why	SCONJ
ihlr-16572	584	16	congress	congress	PROPN
ihlr-16572	584	17	should	should	AUX
ihlr-16572	584	18	be	be	AUX
ihlr-16572	584	19	precluded	preclude	VERB
ihlr-16572	584	20	from	from	ADP
ihlr-16572	584	21	constructing	construct	VERB
ihlr-16572	584	22	a	a	DET
ihlr-16572	584	23	modified	modified	ADJ
ihlr-16572	584	24	version	version	NOUN
ihlr-16572	584	25	of	of	ADP
ihlr-16572	584	26	the	the	DET
ihlr-16572	584	27	hatch	hatch	NOUN
ihlr-16572	584	28	-	-	PUNCT
ihlr-16572	584	29	waxman	waxman	PROPN
ihlr-16572	584	30	act	act	PROPN
ihlr-16572	584	31	,	,	PUNCT
ihlr-16572	584	32	provided	provide	VERB
ihlr-16572	584	33	generic	generic	ADJ
ihlr-16572	584	34	companies	company	NOUN
ihlr-16572	584	35	prove	prove	VERB
ihlr-16572	584	36	that	that	SCONJ
ihlr-16572	584	37	they	they	PRON
ihlr-16572	584	38	are	be	AUX
ihlr-16572	584	39	capable	capable	ADJ
ihlr-16572	584	40	of	of	ADP
ihlr-16572	584	41	safely	safely	ADV
ihlr-16572	584	42	reproduc	reproduc	ADJ
ihlr-16572	584	43	.	.	PUNCT
ihlr-16572	585	1	th	th	X
ihlr-16572	585	2	dru	dru	PROPN
ihlr-16572	585	3	173	173	NUM
ihlr-16572	586	1	mg	mg	PROPN
ihlr-16572	586	2	ese	ese	PROPN
ihlr-16572	586	3	gs	gs	PROPN
ihlr-16572	586	4	.	.	PUNCT
ihlr-16572	586	5	president	president	PROPN
ihlr-16572	586	6	barack	barack	PROPN
ihlr-16572	586	7	obama	obama	PROPN
ihlr-16572	586	8	has	have	AUX
ihlr-16572	586	9	stated	state	VERB
ihlr-16572	586	10	that	that	SCONJ
ihlr-16572	586	11	he	he	PRON
ihlr-16572	586	12	will	will	AUX
ihlr-16572	586	13	seek	seek	VERB
ihlr-16572	586	14	to	to	PART
ihlr-16572	586	15	establish	establish	VERB
ihlr-16572	586	16	a	a	DET
ihlr-16572	586	17	regulatory	regulatory	ADJ
ihlr-16572	586	18	pathway	pathway	NOUN
ihlr-16572	586	19	for	for	ADP
ihlr-16572	586	20	generic	generic	ADJ
ihlr-16572	586	21	biologic	biologic	NOUN
ihlr-16572	586	22	drugs	drug	NOUN
ihlr-16572	586	23	as	as	ADP
ihlr-16572	586	24	part	part	NOUN
ihlr-16572	586	25	of	of	ADP
ihlr-16572	586	26	his	his	PRON
ihlr-16572	586	27	health	health	NOUN
ihlr-16572	586	28	care	care	NOUN
ihlr-16572	586	29	reform	reform	PROPN
ihlr-16572	586	30	plan.174	plan.174	PROPN
ihlr-16572	586	31	in	in	ADP
ihlr-16572	586	32	his	his	PRON
ihlr-16572	586	33	budget	budget	NOUN
ihlr-16572	586	34	report	report	NOUN
ihlr-16572	586	35	for	for	ADP
ihlr-16572	586	36	fiscal	fiscal	ADJ
ihlr-16572	586	37	year	year	NOUN
ihlr-16572	586	38	2010	2010	NUM
ihlr-16572	586	39	,	,	PUNCT
ihlr-16572	586	40	president	president	NOUN
ihlr-16572	586	41	obama	obama	PROPN
ihlr-16572	586	42	acknowledges	acknowledge	VERB
ihlr-16572	586	43	that	that	SCONJ
ihlr-16572	586	44	"	"	PUNCT
ihlr-16572	586	45	[	[	X
ihlr-16572	586	46	p]rescription	p]rescription	NOUN
ihlr-16572	586	47	drug	drug	NOUN
ihlr-16572	586	48	costs	cost	NOUN
ihlr-16572	586	49	are	be	AUX
ihlr-16572	586	50	high	high	ADJ
ihlr-16572	586	51	and	and	CCONJ
ihlr-16572	586	52	rising	rise	VERB
ihlr-16572	586	53	,	,	PUNCT
ihlr-16572	586	54	causing	cause	VERB
ihlr-16572	586	55	too	too	ADV
ihlr-16572	586	56	many·americans	many·american	NOUN
ihlr-16572	586	57	to	to	PART
ihlr-16572	586	58	skip	skip	VERB
ihlr-16572	586	59	doses	dose	NOUN
ihlr-16572	586	60	,	,	PUNCT
ihlr-16572	586	61	split	split	ADJ
ihlr-16572	586	62	pills	pill	NOUN
ihlr-16572	586	63	,	,	PUNCT
ihlr-16572	586	64	or	or	CCONJ
ihlr-16572	586	65	not	not	PART
ihlr-16572	586	66	take	take	VERB
ihlr-16572	586	67	needed	needed	ADJ
ihlr-16572	586	68	medication	medication	NOUN
ihlr-16572	586	69	altogether	altogether	ADV
ihlr-16572	586	70	.	.	PUNCT
ihlr-16572	587	1	"175	"175	PROPN
ihlr-16572	587	2	in	in	ADP
ihlr-16572	587	3	an	an	DET
ihlr-16572	587	4	effort	effort	NOUN
ihlr-16572	587	5	to	to	PART
ihlr-16572	587	6	expand	expand	VERB
ihlr-16572	587	7	access	access	NOUN
ihlr-16572	587	8	to	to	ADP
ihlr-16572	587	9	affordable	affordable	ADJ
ihlr-16572	587	10	biologic	biologic	NOUN
ihlr-16572	587	11	drugs	drug	NOUN
ihlr-16572	587	12	,	,	PUNCT
ihlr-16572	587	13	the	the	DET
ihlr-16572	587	14	administration	administration	NOUN
ihlr-16572	587	15	plans	plan	VERB
ihlr-16572	587	16	to	to	PART
ihlr-16572	587	17	establish	establish	VERB
ihlr-16572	587	18	"	"	PUNCT
ihlr-16572	587	19	a	a	DET
ihlr-16572	587	20	workable	workable	ADJ
ihlr-16572	587	21	regulatory	regulatory	ADJ
ihlr-16572	587	22	,	,	PUNCT
ihlr-16572	587	23	scientific	scientific	ADJ
ihlr-16572	587	24	,	,	PUNCT
ihlr-16572	587	25	and	and	CCONJ
ihlr-16572	587	26	legal	legal	ADJ
ihlr-16572	587	27	pathway	pathway	NOUN
ihlr-16572	587	28	for	for	ADP
ihlr-16572	587	29	generic	generic	ADJ
ihlr-16572	587	30	versions	version	NOUN
ihlr-16572	587	31	of	of	ADP
ihlr-16572	587	32	biologic	biologic	ADJ
ihlr-16572	587	33	drugs	drug	NOUN
ihlr-16572	587	34	.	.	PUNCT
ihlr-16572	588	1	"176	"176	NOUN
ihlr-16572	588	2	though	though	SCONJ
ihlr-16572	588	3	few	few	ADJ
ihlr-16572	588	4	de­	de­	ADJ
ihlr-16572	588	5	tails	tail	NOUN
ihlr-16572	588	6	are	be	AUX
ihlr-16572	588	7	provided	provide	VERB
ihlr-16572	588	8	,	,	PUNCT
ihlr-16572	588	9	president	president	NOUN
ihlr-16572	588	10	obama	obama	PROPN
ihlr-16572	588	11	's	's	PART
ihlr-16572	588	12	budget	budget	NOUN
ihlr-16572	588	13	report	report	NOUN
ihlr-16572	588	14	states	state	VERB
ihlr-16572	588	15	that	that	SCONJ
ihlr-16572	588	16	the	the	DET
ihlr-16572	588	17	admin­	admin­	PROPN
ihlr-16572	588	18	istration	istration	NOUN
ihlr-16572	588	19	will	will	AUX
ihlr-16572	588	20	retain	retain	VERB
ihlr-16572	588	21	the	the	DET
ihlr-16572	588	22	necessary	necessary	ADJ
ihlr-16572	588	23	incentives	incentive	NOUN
ihlr-16572	588	24	for	for	ADP
ihlr-16572	588	25	innovation	innovation	NOUN
ihlr-16572	588	26	by	by	ADP
ihlr-16572	588	27	providing	provide	VERB
ihlr-16572	588	28	"	"	PUNCT
ihlr-16572	588	29	a	a	DET
ihlr-16572	588	30	period	period	NOUN
ihlr-16572	588	31	of	of	ADP
ihlr-16572	588	32	exclusivity	exclusivity	NOUN
ihlr-16572	588	33	...	...	PUNCT
ihlr-16572	588	34	generally	generally	ADV
ihlr-16572	588	35	consistent	consistent	ADJ
ihlr-16572	588	36	with	with	ADP
ihlr-16572	588	37	the	the	DET
ihlr-16572	588	38	principles	principle	NOUN
ihlr-16572	588	39	in	in	ADP
ihlr-16572	588	40	the	the	DET
ihlr-16572	588	41	hatch	hatch	NOUN
ihlr-16572	588	42	-	-	PUNCT
ihlr-16572	588	43	waxman	waxman	NOUN
ihlr-16572	588	44	law	law	NOUN
ihlr-16572	588	45	for	for	ADP
ihlr-16572	588	46	traditional	traditional	ADJ
ihlr-16572	588	47	products	product	NOUN
ihlr-16572	588	48	.	.	PUNCT
ihlr-16572	588	49	"177	"177	PUNCT
ihlr-16572	589	1	the	the	DET
ihlr-16572	589	2	administration	administration	NOUN
ihlr-16572	589	3	also	also	ADV
ihlr-16572	589	4	addressed	address	VERB
ihlr-16572	589	5	the	the	DET
ihlr-16572	589	6	problem	problem	NOUN
ihlr-16572	589	7	of	of	ADP
ihlr-16572	589	8	ever	ever	ADV
ihlr-16572	589	9	-	-	PUNCT
ihlr-16572	589	10	greening	greening	NOUN
ihlr-16572	589	11	,	,	PUNCT
ihlr-16572	589	12	stating	state	VERB
ihlr-16572	589	13	that	that	SCONJ
ihlr-16572	589	14	brand	brand	NOUN
ihlr-16572	589	15	biologic	biologic	NOUN
ihlr-16572	589	16	manu­	manu­	ADJ
ihlr-16572	589	17	facturers	facturer	NOUN
ihlr-16572	589	18	will	will	AUX
ihlr-16572	589	19	be	be	AUX
ihlr-16572	589	20	''	''	PUNCT
ihlr-16572	589	21	prohibited	prohibit	VERB
ihlr-16572	589	22	from	from	ADP
ihlr-16572	589	23	reformulating	reformulate	VERB
ihlr-16572	589	24	existing	exist	VERB
ihlr-16572	589	25	products	product	NOUN
ihlr-16572	589	26	into	into	ADP
ihlr-16572	589	27	new	new	ADJ
ihlr-16572	589	28	products	product	NOUN
ihlr-16572	589	29	to	to	PART
ihlr-16572	589	30	restart	restart	VERB
ihlr-16572	589	31	the	the	DET
ihlr-16572	589	32	exclusivity	exclusivity	NOUN
ihlr-16572	589	33	process	process	NOUN
ihlr-16572	589	34	.	.	PUNCT
ihlr-16572	590	1	"178	"178	PROPN
ihlr-16572	590	2	it	it	PRON
ihlr-16572	590	3	is	be	AUX
ihlr-16572	590	4	encouraging	encouraging	ADJ
ihlr-16572	590	5	that	that	SCONJ
ihlr-16572	590	6	the	the	DET
ihlr-16572	590	7	obama	obama	PROPN
ihlr-16572	590	8	administration	administration	NOUN
ihlr-16572	590	9	plans	plan	VERB
ihlr-16572	590	10	on	on	ADP
ihlr-16572	590	11	addressing	address	VERB
ihlr-16572	590	12	the	the	DET
ihlr-16572	590	13	problem	problem	NOUN
ihlr-16572	590	14	posed	pose	VERB
ihlr-16572	590	15	by	by	ADP
ihlr-16572	590	16	the	the	DET
ihlr-16572	590	17	high	high	ADJ
ihlr-16572	590	18	cost	cost	NOUN
ihlr-16572	590	19	of	of	ADP
ihlr-16572	590	20	biologics	biologic	NOUN
ihlr-16572	590	21	,	,	PUNCT
ihlr-16572	590	22	but	but	CCONJ
ihlr-16572	590	23	the	the	DET
ihlr-16572	590	24	contentious	contentious	ADJ
ihlr-16572	590	25	debate	debate	NOUN
ihlr-16572	590	26	over	over	ADP
ihlr-16572	590	27	what	what	DET
ihlr-16572	590	28	type	type	NOUN
ihlr-16572	590	29	of	of	ADP
ihlr-16572	590	30	legislation	legislation	NOUN
ihlr-16572	590	31	is	be	AUX
ihlr-16572	590	32	most	most	ADV
ihlr-16572	590	33	appropriate	appropriate	ADJ
ihlr-16572	590	34	will	will	AUX
ihlr-16572	590	35	continue	continue	VERB
ihlr-16572	590	36	until	until	SCONJ
ihlr-16572	590	37	a	a	DET
ihlr-16572	590	38	re­	re­	PROPN
ihlr-16572	590	39	sponsible	sponsible	ADJ
ihlr-16572	590	40	compromise	compromise	NOUN
ihlr-16572	590	41	is	be	AUX
ihlr-16572	590	42	met	meet	VERB
ihlr-16572	590	43	.	.	PUNCT
ihlr-16572	591	1	the	the	DET
ihlr-16572	591	2	administration	administration	NOUN
ihlr-16572	591	3	's	's	PART
ihlr-16572	591	4	plan	plan	NOUN
ihlr-16572	591	5	to	to	PART
ihlr-16572	591	6	allow	allow	VERB
ihlr-16572	591	7	for	for	ADP
ihlr-16572	591	8	ex­	ex­	NOUN
ihlr-16572	591	9	clusivity	clusivity	NOUN
ihlr-16572	591	10	of	of	ADP
ihlr-16572	591	11	biologics	biologic	NOUN
ihlr-16572	591	12	"	"	PUNCT
ihlr-16572	591	13	generally	generally	ADV
ihlr-16572	591	14	consistent	consistent	ADJ
ihlr-16572	591	15	with	with	ADP
ihlr-16572	591	16	the	the	DET
ihlr-16572	591	17	...	...	PUNCT
ihlr-16572	591	18	hatch	hatch	NOUN
ihlr-16572	591	19	-	-	PUNCT
ihlr-16572	591	20	waxman	waxman	NOUN
ihlr-16572	591	21	[	[	NOUN
ihlr-16572	591	22	act]"179	act]"179	PROPN
ihlr-16572	591	23	may	may	AUX
ihlr-16572	591	24	be	be	AUX
ihlr-16572	591	25	too	too	ADV
ihlr-16572	591	26	ambitious	ambitious	ADJ
ihlr-16572	591	27	when	when	SCONJ
ihlr-16572	591	28	considering	consider	VERB
ihlr-16572	591	29	the	the	DET
ihlr-16572	591	30	arguably	arguably	ADV
ihlr-16572	591	31	compelling	compelling	ADJ
ihlr-16572	591	32	points	point	NOUN
ihlr-16572	591	33	of	of	ADP
ihlr-16572	591	34	biologics	biologic	NOUN
ihlr-16572	591	35	manufacturers	manufacturer	NOUN
ihlr-16572	591	36	that	that	SCONJ
ihlr-16572	591	37	the	the	DET
ihlr-16572	591	38	greater	great	ADJ
ihlr-16572	591	39	complexity	complexity	NOUN
ihlr-16572	591	40	of	of	ADP
ihlr-16572	591	41	biologics	biologic	NOUN
ihlr-16572	591	42	,	,	PUNCT
ihlr-16572	591	43	and	and	CCONJ
ihlr-16572	591	44	the	the	DET
ihlr-16572	591	45	more	more	ADV
ihlr-16572	591	46	substantial	substantial	ADJ
ihlr-16572	591	47	investment	investment	NOUN
ihlr-16572	591	48	necessary	necessary	ADJ
ihlr-16572	591	49	to	to	PART
ihlr-16572	591	50	bring	bring	VERB
ihlr-16572	591	51	such	such	ADJ
ihlr-16572	591	52	drugs	drug	NOUN
ihlr-16572	591	53	to	to	ADP
ihlr-16572	591	54	market	market	NOUN
ihlr-16572	591	55	necessitates	necessitate	VERB
ihlr-16572	591	56	a	a	DET
ihlr-16572	591	57	longer	long	ADJ
ihlr-16572	591	58	period	period	NOUN
ihlr-16572	591	59	of	of	ADP
ihlr-16572	591	60	exclusivity	exclusivity	NOUN
ihlr-16572	591	61	.	.	PUNCT
ihlr-16572	592	1	if	if	SCONJ
ihlr-16572	592	2	responsible	responsible	ADJ
ihlr-16572	592	3	biologics	biologic	NOUN
ihlr-16572	592	4	legisla­	legisla­	PROPN
ihlr-16572	592	5	tion	tion	NOUN
ihlr-16572	592	6	is	be	AUX
ihlr-16572	592	7	given	give	VERB
ihlr-16572	592	8	appropriate	appropriate	ADJ
ihlr-16572	592	9	attention	attention	NOUN
ihlr-16572	592	10	in	in	ADP
ihlr-16572	592	11	congress	congress	PROPN
ihlr-16572	592	12	,	,	PUNCT
ihlr-16572	592	13	then	then	ADV
ihlr-16572	592	14	a	a	DET
ihlr-16572	592	15	healthy	healthy	ADJ
ihlr-16572	592	16	compromise	compromise	NOUN
ihlr-16572	592	17	is	be	AUX
ihlr-16572	592	18	realistic	realistic	ADJ
ihlr-16572	592	19	.	.	PUNCT
ihlr-16572	593	1	using	use	VERB
ihlr-16572	593	2	the	the	DET
ihlr-16572	593	3	hatch	hatch	NOUN
ihlr-16572	593	4	-	-	PUNCT
ihlr-16572	593	5	waxman	waxman	NOUN
ihlr-16572	593	6	model	model	NOUN
ihlr-16572	593	7	as	as	ADP
ihlr-16572	593	8	a	a	DET
ihlr-16572	593	9	template	template	NOUN
ihlr-16572	593	10	,	,	PUNCT
ihlr-16572	593	11	appropriate	appropriate	ADJ
ihlr-16572	593	12	concessions	concession	NOUN
ihlr-16572	593	13	should	should	AUX
ihlr-16572	593	14	be	be	AUX
ihlr-16572	593	15	made	make	VERB
ihlr-16572	593	16	to	to	PART
ihlr-16572	593	17	account	account	VERB
ihlr-16572	593	18	for	for	ADP
ihlr-16572	593	19	the	the	DET
ihlr-16572	593	20	increased	increase	VERB
ihlr-16572	593	21	complexity	complexity	NOUN
ihlr-16572	593	22	and	and	CCONJ
ihlr-16572	594	1	173	173	NUM
ihlr-16572	594	2	.	.	PUNCT
ihlr-16572	594	3	office	office	NOUN
ihlr-16572	594	4	of	of	ADP
ihlr-16572	594	5	mgmt	mgmt	PROPN
ihlr-16572	594	6	.	.	PUNCT
ihlr-16572	595	1	and	and	CCONJ
ihlr-16572	595	2	budget	budget	NOUN
ihlr-16572	595	3	,	,	PUNCT
ihlr-16572	595	4	executive	executive	ADJ
ihlr-16572	595	5	office	office	NOUN
ihlr-16572	595	6	of	of	ADP
ihlr-16572	595	7	the	the	DET
ihlr-16572	595	8	president	president	NOUN
ihlr-16572	595	9	,	,	PUNCT
ihlr-16572	595	10	a	a	DET
ihlr-16572	595	11	new	new	ADJ
ihlr-16572	595	12	era	era	NOUN
ihlr-16572	595	13	of	of	ADP
ihlr-16572	595	14	responsibility	responsibility	NOUN
ihlr-16572	595	15	:	:	PUNCT
ihlr-16572	595	16	renewing	renew	VERB
ihlr-16572	595	17	america	america	PROPN
ihlr-16572	595	18	's	's	PART
ihlr-16572	595	19	promise	promise	NOUN
ihlr-16572	595	20	28	28	NUM
ihlr-16572	595	21	(	(	PUNCT
ihlr-16572	595	22	2009	2009	NUM
ihlr-16572	595	23	)	)	PUNCT
ihlr-16572	596	1	[	[	X
ihlr-16572	596	2	hereinafter	hereinafter	NOUN
ihlr-16572	596	3	"	"	PUNCT
ihlr-16572	596	4	a	a	DET
ihlr-16572	596	5	new	new	ADJ
ihlr-16572	596	6	era	era	NOUN
ihlr-16572	596	7	"	"	PUNCT
ihlr-16572	596	8	)	)	PUNCT
ihlr-16572	596	9	.	.	PUNCT
ihlr-16572	597	1	174	174	NUM
ihlr-16572	597	2	.	.	PUNCT
ihlr-16572	598	1	i	i	PRON
ihlr-16572	598	2	d.	d.	PROPN
ihlr-16572	598	3	175	175	NUM
ihlr-16572	598	4	.	.	PUNCT
ihlr-16572	599	1	i	i	PRON
ihlr-16572	599	2	d.	d.	PROPN
ihlr-16572	599	3	176	176	NUM
ihlr-16572	599	4	.	.	PUNCT
ihlr-16572	600	1	i	i	PRON
ihlr-16572	600	2	d.	d.	PROPN
ihlr-16572	600	3	177	177	NUM
ihlr-16572	600	4	.	.	PUNCT
ihlr-16572	601	1	i	i	PRON
ihlr-16572	601	2	d.	d.	PROPN
ihlr-16572	601	3	178	178	NUM
ihlr-16572	601	4	.	.	PUNCT
ihlr-16572	602	1	a	a	DET
ihlr-16572	602	2	new	new	ADJ
ihlr-16572	602	3	era	era	NOUN
ihlr-16572	602	4	,	,	PUNCT
ihlr-16572	602	5	supra	supra	PROPN
ihlr-16572	602	6	note	note	PROPN
ihlr-16572	602	7	174	174	NUM
ihlr-16572	602	8	,	,	PUNCT
ihlr-16572	602	9	at	at	ADP
ihlr-16572	602	10	28	28	NUM
ihlr-16572	602	11	.	.	PUNCT
ihlr-16572	603	1	179	179	NUM
ihlr-16572	603	2	.	.	PUNCT
ihlr-16572	604	1	i	i	PRON
ihlr-16572	604	2	d.	d.	PROPN
ihlr-16572	604	3	394	394	NUM
ihlr-16572	604	4	indiana	indiana	PROPN
ihlr-16572	604	5	health	health	PROPN
ihlr-16572	604	6	law	law	NOUN
ihlr-16572	604	7	review	review	NOUN
ihlr-16572	604	8	[	[	X
ihlr-16572	604	9	vol	vol	NOUN
ihlr-16572	604	10	.	.	PUNCT
ihlr-16572	605	1	7:367	7:367	NUM
ihlr-16572	605	2	expense	expense	NOUN
ihlr-16572	605	3	involved	involve	VERB
ihlr-16572	605	4	in	in	ADP
ihlr-16572	605	5	bringing	bring	VERB
ihlr-16572	605	6	a	a	DET
ihlr-16572	605	7	biologic	biologic	NOUN
ihlr-16572	605	8	to	to	ADP
ihlr-16572	605	9	market	market	NOUN
ihlr-16572	605	10	.	.	PUNCT
ihlr-16572	606	1	d.	d.	PROPN
ihlr-16572	606	2	biogeneric	biogeneric	PROPN
ihlr-16572	606	3	legislation	legislation	PROPN
ihlr-16572	606	4	as	as	ADP
ihlr-16572	606	5	a	a	DET
ihlr-16572	606	6	catalyst	catalyst	NOUN
ihlr-16572	606	7	for	for	ADP
ihlr-16572	606	8	innovation	innovation	NOUN
ihlr-16572	606	9	.	.	PUNCT
ihlr-16572	607	1	creative	creative	ADJ
ihlr-16572	607	2	destruction	destruction	NOUN
ihlr-16572	607	3	is	be	AUX
ihlr-16572	607	4	a	a	DET
ihlr-16572	607	5	term	term	NOUN
ihlr-16572	607	6	used	use	VERB
ihlr-16572	607	7	to	to	PART
ihlr-16572	607	8	refer	refer	VERB
ihlr-16572	607	9	to	to	ADP
ihlr-16572	607	10	the	the	DET
ihlr-16572	607	11	cycle	cycle	NOUN
ihlr-16572	607	12	of	of	ADP
ihlr-16572	607	13	innovation	innovation	NOUN
ihlr-16572	607	14	which	which	PRON
ihlr-16572	607	15	is	be	AUX
ihlr-16572	607	16	made	make	VERB
ihlr-16572	607	17	possible	possible	ADJ
ihlr-16572	607	18	by	by	ADP
ihlr-16572	607	19	each	each	DET
ihlr-16572	607	20	innovation	innovation	NOUN
ihlr-16572	607	21	building	build	VERB
ihlr-16572	607	22	on	on	ADP
ihlr-16572	607	23	a	a	DET
ihlr-16572	607	24	prior	prior	ADJ
ihlr-16572	607	25	innova­	innova­	NOUN
ihlr-16572	607	26	tion.180	tion.180	PRON
ihlr-16572	607	27	economic	economic	ADJ
ihlr-16572	607	28	progress	progress	NOUN
ihlr-16572	607	29	,	,	PUNCT
ihlr-16572	607	30	in	in	ADP
ihlr-16572	607	31	capitalist	capitalist	ADJ
ihlr-16572	607	32	society	society	NOUN
ihlr-16572	607	33	,	,	PUNCT
ihlr-16572	607	34	means	mean	VERB
ihlr-16572	607	35	tur­	tur­	ADJ
ihlr-16572	607	36	moil	moil	NOUN
ihlr-16572	607	37	.	.	PUNCT
ihlr-16572	608	1	[	[	X
ihlr-16572	608	2	what	what	PRON
ihlr-16572	608	3	counts	count	VERB
ihlr-16572	608	4	is	be	AUX
ihlr-16572	608	5	]	]	PUNCT
ihlr-16572	608	6	competition	competition	NOUN
ihlr-16572	608	7	from	from	ADP
ihlr-16572	608	8	the	the	DET
ihlr-16572	608	9	new	new	ADJ
ihlr-16572	608	10	commodity	commodity	NOUN
ihlr-16572	608	11	,	,	PUNCT
ihlr-16572	608	12	the	the	DET
ihlr-16572	608	13	new	new	ADJ
ihlr-16572	608	14	technology~	technology~	PROPN
ihlr-16572	608	15	the	the	DET
ihlr-16572	608	16	new	new	ADJ
ihlr-16572	608	17	source	source	NOUN
ihlr-16572	608	18	of	of	ADP
ihlr-16572	608	19	supply	supply	NOUN
ihlr-16572	608	20	,	,	PUNCT
ihlr-16572	608	21	the	the	DET
ihlr-16572	608	22	new	new	ADJ
ihlr-16572	608	23	type	type	NOUN
ihlr-16572	608	24	of	of	ADP
ihlr-16572	608	25	organization	organization	NOUN
ihlr-16572	608	26	...	...	PUNCT
ihlr-16572	609	1	competition	competition	NOUN
ihlr-16572	609	2	which	which	PRON
ihlr-16572	609	3	...	...	PUNCT
ihlr-16572	609	4	strikes	strike	VERB
ihlr-16572	609	5	not	not	PART
ihlr-16572	609	6	at	at	ADP
ihlr-16572	609	7	the	the	DET
ihlr-16572	609	8	margins	margin	NOUN
ihlr-16572	609	9	of	of	ADP
ihlr-16572	609	10	the	the	DET
ihlr-16572	609	11	profits	profit	NOUN
ihlr-16572	609	12	and	and	CCONJ
ihlr-16572	609	13	the	the	DET
ihlr-16572	609	14	outputs	output	NOUN
ihlr-16572	609	15	of	of	ADP
ihlr-16572	609	16	the	the	DET
ihlr-16572	609	17	existin	existin	ADJ
ihlr-16572	609	18	/	/	SYM
ihlr-16572	609	19	i	i	NOUN
ihlr-16572	609	20	firms	firm	NOUN
ihlr-16572	609	21	,	,	PUNCT
ihlr-16572	609	22	but	but	CCONJ
ihlr-16572	609	23	at	at	ADP
ihlr-16572	609	24	their	their	PRON
ihlr-16572	609	25	founda­	founda­	NOUN
ihlr-16572	609	26	tions	tion	NOUN
ihlr-16572	609	27	and	and	CCONJ
ihlr-16572	609	28	their	their	PRON
ihlr-16572	609	29	very	very	ADJ
ihlr-16572	609	30	lives	life	NOUN
ihlr-16572	609	31	.	.	PUNCT
ihlr-16572	610	1	1	1	NUM
ihlr-16572	610	2	*	*	PUNCT
ihlr-16572	610	3	*	*	PUNCT
ihlr-16572	610	4	*	*	PUNCT
ihlr-16572	610	5	[	[	X
ihlr-16572	610	6	e]ach	e]ach	NOUN
ihlr-16572	610	7	innovation	innovation	NOUN
ihlr-16572	610	8	is	be	AUX
ihlr-16572	610	9	part	part	NOUN
ihlr-16572	610	10	of	of	ADP
ihlr-16572	610	11	a	a	DET
ihlr-16572	610	12	chain	chain	NOUN
ihlr-16572	610	13	.	.	PUNCT
ihlr-16572	611	1	today	today	NOUN
ihlr-16572	611	2	's	's	PART
ihlr-16572	611	3	innova­	innova­	NOUN
ihlr-16572	611	4	tion	tion	NOUN
ihlr-16572	611	5	can	can	AUX
ihlr-16572	611	6	not	not	PART
ihlr-16572	611	7	proceed	proceed	VERB
ihlr-16572	611	8	if	if	SCONJ
ihlr-16572	611	9	yesterday	yesterday	NOUN
ihlr-16572	611	10	's	's	PART
ihlr-16572	611	11	is	be	AUX
ihlr-16572	611	12	not	not	PART
ihlr-16572	611	13	accessible	accessible	ADJ
ihlr-16572	611	14	.	.	PUNCT
ihlr-16572	612	1	and	and	CCONJ
ihlr-16572	612	2	tomorrow	tomorrow	NOUN
ihlr-16572	612	3	's	's	PART
ihlr-16572	612	4	innovation	innovation	NOUN
ihlr-16572	612	5	must	must	AUX
ihlr-16572	612	6	wait	wait	VERB
ihlr-16572	612	7	until	until	SCONJ
ihlr-16572	612	8	today	today	NOUN
ihlr-16572	612	9	's	's	PART
ihlr-16572	612	10	innovation	innovation	NOUN
ihlr-16572	612	11	is	be	AUX
ihlr-16572	612	12	available	available	ADJ
ihlr-16572	612	13	for	for	ADP
ihlr-16572	612	14	use	use	NOUN
ihlr-16572	612	15	.	.	PUNCT
ihlr-16572	613	1	moreover	moreover	ADV
ihlr-16572	613	2	,	,	PUNCT
ihlr-16572	613	3	if	if	SCONJ
ihlr-16572	613	4	the	the	DET
ihlr-16572	613	5	cur­	cur­	ADJ
ihlr-16572	613	6	rent	rent	NOUN
ihlr-16572	613	7	length	length	NOUN
ihlr-16572	613	8	of	of	ADP
ihlr-16572	613	9	monopoly	monopoly	NOUN
ihlr-16572	613	10	protection	protection	NOUN
ihlr-16572	613	11	suffices	suffice	VERB
ihlr-16572	613	12	to	to	ADP
ihlr-16572	613	13	incen­	incen­	NOUN
ihlr-16572	613	14	tivize	tivize	VERB
ihlr-16572	613	15	today	today	NOUN
ihlr-16572	613	16	's	's	PART
ihlr-16572	613	17	innovation	innovation	NOUN
ihlr-16572	613	18	,	,	PUNCT
ihlr-16572	613	19	extending	extend	VERB
ihlr-16572	613	20	the	the	DET
ihlr-16572	613	21	length	length	NOUN
ihlr-16572	613	22	of	of	ADP
ihlr-16572	613	23	protection	protection	NOUN
ihlr-16572	613	24	will	will	AUX
ihlr-16572	613	25	do	do	VERB
ihlr-16572	613	26	nothing	nothing	PRON
ihlr-16572	613	27	to	to	PART
ihlr-16572	613	28	increase	increase	VERB
ihlr-16572	613	29	current	current	ADJ
ihlr-16572	613	30	innova­	innova­	NOUN
ihlr-16572	613	31	tion	tion	NOUN
ihlr-16572	613	32	with	with	ADP
ihlr-16572	613	33	the	the	DET
ihlr-16572	613	34	economy	economy	NOUN
ihlr-16572	613	35	,	,	PUNCT
ihlr-16572	613	36	over	over	ADP
ihlr-16572	613	37	time	time	NOUN
ihlr-16572	613	38	,	,	PUNCT
ihlr-16572	613	39	falling	fall	VERB
ihlr-16572	613	40	further	far	ADV
ihlr-16572	613	41	and	and	CCONJ
ihlr-16572	613	42	further	far	ADV
ihlr-16572	613	43	behind	behind	ADV
ihlr-16572	613	44	with	with	ADP
ihlr-16572	613	45	respect	respect	NOUN
ihlr-16572	613	46	to	to	ADP
ihlr-16572	613	47	the	the	DET
ihlr-16572	613	48	level	level	NOUN
ihlr-16572	613	49	of	of	ADP
ihlr-16572	613	50	technology	technology	NOUN
ihlr-16572	613	51	it	it	PRON
ihlr-16572	613	52	would	would	AUX
ihlr-16572	613	53	otherwise	otherwise	ADV
ihlr-16572	613	54	have	have	VERB
ihlr-16572	613	55	available.182	available.182	PROPN
ihlr-16572	613	56	e.	e.	PROPN
ihlr-16572	613	57	economic	economic	PROPN
ihlr-16572	613	58	/	/	SYM
ihlr-16572	613	59	welfare	welfare	NOUN
ihlr-16572	613	60	implications	implication	NOUN
ihlr-16572	613	61	cost	cost	VERB
ihlr-16572	613	62	savings	saving	NOUN
ihlr-16572	613	63	can	can	AUX
ihlr-16572	613	64	be	be	AUX
ihlr-16572	613	65	achieved	achieve	VERB
ihlr-16572	613	66	by	by	ADP
ihlr-16572	613	67	biogenerics	biogeneric	NOUN
ihlr-16572	613	68	industry	industry	NOUN
ihlr-16572	613	69	.	.	PUNCT
ihlr-16572	614	1	in	in	ADP
ihlr-16572	614	2	fact	fact	NOUN
ihlr-16572	614	3	,	,	PUNCT
ihlr-16572	614	4	"	"	PUNCT
ihlr-16572	614	5	[	[	X
ihlr-16572	614	6	r]ecent	r]ecent	NOUN
ihlr-16572	614	7	research	research	NOUN
ihlr-16572	614	8	suggests	suggest	VERB
ihlr-16572	614	9	such	such	DET
ihlr-16572	614	10	an	an	DET
ihlr-16572	614	11	industry	industry	NOUN
ihlr-16572	614	12	would	would	AUX
ihlr-16572	614	13	save	save	VERB
ihlr-16572	614	14	the	the	DET
ihlr-16572	614	15	american	american	ADJ
ihlr-16572	614	16	pub­	pub­	PROPN
ihlr-16572	614	17	lic	lic	PROPN
ihlr-16572	614	18	at	at	ADV
ihlr-16572	614	19	least	least	ADV
ihlr-16572	614	20	$	$	SYM
ihlr-16572	614	21	25	25	NUM
ihlr-16572	614	22	billion	billion	NUM
ihlr-16572	614	23	and	and	CCONJ
ihlr-16572	614	24	as	as	ADV
ihlr-16572	614	25	much	much	ADJ
ihlr-16572	614	26	as	as	ADP
ihlr-16572	614	27	$	$	SYM
ihlr-16572	614	28	108	108	NUM
ihlr-16572	614	29	billion	billion	NUM
ihlr-16572	614	30	over	over	ADP
ihlr-16572	614	31	the	the	DET
ihlr-16572	614	32	next	next	ADJ
ihlr-16572	614	33	decade	decade	NOUN
ihlr-16572	614	34	and	and	CCONJ
ihlr-16572	614	35	greater	great	ADJ
ihlr-16572	614	36	sums	sum	NOUN
ihlr-16572	614	37	thereafter	thereafter	ADV
ihlr-16572	614	38	from	from	ADP
ihlr-16572	614	39	biogenerics	biogeneric	NOUN
ihlr-16572	614	40	legislation	legislation	NOUN
ihlr-16572	614	41	that	that	PRON
ihlr-16572	614	42	properly	properly	ADV
ihlr-16572	614	43	limits	limit	VERB
ihlr-16572	614	44	the	the	DET
ihlr-16572	614	45	duration	duration	NOUN
ihlr-16572	614	46	of	of	ADP
ihlr-16572	614	47	monopoly	monopoly	NOUN
ihlr-16572	614	48	protection	protection	NOUN
ihlr-16572	614	49	.	.	PUNCT
ihlr-16572	615	1	''183	''183	PROPN
ihlr-16572	616	1	a	a	DET
ihlr-16572	616	2	recent	recent	ADJ
ihlr-16572	616	3	new	new	PROPN
ihlr-16572	616	4	york	york	PROPN
ihlr-16572	616	5	times	times	PROPN
ihlr-16572	616	6	article	article	PROPN
ihlr-16572	616	7	180	180	NUM
ihlr-16572	616	8	.	.	PUNCT
ihlr-16572	616	9	kotlikoff	kotlikoff	PROPN
ihlr-16572	616	10	,	,	PUNCT
ihlr-16572	616	11	supra	supra	PROPN
ihlr-16572	616	12	note	note	PROPN
ihlr-16572	616	13	28	28	NUM
ihlr-16572	616	14	,	,	PUNCT
ihlr-16572	616	15	at	at	ADP
ihlr-16572	616	16	14	14	NUM
ihlr-16572	616	17	(	(	PUNCT
ihlr-16572	616	18	citing	cite	VERB
ihlr-16572	616	19	joseph	joseph	PROPN
ihlr-16572	616	20	a.	a.	PROPN
ihlr-16572	616	21	schumpeter	schumpeter	PROPN
ihlr-16572	616	22	,	,	PUNCT
ihlr-16572	616	23	capitalism	capitalism	NOUN
ihlr-16572	616	24	,	,	PUNCT
ihlr-16572	616	25	socialism	socialism	NOUN
ihlr-16572	616	26	,	,	PUNCT
ihlr-16572	616	27	and	and	CCONJ
ihlr-16572	616	28	democracy	democracy	NOUN
ihlr-16572	616	29	{	{	PUNCT
ihlr-16572	616	30	harper	harper	NOUN
ihlr-16572	616	31	&	&	CCONJ
ihlr-16572	616	32	row	row	PROPN
ihlr-16572	616	33	3d	3d	PROPN
ihlr-16572	616	34	ed	ed	NOUN
ihlr-16572	616	35	.	.	PROPN
ihlr-16572	616	36	1950	1950	NUM
ihlr-16572	616	37	)	)	PUNCT
ihlr-16572	616	38	(	(	PUNCT
ihlr-16572	616	39	1942	1942	NUM
ihlr-16572	616	40	)	)	PUNCT
ihlr-16572	616	41	)	)	PUNCT
ihlr-16572	616	42	.	.	PUNCT
ihlr-16572	617	1	181	181	NUM
ihlr-16572	617	2	.	.	PUNCT
ihlr-16572	617	3	!	!	PUNCT
ihlr-16572	618	1	d.	d.	PROPN
ihlr-16572	618	2	182	182	NUM
ihlr-16572	618	3	.	.	PUNCT
ihlr-16572	619	1	kotlikoff	kotlikoff	PROPN
ihlr-16572	619	2	,	,	PUNCT
ihlr-16572	619	3	supra	supra	PROPN
ihlr-16572	619	4	note	note	PROPN
ihlr-16572	619	5	28	28	NUM
ihlr-16572	619	6	,	,	PUNCT
ihlr-16572	619	7	at	at	ADP
ihlr-16572	619	8	14	14	NUM
ihlr-16572	619	9	.	.	PUNCT
ihlr-16572	619	10	183	183	NUM
ihlr-16572	619	11	.	.	PUNCT
ihlr-16572	619	12	!	!	PUNCT
ihlr-16572	620	1	d.	d.	PROPN
ihlr-16572	620	2	at	at	ADP
ihlr-16572	620	3	12	12	NUM
ihlr-16572	620	4	-	-	SYM
ihlr-16572	620	5	13	13	NUM
ihlr-16572	620	6	(	(	PUNCT
ihlr-16572	620	7	teva	teva	PROPN
ihlr-16572	620	8	usa	usa	PROPN
ihlr-16572	620	9	government	government	PROPN
ihlr-16572	620	10	affairs	affair	NOUN
ihlr-16572	620	11	2008	2008	NUM
ihlr-16572	620	12	)	)	PUNCT
ihlr-16572	620	13	(	(	PUNCT
ihlr-16572	620	14	citing	cite	VERB
ihlr-16572	620	15	congressional	congressional	ADJ
ihlr-16572	620	16	budget	budget	NOUN
ihlr-16572	620	17	office	office	NOUN
ihlr-16572	620	18	,	,	PUNCT
ihlr-16572	620	19	cost	cost	NOUN
ihlr-16572	620	20	estimate	estimate	NOUN
ihlr-16572	620	21	:	:	PUNCT
ihlr-16572	620	22	s.	s.	PROPN
ihlr-16572	620	23	1695	1695	NUM
ihlr-16572	620	24	-	-	PUNCT
ihlr-16572	620	25	biologics	biologic	NOUN
ihlr-16572	620	26	price	price	NOUN
ihlr-16572	620	27	competition	competition	NOUN
ihlr-16572	620	28	and	and	CCONJ
ihlr-16572	620	29	innovation	innovation	NOUN
ihlr-16572	620	30	act	act	NOUN
ihlr-16572	620	31	of	of	ADP
ihlr-16572	620	32	2007	2007	NUM
ihlr-16572	620	33	(	(	PUNCT
ihlr-16572	620	34	2008	2008	NUM
ihlr-16572	620	35	)	)	PUNCT
ihlr-16572	620	36	and	and	CCONJ
ihlr-16572	620	37	robert	robert	PROPN
ihlr-16572	620	38	j.	j.	PROPN
ihlr-16572	620	39	shapiro	shapiro	PROPN
ihlr-16572	620	40	,	,	PUNCT
ihlr-16572	620	41	the	the	DET
ihlr-16572	620	42	potential	potential	ADJ
ihlr-16572	620	43	american	american	ADJ
ihlr-16572	620	44	market	market	NOUN
ihlr-16572	620	45	for	for	ADP
ihlr-16572	620	46	generic	generic	ADJ
ihlr-16572	620	47	biological	biological	ADJ
ihlr-16572	620	48	treatments	treatment	NOUN
ihlr-16572	620	49	and	and	CCONJ
ihlr-16572	620	50	the	the	DET
ihlr-16572	620	51	associated	associated	ADJ
ihlr-16572	620	52	cost	cost	NOUN
ihlr-16572	620	53	savings	saving	NOUN
ihlr-16572	620	54	(	(	PUNCT
ihlr-16572	620	55	february	february	NOUN
ihlr-16572	620	56	2008	2008	NUM
ihlr-16572	620	57	)	)	PUNCT
ihlr-16572	620	58	)	)	PUNCT
ihlr-16572	620	59	.	.	PUNCT
ihlr-16572	621	1	2010	2010	NUM
ihlr-16572	621	2	]	]	PUNCT
ihlr-16572	621	3	follow	follow	VERB
ihlr-16572	621	4	-	-	PUNCT
ihlr-16572	621	5	on	on	ADP
ihlr-16572	621	6	biologics	biologic	NOUN
ihlr-16572	621	7	legislation	legislation	NOUN
ihlr-16572	621	8	reported	report	VERB
ihlr-16572	621	9	that	that	SCONJ
ihlr-16572	621	10	[	[	AUX
ihlr-16572	621	11	h]ealth	h]ealth	NOUN
ihlr-16572	621	12	insurance	insurance	NOUN
ihlr-16572	621	13	companies	company	NOUN
ihlr-16572	621	14	are	be	AUX
ihlr-16572	621	15	rapidly	rapidly	ADV
ihlr-16572	621	16	adopting	adopt	VERB
ihlr-16572	621	17	a	a	DET
ihlr-16572	621	18	new	new	ADJ
ihlr-16572	621	19	pricing	pricing	NOUN
ihlr-16572	621	20	system	system	NOUN
ihlr-16572	621	21	for	for	ADP
ihlr-16572	621	22	very	very	ADV
ihlr-16572	621	23	expensive	expensive	ADJ
ihlr-16572	621	24	drugs	drug	NOUN
ihlr-16572	621	25	,	,	PUNCT
ihlr-16572	621	26	asking	ask	VERB
ihlr-16572	621	27	patients	patient	NOUN
ihlr-16572	621	28	to	to	PART
ihlr-16572	621	29	pay	pay	VERB
ihlr-16572	621	30	hundreds	hundred	NOUN
ihlr-16572	621	31	and	and	CCONJ
ihlr-16572	621	32	even	even	ADV
ihlr-16572	621	33	thousands	thousand	NOUN
ihlr-16572	621	34	of	of	ADP
ihlr-16572	621	35	dol­	dol­	ADJ
ihlr-16572	621	36	lars	lar	NOUN
ihlr-16572	621	37	for	for	ADP
ihlr-16572	621	38	prescriptions	prescription	NOUN
ihlr-16572	621	39	[	[	X
ihlr-16572	621	40	and	and	CCONJ
ihlr-16572	621	41	]	]	X
ihlr-16572	621	42	medications	medication	NOUN
ihlr-16572	621	43	that	that	PRON
ihlr-16572	621	44	may	may	AUX
ihlr-16572	621	45	save	save	VERB
ihlr-16572	621	46	their	their	PRON
ihlr-16572	621	47	lives	life	NOUN
ihlr-16572	621	48	or	or	CCONJ
ihlr-16572	621	49	slow	slow	VERB
ihlr-16572	621	50	the	the	DET
ihlr-16572	621	51	progress	progress	NOUN
ihlr-16572	621	52	of	of	ADP
ihlr-16572	621	53	serious	serious	ADJ
ihlr-16572	621	54	diseas­	diseas­	NOUN
ihlr-16572	621	55	es	es	X
ihlr-16572	621	56	...	...	PUNCT
ihlr-16572	622	1	[	[	X
ihlr-16572	622	2	t]he	t]he	ADJ
ihlr-16572	622	3	system	system	NOUN
ihlr-16572	622	4	means	mean	VERB
ihlr-16572	622	5	that	that	SCONJ
ihlr-16572	622	6	the	the	DET
ihlr-16572	622	7	burden	burden	NOUN
ihlr-16572	622	8	of	of	ADP
ihlr-16572	622	9	ex	ex	ADJ
ihlr-16572	622	10	~	~	NOUN
ihlr-16572	622	11	ensive	ensive	ADJ
ihlr-16572	622	12	health	health	NOUN
ihlr-16572	622	13	care	care	NOUN
ihlr-16572	622	14	can	can	AUX
ihlr-16572	622	15	now	now	ADV
ihlr-16572	622	16	affect	affect	VERB
ihlr-16572	622	17	insured	insured	ADJ
ihlr-16572	622	18	people	people	NOUN
ihlr-16572	622	19	,	,	PUNCT
ihlr-16572	622	20	too	too	ADV
ihlr-16572	622	21	.	.	PUNCT
ihlr-16572	623	1	84	84	NUM
ihlr-16572	624	1	395	395	NUM
ihlr-16572	624	2	f.	f.	NOUN
ihlr-16572	624	3	exclusivity	exclusivity	NOUN
ihlr-16572	624	4	provisions	provision	NOUN
ihlr-16572	624	5	should	should	AUX
ihlr-16572	624	6	allow	allow	VERB
ihlr-16572	624	7	for	for	ADP
ihlr-16572	624	8	abbreviated	abbreviate	VERB
ihlr-16572	624	9	periods	period	NOUN
ihlr-16572	624	10	of	of	ADP
ihlr-16572	624	11	monopoly	monopoly	NOUN
ihlr-16572	624	12	protection	protection	NOUN
ihlr-16572	624	13	.	.	PUNCT
ihlr-16572	625	1	competition	competition	NOUN
ihlr-16572	625	2	,	,	PUNCT
ihlr-16572	625	3	not	not	PART
ihlr-16572	625	4	protection	protection	NOUN
ihlr-16572	625	5	,	,	PUNCT
ihlr-16572	625	6	is	be	AUX
ihlr-16572	625	7	the	the	DET
ihlr-16572	625	8	best	good	ADJ
ihlr-16572	625	9	tool	tool	NOUN
ihlr-16572	625	10	to	to	PART
ihlr-16572	625	11	drive	drive	VERB
ihlr-16572	625	12	innovation.185	innovation.185	PROPN
ihlr-16572	625	13	as	as	SCONJ
ihlr-16572	625	14	dr	dr	PROPN
ihlr-16572	625	15	.	.	PROPN
ihlr-16572	625	16	kotlikoff	kotlikoff	PROPN
ihlr-16572	625	17	asserted	assert	VERB
ihlr-16572	625	18	in	in	ADP
ihlr-16572	625	19	his	his	PRON
ihlr-16572	625	20	assessment	assessment	NOUN
ihlr-16572	625	21	of	of	ADP
ihlr-16572	625	22	how	how	SCONJ
ihlr-16572	625	23	to	to	PART
ihlr-16572	625	24	best	well	ADV
ihlr-16572	625	25	promote	promote	VERB
ihlr-16572	625	26	biologics	biologic	NOUN
ihlr-16572	625	27	innovation	innovation	NOUN
ihlr-16572	625	28	,	,	PUNCT
ihlr-16572	625	29	''	''	PUNCT
ihlr-16572	625	30	the	the	DET
ihlr-16572	625	31	new	new	ADJ
ihlr-16572	625	32	drugs	drug	NOUN
ihlr-16572	625	33	of	of	ADP
ihlr-16572	625	34	today	today	NOUN
ihlr-16572	625	35	are	be	AUX
ihlr-16572	625	36	not	not	PART
ihlr-16572	625	37	those	those	PRON
ihlr-16572	625	38	of	of	ADP
ihlr-16572	625	39	tomorrow	tomorrow	NOUN
ihlr-16572	625	40	...	...	PUNCT
ihlr-16572	626	1	inventors	inventor	NOUN
ihlr-16572	626	2	have	have	VERB
ihlr-16572	626	3	strong	strong	ADJ
ihlr-16572	626	4	incentives	incentive	NOUN
ihlr-16572	626	5	to	to	PART
ihlr-16572	626	6	protect	protect	VERB
ihlr-16572	626	7	their	their	PRON
ihlr-16572	626	8	discoveries	discovery	NOUN
ihlr-16572	626	9	,	,	PUNCT
ihlr-16572	626	10	not	not	PART
ihlr-16572	626	11	to	to	PART
ihlr-16572	626	12	make	make	VERB
ihlr-16572	626	13	new	new	ADJ
ihlr-16572	626	14	ones	one	NOUN
ihlr-16572	626	15	whose	whose	DET
ihlr-16572	626	16	arrival	arrival	NOUN
ihlr-16572	626	17	on	on	ADP
ihlr-16572	626	18	the	the	DET
ihlr-16572	626	19	market	market	NOUN
ihlr-16572	626	20	would	would	AUX
ihlr-16572	626	21	undermine	undermine	VERB
ihlr-16572	626	22	their	their	PRON
ihlr-16572	626	23	existing	exist	VERB
ihlr-16572	626	24	profits	profit	NOUN
ihlr-16572	626	25	.	.	PUNCT
ihlr-16572	626	26	"	"	PUNCT
ihlr-16572	627	1	186	186	NUM
ihlr-16572	627	2	while	while	SCONJ
ihlr-16572	627	3	longer	long	ADJ
ihlr-16572	627	4	periods	period	NOUN
ihlr-16572	627	5	of	of	ADP
ihlr-16572	627	6	monopoly	monopoly	NOUN
ihlr-16572	627	7	will	will	AUX
ihlr-16572	627	8	allow	allow	VERB
ihlr-16572	627	9	innovators	innovator	NOUN
ihlr-16572	627	10	to	to	PART
ihlr-16572	627	11	turn	turn	VERB
ihlr-16572	627	12	a	a	DET
ihlr-16572	627	13	greater	great	ADJ
ihlr-16572	627	14	profit	profit	NOUN
ihlr-16572	627	15	per	per	ADP
ihlr-16572	627	16	innovation	innovation	NOUN
ihlr-16572	627	17	,	,	PUNCT
ihlr-16572	627	18	this	this	DET
ihlr-16572	627	19	longevity	longevity	NOUN
ihlr-16572	627	20	of	of	ADP
ihlr-16572	627	21	~rofitability	~rofitability	NUM
ihlr-16572	627	22	of	of	ADP
ihlr-16572	627	23	one	one	NUM
ihlr-16572	627	24	discovery	discovery	NOUN
ihlr-16572	627	25	may	may	AUX
ihlr-16572	627	26	actually	actually	ADV
ihlr-16572	627	27	delay	delay	VERB
ihlr-16572	627	28	subsequent	subsequent	ADJ
ihlr-16572	627	29	discoveries.1	discoveries.1	PROPN
ihlr-16572	627	30	the	the	DET
ihlr-16572	627	31	delay	delay	NOUN
ihlr-16572	627	32	of	of	ADP
ihlr-16572	627	33	discoveries	discovery	NOUN
ihlr-16572	627	34	,	,	PUNCT
ihlr-16572	627	35	or	or	CCONJ
ihlr-16572	627	36	at	at	ADP
ihlr-16572	627	37	least	least	ADJ
ihlr-16572	627	38	the	the	DET
ihlr-16572	627	39	revelation	revelation	NOUN
ihlr-16572	627	40	of	of	ADP
ihlr-16572	627	41	these	these	DET
ihlr-16572	627	42	discoveries	discovery	NOUN
ihlr-16572	627	43	,	,	PUNCT
ihlr-16572	627	44	results	result	NOUN
ihlr-16572	627	45	in	in	ADP
ihlr-16572	627	46	less	less	ADJ
ihlr-16572	627	47	total	total	ADJ
ihlr-16572	627	48	life	life	NOUN
ihlr-16572	627	49	-	-	PUNCT
ihlr-16572	627	50	saving	save	VERB
ihlr-16572	627	51	dis­	dis­	ADJ
ihlr-16572	627	52	coveries	coverie	NOUN
ihlr-16572	627	53	over	over	ADP
ihlr-16572	627	54	time.188	time.188	PROPN
ihlr-16572	627	55	effective	effective	ADJ
ihlr-16572	627	56	legislation	legislation	NOUN
ihlr-16572	627	57	will	will	AUX
ihlr-16572	627	58	seek	seek	VERB
ihlr-16572	627	59	to	to	PART
ihlr-16572	627	60	minimize	minimize	VERB
ihlr-16572	627	61	evergreening	evergreening	NOUN
ihlr-16572	627	62	,	,	PUNCT
ihlr-16572	627	63	particularly	particularly	ADV
ihlr-16572	627	64	provisions	provision	NOUN
ihlr-16572	627	65	which	which	PRON
ihlr-16572	627	66	allow	allow	VERB
ihlr-16572	627	67	innovators	innovator	NOUN
ihlr-16572	627	68	to	to	PART
ihlr-16572	627	69	make	make	VERB
ihlr-16572	627	70	objectively	objectively	ADV
ihlr-16572	627	71	arbitrary	arbitrary	ADJ
ihlr-16572	627	72	modifica­	modifica­	PROPN
ihlr-16572	627	73	tions	tion	NOUN
ihlr-16572	627	74	to	to	ADP
ihlr-16572	627	75	drugs	drug	NOUN
ihlr-16572	627	76	in	in	ADP
ihlr-16572	627	77	order	order	NOUN
ihlr-16572	627	78	to	to	PART
ihlr-16572	627	79	maintain	maintain	VERB
ihlr-16572	627	80	their	their	PRON
ihlr-16572	627	81	monopoly	monopoly	NOUN
ihlr-16572	627	82	.	.	PUNCT
ihlr-16572	628	1	if	if	SCONJ
ihlr-16572	628	2	it	it	PRON
ihlr-16572	628	3	takes	take	VERB
ihlr-16572	628	4	considerably	considerably	ADV
ihlr-16572	628	5	longer	long	ADJ
ihlr-16572	628	6	to	to	PART
ihlr-16572	628	7	obtain	obtain	VERB
ihlr-16572	628	8	fda	fda	PROPN
ihlr-16572	628	9	approval	approval	NOUN
ihlr-16572	628	10	of	of	ADP
ihlr-16572	628	11	generic	generic	ADJ
ihlr-16572	628	12	biologics	biologic	NOUN
ihlr-16572	628	13	than	than	ADP
ihlr-16572	628	14	obtaining	obtain	VERB
ihlr-16572	628	15	fda	fda	PROPN
ihlr-16572	628	16	approval	approval	NOUN
ihlr-16572	628	17	of	of	ADP
ihlr-16572	628	18	chemical	chemical	ADJ
ihlr-16572	628	19	drugs	drug	NOUN
ihlr-16572	628	20	,	,	PUNCT
ihlr-16572	628	21	brand	brand	NOUN
ihlr-16572	628	22	name	name	NOUN
ihlr-16572	628	23	companies	company	NOUN
ihlr-16572	628	24	will	will	AUX
ihlr-16572	628	25	already	already	ADV
ihlr-16572	628	26	be	be	AUX
ihlr-16572	628	27	pro­	pro­	NOUN
ihlr-16572	628	28	vided	vide	VERB
ihlr-16572	628	29	with	with	ADP
ihlr-16572	628	30	effective	effective	ADJ
ihlr-16572	628	31	exclusivity	exclusivity	NOUN
ihlr-16572	628	32	,	,	PUNCT
ihlr-16572	628	33	even	even	ADV
ihlr-16572	628	34	if	if	SCONJ
ihlr-16572	628	35	this	this	DET
ihlr-16572	628	36	exclusivity	exclusivity	NOUN
ihlr-16572	628	37	is	be	AUX
ihlr-16572	628	38	not	not	PART
ihlr-16572	628	39	provided	provide	VERB
ihlr-16572	628	40	by	by	ADP
ihlr-16572	628	41	statute	statute	NOUN
ihlr-16572	628	42	.	.	PROPN
ihlr-16572	629	1	189	189	NUM
ihlr-16572	629	2	the	the	DET
ihlr-16572	629	3	obama	obama	PROPN
ihlr-16572	629	4	administration	administration	NOUN
ihlr-16572	629	5	will	will	AUX
ihlr-16572	629	6	likely	likely	ADV
ihlr-16572	629	7	serve	serve	VERB
ihlr-16572	629	8	as	as	ADP
ihlr-16572	629	9	a	a	DET
ihlr-16572	629	10	catalyst	catalyst	NOUN
ihlr-16572	629	11	for	for	ADP
ihlr-16572	629	12	enact­	enact­	NOUN
ihlr-16572	629	13	ment	ment	NOUN
ihlr-16572	629	14	of	of	ADP
ihlr-16572	629	15	this	this	PRON
ihlr-16572	629	16	legislation.190	legislation.190	VERB
ihlr-16572	629	17	even	even	ADV
ihlr-16572	629	18	though	though	SCONJ
ihlr-16572	629	19	pressure	pressure	NOUN
ihlr-16572	629	20	continues	continue	VERB
ihlr-16572	629	21	to	to	PART
ihlr-16572	629	22	mount	mount	VERB
ihlr-16572	629	23	to	to	PART
ihlr-16572	629	24	pass	pass	VERB
ihlr-16572	629	25	biogenetic	biogenetic	ADJ
ihlr-16572	629	26	legislation	legislation	NOUN
ihlr-16572	629	27	,	,	PUNCT
ihlr-16572	629	28	it	it	PRON
ihlr-16572	629	29	appears	appear	VERB
ihlr-16572	629	30	likely	likely	ADJ
ihlr-16572	629	31	that	that	SCONJ
ihlr-16572	629	32	the	the	DET
ihlr-16572	629	33	public	public	NOUN
ihlr-16572	629	34	will	will	AUX
ihlr-16572	629	35	have	have	VERB
ihlr-16572	629	36	to	to	PART
ihlr-16572	629	37	wait	wait	VERB
ihlr-16572	629	38	until	until	SCONJ
ihlr-16572	629	39	the	the	DET
ihlr-16572	629	40	next	next	ADJ
ihlr-16572	629	41	administration	administration	NOUN
ihlr-16572	629	42	is	be	AUX
ihlr-16572	629	43	in	in	ADP
ihlr-16572	629	44	office	office	NOUN
ihlr-16572	629	45	.	.	PUNCT
ihlr-16572	630	1	the	the	DET
ihlr-16572	630	2	thirty	thirty	NUM
ihlr-16572	630	3	percent	percent	NOUN
ihlr-16572	630	4	savings	saving	NOUN
ihlr-16572	630	5	that	that	PRON
ihlr-16572	630	6	would	would	AUX
ihlr-16572	630	7	be	be	AUX
ihlr-16572	630	8	gained	gain	VERB
ihlr-16572	630	9	has	have	VERB
ihlr-16572	630	10	significant	significant	ADJ
ihlr-16572	630	11	implications	implication	NOUN
ihlr-16572	630	12	for	for	ADP
ihlr-16572	630	13	insurance	insurance	NOUN
ihlr-16572	630	14	companies	company	NOUN
ihlr-16572	630	15	and	and	CCONJ
ihlr-16572	630	16	184	184	NUM
ihlr-16572	630	17	.	.	PUNCT
ihlr-16572	631	1	kolata	kolata	PROPN
ihlr-16572	631	2	,	,	PUNCT
ihlr-16572	631	3	supra	supra	PROPN
ihlr-16572	631	4	note	note	NOUN
ihlr-16572	631	5	42	42	NUM
ihlr-16572	631	6	(	(	PUNCT
ihlr-16572	631	7	emphasis	emphasis	NOUN
ihlr-16572	631	8	added	add	VERB
ihlr-16572	631	9	)	)	PUNCT
ihlr-16572	631	10	.	.	PUNCT
ihlr-16572	632	1	185	185	NUM
ihlr-16572	632	2	.	.	PUNCT
ihlr-16572	632	3	kotlikoff	kotlikoff	NOUN
ihlr-16572	632	4	,	,	PUNCT
ihlr-16572	632	5	supra	supra	PROPN
ihlr-16572	632	6	note	note	PROPN
ihlr-16572	632	7	28	28	NUM
ihlr-16572	632	8	,	,	PUNCT
ihlr-16572	632	9	at	at	ADP
ihlr-16572	632	10	15	15	NUM
ihlr-16572	632	11	.	.	PUNCT
ihlr-16572	632	12	186	186	NUM
ihlr-16572	632	13	.	.	PUNCT
ihlr-16572	633	1	i	i	PRON
ihlr-16572	633	2	d	d	PROPN
ihlr-16572	633	3	at	at	ADP
ihlr-16572	633	4	16	16	NUM
ihlr-16572	633	5	.	.	PUNCT
ihlr-16572	634	1	187	187	NUM
ihlr-16572	634	2	.	.	PUNCT
ihlr-16572	635	1	i	i	PRON
ihlr-16572	635	2	d	d	PROPN
ihlr-16572	635	3	188	188	NUM
ihlr-16572	635	4	.	.	PUNCT
ihlr-16572	636	1	grabowski	grabowski	PROPN
ihlr-16572	636	2	and	and	CCONJ
ihlr-16572	636	3	vernon	vernon	PROPN
ihlr-16572	636	4	,	,	PUNCT
ihlr-16572	636	5	supra	supra	PROPN
ihlr-16572	636	6	note	note	PROPN
ihlr-16572	636	7	111	111	NUM
ihlr-16572	636	8	,	,	PUNCT
ihlr-16572	636	9	at	at	ADP
ihlr-16572	636	10	116	116	NUM
ihlr-16572	636	11	.	.	PUNCT
ihlr-16572	636	12	189	189	NUM
ihlr-16572	636	13	.	.	PUNCT
ihlr-16572	637	1	ld	ld	PROPN
ihlr-16572	637	2	.	.	PUNCT
ihlr-16572	638	1	at	at	ADP
ihlr-16572	638	2	104	104	NUM
ihlr-16572	638	3	.	.	PUNCT
ihlr-16572	639	1	190	190	NUM
ihlr-16572	639	2	.	.	PUNCT
ihlr-16572	640	1	see	see	VERB
ihlr-16572	640	2	julie	julie	PROPN
ihlr-16572	640	3	a.	a.	NOUN
ihlr-16572	640	4	birkofer	birkofer	PROPN
ihlr-16572	640	5	,	,	PUNCT
ihlr-16572	640	6	barack	barack	PROPN
ihlr-16572	640	7	obama	obama	PROPN
ihlr-16572	640	8	's	's	PART
ihlr-16572	640	9	presidential	presidential	ADJ
ihlr-16572	640	10	win	win	NOUN
ihlr-16572	640	11	l)enotes	l)enotes	PUNCT
ihlr-16572	640	12	big	big	ADJ
ihlr-16572	640	13	change	change	NOUN
ihlr-16572	640	14	for	for	ADP
ihlr-16572	640	15	the	the	DET
ihlr-16572	640	16	u.s	u.s	PROPN
ihlr-16572	640	17	.	.	PROPN
ihlr-16572	640	18	,	,	PUNCT
ihlr-16572	640	19	2008	2008	NUM
ihlr-16572	640	20	the	the	DET
ihlr-16572	640	21	source	source	NOUN
ihlr-16572	640	22	16	16	NUM
ihlr-16572	640	23	,	,	PUNCT
ihlr-16572	640	24	16	16	NUM
ihlr-16572	640	25	-	-	SYM
ihlr-16572	640	26	18	18	NUM
ihlr-16572	640	27	,	,	PUNCT
ihlr-16572	640	28	available	available	ADJ
ihlr-16572	640	29	at	at	ADP
ihlr-16572	640	30	http://www.pptaglobal.org/userfilesl	http://www.pptaglobal.org/userfilesl	NOUN
ihlr-16572	640	31	file	file	NOUN
ihlr-16572	640	32	/	/	SYM
ihlr-16572	640	33	source%20magazine	source%20magazine	NOUN
ihlr-16572	640	34	/	/	SYM
ihlr-16572	640	35	obama	obama	NOUN
ihlr-16572	640	36	_	_	PRON
ihlr-16572	640	37	wintet'.42008.pdf(last	wintet'.42008.pdf(last	PROPN
ihlr-16572	640	38	visited	visit	VERB
ihlr-16572	640	39	mar	mar	PROPN
ihlr-16572	640	40	.	.	PROPN
ihlr-16572	640	41	10	10	NUM
ihlr-16572	640	42	,	,	PUNCT
ihlr-16572	640	43	2010	2010	NUM
ihlr-16572	640	44	)	)	PUNCT
ihlr-16572	640	45	.	.	PUNCT
ihlr-16572	641	1	396	396	NUM
ihlr-16572	641	2	indiana	indiana	PROPN
ihlr-16572	641	3	health	health	PROPN
ihlr-16572	641	4	law	law	PROPN
ihlr-16572	641	5	review	review	NOUN
ihlr-16572	641	6	[	[	X
ihlr-16572	641	7	vol	vol	NOUN
ihlr-16572	641	8	.	.	PUNCT
ihlr-16572	642	1	7:367	7:367	NUM
ihlr-16572	642	2	medicare.191	medicare.191	NOUN
ihlr-16572	642	3	any	any	DET
ihlr-16572	642	4	issue	issue	NOUN
ihlr-16572	642	5	affecting	affect	VERB
ihlr-16572	642	6	health	health	NOUN
ihlr-16572	642	7	insurance	insurance	NOUN
ihlr-16572	642	8	and	and	CCONJ
ihlr-16572	642	9	medicare	medicare	PROPN
ihlr-16572	642	10	will	will	AUX
ihlr-16572	642	11	play	play	VERB
ihlr-16572	642	12	a	a	DET
ihlr-16572	642	13	role	role	NOUN
ihlr-16572	642	14	in	in	ADP
ihlr-16572	642	15	the	the	DET
ihlr-16572	642	16	inevitable	inevitable	ADJ
ihlr-16572	642	17	modification	modification	NOUN
ihlr-16572	642	18	of	of	ADP
ihlr-16572	642	19	our	our	PRON
ihlr-16572	642	20	health	health	NOUN
ihlr-16572	642	21	care	care	NOUN
ihlr-16572	642	22	system	system	NOUN
ihlr-16572	642	23	.	.	PUNCT
ihlr-16572	643	1	n.	n.	NOUN
ihlr-16572	643	2	conclusion	conclusion	NOUN
ihlr-16572	643	3	the	the	DET
ihlr-16572	643	4	brand	brand	NOUN
ihlr-16572	643	5	name	name	NOUN
ihlr-16572	643	6	pharmaceutical	pharmaceutical	NOUN
ihlr-16572	643	7	companies	company	NOUN
ihlr-16572	643	8	'	'	PART
ihlr-16572	643	9	case	case	NOUN
ihlr-16572	643	10	against	against	ADP
ihlr-16572	643	11	the	the	DET
ihlr-16572	643	12	introduc­	introduc­	PROPN
ihlr-16572	643	13	tion	tion	NOUN
ihlr-16572	643	14	of	of	ADP
ihlr-16572	643	15	biogenerics	biogeneric	NOUN
ihlr-16572	643	16	,	,	PUNCT
ihlr-16572	643	17	or	or	CCONJ
ihlr-16572	643	18	for	for	ADP
ihlr-16572	643	19	lengthy	lengthy	ADJ
ihlr-16572	643	20	exclusivity	exclusivity	NOUN
ihlr-16572	643	21	provisions	provision	NOUN
ihlr-16572	643	22	,	,	PUNCT
ihlr-16572	643	23	do	do	AUX
ihlr-16572	643	24	not	not	PART
ihlr-16572	643	25	comport	comport	VERB
ihlr-16572	643	26	with	with	ADP
ihlr-16572	643	27	the	the	DET
ihlr-16572	643	28	best	good	ADJ
ihlr-16572	643	29	interests	interest	NOUN
ihlr-16572	643	30	of	of	ADP
ihlr-16572	643	31	our	our	PRON
ihlr-16572	643	32	nation	nation	NOUN
ihlr-16572	643	33	's	's	PART
ihlr-16572	643	34	economy	economy	NOUN
ihlr-16572	643	35	and	and	CCONJ
ihlr-16572	643	36	public	public	ADJ
ihlr-16572	643	37	health	health	NOUN
ihlr-16572	643	38	.	.	PUNCT
ihlr-16572	644	1	appro­	appro­	NOUN
ihlr-16572	644	2	priate	priate	NOUN
ihlr-16572	644	3	measures	measure	NOUN
ihlr-16572	644	4	to	to	PART
ihlr-16572	644	5	protect	protect	VERB
ihlr-16572	644	6	innovators	innovator	NOUN
ihlr-16572	644	7	'	'	PART
ihlr-16572	644	8	investment	investment	NOUN
ihlr-16572	644	9	will	will	AUX
ihlr-16572	644	10	be	be	AUX
ihlr-16572	644	11	an	an	DET
ihlr-16572	644	12	essential	essential	ADJ
ihlr-16572	644	13	part	part	NOUN
ihlr-16572	644	14	of	of	ADP
ihlr-16572	644	15	any	any	DET
ihlr-16572	644	16	follow	follow	NOUN
ihlr-16572	644	17	-	-	PUNCT
ihlr-16572	644	18	on	on	ADP
ihlr-16572	644	19	biologics	biologic	NOUN
ihlr-16572	644	20	legislation	legislation	NOUN
ihlr-16572	644	21	,	,	PUNCT
ihlr-16572	644	22	but	but	CCONJ
ihlr-16572	644	23	excessive	excessive	ADJ
ihlr-16572	644	24	exclusivity	exclusivity	NOUN
ihlr-16572	644	25	will	will	AUX
ihlr-16572	644	26	stifle	stifle	VERB
ihlr-16572	644	27	in­	in­	NOUN
ihlr-16572	644	28	novation	novation	NOUN
ihlr-16572	644	29	and	and	CCONJ
ihlr-16572	644	30	harm	harm	NOUN
ihlr-16572	644	31	consumers	consumer	NOUN
ihlr-16572	644	32	unable	unable	ADJ
ihlr-16572	644	33	to	to	PART
ihlr-16572	644	34	afford	afford	VERB
ihlr-16572	644	35	costly	costly	ADJ
ihlr-16572	644	36	biologics	biologic	NOUN
ihlr-16572	644	37	.	.	PUNCT
ihlr-16572	645	1	the	the	DET
ihlr-16572	645	2	hatch­	hatch­	PROPN
ihlr-16572	645	3	waxman	waxman	PROPN
ihlr-16572	645	4	act	act	PROPN
ihlr-16572	645	5	's	's	PART
ihlr-16572	645	6	success	success	NOUN
ihlr-16572	645	7	in	in	ADP
ihlr-16572	645	8	the	the	DET
ihlr-16572	645	9	regulation	regulation	NOUN
ihlr-16572	645	10	of	of	ADP
ihlr-16572	645	11	generic	generic	ADJ
ihlr-16572	645	12	chemical	chemical	NOUN
ihlr-16572	645	13	drugs	drug	NOUN
ihlr-16572	645	14	indicates	indicate	VERB
ihlr-16572	645	15	that	that	SCONJ
ihlr-16572	645	16	similar	similar	ADJ
ihlr-16572	645	17	legislation	legislation	NOUN
ihlr-16572	645	18	should	should	AUX
ihlr-16572	645	19	be	be	AUX
ihlr-16572	645	20	applied	apply	VERB
ihlr-16572	645	21	to	to	ADP
ihlr-16572	645	22	biogenerics	biogeneric	NOUN
ihlr-16572	645	23	.	.	PUNCT
ihlr-16572	646	1	the	the	DET
ihlr-16572	646	2	hatch­	hatch­	PROPN
ihlr-16572	646	3	w	w	PROPN
ihlr-16572	646	4	axman	axman	PROPN
ihlr-16572	646	5	act	act	NOUN
ihlr-16572	646	6	should	should	AUX
ihlr-16572	646	7	be	be	AUX
ihlr-16572	646	8	used	use	VERB
ihlr-16572	646	9	as	as	ADP
ihlr-16572	646	10	a	a	DET
ihlr-16572	646	11	template	template	NOUN
ihlr-16572	646	12	to	to	PART
ihlr-16572	646	13	craft	craft	VERB
ihlr-16572	646	14	biogeneric	biogeneric	ADJ
ihlr-16572	646	15	legislation	legislation	NOUN
ihlr-16572	646	16	,	,	PUNCT
ihlr-16572	646	17	which	which	PRON
ihlr-16572	646	18	will	will	AUX
ihlr-16572	646	19	provide	provide	VERB
ihlr-16572	646	20	much	much	ADJ
ihlr-16572	646	21	needed	need	VERB
ihlr-16572	646	22	relief	relief	NOUN
ihlr-16572	646	23	to	to	ADP
ihlr-16572	646	24	those	those	PRON
ihlr-16572	646	25	in	in	ADP
ihlr-16572	646	26	need	need	NOUN
ihlr-16572	646	27	of	of	ADP
ihlr-16572	646	28	these	these	DET
ihlr-16572	646	29	expensive	expensive	ADJ
ihlr-16572	646	30	,	,	PUNCT
ihlr-16572	646	31	life	life	NOUN
ihlr-16572	646	32	-	-	PUNCT
ihlr-16572	646	33	saving	save	VERB
ihlr-16572	646	34	drugs	drug	NOUN
ihlr-16572	646	35	.	.	PUNCT
ihlr-16572	647	1	191	191	NUM
ihlr-16572	647	2	.	.	PUNCT
ihlr-16572	648	1	i	i	PRON
ihlr-16572	648	2	d	d	NOUN